Approches sémantiques pour la méta-optimisation des réseaux biomoléculaires complexes by Ayadi, Ali
HAL Id: tel-02168224
https://tel.archives-ouvertes.fr/tel-02168224
Submitted on 28 Jun 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Semantic approaches for the meta-optimization of
complex biomolecular networks
Ali Ayadi
To cite this version:
Ali Ayadi. Semantic approaches for the meta-optimization of complex biomolecular networks. Quan-
titative Methods [q-bio.QM]. Université de Strasbourg; Institut supérieur de gestion (Tunis), 2018.
English. ￿NNT : 2018STRAD035￿. ￿tel-02168224￿
ÉCOLE DOCTORALE "MATHÉMATIQUES, SCIENCES DE
L’INFORMATION ET DE L’INGÉNIEUR"
Laboratoire ICube - UMR7357
ÉCOLE DOCTORALE "SCIENCES DE GESTION"
Laboratoire LARODEC - LR01ES02
Thèse en cotutelle internationale présentée par :
Ali AYADI
soutenue le : 28 septembre 2018
pour obtenir le grade de : Docteur de l’Université de Strasbourg et l’Université de Tunis
Discipline/Spécialité : Informatique
Semantic approaches for the meta-optimization of complex
biomolecular networks
Approches sémantiques pour la méta-optimisation des réseaux
biomoléculaires complexes
THÈSE dirigée par :
Mme Cecilia ZANNI-MERK Professeur, INSA Rouen, Université de Normandie, LITIS
Mme Saoussen KRICHEN Professeur, ISG de Tunis, Université de Tunis, LARODEC
RAPPORTEURS :
Mme Claudia FRYDMAN Professeur, Université d’Aix-Marseille, LIS
Mme Lina SOUALMIA Maîtres de conférences HDR, Université de Rouen, LITIS
Autres membres du jury :
M. Edward SZCZERBICKI Professeur, University of Newcastle Australia
M. François de BERTRAND de BEUVRON Maîtres de conférences, INSA Strasbourg, ICube
M. Olivier POCH Directeur de recherches, Université de Strasbourg, ICube

Acknowledgements
First of all, I would like to express my gratitude to my PhD advisers, Cecilia ZANNI-MERK, François
de BERTRAND de BEUVRON, Saoussen KRICHEN and Julie THOMPSON who have been actively
interested in my work. I would like to thank them as well for encouraging me and for allowing me to
grow as a research scientist.
I deeply acknowledge the extraordinary and meticulous support of Cecilia ZANNI-MERK for the free
exchange of ideas, constructive criticism, guidance, encouragement and moral support throughout the
work. I am truly thankful for helping me achieve personal and professional goals.
Special thanks to François de BERTRAND de BEUVRON who graciously supported me with thesis
comments and for his critical knowledge feedback that enriched my thesis with appropriate context, as
well as for his encouragement and moral support.
I am also thankful to Saoussen KRICHEN for allowing me the opportunity to pursue a career in
research, and for her encouragements.
In addition, I am very thankful to Julie THOMPSON for providing biological data and her help in
validating the experimental results presented in this thesis.
Besides my advisers, I am very thankful to Claudia FRYDMAN and Lina SOUALMIA for accepting
to read and review my thesis manuscript.
I gratefully acknowledge Olivier POCH and Edward SZCZERBICKI for accepting to be members of
my thesis committee.
I would also like to thank my mid-thesis committee, Claudia FRYDMAN and Olivier POCH, for their
insightful comments and encouragement.
I am thankful to thank the University of Strasbourg and the University of Tunis for funding my PhD
studies. In addition, I would like to thank ICube administrative sta.
Lastly, I would like to thank my parents, my sister Zouhayra AYADI, my ancee Eya MERSNI, and
my close friends for their unfailing support and endless inspiration throughout these past three years of
my PhD studies. In particular, Abdoul-Djawadou SALAOU for his help in validating my experimental
results.
i
ii
List of publications
The work of this thesis is based on the following publications:
International peer-reviewed conferences
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen. A multi-objective method for
optimizing the transittability of complex biomolecular networks, 22th International Conference on
Knowledge-Based and Intelligent Information & Engineering Systems, Belgrade, Serbia, Procedia
Computer Science, septembre 2018.
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen. A multi-objective mathematical
model for the optimization of the transittability of complex biomolecular network, 22th International
Conference on Knowledge-Based and Intelligent Information & Engineering Systems, Belgrade,
Serbia, Procedia Computer Science, septembre 2018.
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen. Ontological reasoning for under-
standing the behaviour of complex biomolecular networks. In : Computer Systems and Applications
(AICCSA), 2017 IEEE/ACS 14th International Conference on. IEEE, 2017. p. 1486-1493.
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen. BNO: An ontology for describing
the behaviour of complex biomolecular networks, 21th International Conference on Knowledge-Based
and Intelligent Information & Engineering Systems, Marseille, France, Procedia Computer Science,
septembre 2017, doi:10.1016/j.procs.2017.08.159.
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen. CBNSimulator: a simulator tool
for understanding the behaviour of complex biomolecular networks using discrete time simulation,
21th International Conference on Knowledge-Based and Intelligent Information & Engineering Sys-
tems, Marseille, France, page 8, Procedia Computer Science, avril 2017, doi:10.1016/j.procs.2017.0
8.157.
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron. Understanding the Behaviour of Complex
Biomolecular Networks by Combining Logical and Semantic Modeling, 9th International Conference
Semantic Web Applications and Tools for Life Sciences, Amsterdam, Netherlands, page 12, Volume
1795, décembre 2016.
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron. Qualitative Reasoning for Understanding the
Behaviour of Complex Biomolecular Networks, the 8th International Joint Conference on Knowledge
Discovery, Knowledge Engineering and Knowledge Management - KEOD 2016, Porto, Portugal,
pages 144-149, Volume 2, n◦ 978-989-758-203-5, octobre 2016, doi:10.5220/0006065901440149.
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen. Logical Semantic Modeling
of Complex Biomolecular Networks, Knowledge-Based and Intelligent Information & Engineering
Systems: Proceedings of the 20th International Conference KES-2016, York, United Kingdom, pages
475 - 484, Procedia Computer Science, Volume 96, septembre 2016, doi:http://dx.doi.org/10.1016
/j.procs.2016.08.108.
• A. Ayadi, F. de Bertrand de Beuvron, C. Zanni-Merk, J. Thompson. Formalisation des réseaux
biomoléculaires complexes, EGC 2016  16èmes Journées Francophones "Extraction et Gestion
des Connaissances", Reims, France, Revue des Nouvelles Technologies de l'Information, Volume
RNTI-E-30, janvier 2016.
iii
International peer-reviewed journals
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen and Julie Thompson. A multi-
objective method for optimizing the transittability of complex biomolecular networks, IEEE Trans-
actions on Biomedical Engineering (submitted July 2018).
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen and Julie Thompson. A novel
semantic approach for understanding the dynamic behaviour of biological networks, International
Journal of Kinesiology and Sport Science (submitted June 2018).
• A. Ayadi, C. Zanni-Merk, F. de Bertrand de Beuvron, S. Krichen and Julie Thompson. BNO -
an ontology for understanding the transittability of complex biomolecular networks, Journal of Web
Semantics (submitted November 2017).
iv
Contents
Acknowledgements i
List of publications iii
List of Figures xiii
List of tables xv
General introduction 1
Biological and scientic context . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Aims and objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Contributions and elds of research concerned . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Thesis outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
I State-of-the-Art 7
1 Biological environment: from molecular biology to systems biology 9
1.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2 Biological background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2.1 Deoxyribonucleic acid (DNA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2.2 Ribonucleic acid (RNA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2.3 Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.2.4 Metabolites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.2.5 Gene expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.3 From molecular biology to systems biology . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.4 Complex biomolecular networks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.5 Transittability of complex biomolecular networks . . . . . . . . . . . . . . . . . . . . . . . 16
1.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2 Modelling in systems biology 19
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2 Major properties and dimensions of modelling . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2.1 Discrete vs Continuous vs Hybrid models . . . . . . . . . . . . . . . . . . . . . . . 20
2.2.1.1 Discrete models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2.1.2 Continuous models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2.1.3 Hybrid models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2.2 Quantitative vs Qualitative models . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.2.2.1 Quantitative models: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.2.2.2 Qualitative models: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.3 Overview of the existing mathematical models in systems biology . . . . . . . . . . . . . . 21
2.3.1 Boolean models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.3.2 Logical models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.3.3 Petri nets models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.3.4 Bayesian network models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
v
CONTENTS
2.3.5 Graphical Gaussian models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.3.6 Dierential equation models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.3.7 Cellular automata models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.3.8 Agent-based models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.4 Comparison among these modelling formalisms . . . . . . . . . . . . . . . . . . . . . . . . 24
2.5 Thesis contribution in this eld . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3 Ontologies in systems biology 27
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.2 Concept of Ontology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.3 Ontology components . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.4 Typologies of ontologies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.4.1 According to the object of generality . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.4.2 According to the level of detail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.4.3 According to the level of formality . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.5 Ontology building: methodologies, formalisms, languages and tools . . . . . . . . . . . . . 30
3.5.1 Ontology engineering methodologies . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.5.1.1 Uschold and King's method . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.5.1.2 SENSUS method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.5.1.3 METHONTOLOGY method . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.5.1.4 The Stanford's method . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.5.2 Types of formalisms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.5.3 Languages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.5.3.1 KIF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.5.3.2 KL-ONE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.5.3.3 RDF and RDF Schema . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.5.3.4 DAML-ONT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.5.3.5 DAML + OIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.5.3.6 OWL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.5.3.7 OCL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.5.4 Editing tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.6 Ontology reasoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.6.1 Semantic Web Rule Language . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.6.2 SWRL sytax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.6.3 Reasoning systems for description logic . . . . . . . . . . . . . . . . . . . . . . . . 35
3.7 Overview of existing ontology applications in systems biology . . . . . . . . . . . . . . . . 35
3.8 Comparison among these bio-ontologies . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.9 Thesis contribution in this eld . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.10 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
4 Simulation tools in systems biology 39
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
4.2 Principles of simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
4.2.1 Denition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
4.2.2 Relation between modelling and simulation concepts . . . . . . . . . . . . . . . . . 40
4.2.3 Uses of simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
4.2.4 Levels of abstraction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
4.3 Overview of existing simulation tools in systems biology . . . . . . . . . . . . . . . . . . . 41
4.3.1 Mathematical and population-based simulation . . . . . . . . . . . . . . . . . . . . 42
4.3.2 Individual-based simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.3.2.1 Cellular Automata . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.3.2.2 Multi-Agent Systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.3.2.3 Potts model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
4.3.2.4 Lattice gas automata . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
4.3.3 Computational simulation platforms . . . . . . . . . . . . . . . . . . . . . . . . . . 43
vi
CONTENTS
4.3.3.1 Simulation standard . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
4.3.3.2 Simulation tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.3.4 Discrete Event System Specication . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.3.4.1 Basic Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.3.4.2 Coupled models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.3.4.3 Benets of DEVS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.4 Comparison among these simulation tools and platforms . . . . . . . . . . . . . . . . . . . 46
4.5 Thesis contribution in this eld . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
5 Optimization tools in systems biology 51
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
5.2 Optimization problem: denition and basic concepts . . . . . . . . . . . . . . . . . . . . . 52
5.2.1 Denition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
5.2.2 The objective function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
5.2.3 The vector of decision variables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
5.2.4 Constraints and delimitation of the research space . . . . . . . . . . . . . . . . . . 53
5.2.5 The dierent types of optimum points . . . . . . . . . . . . . . . . . . . . . . . . . 53
5.2.5.1 Local maximum and minimum . . . . . . . . . . . . . . . . . . . . . . . . 54
5.2.5.2 Global maximum and minimum . . . . . . . . . . . . . . . . . . . . . . . 54
5.3 Classication of optimization problems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
5.4 Mono-objective optimization problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
5.5 Multi-objective optimization problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
5.5.1 Dominance relation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
5.5.2 Pareto-optimal solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
5.6 Optimization methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
5.6.1 The methods based on a metaheuristic approach . . . . . . . . . . . . . . . . . . . 57
5.6.1.1 Simulated annealing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
5.6.1.2 Tabu search . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
5.6.1.3 Evolutionary Algorithms . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
5.6.1.4 Ant colony . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
5.7 Optimization problems in system biology . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
5.7.1 Optimization in the design of optimal dynamic experiments . . . . . . . . . . . . . 62
5.7.2 Optimization in the parameter estimation in cell systems modelling . . . . . . . . 62
5.7.3 Optimization in biological network alignment . . . . . . . . . . . . . . . . . . . . . 63
5.7.4 Optimization of biochemical reaction networks . . . . . . . . . . . . . . . . . . . . 63
5.7.5 Optimization in the sequence alignment problem . . . . . . . . . . . . . . . . . . . 63
5.7.6 Optimization in inferring networks . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
5.7.7 Optimization in the network controllability . . . . . . . . . . . . . . . . . . . . . . 64
5.8 Comparison among these optimization tools and problems . . . . . . . . . . . . . . . . . . 64
5.9 Thesis contribution in this eld . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
5.10 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
II Contributions 67
6 Logical-based modelling of complex biomolecular networks 69
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
6.2 Motivating example: the bacteriophage T4 gene 32 . . . . . . . . . . . . . . . . . . . . . . 70
6.3 System theory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
6.3.1 Complex systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
6.3.2 System theory objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
6.3.3 System theory axes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
6.4 Logic-based approach for modelling biomolecular networks . . . . . . . . . . . . . . . . . . 73
6.4.1 Structural modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
6.4.2 Functional modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
vii
CONTENTS
6.4.3 Behavioural modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
6.4.3.1 State of the network . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
6.4.3.2 Transition of the network state . . . . . . . . . . . . . . . . . . . . . . . . 76
6.4.3.3 Steering the network to a given state . . . . . . . . . . . . . . . . . . . . 76
6.4.3.4 Behaviour . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
6.5 Application to the motivating example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
6.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
7 Semantic modelling of complex biomolecular networks 79
7.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
7.2 Semantic approach for analysing the transittability of complex biomolecular networks . . 80
7.2.1 The global architecture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
7.2.2 The Gene Ontology (GO) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
7.2.3 The Simple Event Model Ontology (SEMO) . . . . . . . . . . . . . . . . . . . . . . 82
7.2.4 The Time Ontology (TO) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
7.2.5 The Biomolecular Network Ontology (BNO) . . . . . . . . . . . . . . . . . . . . . 82
7.2.6 The relations among these ontologies . . . . . . . . . . . . . . . . . . . . . . . . . . 82
7.3 The Biomolecular Network Ontology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
7.3.1 Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
7.3.2 The key concepts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
7.3.3 The major properties and data types . . . . . . . . . . . . . . . . . . . . . . . . . . 85
7.4 Application to the motivating example: the bacteriophage T4 gene 32 . . . . . . . . . . . 86
7.4.1 Instantiation of the BNO ontology . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
7.4.2 SWRL rule-based reasoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
7.4.2.1 Inhibition SWRL rule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
7.4.2.2 Activation SWRL rule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
7.4.2.3 Transcription SWRL rule . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
7.4.2.4 Negative regulation SWRL rule . . . . . . . . . . . . . . . . . . . . . . . 91
7.4.3 Rule-based qualitative reasoner within MATLAB . . . . . . . . . . . . . . . . . . . 92
7.5 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
8 Qualitative, discrete-event simulation of complex biomolecular networks 97
8.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
8.2 Qualitative simulation model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
8.2.1 Qualitative reasoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
8.2.2 Basic concepts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
8.2.2.1 The causal graph . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
8.2.2.2 Quantitative variables & Quantity space . . . . . . . . . . . . . . . . . . 99
8.2.2.3 Operations and rules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
8.2.3 Application to the motivating example: the bacteriophage T4 gene 32 . . . . . . . 100
8.2.3.1 The variables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
8.2.3.2 The causal graph . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
8.2.3.3 The partition rules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
8.2.3.4 The propagation rules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
8.2.3.5 The simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
8.2.3.6 The behaviour . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
8.3 Discrete-event simulation model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
8.3.1 Mapping the logical based modelling with the DEVS formalism . . . . . . . . . . . 103
8.3.2 Discrete-event simulation algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . 103
8.3.3 Application to the motivating example: the bacteriophage T4 gene 32 . . . . . . . 105
8.4 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
viii
CONTENTS
9 A multi-objective optimization method for solving the transittability of complex
biomolecular networks 109
9.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
9.2 Problem statement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
9.3 Proposed multi-objective mathematical model . . . . . . . . . . . . . . . . . . . . . . . . . 111
9.3.1 Parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
9.3.2 Decision variables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
9.3.3 Objective functions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
9.3.3.1 Minimizing the distance between the simulated nal network state and
the desired network state . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
9.3.3.2 Minimizing the number of external stimuli . . . . . . . . . . . . . . . . . 113
9.3.3.3 Minimizing the cost of the external stimuli . . . . . . . . . . . . . . . . . 113
9.3.3.4 Minimizing the number of target nodes . . . . . . . . . . . . . . . . . . . 114
9.3.3.5 Minimizing the patient discomfort . . . . . . . . . . . . . . . . . . . . . . 114
9.3.4 Constraints . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
9.4 Multi-objective optimization approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
9.4.1 First step: search process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
9.4.1.1 NSGA-II algorithm overview . . . . . . . . . . . . . . . . . . . . . . . . . 117
9.4.1.2 NSGA-II algorithm operation . . . . . . . . . . . . . . . . . . . . . . . . . 118
9.4.1.3 Genetic algorithm implementation . . . . . . . . . . . . . . . . . . . . . . 118
9.4.2 Second step: decision making . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
9.4.2.1 TOPSIS method overview . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
9.4.2.2 TOPSIS method operation . . . . . . . . . . . . . . . . . . . . . . . . . . 121
9.5 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
III Experiments and discussion 123
10 Prototype: the CBNSimulator 125
10.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
10.2 Aims of the CBNSimulator platform . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
10.3 Overview of the CBNSimulator platform . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
10.4 Development tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
10.5 Experimental results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
10.5.1 Case study 1: the bacteriophage T4 gene 32 . . . . . . . . . . . . . . . . . . . . . . 128
10.5.1.1 Description . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
10.5.1.2 Logical modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
10.5.1.3 Semantic modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
10.5.1.4 Simulation under the CBNSimulator . . . . . . . . . . . . . . . . . . . . . 129
10.5.2 Case study 2: the control of the lifecycle of bacteriophage lambda . . . . . . . . . 129
10.5.2.1 Description . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
10.5.2.2 Logic-based modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
10.5.2.3 Semantic modelling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
10.5.2.4 Simulation under the CBNSimulator . . . . . . . . . . . . . . . . . . . . . 134
10.5.3 Case study 3: the p53-mediated DNA damage response network . . . . . . . . . . 137
10.5.3.1 Description . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
10.5.3.2 Simulation under the CBNSimulator . . . . . . . . . . . . . . . . . . . . . 138
10.5.3.3 Optimization of the p53-mediated DNA damage response network . . . . 141
10.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
11 Discussion and evaluation 149
11.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
11.2 Logic-based modelling discussion and evaluation . . . . . . . . . . . . . . . . . . . . . . . 150
11.3 Ontology discussion and evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
11.4 Simulation discussion and evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 156
11.5 Optimization discussion and evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
ix
CONTENTS
11.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
General conclusion and future research 161
Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
Contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Directions on future research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
Detailed abstract in French 167
Bibliography 179
x
List of Figures
1 Research laboratories and institutions in which this thesis has been conducted. . . . . . . 2
2 General architecture of our proposed platform. . . . . . . . . . . . . . . . . . . . . . . . . 3
3 The main structure of this thesis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.1 DNA and RNA structure (Image credit: Wikimedia). . . . . . . . . . . . . . . . . . . . . . 11
1.2 Protein structure (Image credit: Wikimedia). . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.3 Examples of metabolites (Image credit: the West Coast Metabolomics Center). . . . . . . 13
1.4 The central drogma of life. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.5 Types of biological networks according to molecular components using high-throughput
omics technologies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.6 Multi-level modelling of a biomolecular network from a real cell. . . . . . . . . . . . . . . 15
1.7 The transittability of the P53-mediated cell damage response network: colour changes in
the nodes indicate changes in the concentration of the associated molecules. . . . . . . . . 16
5.1 Modelling and resolution steps of an optimization problem. . . . . . . . . . . . . . . . . . 52
5.2 Example of merging: 5.2a The research space. 5.2b The achievable space. . . . . . . . . . 53
5.3 Global minimum and local minima [1]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
5.4 Diagram illustrates the process of the simulated annealing [2]. . . . . . . . . . . . . . . . . 59
5.5 Diagram illustrates the process of the tabu search [2]. . . . . . . . . . . . . . . . . . . . . 60
5.6 Diagram illustrates the process of the evolutionary algorithm [2]. . . . . . . . . . . . . . . 61
5.7 Diagram illustrates the process of the genetic algorithm [2]. . . . . . . . . . . . . . . . . . 61
6.1 The bacteriophage T4 gene 32 use case. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
6.2 The four axes of Systems theory according to Le Moigne [3]. . . . . . . . . . . . . . . . . . 73
6.3 The three axes of our proposed logical-based modelling. . . . . . . . . . . . . . . . . . . . 73
6.4 A subset of the taxonomy of the Interaction Ontology [4]. . . . . . . . . . . . . . . . . . . 75
7.1 Global architecture of our proposed semantic modelling. . . . . . . . . . . . . . . . . . . . 81
7.2 Correspondence between the logical and semantic modelling. . . . . . . . . . . . . . . . . 81
7.3 Example of merging: 7.3a The Gene ontology concepts to the Biomolecular Network on-
tology concepts. 7.3b The Time ontology within the Simple Event Model ontology. . . . . 83
7.4 The Biomolecular Network Ontology: hierarchy of concepts, hierarchy of properties and
hierarchy of data properties. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
7.5 Instantiation of the BNO ontology for the given example. . . . . . . . . . . . . . . . . . . 86
7.6 A snapshot look at the BNO node instances associated with the given example displaying
respectively: (1) the gene G32, (2) the protein p32 and (3) the metabolite m32. . . . . . . 87
7.7 A snapshot look at the BNO interaction instances associated with the given example
displaying respectively: (1) Activation, (2) Inhibition, (3) Transcription and (4) Catalysis. 87
7.8 Results of the reasoning process for the Inhibition SWRL rule. . . . . . . . . . . . . . . . 88
7.9 Results of the reasoning process for the Activation SWRL rule. . . . . . . . . . . . . . . . 89
7.10 Results of the reasoning process for the Transcription SWRL rule. . . . . . . . . . . . . . 90
7.11 Results of the reasoning process for the inverse of Transcription SWRL rule. . . . . . . . . 90
7.12 Results of the reasoning process for the Negative regulation SWRL rule. . . . . . . . . . . 91
7.13 Results of the reasoning process for the inverse of the Negative regulation SWRL rule. . . 92
7.14 Simulation results plotted with the MATLAB environment: the individual qualitative
behaviour of the biomolecular components. . . . . . . . . . . . . . . . . . . . . . . . . . . 93
xi
LIST OF FIGURES
7.15 The Biomolecular Network Ontology (BNO). . . . . . . . . . . . . . . . . . . . . . . . . . 95
8.1 Description of the EQen(m,t) partitioning algorithm. . . . . . . . . . . . . . . . . . . . . . 100
8.2 Qualitative reasoning mechanism. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
8.3 All possible simulation results of our example. . . . . . . . . . . . . . . . . . . . . . . . . . 103
8.4 Denition of the necessary elements describing the structure of the bacteriophage T4 gene
32 network. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
8.5 The simulator's graphical interface. Evolution of the component's behaviour during the
simulation period: the red curve represents the dierent values of the protein p32 during
the period of simulation and the yellow surface represents the dierent states of the gene
G32. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
9.1 A simple illustration of the transittability of complex biomolecular networks from the
number and cost of external stimuli perspective. . . . . . . . . . . . . . . . . . . . . . . . 113
9.2 Flowchart of the proposed resolution approach. . . . . . . . . . . . . . . . . . . . . . . . . 117
9.3 Flowchart of the proposed multi-objective optimization method based on the NSGA-II
algorithm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
9.4 Chromosome encoding. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
9.5 Single point crossover. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
10.1 Overall architecture of the CBNSimulator platform. . . . . . . . . . . . . . . . . . . . . . 127
10.2 The bacteriophage T4 gene 32 use case. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
10.3 The lifecycle of bacteriophage lambda. (inspired from [5]) . . . . . . . . . . . . . . . . . . 130
10.4 Functioning rules of the phage lambda. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
10.5 An excerpt of the possible states that can have the phage lambda network during the
simulation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
10.6 Semantic modelling of the phage lambda within the Protégé editor. The molecular com-
ponents: A- G_CI, B- G_CRO, C- G_OR3, D- G_OR1, E- P_CI, F- P_CRO. Some
interactions: a- i3, b- i7, c- i2, d- i6, e- i1, f- i5. . . . . . . . . . . . . . . . . . . . . . . . . 132
10.7 Results of the reasoning process for the Inhibition SWRL rule between the proteins and
their targeted genes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
10.8 Results of the reasoning process for the Inhibition SWRL rule between genes. . . . . . . . 134
10.9 Results of the reasoning process for the Transcription SWRL rule. . . . . . . . . . . . . . 135
10.10The CBNSimulator's graphical interface. Evolution of the component's behaviour during
the lysogenic cycle of the phage lambda. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
10.11The CBNSimulator's graphical interface. Evolution of the component's behaviour during
the lytic cycle of the phage lambda. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
10.12The p53-mediated DNA damage response network [6]. . . . . . . . . . . . . . . . . . . . . 137
10.13The CBNSimulator's input le. Denition of the necessary elements describing the simu-
lation parameters of the p53-mediated DNA damage response network. . . . . . . . . . . . 138
10.14The CBNSimulator's graphical interface. The p53-mediated DNA damage response net-
work at the normal state. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
10.15The CBNSimulator's graphical interface. Steering the p53-mediated DNA damage response
network from the normal state to the cell cycle arrest state (using three stimuli less than
3 Gy). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
10.16The CBNSimulator's graphical interface. Steering the p53-mediated DNA damage response
network from the normal state to the apoptosis state (using 5 stimuli greater than 4 Gy). 140
10.17The CBNSimulator's graphical interface. The transition of the p53-mediated DNA damage
response network from the cell cycle arrest state to the apoptosis state (by progressively
adding stimuli). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
10.18Trade-os between the number of external stimuli, their costs, and the number of targeted
nodes objectives for the given example. 10.18a Obtained results in the rst generation.
10.18b Obtained results in the last generation. . . . . . . . . . . . . . . . . . . . . . . . . 142
10.19The CBNSimulator's graphical interface. Steering the p53-mediated DNA damage response
network from the normal state to the cell cycle arrest state (with IR dose greater than 4
Gy). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
xii
LIST OF FIGURES
10.20The CBNSimulator's graphical interface. Steering the p53-mediated DNA damage response
network from the normal state to the cell cycle arrest state (with IR dose greater than 4
Gy). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
10.21The simulation results showing the response of the p53 system to three stimuli versus its
response to ve stimuli. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
11.1 Steps of the expert knowledge evaluation approach. . . . . . . . . . . . . . . . . . . . . . . 154
xiii
LIST OF FIGURES
xiv
List of Tables
2.1 Table of the main approaches applied to modelling biological networks. . . . . . . . . . . . 25
3.1 Description of some popular biological ontologies. . . . . . . . . . . . . . . . . . . . . . . . 37
4.1 Comparison table of the main approaches applied to simulate biological networks according
to their characteristics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
5.1 Summary of optimization approaches in systems biology. . . . . . . . . . . . . . . . . . . . 65
6.1 Levels of system complexity [7]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
6.2 Comparison between simple and complex systems. . . . . . . . . . . . . . . . . . . . . . . 72
6.3 Possible interaction types depending on the type of graph edge. . . . . . . . . . . . . . . . 75
6.4 Logical modelling of the autoregulation of the bacteriophage T4 gene 32. . . . . . . . . . . 78
7.1 Linking of Gene Ontology concepts to the Biomolecular Network ontology. . . . . . . . . . 83
7.2 A summary of concepts in the Biomolecular Network ontology. The left column presents
the ve major concepts and their immediate sub-classes. The right column presents the
description of these concepts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
7.3 A summary of the properties, including their domain, range and inverse. . . . . . . . . . . 86
8.1 Unary operations on quantity spaces presented in [8]. . . . . . . . . . . . . . . . . . . . . . 101
9.1 Nomenclature used in the proposed mathematical model. . . . . . . . . . . . . . . . . . . 111
10.1 Logical modelling of the phage lambda. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
10.2 Stimuli properties used for steering the states of the p53-mediated DNA damage response
network. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
11.1 A summary of ontology validation evaluation approaches. . . . . . . . . . . . . . . . . . . 153
11.2 An excerpt of ontological questions and their translation into Boolean questions addressed
to biologists. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
11.3 Number of questions generated according to the size of the BNO ontology. . . . . . . . . . 155
xv
LIST OF TABLES
xvi
General introduction
We oer here a general introduction of this thesis, realized at the Engineering Science, Computer Science
and Imaging (ICube) laboratory within the context of a Joint PhD program ('thèse en cotutelle') with
the Operational Research, Decision and Process Control (LARODEC) laboratory.
The research work began on 15 May 2015 and was conducted simultaneously between two teams
(Figure 1):
• In France, within the SDC (Sciences, Données et Connaissances) team in collaboration with the
CSTB (Complex Systems and Translational Bioinformatics) team of the ICube laboratory in Stras-
bourg (Laboratoire des sciences de l'Ingénieur, de l'Informatique et de l'Imagerie - UMR7357)
under the direction of professor Cecilia ZANNI-MERK and the co-supervision of François de
BERTRAND de BEUVRON and Julie THOMPSON.
The SDC team, in particular, Cecilia and François fundamentally work in designing and producing
formal models for the development of Knowledge-Based Systems. These software reproduce the
behaviour of a human expert performing an intellectual task in a specic eld. They are based on
the explicit nature of knowledge, which is formalized in dierent ways. Among these formal models,
ontologies which are generally used with a set of rules that are chained together to simulate the
reasoning of a human expert.
With respect to the CSTB team, they are working on developing validated high throughput com-
putational biology to study the behaviour of biological systems ranging from protein families to
relational systems such as "hyperstructures" (macromolecular complex, organelles, viruses) or bio-
logical networks (metabolosome, transcriptional, developmental or disease-related networks).
• In Tunisia, within the Decision Support and Game Theory team of the LARODEC laboratory
(Laboratoire de Recherche Opérationnelle, de Décision et de Contrôle de processus LR01ES02)
under the direction of professor Saoussen KRICHEN.
This team focuses on the theoretical aspects (formal models, axiomatic analyses, complex studies),
for the representation of complex problems and the production of algorithms for their exact or
approached resolution, the design of intelligent systems (knowledge-based systems, decision support
systems, etc.) and their implementation in real applications.
The interdisciplinary nature of this project is enriched by the contribution of the three teams mentioned
above. The complementarity of their skills promoted the elaboration and management of the project.
Biological and scientic context
Cells do not live in stable conditions but are subject to intra and extra-cellular stimuli from their envi-
ronments that vary over time [9]. With the recent development of high-throughput technologies, huge
amounts of data have been generated to describe the complex processes and molecular mechanisms at
work in the cell, through the study of cellular components on several levels (genes, proteins, metabolites,
etc.) [10, 11, 12]. A major challenge is how to extract important knowledge from all these data in order
to understand and infer cellular functions and behaviour in dierent conditions. Systems biology involves
a comprehensive quantitative analysis of the manner in which all the components of a biological system
interact functionally over time [13]. This integrative discipline aims to combine all information (from
dierent levels) in order to understand the processes and behaviours of all cellular components while
studying the interactions that take place among them.
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Figure 1  Research laboratories and institutions in which this thesis has been conducted.
The cell can be considered as a complex system consisting of thousands of dierent molecular entities
(genes, proteins and metabolites), which interact with each other physically, functionally and logically to
create a molecular network [6, 14]. To reduce the complexity, most traditional studies have focused only
on a particular level of the cellular system, such as gene regulatory networks, protein-protein interaction
networks, or metabolic networks. Various approaches have been developed to model, analyse and under-
stand such networks, including ordinary dierential equations [15], stochastic methods [16, 17], Boolean
networks [18], Bayesian networks [19], Petri nets [20], etc., and comparative studies of these techniques
have been performed (e.g. [21], [22], [23]). Nevertheless, few approaches have been developed to study
the cellular system as a whole, and in particular the interactions among the dierent types of molecular
networks. Furthermore, most of the existing modelling techniques do not take into account the dynamics
of the network [24, 25, 26, 27].
Recently, some authors have started to address the dynamic aspects, and have introduced concepts
such as the 'controllability' [28] of a network, where the ability to steer a complex directed network from
any initial state toward any other desired state is measured by the minimum number of required driver
nodes (nodes with the ability to steer the entire network). They showed that in order to have complete
controllability, the minimum number of driver nodes is 80% of nodes in a regulatory biomolecular network.
This result led other groups to develop a theoretic framework for studying transitions between two specic
states of directed complex networks, a concept they call the 'transittability' [6] of the network.
Our thesis belongs within this context by designing and developing a new platform to simulate the
state changes of complex molecular networks to understand and steer their behaviour over time.
Aims and objectives
As discussed in the previous section, the overall goal of this study is to propose an intelligent system that
enables biologists to simulate the state changes of biomolecular networks with the goal of steering their
behaviours.
To achieve this aim, our objectives are:
• characterise the molecular components of a cell;
• understand the dynamic interactions between molecular components and environmental stimuli;
• provide a tool for biologists to reproduce the behaviour of complex networks;
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• infer an optimal set of external stimuli to be applied during a predetermined time interval to steer
the network from its current state to the desired state.
Figure 2  General architecture of our proposed platform.
Figure 2 illustrates, the general architecture of our platform which combines four modules:
• The rst module must provide a comprehensive approach to model a complex biomolecular network
considering all its levels and their molecular components. This logical formalization must take
into account the complexity and heterogeneity of these molecular components and their multilevel
structure.
• The second module has an essential role because it ensures the management, modelling and sharing
of expert knowledge. This ontological module is based on a formal model providing a better
integration and interoperability of diverse information assets and can easily accommodate changes
without requiring to re-dene the platform's design. This module uses semantic technologies which
oer new knowledge or new relationships in order to enable machines to understand and respond to
complex human requests based on their semantic and contextual meaning [29]. This module takes
as input all the native information introduced by the expert (state of the network, its structure,
etc) through the logic-based formalization provided by the rst module. Then, the ontological
module provides output inferred network that is composed of native and inferred knowledge about
its transition states.
• The simulation module consists of a simulator of qualitative models of complex biomolecular net-
works based on a discrete, logical formalism. It also allows users to simulate and/or analyse its
qualitative dynamical behaviour. Indeed, this simulator integrates all the information given by the
expert (the enriched network with native and inferred knowledge) with other parameters in order
to better reproduce the conditions of the evaluated biomolecular network and its components over
time. The results generated during the simulation are graphically displayed to the users to facilitate
their interpretation and are then transmitted to the optimization module.
• The optimization module rstly parses the input le in order to extract the initial and desired states
of the networks, and all the possible external stimuli dened by the practitioner. Then, based on
the evaluation criteria values, this module will oer the best transition sequences for driving the
biomolecular network from the initial state to the desired state.
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Contributions and elds of research concerned
As Figure 2 illustrates, the architecture of this platform combines four module. Each module corresponds
to an independent discipline. Consequently, our contributions have been classied into four disciplines as
follows:
• Mathematical systems modelling: In this domain, we propose a logic-based modelling approach
to addresses the problem of modelling complex biomolecular networks considering the diversity
and heterogeneity of their molecular components, and adopting a global vision which considers
their multi-level aspects. This formalization focuses on the structure of the network (model the
diverse components and their interactions), network control (identify the function and role of each
component) and network dynamics (observe its behaviour over time).
• Knowledge engineering: The main goal of this work is to provide a semantic approach which pro-
vides the necessary knowledge for modelling and understanding the behaviour of complex biomolec-
ular networks and their state changes. Moreover, we develop the Biomolecular Network Ontology to
formalize the domain knowledge of complex biomolecular networks making it visible and accessible
to all biologists working on this topic.
• Computer simulation: In this eld we propose two approaches to simulate biomolecular net-
works: qualitative and quantitative. These approaches are both based on logic-based modelling
and reproduce the behaviour of complex biomolecular networks and their components over time.
• Combinatorial optimization: In this discipline, our works consist of adapting existing optimiza-
tion technologies such as the multi-objective genetic algorithm, with the goal of optimizing the
transittability of complex biomolecular networks. This approach provides the best set of external
stimuli for driving the network.
Thesis outline
As shown in Figure 3, the structure of this dissertation is organized as follows:
• The Introduction gives a general introduction for the research background, research issues, re-
search scope and contributions.
• The rst part I State-of-the-art presents the theoretical foundations of this thesis, including a
detailed literature review on all previous research done on each topic.
 Chapter 1 presents the biological environment we are working in. Our main focus lies in
complex biomolecular networks and their transittability.
 Chapter 2 provides an overview of the background information about mathematical models
in systems biology, reviews the most popular among them, and presents the main problem
addressed by our thesis in this eld: a logical modelling of complex biomolecular networks.
 Chapter 3 provides an overview of the background information about ontologies, describes
the major bio-ontologies in systems biology, and presents the main problem addressed by our
thesis: a domain ontology for describing the complex biomolecular networks domain.
 Chapter 4 provides an overview of the background information about the simulation in systems
biology, details the major simulation tools and platforms in literature, and presents the main
problem addressed by our thesis in this topic: a qualitative and discrete-event simulator for
understanding the behaviour of complex biomolecular networks.
 Chapter 5 provides an overview of the background information about optimization tools, in-
cluding a synthesis of the works conducted in systems biology optimization problems, and
presents the main problem addressed by our thesis in this eld: a genetic algorithm for solving
and optimizing the transittability of complex biomolecular networks.
• The second part II Contributions describes our theoretical contributions. It is divided into four
chapters 6, 7, 8 and 9. Each chapter present our contributions within a specic research area.
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 Chapter 6 introduces the proposed logic-based approach for describing and modelling complex
biomolecular networks following systems theory: the structural, functional and behavioural
aspects. This ecient formalism aims to represent the dynamic behaviour of biomolecular
networks. Then, we explain this proposed approach with a concrete case study clarifying how
this technique can be used in practice.
 Chapter 7 details a proposed semantic approach based on four ontologies to provide a rich
description for modelling biomolecular networks and their state changes. Moreover, we detail
our development of the Biomolecular Network Ontology (BNO) which formalizes the domain
knowledge of complex biomolecular networks and then applies the method to an application
case study. This semantic approach provides the necessary concepts for modelling the dynamic
behaviour and the transition states of complex biomolecular networks.
 Chapter 8 presents two approaches for simulating complex biomolecular networks. The rst
one consists of a method of qualitative simulation based on the formal logical modelling (pre-
sented in Chapter 6) that qualitatively simulate the biomolecular network and interpret it
behaviour over time. The second proposed approach is inspired by the Discrete Event System
Specication formalism (DEVS) to easily reproduce, analyse and understand the behaviour
of complex biomolecular networks. The proposed simulation approaches have been applied to
the same case study.
 Chapter 9 introduces a multi-objective genetic algorithm-based method for optimizing the
transittability of complex biomolecular networks considering various criteria such as the min-
imization of the distance between the simulated nal network state and the desired network
state, the minimization of the number of input signals, the minimization of the cost of these
signals, the minimization of the number of target nodes, the minimization of patient discom-
fort.
• The third part III Validation presents, details and discusses our results.
 Chapter 10 presents a prototype that we have developed to validate our proposals as well as the
experiments we have conducted to determine the performance of our prototype. We propose
a simulation tool, so-called 'CBNSimulator', based on the logical model of the biomolecular
network and taking advantage of the performance of a discrete-event simulation model for
understanding the evolution and the behaviour of complex biomolecular networks.
 Chapter 11 discusses the results of various experiments that we have conducted in order to
evaluate our contributions and compare the performance of our approaches with the literature
researches.
• The Conclusion summarises the results of this thesis and proposes some future directions.
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Figure 3  The main structure of this thesis.
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Part I
State-of-the-Art
This rst part aims rstly to present the biological environment we are working in by exploring the conceptual
history of systems biology and dening its main concepts. Then, secondly, to give an overview of the various
tools and approaches that have been proposed in the dierent research elds covered by this thesis. At the end of
each chapter, a section will be devoted to dene the problem statement related to each particular eld of research.
This part is divided into ve chapters:
1 Biological environment: from molecular biology to systems biology ....... 9
2 Modelling in systems biology ..................................................................19
3 Ontologies in systems biology ....................................................................27
4 Simulation tools in systems biology .................................................................39
5 Optimization tools in systems biology .................................................................51
7

Chapter 1
Biological environment: from molecular
biology to systems biology
Contents
1.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2 Biological background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2.1 Deoxyribonucleic acid (DNA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2.2 Ribonucleic acid (RNA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.2.3 Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.2.4 Metabolites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.2.5 Gene expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.3 From molecular biology to systems biology . . . . . . . . . . . . . . . . . . . 14
1.4 Complex biomolecular networks . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.5 Transittability of complex biomolecular networks . . . . . . . . . . . . . . . 16
1.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
9
1.1. INTRODUCTION
1.1 Introduction
The objective of this chapter is rst to describe the cellular system in which we are interested, its charac-
teristics and its functions. Then, we will address the specic context that interests us, the 'transittability'
of complex biomolecular networks which concerns the ability to steer this network from a specic state
to another desired state [6].
This background chapter will start by providing a brief introduction to biology, such as the denition
of the DNA, RNA, genes, chromosomes, proteins, metabolites and the gene expression from DNA to
proteins. Then we highlight the rapid accumulation of biological data in recent decades and how they
gave rise to systems biology. We then outline the goal of systems biology and the requirement for
other methods for studying the behaviour of complex biomolecular networks and their components. We
present also various types of molecular networks, in particular: the gene regulatory network (GRN),
protein-protein interaction (PPI) network, and metabolic network (MN) in order to focus on their global
properties and characteristics. And nally, we discuss some concepts related to the controllability of
complex biological networks allowing to steer the dynamic network behaviour from a state to another
one.
1.2 Biological background
1.2.1 Deoxyribonucleic acid (DNA)
The Deoxyribonucleic acid (DNA) was discovered by Frederich Miescher in 1869, then in 1953, James
Watson determines its structure [30]. The DNA contains all the genetic information, called the genome,
which enables the development, functioning and reproduction of living organisms [31]. This genetic
information determines the role of dierent cells (in multicellular organisms), and all the mechanisms
to survive and reproduce (in single-cell organisms). The DNA is composed of two polynucleotide chains
composed of four units called nucleotides1. Each nucleotide includes phosphate, sugar and one of the four
bases: Adenine (A), Guanine (G), Cytosine (C) and Thymine (T). As described in Figure 1.1, nucleotides
are attached together to form two long strands creating a structure called a double helix [32]. Each helix
is a polymer of nucleotides attached together by phosphodiester bonds and the two helices are connected
together through hydrogen bonds. These bonds are formed by pairs of bases, considering that each base
pair is composed of one purine base (A or G) and one pyrimidine base (C or T), matched according to
these rules: G pairs with C, and A pairs with T. The total length of the human DNA is around 3 billion
bases2.
Physically, DNA is stored as a component of the sub-cellular structures called chromosomes, located
in the nucleus in the Eukaryotic cell. The number of chromosomes varies among species. Humans have
22 pairs of chromosomes, plus the sex chromosomes.
A gene is a specic sequence of nucleotide bases along a chromosome containing information for the
construction of proteins. A gene is divided into non-coding regions (introns) and coding regions (exons)
[31]. All the DNA of a cell constitutes the genome.
1.2.2 Ribonucleic acid (RNA)
The Ribonucleic acid (RNA) is another type of nucleic acid that can also contain or transport genetic
information. RNA can be found on both nucleus and cytoplasm in contrast to DNA which is only located
in the nucleus of the cell [33]. As showed in Figure 1.1 and similarly to DNA, RNA is also built from
purine and pyrimidine nucleotides (Uracil take the place of Thymine), but forms a single helices (unlike
the DNA's double helix)3. Biologically, RNA molecules are produced as a result of gene transcription
from one of the two helix of the DNA molecule and can be in one of three dierent types: messenger RNA
(mRNA), transfer RNA (tRNA) or ribosomal RNA (rRNA) [33]. The messenger RNA is a chemically
unstable molecule that is synthesized in the nucleus based on a single DNA strand using the RNA
polymerase enzyme to carry the sequence information.
1https://www.ncbi.nlm.nih.gov/books/NBK26821/
2http://www.livescience.com/37247-dna.html
3https://www.nature.com/scitable/definition/ribonucleic-acid-rna-45
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Figure 1.1  DNA and RNA structure (Image credit: Wikimedia).
During the translation process, mRNA is edited by the elimination of introns via RNA splicing, and
only exons are transported to the ribosome. The information in the mRNA is organized as a series of
codons, each one containing three bases, then it is translated into a specic protein by the transfer RNA
which is an RNA molecule acting as an adapter among amino acids and mRNA [34].
All the RNAs of a cell constitutes the transcriptome, and it is specic to each cell according to its
identity, as well as its immediate needs.
1.2.3 Proteins
Proteins4 perform a vast array of functions within organisms. As illustrated in Figure 1.2, a protein is
a polypeptide or a macromolecule consisting of building blocks called amino acids attached together in
a linear chain. Proteins have a complex structure and their functional diversity is largely due to the
diversity of their three-dimensional structure5. We distinguish three main protein's roles [33]: (i) Cell
structure and cell mobility, for example the muscles, are almost entirely composed of proteins, which allow
its contraction. (ii) Recognition, signal detection and transmission of information, such as haemoglobin
that is used to transport oxygen in the blood. And (iii) Chemical metabolism, indeed a specic class of
proteins called enzymes increases these chemical reactions (catalysis, etc.).
The set of proteins in a cell constitutes the proteome which is the functional product of gene ex-
pression.
1.2.4 Metabolites
Metabolites6 are the intermediate products of metabolic reactions catalyzed by diverse enzymes that
naturally occur within cells. This term is used to describe small molecules. We distinguish two kinds
4https://www.khanacademy.org/science/biology/macromolecules/proteins-and-amino-acids/a/
introduction-to-proteins-and-amino-acids
5https://www.nature.com/scitable/topicpage/protein-structure-14122136
6https://www.news-medical.net/life-sciences/What-are-Metabolites.aspx
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Figure 1.2  Protein structure (Image credit: Wikimedia).
of metabolites: (i) The primary metabolites which are synthesized by the cell because they are indis-
pensable for its growth, such as amino acids, alcohols, vitamins, organic acids, nucleotides (inosine-5'-
monophosphate and guanosine-5'-monophosphate) [33]. And (ii) the secondary metabolites which are
compounds produced by an organism that is not required for primary metabolic processes, although they
can have other functions. As illustrated in Figure 1.3 displays the structure of some metabolites.
The set of primary and secondary metabolites constitutes the metabolome. Unlike the genome, the
transcriptome and the proteome, the metabolome is not encoded.
We must also note that metabolites can be the reactants, products of the metabolic pathway which
is a linked series of chemical reactions occurring within a cell.
1.2.5 Gene expression
As discussed previously, the DNA stores all the genomic information required for a cell to operate. Gene
expression focuses on the study of the process by which the instructions in DNA are converted into a
functional product which is called 'the central dogma of molecular biology ' [33, 35, 36, 37]. This claries
the ow of genetic information from DNA to RNA to produce a protein. The process by which the
DNA instructions are converted into proteins is called gene expression, which has two main steps: (i) the
transcription and (ii) the translation [37].
In the transcription step, the information in the DNA of every cell is converted into small, portable
mRNA. And during the translation step, these mRNA travel from the cell nucleus to the ribosomes where
they are ready to make specic proteins.
As described in Figure 1.4, we distinguish three states of the central dogma:
• From existing DNA to make new DNA: DNA replication phase,
• From DNA to make new RNA: transcription phase,
• From RNA to make new proteins:translation phase.
The gene expression process starts with the DNA replication in which there is a production of identical
DNA helices from a single double-stranded DNA molecule in order to ensure that each new cell receives
the correct number of chromosomes. The gene expression has transcription as a second step [36]. Here,
one of the DNA double helices serves as a template for the production of the RNA. In post-transcriptional
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Figure 1.3  Examples of metabolites (Image credit: the West Coast Metabolomics Center).
Figure 1.4  The central drogma of life.
processing, a pre-mRNA is edited to contain only coding sections (exons) to form a mature mRNA script.
The mRNA is then transmitted to the cytoplasm where it is matched to ribosomes for protein synthesis
[33]. Finally, the tRNA attaches specic amino acids to the mRNA to form complete polypeptide chains:
the proteins. Thus this translation phase ensures the conversion of the genetic information in DNA into
proteins.
Therefore, genome, transcriptome, proteome and metabolome are the major molecular com-
plexes of cells [38, 39]. A correlation among these four large sets can be explained by the expression of the
genome denes a transcriptome, then a specic proteome determines the metabolome. In contrast, the
metabolome regulates gene expression so that the cell permanently adapts its proteome to its metabolic
state. However, it should not be forgotten that the control of the metabolome is only part of one of the
proteome's functions, which also realize many other roles such as the communication of the cell with its
environment or the structuring of the cell [33].
Merging proteomic, transcriptomic, and metabolomic information to facilitate the study of cellular
behaviour, is among the major aims of systems biology.
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1.3 From molecular biology to systems biology
In the 20th century, there has been an important revolution of molecular biology. This advance is due to
the explosion of high-throughput technologies which generate huge amounts of molecular-level data. These
so-called 'omics' (genomic, transcriptomic, proteomic and metabolomic) techniques aimed primarily at
the detection and the study of genes (total gene expression analysis [40]), RNAs (RNA-Seq [41]), proteins
(mass spectrometry [42]) and metabolites (liquid chromatography [43]) in a specic biological sample [44].
However, despite these advances, the molecular biology of the 20th century has remained fragmented and
incomplete. Indeed, each laboratory focus only on a particular phenomenon concerning a cellular type of
a specic organ in an environment. This limitation is due to the inability of classical biological approaches
to address biological systems as wholes and thus to confront their complexity. This complexity results
from the heterogeneity and diversity of the components involved, the dynamic nature of the interactions
among these components, and the non-linear nature of the behaviour resulting from these interactions.
According to Sauer et al. in [45]: 'The reductionist approach has successfully identied most of the
components and many of the interactions but, unfortunately, oers no convincing concepts or methods to
understand how system properties emerge . . . the pluralism of causes and eects in biological networks is
better addressed by observing, through quantitative measures, multiple components simultaneously and by
rigorous data integration with mathematical models'.
To ll these gaps, the area of systems biology was introduced to complete classical biological ap-
proaches. Systems biology is an approach that addresses the complexity of biological systems and their
dynamic behaviour at all relevant organizational levels (from molecules, cells and organs to organisms).
It combines reducing and integrative methods to emphasise both the components of the system and the
interactions among them which generate emergence phenomena at higher organizational levels.
In contrast to classical biology, this eld is based on the understanding that the whole is greater than
the sum of the parts7. It approaches the complexity of biological systems with the integration of many
scientic disciplines such: biology, computer science, engineering, bioinformatics, physics and others, to
predict how these systems change over time and under diverse conditions.
It is now clear in the minds of all biologists that understanding cellular behaviour requires analysis
of its dynamic interactions (its evolution), its multi-variate data (measurements of millions of molecules
and multiple parameters) and its multi-level data (from genome to metabolome).
1.4 Complex biomolecular networks
As discussed in the previous section, with the rapid accumulation of omics-data from high-throughput
technologies, the study of biomolecular networks has become one of the keys focuses in systems biol-
ogy. Indeed, high-throughput technologies pave the way for the reconstructions of dierent biomolecular
networks according to molecular-level dened by omics data. Figure 1.5 depicts the dierent types of
biological networks according to molecular components using high-throughput omics technologies. In
this section, we review these dierent types of molecular networks and dene the complex biomolecular
network.
Therefore, depending on the type of its cellular elements and their interactions, we can distinguish the
three basic types of networks, the Gene Regulatory networks (GRNs), the Protein-Protein Interaction
networks (PPINs), and the Metabolic networks (MNs).
• The Gene Regulatory networks (GRNs) describe the interactions among approximately 21,000 genes
(DNAs and RNAs). They are represented as directed graphs where the nodes represent genes and
edges model the type of regulation (activation or inhibition) if one gene regulates the transcription
of the other gene [46].
• The Protein-Protein-Interaction networks (PPINs) model the interactions among proteins within
an organism (about 80,000 proteins in the human organism). These networks are represented as
undirected graphs where the nodes are the proteins and the undirected edges model the connection
between them. These types of interactions depend on the physical or biochemical interaction that
exists between the pair of proteins [47]. This network mainly contains details on how proteins
perform together to ensure the biological processes.
7https://www.systemsbiology.org/about/what-is-systems-biology/
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Figure 1.5  Types of biological networks according to molecular components using high-throughput
omics technologies.
• The metabolic process consists of a series of chemical reactions that begins with a particular metabo-
lite called 'substrate' and converts it into some other metabolites called 'products' [48]. Thus, the
Metabolic networks (MNs) describe the biochemical reactions among approximately 42,000 metabo-
lites. They are represented as directed graphs whose nodes are the metabolites and the edges repre-
sent the type of the biochemical reaction which transforms the substrates into products by the help
of enzymes. They are labelled by the stoichiometric coecient of the metabolites in the reaction.
Figure 1.6  Multi-level modelling of a biomolecular network from a real cell.
As discussed above, the cell is a complex system consisting of thousands of diverse molecular entities
(genes, proteins and metabolites) which interact with each other physically, functionally and logically cre-
ating a biomolecular network [6, 14]. Indeed, omics technologies describe the cell networks and processes
through the study of cellular entities. These technologies operate at various levels such as in genomics (the
qualitative study of genes), in proteomics (the quantitative study of proteins) and in metabolomics (the
quantitative study of metabolites) [49, 50]. Thus, the complexity of this complex biomolecular network
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appears by its decomposition into the three levels presented above: the genome, transcriptome, proteome
and metabolome which are the major molecular complexes composing the cell [38, 39]. As illustrated in
Figure 1.6, complex biomolecular networks typically include gene regulatory networks, protein-protein
interaction networks and metabolic networks. It consists of dierent types of nodes, denoting cellular
entities, and various nature of edges, representing interactions among cellular components.
This complex network facilitates the understanding of biological mechanisms of a cell and its transit-
tability.
1.5 Transittability of complex biomolecular networks
Figure 1.7  The transittability of the P53-mediated cell damage response network: colour changes in the
nodes indicate changes in the concentration of the associated molecules.
Cells do not live in stable conditions, but in environments that vary over time [9]. In fact, they
are always subjected to intra and extra-cellular stimuli, such as changes in their physical and chemical
properties or in their environment. In order to survive, the cell reacts more or less rapidly by adapting
its behaviour in accordance with the new features of its environment. As discussed in the previous
section, biomolecular components interact with each other to form so-called biomolecular networks, which
determine the cellular behaviours of living organisms. Indeed, controlling the cellular behaviours by
regulating some biomolecular components in the network is one of the most outstanding problems in
systems biology.
Recently, some authors have started to address the dynamic aspects of biological systems, and have
introduced concepts such as the 'controllability' [28, 51] of a network, where the ability to steer a complex
directed network from any initial state toward any other desired state is measured by the minimum number
of required driver nodes (nodes with the ability to steer the entire network). It has been shown that in
order to achieve complete controllability, the minimum number of driver nodes is 80% of the nodes
in a regulatory biomolecular network. This result led other groups to develop a theoretic framework
for studying transitions between two specic states of directed complex networks, a concept they call
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'transittability' [6]. In general, this concept expresses the idea of steering the complex biomolecular
network from an unexpected state to a desired state. The theorems were developed with continuous-time
linear time-invariant systems (a theory investigating the response of a linear and time-invariant system
to an arbitrary input signal) and applied to 4 dierent biological systems consisting of up to 17 molecules
and 40 interactions. Figure 1.7 shows an example of a biological system. At each stage of this network,
the blue-lled node indicates that the level of this node concentration at that state, a blue-lled node
means high level and an empty node means low level. For more details about the components of the
P53-mediated cell damage response network, please refer to the TP53 website at http://p53.fr/ which
contains extensive information on various aspects on p53 and also links to other p53 sites. Moreover, this
example is described in detail in [6].
With the idea of making the biomolecular network evolve, our research works aim to design and develop
a platform that provides an optimal set of external stimuli to be applied during a predetermined time
interval to steer the biomolecular network from its current state to a desired state. Our original approach
is based on the cooperation of semantic technologies [52], combinatorial optimization and simulation.
1.6 Summary
In this chapter, we presented the biological environment we are working in by dening its main concepts
such as DNA, ARN, proteins, metabolites and gene expression. Then we give a brief history of biology
area describing its revolution from the classical molecular biology to the appearance of systems biology.
We discussed also how omics technologies operate at various levels (genomics, proteomics, metabolomics)
creating complex biomolecular networks. Finally, we discussed some concepts which are introduced
to study the dynamic behaviour of complex biomolecular networks, such as the 'controllability' and
'transittability', some of which have inspired the work presented in this thesis.
In the next chapters, we will present the state-of-the-art of the dierent disciplines covered by this
thesis.
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2.1. INTRODUCTION
2.1 Introduction
Numerous formalisms have been proposed in the literature for describing and studying biological networks.
Indeed, modelling these complex systems is the rst step towards understanding, designing, simulating
and controlling the behaviour of these biological networks [53]. Therefore we can use dierent kinds
of models: discrete, continuous or hybrid models for the same biological network. This classication is
done according to the nature of the mathematical formalisms used (Boolean, logic, dierential equations,
etc.) [54]. Thus, each model focuses on a specic problem and treats a well-dened level of intracellular
abstraction.
This chapter aims to classify and detail these mathematical tools for modelling biological networks.
We rstly introduce a classication of modelling tools based on their major properties and then highlight
some of the most popular and important mathematical models in systems biology. Finally, we provide a
comparison among these modelling formalisms and discuss their main characteristics.
2.2 Major properties and dimensions of modelling
With the explosion of high-throughput technologies which generated huge amounts of molecular-level omic
data, it becomes necessary to provide models that can be used to understand and formalize knowledge
about them. Therefore several mathematical models have been proposed in the literature. These models
are very varied from the point of view of abstraction levels (from the gene level to the metabolic level
through proteins), details of analysis (discrete, continuous), etc. A number of bibliographic reviews
focused on these modelling tools. Most of them classify these models according to dierent criteria. In
the following section, we will focus on these categories and detail some of the most popular models.
2.2.1 Discrete vs Continuous vs Hybrid models
2.2.1.1 Discrete models
These methods consider a molecular component as an object that can steer from a state to another and
represent the biological interactions among these entities as Boolean functions [55]. Discrete models sim-
plify the calculation and oer the possibility of realizing formal checks. However, despite their simplicity
to model and simulate specic biological questions, they are too complex when the user focuses on an
important number of states. Moreover, modelling a molecular component by a Boolean value do not take
into account the reality because it can not have intermediate states [56].
2.2.1.2 Continuous models
In order to understand in detail the functioning of a biological system (especially from a temporal point
of view), this approach focuses on its continuous evolution. The variables represent the concentrations of
molecular components comprising the system, and the global evolution is guided by a system of dierential
equations. This approach can be close to the real-life but is dicult to implement when the size of the
system is high. This complexity is due to the non-linear character of the dierential equations. To address
this limits, an intermediate approach called hybrid model was proposed.
2.2.1.3 Hybrid models
They are dynamical models that combine the advantages of both discrete and continuous models. The
principle is to mix between the classic dierential equations representing the evolution of chemical con-
centrations, with cellular automata or agent-based models representing the individual behaviour of some
molecular components of interest. Thus, a hybrid model corresponds to any interaction or coupling be-
tween two or more models that are not based on the same formalism [57]. More details about hybrid
modelling in biology are presented in a review Hybrid Modelling in Biology: a Classication Review [57]
written by Stéphanou and Volpert.
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2.2.2 Quantitative vs Qualitative models
2.2.2.1 Quantitative models:
They are usually represented as a set of dierential equations given that they are a suitable approach for
modelling real systems. These models require all the parameters to be dened, but given the large size
of biological systems, it is not possible to list all of them, moreover, their values are not yet known.
2.2.2.2 Qualitative models:
Unlike quantitative models, these models provide general descriptions of biological systems because they
require few or no parameters. These models are usually representing as discrete or hybrid models.
A detailed comparison study between quantitative and qualitative models can be found in [58].
2.3 Overview of the existing mathematical models in systems bi-
ology
Biological networks are extremely complex. To understand their operation, we not only need to identify
their molecular components (genes, proteins and metabolites) and their interactions but also we need to
know how their dynamics evolve over time [59].
This section highlights some of the most popular and important modelling tools.
2.3.1 Boolean models
Boolean network models were initially proposed as a special case of discrete dynamic models. A Boolean
network model consists of a set of nodes whose state is binary (0 or 1 ) and is determined by other
nodes in the network through Boolean functions. These Boolean functions are expressed together with
the logical operators: AND, OR, and NOT. In terms of complexity, Boolean networks lie between static
network models and continuous dynamic models, making them attractable and powerful approaches to
model large-level biological systems. Boolean models can be used to describe the qualitative temporal
behaviour of the system and to understand how perturbations change its behaviours. They also provide
a coherent network representation.
This Boolean model has been applied to the modelling of several genetic regulation networks of diverse
organisms such as: the dierentiation of oral organs in Arabidopsis thaliana plants [60], the embryonic
development of Drosophila [61], the mammalian cerebral cortex [62], the process of apoptosis (cell death)
[63], and signalling networks in a variety of biological systems such: the ABA Signal Transduction network
[64], the Embryonic stem cells (ES cells) [65].
2.3.2 Logical models
The logical approach was initially developed by René Thomas and his collaborators [66], then it was
introduced in biology by Kauman [18, 56]. This model represents a compromise between the static
model (structural analysis) and dierential equations in terms of complexity and precision [67]. In a
logical graph, the nodes represent genes which are associated with discrete levels of expression, and edges
represent the interactions among genes. Each interaction is associated with an expression level threshold
from which the regulator (starting node of the interaction) has an eect on the target gene. For each
gene, a discrete logical function indicates to which qualitative level the gene tends when he is submitted
to a given combination of interactions. In their simplest form, logic models associate to each molecular
component one of this two discrete states: ON or OFF. Therefore, logic models with only two binary
states are generally considered as Boolean models.
Logic models have been applied to the modelling of several signal transduction pathways involved in
diverse processes such as: proliferation [68], cell cycle regulation [69], apoptosis [70], or dierentiation
[71]. A detailed survey of logic models can be found in [72].
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2.3.3 Petri nets models
Petri net is a graphical and mathematical approach for modelling systems in which the notion of events
and evolution is important. Initially, this model was developed by Petri in 1962 [73] to represent discrete-
event systems. Originally, only systems that changed discreetly could be represented with Petri networks.
Then, many extensions were produced (Wim Bos list the main extensions in [74]). Some of them are
really dedicated to biological system modelling, such as the hybrid Petri net networks which are used
to model the evolution of systems in which some variables evolve discreetly, others continuously, and
whose rates of change depending on the system's variables. In general, a Petri net is a directed, weighted
bipartite graph consisting of two types of nodes: places and transitions. In this network, circles represent
the places and boxes represent the transitions. We usually consider a token to be a unit of weight of a
molecule. A place-transition or transition-place connection is made by a weighted edge representing how
much of the input places (reactants) are required to produce tokens for the output places (products) in a
reaction. A transition can only re when it is enabled, meaning that each of its input places has at least
one token in the current marking. More formally, a Petri network consists of ve elements:
• P = {p1, p2, . . . , pm} a set of places,
• T = {t1, t2, . . . , tn} a set of transitions,
• F ⊆ (P ∗ T ) ∪ (T ∗ P ) a set of edges,
• W : F → {1, 2, 3, . . .} a weight function,
• M0 : P → {0, 1, 2, 3, . . .} the initial marking.
Petri net was mainly used to model signalling pathway networks [75]. This signaling Petri net aims to
predict signal ow through a cell-specic network in experimental conditions [75]. Each place is devoted
to a signaling protein, and each transition is associated with a phosphorylation interaction.
A number of research studies have been focused on Petri net to model biological systems such as
for modelling and validation of the sucrose breakdown pathway in the potato tuber [76], the enzymatic
reaction chains [77], and the biochemical reaction systems [78]. More details on approaches using Petri
net for modelling biological systems can be found in dedicated survey [79, 80, 81].
2.3.4 Bayesian network models
The Bayesian models were initially introduced into biology issues in order to infer regulatory networks
from DNA chips by Friedman et al. in [82]. Then, Microsoft's research contributed to the development
of approaches based on Bayesian models [83, 84]. In a Bayesian model, the variables can be discrete or
continuous. Bayesian models are static in nature, but they are easily extensible to dynamic modelling
problems [85].
This graphical formalism denes and simplies a joint law of probabilities of a model. It is, therefore, a
graphical and probabilistic model. The variables have a probability distribution conditioned by the state
of other variables in the model. These variables represented by nodes are associated with conditional
probability distributions. The edges indicate a statistical dependence between two variables [86]. Bayesian
network model consists of three major steps: (i) the structure must be proposed, (ii) the parameters or
probabilities associated with edges and nodes must be set, and (iii) the nal network must be evaluated.
Bayesian networks have been applied for inferring the structure of many biological networks from ex-
perimental data. Among these applications, we can cite the Characterizing Loss Of Cell Cycle Synchrony
(CLOCCS) [87], the comparison of Acute Lymphoblastic Leukemia (ALL) [88].
2.3.5 Graphical Gaussian models
Graphical Gaussian models also called covariance selection or concentration graph models, have been
used to model gene association networks. The main objective of Graphical Gaussian models is to use
partial correlations as a measure of independence of any two genes. This model relies on assessing
the conditional dependencies among genes in terms of partial correlation coecients among the gene
expressions and results are displayed in an undirected network [89]. A detailed introduction to Graphical
Gaussian models can be found in [90] and [91].
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Graphical Gaussian models have been applied for inferring the genetic network of many biological
systems such as the genetic network of S. cerevisiae [92], the Arabidopsis thaliana transcriptome [93], the
isoprenoid gene network in Arabidopsis thaliana [94].
2.3.6 Dierential equation models
Among dynamic modelling methods, the most commonly used in biology is the dierential description.
Concentrations or activities of molecular components are usually represented by positive real quantities
called also variables which can vary continuously over time. The variation of these quantities is formalized
by writing a system of coupled dierential equations. Thus, molecular components and their interactions
constitute a system of ordinary dierential equations. In most biological systems, the interactions con-
sidered are non-linear which leads to dierential models that are almost impossible to solve and analyse.
Consequently, this model requires the use of 'numerical simulations'. Starting from initial constraints and
conditions, this model tries to have a solution similar to the exact solution by calculating the values of the
concentrations of molecular components involved over time, using small time intervals. Moreover, this
approach requires to dene the values for all parameters. Since these values are not always established
experimentally, simulations are carried out with very approximate or arbitrary values. Therefore, it is
dicult to predict the dynamic behaviour of the biological system. Thus, this method can be used to
model small systems where it is possible to know in advance the exact values of their parameters, but
for more complex biological models, it is dicult to specify all the corresponding dynamic properties and
associated conditions.
During the last decades, several kinds of researches have been proposed to describe the regulation of
gene expression using a dierential equation model. Among them, we can cite [95, 96, 97, 98, 99, 100].
Diláo et al. [101] developed the 'GeneticNetworks' which is a software tool, for modelling genetic networks
using linear dierential equations. Other authors have proposed and simulated dierential models for
molecular networks, for example in the gene expression regulation in bacteria [102], cell-cycle control [103],
Circadian rhythms [104], specic gene expression proles during embryonic development [105, 106, 107]
and response of Escherichia coli cells to carbon deprivation [108]. Moreover, dierential equations models
have been used to model metabolic networks, for example for analysing the central metabolism of an
environmental bacterium: the Methylobacterium extorquens in [109] or in Corynebacterium glutamicum
[110]. Dierential equation models are also applied to protein-protein interaction networks (only from
the perspective of studying signal transduction networks) as studying feedback eects on signal dynamics
in a Mitogen-Activated Protein Kinase (MAPK) [111], controlling signal transduction cycles [112], and
understanding the CovR/S signal transduction system in [113].
2.3.7 Cellular automata models
Cellular Automata model is a discrete dynamical formalism. Within this model the notions of space,
time, and states of the system are discrete. Each point in the spatial network is called a cell which may
have any one of the nite numbers of states. The states of the cells in the network are updated according
to a local rule. Consequently, the state of a cell at a given time t depends only on its state at time t− 1
and the states of its neighbours at time t−1, and all the cells on the network are updated synchronously.
Using cellular automata it is possible to model diverse systems. The rst works on cellular automata
were made by Von-Neumann in [114]. Subsequently, this model was detailed by Stephen Wolfram in the
1980s [115].
Application of cellular automata models can be seen in the modelling of the immune system [116], the
development of an articial brain [117], the enzymatic reaction [118] and some other biological systems
[119].
2.3.8 Agent-based models
Agent-based model is a rule-based, discrete-event and discrete-time computational modelling method-
ology that employs computational objects focusing on the rules and interactions among the individual
components (agents) of the system [120, 121, 122].
An agent is an interactive computer system situated in an environment and able to autonomous action
in this environment in order to meet its design objectives. A multi-agent system consists of a set of agents
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interacting in a dynamic environment as dened by Michael Wooldridge in [123].
Application of agent-based models can be seen in the modelling of the control pathways aecting
the transcription factor nuclear factor kappa B (NF-kB) [124], the behaviour of the toll-like receptor 4
(TLR-4) signalling pathway [125] and the Pseudomonas aeruginosa Biolm Formation [126].
2.4 Comparison among these modelling formalisms
As detailed above, biological systems and in particular intracellular components have been modelled
by diverse modelling approaches. This diversity is essentially due to the complexity and heterogeneity
of the molecular components and their interactions [54]. After analysing each modelling approach, we
should note that each model has its own benets and drawbacks, and can be used according to the user's
objective.
Indeed, there is no perfect approach to model a complex biomolecular network considering all its levels
and their molecular components. Moreover, we note that there is no agreement on the classication of
these models because we cannot compare them on the basis of a particular criterion. The same model
can be used in dierent ways with dierent interpretations of biology. But, we note that these models
dier in many other criteria including how to interpret biological facts. In order to highlight their
properties and their utility, we compare them according to various criteria. The classication proposed
here aims to illustrate the major characteristics of each approach for modelling biological systems. Table
2.1 summarises the main features of these models.
For example, Boolean models have the capacity to simplify the dynamics of gene networks which
enable an ecient analysis of large-scale networks. However, it ignores the intermediate states of gene
expression and it can update the gene in an asynchronous way which may miss many important dynamic
behaviours.
The power of Petri net models is their capacity to provide an intuitive representation of a biological
system due to their graph-based structure which is suitable for analysing the global behaviour of the
system. However, the graphical representation becomes too complex for analysis when the biological
network is large because it requires to dene a lot of transition rules.
Bayesian networks provide a graphical formalism dening a joint law of probabilities of a model
which is easily extensible. However, they are computationally expensive because it needs to analyse
all potential network topologies corresponding to all possible sets of directed acyclic graphs linking the
molecular components. This causes a combinatorial explosion of the number of possible structures and
parameters creating an NP problem.
Graphical Gaussian models provide a powerful model to represent statistical dependencies among
random variables. However, they suer from poor scalability and interpretability.
Dierential equation models have the capacity to model and analyse the dynamics of the system. This
model provides a result similar to the exact and real solution. However, the power of this model can only
be applied to a small-scale system. In fact, despite the evolution of high-throughput technologies, there
is always a lack of data. Moreover, if the network scale is large, parameter estimation will generate a high
computational cost. Indeed, the simulation of large-scale networks using dierential equations cannot
be performed because of the complexity of the problem and the high number of network components.
Also, the quantitative parameters of biological systems cannot be experimentally measured. This leads
to creating more diculties in setting the inial conditions of the network simulation. We note that
dierential equation models are more precise and specic about a system, but require a large eort in
model construction and a complete set of quantitative data.
Agent-based models can be constructed in the lack of complete knowledge about the system using sim-
ple rules. Also, these models easily incorporate space because they have their origins in two-dimensional
cellular automata. Agent-based models incorporate stochastic aspects. However, they do not allow to
nd patterns in an existing dataset. Moreover, they require a lot of interactions among each agent and
they need frequent communication.
Table 2.1 classies these modelling methods according to their properties.
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2.5 Thesis contribution in this eld
Several studies have been conducted to model, analyse and understand the behaviour and processes
of cells. However, most of them do not examine the interactions among all the intervening molecules
types and do not consider the dierent abstraction level within the cell. As a result, these modelling
approaches are impractical to understand the transittability of complex biomolecular networks. Therefore,
to accomplish this task, we must take into account the analysis of the structure and dynamics of the whole
cell rather than just focusing on isolated parts [24, 25, 26, 27].
With this idea in mind, we think that a formal logic-based formalism is needed for modelling and un-
derstanding complex biomolecular networks as a whole considering its structure, function and behaviour.
Indeed, we aim to design and develop a logic formalism for biologist that allows (i) the formal expression
of various types of biological knowledge, (ii) the translation of this knowledge into logical notions for
analysis, simulation and optimization, (iii) the integration of the dierent levels of intracellular abstrac-
tion (genomic, proteomic and metabolic). Therefore, this model will be considered as a well-organized
knowledge base that contains all the available information for modelling a biological network in a logic,
clear and consistent manner.
It is important to note that this logic-based model can be considered as a logical model. Logical models
represent one of the youngest approaches to model and formalize the multi-level aspect of biomolecular
networks underlying their dierent level properties. Indeed, this model is capable of modelling the
biomolecular network processes and functions on dierent temporal and spatial levels in an explicit way.
Moreover, this multi-level model can be a good framework for the integration of additional computational
module, in our case it serves to integrate the logic modelling with the semantic modelling module, the
simulation module and the optimization module. All of these modules are based and joined together
using this logic-based model. Using this type of models, we can also integrate discrete with continuous
modelling, thereby opening the possibility to simulate modules that can be best represented with discrete
values and modules best described using continuous equations. Furthermore, this model oers a higher
expressive power due to its formal language. Indeed, in these logical models, there is a class of well
dened mathematical structure in which the domain knowledge (all the elements required for modelling
biomolecular networks) is interpreted.
2.6 Summary
In this chapter, we focused only on some popular mathematical modelling tools. Many literature reviews
detailed these modelling approaches and are available in [26, 127, 128]. In fact, dierent modelling
approaches are used in systems biology and we cannot say that a model is better than other. As detailed
above, some models are too small systems, others to large systems, and some of them are qualitative,
others are quantitative. Each of these models focuses on a specic problem and treats a well-dened level
of intracellular abstraction. These models can also be applied to the same biological network to study
dierent problems with dierent point of views. However, all these models are not adequate and do not
allow to understand the transittability of complex biomolecular networks. In fact, they are more specic
and oriented to a particular problem in systems biology. Therefore, with the goal of understanding and
analysing the transittability of biomolecular networks, we need to implement a more specic model which
can provide all the elements required for studying this problem. That is why we hope to contribute to this
discipline by proposing a logical-based approach for modelling the dynamic behaviour of biomolecular
networks. This formalism is based on the three levels of analysis dened by the systems theory: structural,
functional and behavioural modelling. Indeed, it aims at describing and analysing all the properties and
mechanisms of complex biomolecular networks. This logic-based modelling will form the basic element
for modelling and understanding the transittability of these complex networks.
Despite existing mathematical modelling tools for formalizing biological networks, there are also se-
mantic technologies which are useful to provide a powerful integration and management of available
biological data and knowledge, thus making them more understandable to biologists, enabling an e-
cient analysis of biological networks and reasoning. The next chapter is devoted to exploring the role of
semantic technologies, especially ontologies in systems biology.
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3.1. INTRODUCTION
3.1 Introduction
Modelling knowledge requires semantic structures and representation formalisms that translate the com-
plexity of human thought and describe characteristics of the real word. Actually, it is the eld of semantic
technologies and more particularly ontologies that address these issues. An ontology is considered as a
cognitive artefact allowing the conceptualization and shared exploitation of knowledge. It consists of a
vocabulary of the eld in which the meaning of the terms and the relationships between the dierent
notions are specied. Beyond its descriptive ability, ontologies provide reasoning capabilities.
In this chapter, we present a complete state-of-the-art on ontologies. First, we give some background
information about ontology by presenting its dierent denitions, components and typologies. Next, we
describe the methodologies, formalisms, languages and editor tools of ontology construction. We then
dene the dierent languages and software for ontology reasoning. Moreover, we review the major appli-
cations of ontologies in systems biology through a comparison study. Finally, we discuss the contribution
of our thesis to both ontology and systems biology eld.
3.2 Concept of Ontology
An ontology has two dierent denitions depending on the eld of interest, philosophy or computer
science:
In philosophy In philosophy, the term ontology 'is the philosophical study of the nature of being,
becoming, existence, or reality, as well as the basic categories of being and their relations' 1.
In computer science In the eld of Articial Intelligence (AI) the most cited denition of ontology is
the denition proposed by Gruber [129]: 'An ontology is an explicit specication of a conceptualization'.
Other denitions of ontology for ontological engineering have been proposed and are sometimes improve-
ment of already proposed denitions or are complementary to them. For example, Studer et al. [130]
denes an ontology as 'a formal, explicit specication of shared conceptualization'. Moreover, Pierra et
al. in [131] dene an ontology as 'a collection of explicit, formal and consensual descriptions of all the
concepts of a domain in the context where these concepts have a precise meaning, without any restriction
or rule corresponding to a particular use'.
These proposed denitions gave emphasis to the notions of specication and conceptualization. The
concept of specication is a formal description of how an object should be dened to satisfy a specic
criterion. Therefore, a specication must be explicit because all the concepts of an ontology must be
clearly dened. The second concept of conceptualization can be dened as an intentional semantic
structure that encodes implicit knowledge constraining the structure of a piece of a domain. It is usually
a logical theory that conceptualization explicitly in some language.
The following section presents the basic components of an ontology.
3.3 Ontology components
Ontologies represent the semantics of a domain's concepts in terms of classes and properties. A class also
called concept regroups and abstracts the domain objects having common characteristics. A property
called also attribute characterizes the objects of the domain by one or more values. The property can be
dened on a domain indicating the class of objects it describes and associated with a codomain indicating
the type of data in which it can take its values. Classes have an extension consisting of a set of instances
called also individuals that indicate objects in the domain. An instance belongs to one or more classes
and a set of property values.
Pierra et al. [131] denes formally an ontology by this quadruplet:
O =< C,P, Sub,Applic >
where:
1https://www.merriam-webster.com/dictionary/ontology
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• C: represents all the classes used to describe the concepts of a given domain,
• P : represents the set of properties used to describe the instances of all the classes C,
• Sub: C → 2C is the subsumption relation which, for each class ci of the ontology, associates its
direct subsumed classes. These classes check the property ∀c1, c2 ∈ C, c1 subsume c2 if and only if
∀x ∈ c2, x ∈ c1. Sub denes a partial order on C and 2C denotes the power set of C,
• Applic: C → 2P associates to each ontology class the properties that are applicable for each instance
of this class.
3.4 Typologies of ontologies
Ontologies can be classied according to several domains [132],[133], [134] depending on:
• the object of generality,
• the level of detail,
• the level of completeness,
• the level of representation formalism.
Each domain contains dierent kinds of ontologies.
3.4.1 According to the object of generality
The ontology types are classied into four groups according to the level of generality used in the description
of a domain [135].
• Top-level ontologies: These ontologies aim to dene the largest possible knowledge because they
contain general concepts. They are reusable among dierent domains and reduce the ambiguity
of the basis of the ontology. In these ontologies, it is rare to nd individuals because they aim
only to propose a hierarchy of knowledge. An example of this type of ontologies in biology is the
GENIA ontology [136] which propose a general description of the basic ontological entities in the
life sciences domain.
• Domain ontologies: They are a specication of a high-level ontology. These ontologies specify par-
ticular domains and are linked to high-level ontologies by one or more high-level ontology concepts.
• Task ontologies: They are used to describe concepts for solving specic activity problems. They
contain terms and properties that describe problem solutions. These ontologies are independent of
the domain.
• Application ontologies: A more precise level is specied in the application ontologies. They describe
precisely the specic activities of an application domain. It is possible to consider these ontologies
as an association between task and domain ontologies.
3.4.2 According to the level of detail
According to the level of detail and the precision of the ontology, we distinguish two kinds of ontologies
[137]:
• Large granularity : This type consists of high-level ontologies having a broad granularity because
the concepts they contain will be rened later in other domain or application ontologies.
• Fine granularity : In contrast to the previous type, these ontologies are very detailed and have a
richer vocabulary providing a detailed description of the relevant concepts of a domain or task.
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3.4.3 According to the level of formality
According to the used language or formalisms of representation, we distinguish four kinds of ontologies
[138]:
• Informal ontologies: they are expressed in natural language and are easily understandable by the
users.
• Semi-informal ontologies: they are expressed in a more structured and limited.langage.
• Semi-formal ontologies: they are expressed in an articial language.
• Formal ontologies: they are expressed in an articial language with a formal semantics that allows
verication.
These dierent types of ontologies are used according to the eld of application and the purpose of
the ontology.
3.5 Ontology building: methodologies, formalisms, languages and
tools
Over the years, the use of ontologies in knowledge engineering has known dierent methodologies, for-
malisms, languages and tools [139]. In the following sections, we will detail each of them.
3.5.1 Ontology engineering methodologies
There are several detailed reviews for ontology engineering methodologies such as the works of Fernández-
López Mariano [140]. Here, we briey review the literature by citing only some of the major methods
such as the Uschold and King's method, SENSUS method, METHONDOLOGY method and Stanford's
method.
3.5.1.1 Uschold and King's method
This method proposed by Mike Uschold and Martin King in [141] consists of four steps:
• Identifying the objectives and context of ontology : this step aims to dene why this ontology will
be developed, for what purpose and who will use this ontology.
• Ontology development : this step is divided into three activities: (i) identifying the concepts and
relationships among them, (ii) ontology coding using a language such OWL, RDF, etc., and (iii)
integration and reuse of existing ontologies.
• Ontology evaluation: this step consists in checking and evaluating the ontology.
• Documentation of the ontology : this step comments and documents the code of the ontology in
order to facilitate its maintenance.
This method is one of the rst proposed in the ontology engineering literature. Its general steps are
considered as the basis of any ontology construction.
3.5.1.2 SENSUS method
The SENSUS method [142] proposes to develop a domain ontology from a top-level ontology. It proposes
to dene the relationships among the specic and general terms of the domain, then to delete the terms
that are not specic to the domain of the ontology. This method aims to re-use the terms of existing
ontologies. The Sensus ontology was developed based on the SENSUS method and contains more than
50000 concepts hierarchically organized.
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3.5.1.3 METHONTOLOGY method
This method [143] follows several steps:
• Identication of the ontology development process,
• Lifecycle based on the evolution of prototypes,
• Project management, development and support activities.
The METHONTOLOGY follows the project management techniques in which the ontology is consid-
ered as a nality of the method. In this method, ve development steps are dened:
• Specication: What is the purpose of the ontology, who are its users and what is its size?
• Conceptualization: This is the most important step in the construction. This step treats the
organisation of knowledge from dening the candidate terms to dene the instances.
• Formalization: This step translates knowledge into an ontology.
• Implementation: This step translates the ontology into a specic ontology language such as OWL,
RDF, etc.
• Maintenance: This step corrects and updates the ontology.
3.5.1.4 The Stanford's method
The Standford's method [144] has been developed by Stanford University. It is divided into seven steps:
• Determine the domain and the scope of the ontology,
• Reuse existing ontologies,
• List important ontology terms,
• Dene classes and hierarchy,
• Dene the class properties and their attributes,
• Dene the facets (restrictions or constraints) of attributes,
• Create instances of classes in the hierarchy.
These dierent steps are implemented through a set of questions, for example concerning the rst
step, 'what will ontology cover?', 'What is the purpose of the ontology?', 'What is the kind of questions
that the ontology has to answer?', 'Who will use and manage the maintenance of the ontology?'.
This is the method used in our research because it appeared clear and rigorous. Moreover, this method
is linked to the Protégé editor.
3.5.2 Types of formalisms
There are diverse types of formalisms to model an ontology and dierent languages for each type.
• Graphs:
 Topic Maps2, Semantic Networks3
 Web-oriented: RDF and RDF Diagram
• Logic:
 First order: KIF
 Description: KL-One, OIL, DAML+OIL, OWL
• Object orientation: UML + OCL
In order to understand the structure of ontologies and the power they can provide to the world of
knowledge representation, we present in the following sections some of these languages.
2http://www.topicmaps.org/
3http://intelligence.worldofcomputing.net/knowledge-representation/semantic-nets.html
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3.5.3 Languages
An ontology language is a formal language used to encode ontologies. A number of ontology languages
have been developed during the past few years by the research community [145], such as common Algebraic
specication language, common logic, CycL, DOGMA, Gellish, IDEF5, KIF, RIF, and OWL. Ontology
languages can be classied into three categories (i) logical languages, (ii) frame based languages and (iii)
graph-based languages. The following sections detail some major languages.
3.5.3.1 KIF
Knowledge Interchange Format (KIF) [146] is a language based on rst-order predicates with extensions
to model denitions and meta-knowledge. As described in its website4, KIF has declarative semantics
and is logically comprehensive. The Ontolingua tool5 allows users to build KIF ontologies at a higher
level of description by importing denitions of predened ontologies.
3.5.3.2 KL-ONE
KL-ONE [147] is a language based on description logic [148]. It is a formalization of knowledge represen-
tation based on frames [146]. This formalism divides its descriptions into two basic classes of concepts:
primitive and dened. Primitives are domain concepts that are not fully dened6.In fact, new terms can
be dened using operations of concept conjunction, for example, the 'and ' operator is used to specify
that a new concept is a common specialization of several other concepts. Moreover, new roles can be
introduced to represent the properties that exist among individuals in the modelled domain. Denitions
of concepts include restrictions on possible values, the number of values, or the type of values a role can
have for a concept.
3.5.3.3 RDF and RDF Schema
Resource Description Framework (RDF) RDF7 is a graphical formalism for modelling and de-
scribing meta-data. RDF is based on the notion of the triplet (subject, predicate and object).
• Subject (resource): it is an information entity that can be referenced by an identier. This identier
must be a URI (Universal Resource Identiers).
• Predicate (property): it is a specic aspect, an attribute, a characteristic or a relationship used to
describe a resource.
• Object (value): it is a literal (single string) or a resource.
The subject and the object are resources linked together by the predicate. RDF uses XML syntax, but it
gives no specic meaning for vocabulary as 'a subclass of' or 'type'. The modelling primitives provided
by RDF are basic and limited.
Resource Description Framework Schema (RDFS) RDF Schema8 is a language that complete
RDF with a vocabulary of terms and relationships such as: rdfs:Class, rdfs:Property, rdfs:type, rdfs:subClassOf,
rdfs:subPropertyOf, rdfs:range and rdfs:domain. RDFS is recognized as an ontology language since it al-
lows to organize resources hierarchically using subsumption links (rdfs:subClassOf, rdfs:subPropertyOf),
to specify constraints on property values (rdfs:domain, rdfs:range). Thus, the specic classes of a domain
will be dened as instances of the Resource Class and its properties as instances of the Resource Property.
Then, the notion of hierarchy (of classes or properties) will be realized using the properties subClassOf
or subPropertyOf.
4www-ksl.stanford.edu/knowldge-sharing/kif/
5http://ksl-web.stanford.edu/kst/ontolingua.html
6https://en.wikipedia.org/wiki/KL-ONE
7https://www.w3.org/RDF/
8https://www.w3.org/TR/rdf-schema/
32
3.5. ONTOLOGY BUILDING: METHODOLOGIES, FORMALISMS, LANGUAGES AND TOOLS
RDF and RDFS limits While RDF and RDFS have been designed to be as generic as possible, this
simplicity of language is not enough to describe complex situations. For example, it is impossible to
dene that two classes are disjoint or to dene cardinality restrictions [149]. In order to address these
issues, the W3C proposed a new and more expressive language: the Web Ontology Language.
3.5.3.4 DAML-ONT
DARPA Agent Markup Language (DAML-ONT) [150] is based on XML and RDF. DAML-ONT has been
developed in October 2000 by the Defense Advanced Research Projects Agency (DARPA) to propose a
more advanced expression of RDF classes.
3.5.3.5 DAML + OIL
A number of work has been done in the eld of knowledge representation, among them we can cite
the most important such as: Simple HTML Ontology Extensions (SHOE)9, OntoBroker10, Ontology
Inference Layer (OIL)11, and DAML + OIL12 which replaced DAML-ONT13. DAML + OIL is a language
based on previous Semantic Web Working Group (W3C) standards such as RDF and RDF Schema.
It completes these languages with richer modelling primitives. DAML+OIL was developed using the
ontology language DAML-ONT in order to combine several components of the OIL language. OIL is a
web-based representation and an inference layer for ontologies. It combines the primitives of frame-based
language with the formal semantics and reasoning provided by description logic.
3.5.3.6 OWL
Web Ontology Language (OWL)14 was developed in 2004 by the Semantic Web Working Group (W3C) in
order to explicitly represent the meanings of vocabulary terms and the relationships among them. OWL
also aims to make the web-based resources easily accessible to automated processes [151] by structuring
them in an understandable and standardized way, and by adding them with meta-information. To do
this, OWL has more powerful functionalities to express meaning and semantics than XML, RDF, and
RDF Schema [152]. In addition, OWL takes into account the diused nature of knowledge sources and
allows information to be collected from distributed sources [153].
- Why OWL?
XML15 provides a syntax for structured documents but does not impose semantic constraints on the
meaning of documents. RDF is a data model to represent objects (resources) and relationships among
them. This model provides a simple semantics that can be represented in XML syntax. RDFS is a
vocabulary denition language for describing properties and classes represented by RDF resources. RDFS
denes graphs of RDF triplets with a semantics of generalization or hierarchization of these properties
and classes. OWL adds vocabularies for the description of properties and classes, relationships among
classes, cardinalities, characteristics of properties, and enumerated classes. OWL is developed as an
extension of the RDF vocabulary and is derived from the ontology language DAML + OIL. Therefore,
OWL shares several features in common with RDF, RDFS and XML.
- Sub-languages of OWL
OWL consists of three expressive sub-languages: OWL Lite, OWL DL, and OWL Full.
• OWL Lite: supports users who mainly need a classication hierarchy and simple constraints. It is
a restriction of OWL DL. OWL Lite only supports a subset of OWL language constructions and is
easy to implement.
9https://www.cs.umd.edu/projects/plus/SHOE/onts/
10http://www.semafora-systems.com/en/products/ontobroker/
11http://xml.coverpages.org/oil.html
12https://www.w3.org/TR/daml+oil-reference
13http://www.daml.org/2000/10/daml-ont.html
14https://www.w3.org/OWL/
15https://www.w3.org/XML/
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• OWL DL: uses the description logic (DL) [154]. It supports users who need maximum expressiveness
while retaining computer completeness and the possibility of decision making. It includes all the
constructions of the OWL language which can only be used under certain restrictions.
• OWL Full : is the entire language and uses all the above OWL primitives. It allows free mixing of the
OWL with RDF Schema and does not enforce a strict separation of classes, properties, individuals,
and data values. OWL Full is designed for maximal RDF compatibility and is, therefore, the natural
place to start for RDF users.
3.5.3.7 OCL
Object Constraint Language (OCL)16 is a language that allows users to write expressions and constraints
on object-oriented models. OCL allows expressing two types of constraints on the state of an object or
a set of objects.
3.5.4 Editing tools
Many ontology building tools (editing and visualization) use various formalisms and oer dierent func-
tionalities. All of these tools oer support for the ontology construction process but few of them oer
conceptualization assistance. Among these tools we can cite:
• The Protégé editor17 has been developed at Stanford University [136] and it was currently the most
used editor for ontology. Initially based on the frame model [155], the current version of Protégé
allows the development of ontologies according to the OWL ontology model. Protégé oers all the
necessary functionalities for editing the diverse elements of an OWL ontology (concepts, properties,
instances, etc.). Moreover, it oers the ability to specify constraints and use external reasoners and
rule engines such as Pellet18, Fact++19, Hermit20, etc., to check the consistency of the ontology
and infer new knowledge. Protégé is enriched by the contributions of the users and developers
community thanks to its architecture based on plugins that allow extending its functionalities.
Actually, this editor is able to integrate several ontologies and manage dierent versions of the
same ontology.
• OntoEdit21 was developed by the Knowledge Management Group of the University of Karlsruhe.
This editor provides a graphical environment for inspection, navigation, coding and modication
of an ontology. OntoEdit provides functional subsets to export an ontology according to diverse
representation languages (XML, Flogic, RDFS, DAML + OIL). In its commercial version, OntoEdit
is part of the software suite proposed by Ontoprise.
• PLibEditor22 allows the development of ontologies according to the PLIB ontology model. This
editor is based on an ontological database architecture (OntoDB) [156] which allows storing the
ontology model, the ontology and its instances. PLIBEditor can also manipulate OWL ontologies.
In fact, in its last version presented in [157], OntoDB allows to store both PLIB and OWL ontology
models and ensures a transformation between these two models. PLIBEditor is also able to check the
content of an ontology or a set of ontological-based instances and reason on them. This editor can
also import and export ontologies and their instances in the standardized PLIB exchange format.
• Ontolingua23 is a server situated at Stanford University and allows a user, or a group of users, to
visualize existing ontologies and develop new ontologies through a standard web browser. This tool
oers dierent functionalities such as the reuse (by merging or extension) of existing ontologies in
dierent domains, the real-time collaboration of a geographically distributed group to develop an
ontology, export of ontologies in dierent formats in order to use them in diverse applications.
16http://www.omg.org/spec/OCL/2.0/About-OCL/
17https://protege.stanford.edu/
18https://www.w3.org/2001/sw/wiki/Pellet
19http://owl.man.ac.uk/factplusplus/
20http://www.hermit-reasoner.com/
21http://www.semafora-systems.com/
22http://www.plib.ensma.fr/
23http://www.ksl.stanford.edu/software/ontolingua/
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• Unlike Protégé, OntoEdit and PLibEditor, which are more interested in the formal representation of
the ontology concepts, the Dierential Ontology Editor DOE editor24 privileges informal description
to describe concepts more precisely. This editor uses a 'dierential semantics' to annotate the
generalization or specialization hierarchies by applying a number of rules detailed in [158].
Here, we have detailed only the most popular ontology editors but there are others in the literature
such as KAD-Oce25, SWOOP26, etc.
3.6 Ontology reasoning
3.6.1 Semantic Web Rule Language
Semantic Web Rule Language (SWRL)27 is a standard language proposed by the W3C. This language
combines OWL DL and the Rule Markup Language (RuleML) [159]. SWRL retains the expressivity of
OWL DL and rules from RuleML.
3.6.2 SWRL sytax
Rules in the SWRL language are implication rules. Hence, the syntax of SWRL is in this form [160]:
antecedent→ consequent
This syntax implies that the consequent must be true when the antecedent is satised. OWL expressions
can occur in both antecedent and consequent [161]. Both the antecedent and consequent consist of
zero or more atoms. An empty antecedent is treated as true (satised by every interpretation), so the
consequent must also be satised by every interpretation, however, an empty consequent is treated as
false (not satised by any interpretation), so the antecedent must also not satised by any interpretation.
Multiple atoms are treated as a conjunction written: atom1 ∧ atom2 ∧ . . . ∧ atomn.
3.6.3 Reasoning systems for description logic
A number of software systems have been implemented to reason on various description logics. Among
these reasoners we can cite CEL28, Fact++29, fuzzyDL30, KAON31, SPASS/MSPASS32, Pellet33, QuOnto34,
RacerPro35, etc.
3.7 Overview of existing ontology applications in systems biology
Bioinformatics is the study of information content and information ow in biological systems and processes
[162]. With the explosion of biological data generated by high-throughput technologies, bioinformatics has
grown rapidly in the past two decades to deliver software and applications for assisting expert biologists
in their works [163].
As detailed in Chapter 2, over the last decades' new omics technologies have emerged and revolution-
ized biological researches producing an accumulation of data and knowledge about molecular mechanisms
in cells. All these data were stored in heterogeneous and various sources of data. In this way, diverse
data sources have been developed to allow researchers to share and reuse these data in the life sciences
[164]. However, the diversity of these data sources induce the propagation of misinformation. These data
24http://www.eurecom.fr/~troncy/DOE/
25https://www.topincs.com/SemanticPLM/1435
26http://semanticweb.org/wiki/Swoop.html
27https://www.w3.org/Submission/SWRL/
28http://lat.inf.tu-dresden.de/systems/cel/
29http://owl.man.ac.uk/factplusplus/
30http://gaia.isti.cnr.it/~straccia/software/fuzzyDL/fuzzyDL.html
31http://kaon2.semanticweb.org/
32http://www.cs.man.ac.uk/~schmidt/mspass/
33http://pellet.owldl.com/
34http://www.dis.uniroma1.it/~quonto/
35http://www.racer-systems.com/
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3.8. COMPARISON AMONG THESE BIO-ONTOLOGIES
integration problems gave rise to semantic web technologies, especially ontologies which may be used as a
unifying framework to solve these problems. In particular, ontologies are used in a wide range of systems
biology. Moreover, with the creation of the National Center for Biomedical Ontology (NCBO) in 2006
[165, 166, 167], an incredible amount of ontologies has emerged in the Open Biological and Biomedical
Ontologies (OBO) Foundry36 providing a large variety of bio-ontologies. By the exploration of these
bio-ontologies via browsers such the Ontology Lookup Service37 and the BioPortal38, it is remarked that
these ontologies treat dierent parts of systems biology such as cell types [168, 169], molecular functions
[170], experimental data analysis [171], etc.
Among these bio-ontologies, we can count the popular Gene Ontology (GO) [170] which aims to
formalize knowledge about biological processes, molecular functions and cell components. The Cell On-
tology (CO) [168] which provides a rich vocabulary for cell types. The Protein Ontology (PO) [172] which
provides an ontological representation of protein-related entities by explicitly dening them and showing
the relationships among them. The Systems Biology Ontology (SBO) [173] which is a set of controlled
vocabularies of terms commonly used in Systems Biology, and in particular in computational modelling.
The Biological Pathway Exchange (BioPAX) [174] which is an ontology that denes biological pathway
data, such as metabolic pathways or molecular interactions. It works based on the mathematical formal-
ism CellML39. The Anatomical Entity Ontology (AEO) [175] which provides a detailed classication for
tissues and organs. The Mammalian Phenotype Ontology (MPO) [176] which provides a classication of
phenotypic information related to the mouse and other mammalian species. The Phenotype and Trait
Ontology (PATO) [177] which denes composite phenotypes and phenotype annotation. The Human
Phenotype Ontology (HPO) [178] which provides a standardized vocabulary of phenotypic abnormalities
encountered in human disease. These ontologies (MP, PATO, and HPO) were originally designed for the
reporting of phenotypes.
3.8 Comparison among these bio-ontologies
As presented in Table 3.1 these bio-ontologies dier in the type of knowledge they describe, their intended
purpose and their level of abstraction. Although there are several promising bio-ontologies in the systems
biology domain, until now and to the best of our knowledge, there is no ontology for modelling the
behaviour of complex biomolecular networks. In fact, very few researches use ontologies for dening
the possible biological functions, like signal transducer activity in the case of the GO [170], or the Cell
Behaviour Ontology (CBO) [179] which describes and focuses on cell and tissue biology.
3.9 Thesis contribution in this eld
As was discussed, current ontologies for systems biology domain do not focus on the description of the
biomolecular network's transittability. In fact, there is a lack of standard representation of complex
biomolecular network's components and their interactions which are the basics of the transittability
notion. As was shown in the previous chapters, these entities are complex and have several kinds of
interactions among them. So, developing an ontology to formally dene this concrete domain is more
than necessary. This will be the topic of one of our contributions (Chapter 7), in which we propose a
new ontology for the representation of this domain.
3.10 Summary
This chapter has reviewed ontology by presenting the denition of the basic ontology's concepts (compo-
nents, types, ontologies development, etc.). It also describes the important literature and applications of
ontologies in systems biology highlighting their important role in cell classication, phenotype descrip-
tions, etc. This chapter discusses also issues and limits of these bio-ontologies, especially for modelling
36http://www.obofoundry.org/
37http://www.ebi.ac.uk/ols/index
38http://bioportal.bioontology.org/
39https://www.cellml.org/
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3.10. SUMMARY
the behaviour of complex biomolecular networks, and suggests some approaches that might be useful in
the future.
Before detailing the proposed semantic modelling of biomolecular networks, the following chapter will
review background on simulation and optimization methods in systems biology.
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Simulation tools in systems biology
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4.1. INTRODUCTION
4.1 Introduction
Simulation of biomolecular networks is essential for studying biological systems from small reaction net-
works to large sets of cells [180]. Models are useful for many dierent purposes, among them testing
theoretical hypotheses, guiding experiments and looking at experimentally unreachable scenarios, as well
as the ability to predict new behaviours of these complex networks.
This chapter focuses on the notion of simulation with emphasis on its use in biological systems. The
rst section presents the principles and characteristics of the simulation theory. The second section
reviews the most popular simulation tools and platforms in systems biology through a comparison study.
We will also discuss the issues and limits of these simulations and dene the contribution of our thesis in
this eld.
4.2 Principles of simulation
4.2.1 Denition
The simulation is one of the most eective decision support tools available to designers and managers of
complex systems. It consists in constructing a model of a real system and performing experiments on
this model in order to understand the behaviour of this system and improve its performance.
Formally, the simulation is the imitation of a real-world process or the functioning of a system over
time [181]. Thus, a simulation can be dened as a representation of the functioning of a system or process.
Through simulation, a model is implanted with unlimited variations producing complex scenarios. These
capabilities allow analysis and understanding of how individual elements interact and aect the simulated
environment.
Advances in computer science have signicantly increased the power of simulations. Computer sim-
ulations are often based on iterative methods for calculating the detailed state of an entire system at
the instant t + 1 depending on its state at the instant t. They are holistic because they simultaneously
consider many properties of a system.
4.2.2 Relation between modelling and simulation concepts
The concept 'modelling ' has dierent meanings: (i) modelling refers to all the activities of creation,
development and execution of virtual models of the system to be studied. (ii) Modelling merges with
numerical simulation. (iii) Modelling is the development of relationships between the characteristic
variables of a given system, able to simulate the behaviour of that system in a given context.
In our research, we follow the third denition. In order to study the behaviour of a complex system,
it is essential to distinguish between two dierent phases: (i) the development of models and (ii) their
use in a concrete study. Only the rst phase is called modelling (which we have detailed in Chapter 2)
and the second phase is called simulation (that is the main topic of this chapter). The use of models
is not limited to the simulation. Thus, the simulation is one among several objectives of the modelling.
The separation and distinction between the two phases contribute to the exchange of models and their
application.
As discussed in Chapter 2, the modelling aims to conceptualize the real world to nd a relevant
representation of reality. This concept is developed through examples and generalizations based on logical
reasoning. In fact, every object in the real world has not a universal denition and does not depend totally
on a specic model. Everyone is able to provide a personal denition based on its ideas. Communication
between humans is only possible through common and shared parts of a concept. Thus, the main objective
of modelling is the formal description of this concept (usually expressed in mathematical formalism). In
chapter 2, we have detailed these dierent categories of mathematical models.
On the other hand, the simulation phase consists of one possible exploitation of this modelling. This
simulation is guided by the objectives of its study by applying simplications on the real properties of the
studied object. For a concrete system, the models developed during the modelling phase are used and
applied to its problem. It is at this stage that the simulation of the modelled system is used to obtain
results that are otherwise too dicult to obtain.
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4.2.3 Uses of simulation
Simulation is used in research to study the behaviour of complex systems, or systems composed of multiple
interdependent processes [182], and it can be used for a variety of research purposes [183] such as:
• Prediction: the simulation provides hypotheses about the future behaviour of a system or phenom-
ena.
• Proof : the simulation conrms the theoretical knowledge.
• Discovery : the simulation is used to predict and discover new unexpected consequences or knowl-
edge.
• Explanation: the simulation is used to clarify the behaviours which are observed but their reasons
are unknown.
• Critique: the simulation can be used to explore, modify and correct the theoretical explanations
for phenomena proposed by researchers.
• Prescription: the simulation can propose a better mode of operation or method of analysis.
4.2.4 Levels of abstraction
According to the aim of the simulation and the degree of detail of the behaviour analysis that the user
wishes to simulate, diverse levels of abstraction are possible: macro, meso and micro levels.
• Themacro-simulations are simulations in which the system is studied as a whole without considering
local actions and interactions [184]. These simulations analyse global characteristics of the system.
They are important when the real system is too complex and need to be divided into small elements.
• The meso-simulations do not study a system at a global or local level but use the aggregation of
local elements and focus on the interactions among these aggregations [185]. These simulations
constitute an intermediate level where local and global components are combined in the analysis
of the system. They are used in the case of a system that is dicult to qualify and quantify at
local levels or when the user does not require ne decomposition (when it is necessary to study the
interactions among the components of the system).
• The micro-simulations have gradually emerged in diverse elds where scientists want to make
progress in the detail, realism and understanding of system [186]. These simulations consider the
system at its most local level.
In the case of meso-simulations and micro-simulations, the global behaviour is the implication of the
most local levels and results from interactions among local components. Consequently, it is possible to
combine these dierent levels of abstraction within the same simulation.
4.3 Overview of existing simulation tools in systems biology
There are two kinds of simulation tools based on the mathematical modelling approaches detailed in
Chapter 2: population-based models and individual-based models (called also agent models).
Population-based models describe the general behaviour of the whole system by the aggregation of
all the individual states and behaviours. These models are represented by a mathematical formalism
(detailed in Chapter 2). They can not describe the behaviour of individual components independently
of others. However, in order to simulate individual behaviours, it is necessary to use individual-based
models. These models are described by rules applying to each individual in order to manage their
behaviour. These rules are simple or complex.
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4.3.1 Mathematical and population-based simulation
Based on dierent approaches for modelling biological systems, diverse platforms for the simulation of
their properties have been developed.
These simulators started with the development of the BioProcess simulator (BPS) by Aspen Technol-
ogy [187] in 1985. This simulator includes a number of operation modules specic for diverse biochemical
processes such as the ultraltration, the chromatography, etc. Inspired by the BioProcess, other simu-
lators were developed such as the BioPro designer developed by the Biotechnology Process Engineering
Center at the Massachusetts Institute of Technology (MIT) and completed by INTELLIGENT [188],
the Environmental Simulation Program (ESP) developed by OLI systems, and the GPS-X [189] devel-
oped by Hydromantis. All these simulators share the same characteristics of the BioProcess simulator
and are mostly developed to simulate macroscopic behaviour such as cell development and are based on
unstructured models.
Other simulation tools to understand biochemical pathways in the cell, using a structured model of
the system have been published by diverse academic groups. We can cite: KINSIM [190], MetaModel
[191], Jarnac/SCAMP [192], MIST [193], Gepasi [194], DBsolve [195], ProMot/Diva [196] and BioSPICE
[197]. All these simulator tools aim to simulate metabolic networks based on dierential equations. These
simulations tools are basically designed to simulate structured, dynamic, and deterministic systems.
On the other hand, MetaFluxNet [198] has recently been developed to execute static simulations
used for metabolic analysis. This simulator interacts with users through standard SQL commands for
querying three databases: ENZYME [199], LIGAND [199] and EcoCyc [200]. Based on these three
databases, MetaFluxNet allows users to develop metabolic models corresponding to their objectives.
Another type of mathematical modelling based on stochastic aspects is used for simulating gene
expression. In this category, we can cite the STOCKS simulator which is a software for stochastic
simulation based on the Gillespie algorithm [201]. This simulator was used for simulating the protein
synthesis and mRNA levels of the LacZ gene of E. coli. Another simulator the StochSim [202] which is
also based on a stochastic simulation algorithm and a simple two-dimensional spatial structure. StochSim
was used to simulate the pathway controlling chemotaxis in E. coli [203].
4.3.2 Individual-based simulation
Among the popular individual-based models used for simulating biological systems, we have selected
the Potts model, Lattice gas automata, Cellular automata and Multi-agent systems. There are several
reviews that cover the uses of these models for simulating biological systems, three of them were used in
the development of this section [204], [205].
4.3.2.1 Cellular Automata
This model was detailed in Chapter 2. Cellular automata were adopted in 1966 with the publication
of Von Neumann's book 'Theory of self-reproducing automata' [206]. Then they were popularized by
John Conway through the Game of Life which was described in an article by Martin Gardner [207].
Cell automata have been used to model diverse systems such as the developmental processes in biology
[208, 209], the entire developmental lifecycle of the cellular slime mould Dictyostelium discoideum [210,
211], the cell growth and cell death [212], and the cell polarity [213]. A detailed survey containing more
examples simulated with cellular automata can be found in [205].
4.3.2.2 Multi-Agent Systems
As already detailed in Chapter 2, multi-agent systems are based on the modelling of interacting agents. It
is not necessary to model an environment because it is always modelled implicitly in the form of an agent.
Each modelled agent have its own rules and there are several types of agents as detailed in Chapter 2.
According to Grimm, multi-agent systems have two advantages. The rst is characterised as 'pragmatic'
and comes from the diculty of studying complex behaviour using mathematical models. The second
reason is called 'paradigmatic' and it occurs when mathematical models show their limits to simulate
and explain the regulation, emergence, resilience, persistence, etc. in ecosystems [214]. However, there
is no precise denition of a Multi-agent system and the evaluation of this model is delicate for lack of
tools and methodology [215, 216]. There are many multi-agent model used to simulate systems in diverse
42
4.3. OVERVIEW OF EXISTING SIMULATION TOOLS IN SYSTEMS BIOLOGY
areas, such as ecology [217, 218], solving complex problems like the Travelling salesman problem [219]. In
systems biology, works focus on protein relocations [220], the immune system [221] and cellular functions
[222].
4.3.2.3 Potts model
The Potts model was developed to model and simulate the spin interactions in the crystalline networks
[223]. This model is sometimes described as a modied cellular automaton. It consists of a regular matrix
of cells and each cell have a value describing its state. The dierence with the cellular automata is that
the individual can cover several boxes (meshes) where an individual in the cellular automata can cover
only one box (mesh). In the Potts model, an individual is represented by a region of the matrix and
the boxes have a label that allows them to know to which individual they belong. The Potts model is
related to and generalized by several other models including the XY model, the Heisenberg model and
the N-vector model. This model was used to analyse the tissue reorganization by self-organization of cells
according to the relationships among them [210, 224]. The Potts model is sometimes described as the
Cellular Potts Model or CPM [204].
4.3.2.4 Lattice gas automata
The Lattice-Gas system is called also interacting Particle System. This model was proposed by Hardy,
Pazzis and Pomeau who were interested in uid mechanics [225]. The Lattice-Gas model became known
in 1986 with the work of Frish, Hasslacher and Pomeau on the Navier-Stokes equation [226]. Lattice-Gas
system consists of a regular matrix in which each box (mesh) has several sites, each site corresponds to
one direction called a channel. In the description of this system, the commonly used term is not a box
(mesh) but we talk about a node. A particle placed in this network moves from a node to another through
the channels corresponding to its direction. Each particle takes the information concerning its velocity
to know how many nodes it must move in steps of time. This allows the management of collisions among
the particles. This notion of the node to node moving makes the Lattice-Gas system closer to cellular
automata that's why many studies called it LGCA for Lattice-Gas Cellular Automata [226]. Collision
management can be compared with the transition rules of a cellular automaton [205, 227]. A recent
extension of the LGCA model considers continuous models instead of discrete entities and it is called
the LBCA for Lattice Boltzmann Cellular Automata. This model was mainly used for the simulation
of physical systems, such as uid mechanics. Nevertheless, there are some interesting implementations
of biological systems simulation in hemodynamics [228, 229] and the metastasis formation in cancer
development [230].
4.3.3 Computational simulation platforms
4.3.3.1 Simulation standard
SBML
System Biology Markup Language (SBML)1 is a modelling language project introduced by Hiroaki Kitano
[48] in 2001 and derived from the XML standard. The SBML aims to standardize the biochemical process
models. The rst version was produced in 2001 [231] and published in 2003 [231]. Dierent versions of
the platform appeared like SBML Level 3 Version 1 Core in 2010 [232]. Some software are able to edit
models in SBML standards such as CellDesigner, V-Cell and Snoopy.
CellML
Similarly to the SBML, CellML2 is also a language project deriving from the XML standard. This project
is supported by the Bioengineering Institute of Auckland University. It was initially introduced by Waren
Hedley and Melanie Nelson [233] in 2000 on the Physiome project designed to model organ functioning
from the cellular level. Some software are able to edit models in the CellML formats such as OpenCell
and V-Cell.
1http://sbml.org/Main_Page
2https://www.cellml.org/
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4.3.3.2 Simulation tools
E-Cell
E-Cell3 is a project started in 1996 at the Laboratory for Bioinformatics at Shonan-Fujisawa University
in Keio in Japan, under the name of ECL for Electronic Cell Laboratory. Actually, it is in its third
version. This platform was developed to model the biochemical processes of the cell. The objective
of the platform's authors is to provide a model as precise as possible of a real cell and to describe the
structural characteristics of the cell taking into account its physic and chemistry reactions. E-Cell requires
models written in SBML or EML (E-Cell Model) languages. It has been used to model the mitochondrial
metabolism [234], the red blood cell metabolism [235] and the circadian rhythm in Drosophila under the
inuence of light [236].
CompuCell3D
CompuCell3D4 is available online in its version 3.7.2. This platform appeared in 2003 before being
ocially introduced by Lzaguirre et al. in 2004 [237]. It derives from the work of François Graner and
James Glazier (CPM and Q-Potts) in 1992 [224, 238]. CompuCell3D is presented by its authors as a
multi-model support because it is based on the parallel use of three components: a Potts model, a diusion
management module, and a module that manage the continuous mathematical models. CompuCell3D is
developed for the study of morphogenesis and is based on the authors' expertise to model the cellular
rearrangements directed by the forces acting on their surface, complemented by the consideration of cell
genetics and the presence of chemical substances in the environment. This platform requires models
written in CCML or CC3DML which are derived from the XML standard. CC3DML is an extension of
the CCML language that allows the description of phenomena in 3 dimensions and CCML is limited to
2 dimensions. CompuCell3D has provided convincing results in morphogenesis by reproducing patterns
characteristic of microbial evolution in [239], in embryogenesis by allowing simulation of the gastrulation
process in the chicken embryo [240], and in the segmentation of the vertebrate embryo [241, 242]. Several
examples of simulation done by this platform have been referenced by Maciej Swat [243].
SimCell
SimCell5 is a model based on a variant of cellular automata called dynamic cellular automata proposed
by Wishart et al. [244]. This dynamic cellular automaton consists of cellular automata in which a
box of the cellular automata represents at most one macromolecule or a multitude of small molecules.
The rest of cellular automata characteristics describes a regular two-dimensional cellular automaton
with heterogeneous, probabilistic and synchronous functioning. This model is intended to be a general
structure for simulating most cellular processes. SimCell has three steps: (i) create the network using the
graphical user interface, (ii) simulate the behaviour of this network using the cellular automata, and (iii)
generate at any time during the simulation, graphs and tables to present the evolution of the dierent
entities involved in the network. SimCell uses colours to model species, however, it contains 70 colours,
therefore it is limited to 70 species. In addition, when the number of molecules is large, the clarity of
the cellular automata becomes complicated. As well as the analysis of the graphs. SimCell is suitable for
simulating simple biochemical networks in a reduced environment. It gives good results to analyse the
Brownian movement and highlight the role of luck in the proper functioning and regulation of cellular
processes [244].
V-Cell
V-Cell6 has been developed by the CCAM (Center for Cell Analysis and Modeling) in 1997 and is based
on the work of Scha et al. [245]. It is designed as a modelling tool for cellular processes for research in
cell biology. For this reason, it is able to model the dierent nature of complex models (mathematical or
empirical). V-Cell is comparable to SimCell in many characteristics. The dierence between them is that
SimCell is constrained to 70 kinds of entities, however, there is no limit of entities for V-Cell. Moreover,
3http://www.e-cell.org/
4http://www.compucell3d.org/
5http://wishart.biology.ualberta.ca/SimCell/
6http://vcell.org/
44
4.3. OVERVIEW OF EXISTING SIMULATION TOOLS IN SYSTEMS BIOLOGY
the managed space is not two-dimensional but three-dimensional. V-cell is less suitable for simulating the
details of elementary processes such as the diusion but is more suitable for understanding the general
functioning of the cell. It has been used to model cytoskeleton dynamics [246] and the biochemical origin
of electrophysiological phenomena in neurons [247].
4.3.4 Discrete Event System Specication
Based on systems theory, the Discrete Event System Specication (DEVS) is a formalism introduced by
Zeigler in 1976 to describe discrete-event system in a hierarchical and modular manner. It is theoretically
a well-dened system formalism [248]. The DEVS models are seen as black boxes with input and output
ports used to describe system structure and behaviour. Therefore, DEVS oers a platform for modelling
and simulating complex systems in dierent domains. DEVS denes two kinds of models: atomic models
and coupled models representing respectively the behaviour and the internal structure of a part of a
model.
4.3.4.1 Basic Models
Formally, an atomic model is dened as a seven-tuple AM = 〈X,Y, S, δint, δext, λ, ta〉 where X is the set
of input events, Y is the set of output events, S is the set of state variables, δint : S → S is the internal
transition function, and ta : S → R+0,+∞ is the time advance function. δext : Q×X → S is the external
transition function, where Q = {(s, e)|s ∈ S, 0 ≤ e ≤ ta(s)} is the set of total states and e is the time
elapsed since the last transition and λ : S → Y is the output function.
A DEVS model is always in a state s ∈ S at a given time. The model can transit from a state to
another using the transition functions δint and δext. In the absence of external events, it remains in
the state s for a lifetime of ta(s). When ta(s) is reached, the model outputs value y ∈ Y through its
ports using the output function λ(s), then it changes to a new state dened by δint(s). In the case of
an external event triggered by external inputs, the external transition function determines the new state
given by δext(s, e, x), where s is the current state, e is the time elapsed since the last transition, and
x ∈ X is the external event received.
4.3.4.2 Coupled models
A coupled model denes how a set of models (atomic or coupled) are matched together to create a new
model. Formally, a coupled DEVS model can be dened as CM = 〈X,Y,D,Md ∈ D,EIC,EOC, IC, select〉
where X is the set of input ports for the reception of external events, Y is the set of output ports for the
emission of external events, D is the set of all DEVS components (atomic and coupled), Md is the DEVS
model of the component d ∈ D, EIC is the set of input links that connect the inputs of the components
that it contains, EOC is the set of output links that connect components to the output of coupled model,
IC the set of internal links that connects the output ports of the components to the input ports of the
components in the coupled models, and select(D) → md the selection function to resolve the activation
process of models.
Through the select function, the coupled model can organize the modelling. This determines the order
in which conicting models (external or internal) are to be scheduled.
4.3.4.3 Benets of DEVS
DEVS has been extended in order to be able to model and simulate continuous and complex systems.
Several works [249, 250, 251, 252] have proved that discrete-event methods and in particular the DEVS
formalism present several advantages:
• Separation of the modelling and simulation phases.
• Ability to represent a system in its functional and structural form.
• Hierarchical modular modelling, which improves verication and validation, also enhancing reusabil-
ity.
• Computational time reduction: for a given precision, the number of calculations can decrease.
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• Hybrid systems modelling: the discrete-event paradigm provides a unied theory to model and
simulate systems with continuous and discrete components.
• Ability to be extended to new elds of study or to be integrated into other modelling approaches
(Petri nets, cellular automata, etc.).
The DEVS formalism has been used to simulate enzymes [253] and the tryptophan synthetase metabolic
pathway [254].
4.4 Comparison among these simulation tools and platforms
Most of these simulation tools propose the use of complicated mathematical models that are composed
of equations for simulating the behaviour of biomolecular systems. However, the mathematical models
for simulating the behaviour of biomolecular systems are sometimes complicated to solve considering the
high number of molecular components and their heterogeneity. In fact, one of the major problems in
simulating complex biological systems using mathematical models is the lack of quantitative data. Indeed,
most of the biological knowledge available is qualitative but for quantitative simulation, a large amount
of numerical data (such as concentrations of metabolites and enzymes, ux rates, kinetic parameters and
dissociation constants) is required.
Moreover, these methods do not follow individuals over time, instead, they track only total popu-
lations. They also consider that the interactions among molecular components are homogeneous and
assume that the entire system is just the sum of its components which is not necessarily true.
Others simulation tools such as Boolean and logic networks are suited to simulate the small network
and particularly Gene Regulatory Networks and signalling pathways. However, it becomes impractical
to simulate large biomolecular network sizes (for n nodes, we have 2n possible states).
Despite mathematical methods, we have also focused on individual-based models such as cellular
automata, Potts models, Lattice gas models, multi-agent models, etc. Both can be considered as cellular
automata and they have the same characteristics. These models respond to the simulation of complex
systems and are a suitable tool for studying the behaviour of such systems. The advantages of this
kind of simulation tools are that they are easy to implement and simple in design. But the interactions
and relationships among individuals are complex. Multi-agent models provide a detailed description of
complex systems. However, if they provide a high level of detail, their design generates a high cost.
As well as, the disadvantages of such systems consist of the inability of agents to the more complex
organization and the excess parallelism of task's execution. This creates dicult and obscure models.
Others simulation tools such as SimCell, are respectively based on the cellular automata and a discrete
model was totally designed for analysing the response of each individual in a population (respectively,
each component in the biological system) and how this individual contributes within the population.
Thus, these models focus only on the equilibrium and regulation of populations through interactions
that exist among their individuals under the constraints of the environment. These models focus only
on reproducing the modication of individuals over generations under the constraints of environmental
change or competition among individuals. Consequently, they aim only on the evolution of systems at
the population scale. Thus, we can conclude that all these simulation tools are dedicated to very specic
problems.
On the other hand, some platforms are designed to treat dierent problems, such as V-Cell. These
generic platforms require that the system must be formalized under the required standard formalism to
be simulated. Among these specic standards, we have discussed the SBML and CellML corresponding
respectively to the V-Cell and Snoopy platforms. The limit of these generic platforms is that they can
not simulate multi-level models. They are designed to address only a specic level of the system that
typically takes place at a given time and place. Therefore, they can not focus on the interactions among
the dierent omics levels.
We also discussed another formalism the discrete-event system specication for coupling dierent
heterogeneous data models, dierent levels of a system, specication of sub-models of the system in a
single formalism, etc. Under the DEVS formalism, the behaviour of the whole system is easier to simulate
if it is represented by a set of states that characterize the individual's activity. In this formalism, a denite
type of response of the individual to external stimulus corresponds to a set of states. Moreover, these
stimuli are generally not represented by continuous functions in the environment but by occasional events.
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In its original version, DEVS formalism allows the specication of event status changes and provides a
modular and hierarchical view of dynamic systems. So, we think that it is the most suitable for simulating
complex biological systems.
Table 4.1 provides a comparison of all these methods according to their characteristics. Indeed, we
compare these dierent simulation methods based on various criteria, such as
• The abstraction level focuses on the level of detail (macro-, meso- and micro-levels).
• The topic interest focuses on the interested subject (specic to a subject or general to diverse
topics).
• The network size focuses on the size of the biomolecular network (small- or large-scale).
• The category focuses on the type of the simulation (discrete, continuous or stochastic).
• The data type focuses on the type of data to be simulated (qualitative or quantitative data).
• The dynamic simulation focuses on the level of details of the simulation (local or global vision)
• The diculty level focuses on the complexity with which the model can be understood and manip-
ulated (easy or hard).
• Cost : includes all the charges for design, implementation, operation and maintenance (low or high
cost).
After discussing all the properties of these simulation methods, we note that no method is better
than the rest, only more suitable for a certain problem. Each of these tools has its own uses and is best
suited for solving problems of certain scale and complexity. However, most of these methods consider
the biomolecular network as a simple network usually taking account only one level by focusing only
on modelling isolated parts of this network, such as metabolic networks, gene regulation networks, and
protein-protein interaction networks. However, the interconnection among these dierent network levels
reects the importance of a general approach that focuses on the multi-level properties of biomolecular
networks to replace these traditional methods. In practice, qualitative models and quantitative models
complement each other. The choice between qualitative models and quantitative models depends on the
availability of kinetic information, the size of the systems and the types of questions to be addressed.
So, we conclude that the choice of a simulation method is determined by the characteristics of the
system in which we are interested, how realistic an estimation of it we want, and our mathematical and
computational resources. Thus, all of these simulation methods can be used but each method incorporates
dierent levels of detail and requires dierent computational eort.
4.5 Thesis contribution in this eld
The whole behaviour of the cell is an emergent behaviour of many component's interactions (such as DNA,
proteins, and metabolites) belonging to dierent levels (genome, proteome and metabolome). That is
why, after the detailed comparison presented above, we conclude that it is not enough to simply describe
the system's components or to only simulate a specic level such as genetic or metabolic level, etc. Indeed,
there are still many diculties that inhibit the construction of a complete simulation method. Therefore,
in order to understand the global behaviour of biological systems, it is also necessary to detail the local
behaviour of each component at the molecular level and to understand what happens when certain
external stimuli or intern malfunctions occur. So, rather than the previous approaches which focus
on traditional reductionist methods, we think that the behaviour of the complex biomolecular network
emerges from the network-level interactions and requires an integrative simulation tool. That is why we
will propose in Chapter 8 a simulation approach based on the DEVS formalism and combines logical-
based modelling and qualitative simulation. This simulation approach will consider all the omic-levels
and will be able to predict and reproduce the behaviour of the biomolecular network and its components
under a wide variety of stimuli or stresses.
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4.6 Summary
This chapter presented the principles (denitions, uses, levels of abstraction, etc.) that characterize the
concept of simulation in general. It also detailed the dierent simulation tools and platforms in dierent
categories and for dierent purposes. In fact, each simulation uses a model that makes it possible to
study a particular phenomenon and explain the performance of the simulation results in relation to the
real phenomenon and the user's desired objective. This state-of-the-art reveals the limitations of some
simulation tools based on mathematical modelling (due to their enormous size it becomes complicated to
dene exactly their parameters).
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5.1 Introduction
Optimization is a rapidly growing discipline that aects various research elds, such as vehicle routing
problems, scheduling problems, assignment problems, air trac problems, etc. but also satisfy the needs
of system biology. The optimization of these systems allows nding an ideal conguration for saving
eort, time, money, energy or improving satisfaction. Some real-world problems require the simulta-
neous optimization of several criteria which can sometimes be contradictory. This is the case of the
transittability of complex biomolecular networks that can be considered as multi-objective optimization
problems.
In this chapter, we present the state of the art of optimization methods in general and multi-objective
optimization methods in particular. The rst section presents some background denitions about the
optimization concept and its basic components. Next, we give the dierent classication of optimization
problems according to their characteristics by focusing on mono and multi-objective optimization prob-
lems. Then we present the popular optimization methods for solving multi-objective problems. Moreover,
we review the major applications of optimization problems in systems biology through a comparison study.
Finally, we discuss the contribution of our thesis to understand the transittability of complex biomolecular
networks.
5.2 Optimization problem: denition and basic concepts
In this section, we will dene all the basic components of the optimization problem. To do this, we refer
to many literature reviews detailing these notions and available in [1, 255, 256].
5.2.1 Denition
An optimization problem is dened as a problem that aims to search the minimum or maximum (the
optimum) of a given function f , so-called objective function [257].
According to M. Ejday [257] the optimization concept consists of two steps. These steps are illustrated
in Figure 5.1.
• A rst modelling step in which the user denes the objective function, the main optimization
variables so-called decision variables, and the equality and inequality constraints. In the next
sections, we will detail these concepts.
• The second step of resolution consists in the search for the best values by optimizing the objec-
tive function dened in the rst modelling step. This resolution is done through an optimization
algorithm [258].
Figure 5.1  Modelling and resolution steps of an optimization problem.
Optimization has been introduced in order to improve the services provided regardless of their appli-
cation areas. Indeed, the need for optimization comes from the engineer's need to provide the user with a
system that best meets its requirements. This system must be designed to (i) use the minimum necessary
for its functioning (a minimum cost of resources), (ii) consume less energy (minimum operating cost),
and (iii) respond to the user's request (satisfy all requirements).
This section denes some basic concepts of optimization theory. To do this, we have used these works
[1, 255, 257, 256] to give some denitions of these notions.
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5.2.2 The objective function
The objective function called also cost function or optimization criterion denoted by f is used in math-
ematical optimization to describe a function that the optimization algorithm will have to optimize (nd
an optimum). This function represents the goal that the decision-maker wishes to achieve, and it is also
used for measuring the goodness of values for the decision variable.
5.2.3 The vector of decision variables
The decision vector X is composed of the dierent decision variables of the problem. These variables
express qualitative or quantitative data that need to be determined in order to solve the given problem.
A decision variable is denoted by x ∈ X and can be a number, vector, function, etc. It is by changing
the values in this vector that an optimum of the function f is obtained.
5.2.4 Constraints and delimitation of the research space
There are two types of constraints: inequality constraints denoted by the vector g(x) and inequality
constraints denoted by the vector h(x). These sets of constraints dene a restricted space for nding the
optimal solution.
We distinguish two kinds of inequality constraints:
• Constraints of type Biinf ≤ x ≤ Bisup: the values of the decision variables that validate these
constraints dene the research space or state space. This space is the space of all possible and
complete solutions for the optimization problem. This space is nite and dened by the domains
of denition of the dierent decision variables of the problem (Figure 5.2a).
• Constraints of type c(x) ≤ 0 or c(x) ≥ 0: the values of the decision variables that check these
constraints dene the space of the achievable values. This space is shown in Figure 5.2b.
(a) (b)
Figure 5.2  Example of merging: 5.2a The research space. 5.2b The achievable space.
5.2.5 The dierent types of optimum points
For a given function f , there may be few points at which the function reaches larger (or smaller) values
which may be higher (or lower) within some given neighbourhood. The higher points are called relative
maxima (or local maxima), while the lower points are called as relative minima (or local minima). Within
a given interval, a function must have one (or more) highest and lowest point(s)1. As well as, the highest
point is called global maximum and the lowest point is called global minimum [1, 259].
1https://math.tutorvista.com/statistics/global-minimum.html
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In the following sections, we will only consider the problem of minimization. In fact, the problem of
maximization follow the same rules. Here, we treat the case of the minimization without losing generality
because maximizing fi means minimizing −fi. Since, for example if f is a numerical objective function,
maximizing (f) is same as minimizing (−f).
5.2.5.1 Local maximum and minimum
Optimization functions can have 'hills and valleys': places where they reach a minimum or maximum
value. It may not be the minimum or maximum for the whole function, but only for a local interval.
Local minimum
First, we need to choose an interval. Then we can say that a local minimum is the point where the height
of the function at a is smaller than (or equal to) the height anywhere else in that interval. Formally, if
and only if f(a) ≤ f(x) for all x in the interval.
Formally, a point x∗ is a local minimum of the function f only if f(x∗) ≤ f(x) for all x ∈ V (x∗),
where V (x∗) denes the interval of a neighborhood of the point x∗. This denition corresponds to points
M1 M2 and M4 in Figure 5.3.
Local maximum
Likewise, a local maximum is the point where the height of the function at a is greater than (or equal to)
the height anywhere else in that interval. Formally, if and only if f(a) ≥ f(x) for all x in the interval.
5.2.5.2 Global maximum and minimum
The maximum or minimum over the entire function f is called a Global maximum or minimum. Formally,
a point x∗ is a global minima only if f(x∗) ≤ f(x), for all x in the domain of f . This denition corresponds
to the point M3 in Figure 5.3.
Figure 5.3  Global minimum and local minima [1].
5.3 Classication of optimization problems
According to [1], the dierent optimization problems are classied according to their characteristics as
follows:
• Number of decision variables:
 One =⇒ single-variable or mono-objective optimization problem.
 Multiple =⇒ multi-variable or multi-objective optimization problem.
• Type of decision variables:
 Continuous real number =⇒ continuous optimization problem.
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 Integer number =⇒ discrete optimization problem.
 Permutation on a nite set of numbers =⇒ combinatorial optimization problem.
• Type of the objective function:
 Linear function of the decision variables =⇒ linear optimization problem.
 Quadratic function of the decision variables =⇒ quadratic optimization problem.
 Non-linear function of decision variables =⇒ non-linear optimization problem.
• Formulation of the problem:
 With constraints =⇒ constrained optimization problem.
 Without constraints =⇒ unconstrained optimization problem.
Indeed, there are dierent types of optimization problems that depend on the number and type
of the decision variables, the type of the objective function (linear, quadratic or non-linear) and the
formulation of the problem (with or without constraints). In addition to these characteristics, the number
of optimization objectives divides optimization problems into two major kinds. In this chapter, we
focus on these two categories of optimization problems: mono-objective optimization and multi-objective
optimization. In the following sections, we present the main concepts that are related to them. Moreover,
we dene some optimization methods for solving these problems.
5.4 Mono-objective optimization problem
Mono-objective optimization consists of one and only one objective or criterion to be optimized. This
is a category of optimization problems that are generally 'easy' to solve. The term easy here is used not to
denote the level of diculty of this type of problems but their diculty in comparison with multi-objective
problems [1]. Indeed, mono-objective problems do not present a conict of interest in focusing on one of
several optimization criteria in contrast to multi-objective problems that have to consider several criteria.
Mono-objective optimization seems easy, but they have also diculties such as the non-linear objective
function that cannot be expressed analytically in terms of parameters. In fact, modelling the problem
in the form of a single equation can be a very dicult task. Moreover, reducing the mathematical
formulation of the problem to a single objective function can lead to errors and mistakes in the modelling.
This problem does not exist in the multi-objective optimization where a certain degree of exibility is
allowed [1].
A mono-objective optimization problem is mathematically dened as:
Minimize/Maximize f(x) (function to be optimized)
with g(x) ≤ 0 (inequality constraints)
With x ∈ Rm, g(x) ∈ Rp and h(x) ∈ Rq.
5.5 Multi-objective optimization problem
Most real optimization problems are described by several criteria frequently contradictory and which
must be optimized simultaneously [255]. Multi-objective optimization aims to optimize these multitudes
of objectives at the same time considering that they can be contradictory and generate conicts of
interest. These objectives can be explicitly dened as objective optimization criteria or formulated as
constraints. Formally, a multi-objective optimization problem is dened by the triplet (X,F, g) that
consists in minimizing F (X) for X ∈ X with g(X) ≤ 0, and mathematically dened as follows:
Minimize F (X) = (f1(X), f2(X), . . . , fn(X)) (functions to be optimized)
for X ∈ X
with g(X) ≤ 0 (inequality constraints)
With x ∈ Rm,F (X) ∈ Rn , g(x) ∈ Rp and h(x) ∈ Rq.
The m decision variables are the values to be chosen in an optimization problem. These values
are denoted by xi with i ∈ {1, . . . ,m}. The vector X of the m decision variables is denoted by X =
(x1, x2, ..., xm). The set of decision variable vectors form the search space X . The n objective functions
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to be optimized are denoted by fi with i ∈ {1, . . . , n}. The vector F of the n objectives (for X ∈ X )
is represented by F (X) = (f1(X), f2(X), . . . , fn(X)). The p inequality constraints and the q equality
constraints limit the values that the decision variables can take. They are respectively denoted by gi(X)
with i ∈ {1, . . . , p} and hi(X) with i ∈ {1, . . . , q}.
As discussed above, a multi-objective optimization problem has the advantage of providing a level of
exibility which is absent in mono-objective optimization. In addition, this exibility aects the space of
solutions by changing it from a single solution to several solutions. As well as, this space depends on the
adopted optimization approach. Indeed, the objectives are sometimes contradictory, therefore, optimizing
one objective can negatively aect one or more others. As a result, an optimal solution does not exist
but we are talking about optimized solutions because multi-objective optimization cannot optimize all
the objectives at the same time and should give the priority to only some of them. It is in this case
that the concept of compromise is introduced because certain objectives will be preferred (optimized)
to the exclusion of others having a bad quality performance. These solutions are considered useful and
appropriate according to the user requirements.
Thus, in contrast to the mono-objective optimization problem, where the optimum is not a simple
point but a set of points so-called the set of the best compromises or Pareto Front which is an area of
solutions that oer a good compromise between the dierent objectives [1]. Therefore, the optimality
in a multi-objective context is based on the notion of dominance relation and Pareto-optimal (ecient)
solution. We will recall their denitions in the following sections.
5.5.1 Dominance relation
In multi-objective optimization problem, the solutions extracted are called Pareto solutions and constitute
the surface of compromise. The goodness of a solution is determined by the dominance relation. A solution
x1 dominates another solution x2 (noted x1 ≺ x2) if both the following conditions are true:
• Solution x1 is no worse than x2 in all objectives.
• Solution x1 is strictly better than x2 in at least one objective.
x1 ≺ x2
{
fi(x1) ≤ fi(x2) ∀i ∈ 1, . . . , n
∃j ∈ 1, . . . , n fj(x1) < fj(x2)
Solutions that dominate the others but are not dominate themselves are called non-dominated solutions.
Through this denition, the dominance relation is considered as a lter of the bad elements to keep only
solutions that cannot be compared with each other.
5.5.2 Pareto-optimal solutions
A number of criteria distinguish the selected solutions called Pareto-optimal solutions (or non-dominated
solutions) when they are not dominated by any other solutions in the feasible space. The non-dominated
set of the entire feasible decision space is called the Pareto-optimal set. The boundary dened by the set
of all point mapped from the Pareto-optimal set is called the Pareto-optimal front.
Like there are global and local optimum in the case of mono-objective optimization, we can also dene
global and local Pareto-optimal sets in multi-objective optimization. According to [256] we have:
• Local optimality in the Pareto sense: A solution x1 is locally optimal in the Pareto sense, if there
exists a positive real ε > 0 such that there is no other solution x2 that dominates the solution x1,
with x2 ∈ Rm ∩B(x1, ε), where B(x1, ε) shows a bowl having a center x1 and a radius ε.
• Global optimality in the Pareto sense: A solution x1 is globally optimal in the Pareto sense, if there
does not exist any vector x2 that dominates the vector x1.
The main dierence between the global and local optimality lies in the fact that we do not have a
restriction on the set Rm anymore. Thus, the Pareto set or the ecient set is the collection of all
Pareto-optimal solutions and their corresponding images in the objective space is called the Pareto front.
These solutions are obtained using a precise approach based on a specic optimization method among
a wide range of techniques available in the literature [2]. The choice of the method to be applied must be
adapted to the optimization problem to be solved. This choice represents a signicant diculty because
it is responsible for the success or not of the adopted method.
In the following, we focus on the optimization methods that can be used in this context.
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5.6 Optimization methods
As discussed in the previous section, depending on the case (whether a single-variable or multi-variable,
continuous or discrete problem, etc.), an appropriate optimization method is carefully chosen to solve the
problem in an ecient way [259]. Several methods have been developed to solve mono-objective problems
such as exact, heuristics, meta-heuristics, hybrid, etc. [2]. However, not all of them are appropriate for
the multi-objective optimization problems, therefore a reasonable choice should be made according to the
nature and complexity of the given problem.
There are dierent classications of these various optimization methods for solving multi-objective
optimization problems in literature. According to DA Van Veldhuizen [260], optimization methods can
be grouped into four main categories:
• No preference methods which are methods where the decision maker is not considered and the
problem is saved using a simple method that presents directly the solution to the decision maker.
• A priori optimization methods which are methods where the compromises and preferences that we
would like to optimize are determined before the execution of the optimization method. In this
method, the preferences of the decision maker are asked and then the best solution according to
the given preferences is found.
• A posteriori methods which aim to generate a representative set of Pareto-optimal solutions and
the decision maker chooses the best one among them. This method allows the decision maker to
choose the solution that is suitable for his problem by comparing it with the rest of the solutions.
• Interactive methods called also progressive optimization methods allow the interaction of the decision
maker during the optimization process. This interaction is done by asking questions with the
decision maker.
In the following sections, we will only present the most used methods. To do this we follow the
classication proposed by Colette et al. in their work [1] to group all the optimization methods into four
categories: the interactive methods, scalar methods, fuzzy methods, and methods based on metaheuris-
tics.
• Interactive methods: As discussed in the previous section, these methods are considered as pro-
gressive methods which allow searching a single solution. They are based on the interaction with
the decision maker who can choose the solution that best corresponds to his preferences. In this
category, we cite the STEP method, the substitution compromise method, the Fandel method, etc.
• Scalar methods: They include a set of methods which are the most evident approach for solving
multi-objective optimization problems. This approach called `naïve approach' aims to reformulate
the optimization problem in order to return to a mono-objective optimization. This process is
frequently achieved by using the aggregation (or the sum) of all objective functions in a single
function. A weighting coecient is assigned to each objective function to indicate its importance
in the global objective function. By aggregating these weighted objective functions, we obtain a
single objective function. In this category of methods, we can also nd the Keeney-Raia method
[261], the distance to a reference objective method, etc.
• Fuzzy methods: These methods are inspired by fuzzy logic theory. They aim to neglect the binary
logic (true or false) and consider a certain degree of exibility in order to accept the uncertainty
and imprecision of human knowledge. In this category, we nd the Sakawa method, the Reardon
method, etc.
For more detail, we can refer to the works of Colette et al. [1] in which they list, detail and formalize
all these methods.
5.6.1 The methods based on a metaheuristic approach
These methods have been developed since the 1980s. They include tabu search methods, simulated
annealing, genetic algorithms, ant colony algorithms, etc. The concept of metaheuristic was introduced
57
5.6. OPTIMIZATION METHODS
by Fred Glover in [262] who dened it as follows: 'A metaheuristic refers to a master strategy that guides
and modies other heuristics to produce solutions beyond those that are normally generated in a quest
for local optimality '. As well as, another denition was proposed in [263], 'metaheuristics are solution
methods that orchestrate an interaction between local improvement procedures and higher level strategies
to create a process capable of escaping from local optima and performing a robust search of a solution
space'.
Their major objective is to solve dicult optimization problems. In fact, metaheuristics were initially
dedicated to solving the diculty of optimization problems. In contrast to traditional optimization
methods (which take the path of the biggest slope to quickly nd the local minima, but once they get they
found the local minimum they do not search anymore), the main advantage of these methods is their ability
to avoid local minima. In fact, traditional methods start from an initial conguration and search for the
best value through a series of iterations, while metaheuristics tolerate the momentary deterioration of the
situation. This idea has proven to be eective in avoiding local minima (or maxima) for solving complex
problems and become the basis of all neighbourhood metaheuristics (simulated annealing, tabu search,
etc.). There are also other metaheuristics so-called distributed metaheuristics, such as evolutionary
algorithms which also have very particular techniques to solve local minima (or maxima) problems.
In the next sections, we review metaheuristics cited above introducing their properties and functioning.
5.6.1.1 Simulated annealing
The simulated annealing method [264] is inspired by the annealing process and based on the principle of
starting from a given conguration to achieve the desired result. This result concerns the global optimum
(or a result that is close to it) achieved by applying elementary transformations into a nite number of
iterations.
In practice, this method uses the Metropolis algorithm which denes and represents the behaviour
of a system in thermodynamic equilibriumat a specic temperature (T ) [264]. Starting from a given
conguration, this method changes the system by modifying its basic elements such as the translation of
a component or the exchange of two components. If this modication generates an improvement to the
desired objectives (for example a reduction of the objective function), it is accepted. On the other hand,
even if this same change leads to a deterioration, it will be accepted but only with a certain probability
of e−δE/T . Much that the higher the temperature, the more highly to keep the deteriorated state. This
procedure is repeated by keeping the temperature T constant until the thermodynamic equilibrium is
reached after a number of iterations. Once this goal has been reached, the whole process is repeated for
a new lower temperature value. A series of transformations is then performed on this value again.
Figure 5.4 presents the main steps of the simulated annealing algorithm [265]. In this gure, the
process described above is summarised and presented under a diagram summarizing the main steps
followed when applying an optimization method based on simulated annealing. There are several variants
of the simulated annealing method such as the simulated diusion, micro-canonic annealing, threshold
method, ooding method or record-breaking trip method.
5.6.1.2 Tabu search
The tabu search method was formalized in 1986 by F. Glover in [266]. The main advantages of this
method are based on techniques inspired by human memory. In contrast to the simulated annealing
method which is completely devoid of memory, the tabu search saves the history of the dierent steps of
its application. It is able to react based on the lessons of the past. The actions performed in the current
iteration are aected by the previous actions that constitute the history of its execution. In addition,
the tabu search method is simple. In fact, its procedure is similar to the simulated annealing method
and consists in applying a series of changes to several iterations of the process. The tabu search method
works with only one conguration at the same time. Initially, this conguration is obtained arbitrary and
then locally updated (only small changes at each step). At each iteration, the mechanism of switching
from a given conguration c to a successor conguration c
′
follows these steps [267]:
1. The construction of all the neighbours of c. This set represents all possible and achievable congura-
tions accessible in a single elementary movement applied to c. If this set is too large, a well-dened
technique is applied to reduce its size. Among these techniques: the selection of a list of candidates
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Figure 5.4  Diagram illustrates the process of the simulated annealing [2].
or the random extraction of a subset of xed-size neighbours. V (c) denotes the set (or the subset)
of these neighbours.
2. The evaluation of the objective function f in each of the congurations belonging to V (c). In terms
of optimizing the objective function, the conguration c
′
that succeeds c would be the best among
those constituting the set V (c). In addition, this same conguration c
′
can be taken into account
even if it proves to be less good than the rst one c ( f(c
′
) > f(c)). This emphasizes the particularity
that constitutes the main advantage of metaheuristics (especially the tabu search method in this
case) which consists in avoiding the local minima (or maxima) of the objective function f .
This procedure is sometimes ineective because there is a frequent risk of returning to a previous con-
guration already retained in a previous iteration. This generates a cycle and consequently the blockage
on an innite loop. In order to avoid this problem, the tabu search method introduces the concept of the
prohibited actions resulting in the construction of a list of prohibited movements. At each iteration, this
list which is continuously updated is used. The tabu search method takes its name from this list which is
itself called the tabu list. This list contains a nite number m of prohibited movements (c→ c′) applied
to c to have the c
′
conguration. Figure 5.5 presents a detailed diagram for the execution of the tabu
search method.
The tabu search method is eective and provides excellent results in solving some optimization prob-
lems [2]. In addition, this method has fewer parameters in its basic form and is easier than the simulated
annealing method. However, if we add the mechanisms associated with this method such as intensication
and diversication, we can see an increase in its complexity.
5.6.1.3 Evolutionary Algorithms
Evolutionary algorithms were introduced in the 1950s [268]. They use research methods inspired by the
biological evolution of species. They have initially attracted limited interest due to their high computa-
tional cost. However, interest in these techniques has considerably increased over the last two decades
thanks to the increase in the performance of computers. The principle of an evolutionary algorithm is
simple. Indeed, it is a question of considering a set of N points chosen randomly in a space of initial
search. This set constitutes the initial population. Each individual x in the population has a certain level
of performance which measure its adaptation to the target objective.
The basic principle of an evolutionary algorithm is to progressively change (by successive generations of
individuals) the composition of the population while maintaining its constant size. Over the generations,
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Figure 5.5  Diagram illustrates the process of the tabu search [2].
the main objective is to improve the overall performance of individuals. To achieve this objective, the
evolutionary algorithm uses two main mechanisms that determine the evolution of living organisms.
These mechanisms are dened by C. Darwin's theory [269]:
1. The selection mechanism that focuses on reproduction and survival of the best performing individ-
uals.
2. The reproduction mechanism that consists of mixing, recombining and changing the hereditary
characteristics of parents in order to form descendants with new potentialities.
In practice, a well-dened representation of the individuals in a population must be chosen. For example,
for combinatorial problems, an individual can be classically assimilated to a list of integers. However, for
numerical problems manipulating variables in continuous spaces an individual is represented by a vector
of real numbers, a string of binary numbers in the case of Boolean problems, or a combination of these
representations in more complex structures. At each iteration of the algorithm execution, there are four
phases of transition from one generation to another:
• A selection phase which consists of identifying and selecting chromosomes from the population to
be parents to crossover. According to Darwin's evolution theory, the best ones should survive and
create new ospring. There are many methods how to select the best chromosomes such as the
roulette wheel selection, the rank selection, etc.
• A reproduction phase consists of applying specic variation operators to the copies of the selected
individuals in order to generate new ones. Among these operators, the crossing (or recombination)
that allows producing one or two descendants from two parents, and the mutation that allows
producing a new individual from a single individual. The structure of the variation operators is
based on the representation chosen for individuals that strongly depends on their coding.
• An evaluation phase aims to evaluate the performance of the new individuals generated in the
previous phase according to the desired objectives.
• A replacement phase that concludes the process of dening a new generation of solutions and deter-
mines the choice of its members. For example, the lowest performing individuals in the population
can be replaced by the best (the highest performing) individuals produced. The algorithm is stopped
after a certain number of generations according to a stop criterion specied by the user.
If the optimization problem is based on an objective function with several global optima, evolutionary
algorithms are particularly suited to propose a set of diverse solutions. Indeed, they can provide a variety
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Figure 5.6  Diagram illustrates the process of the evolutionary algorithm [2].
Figure 5.7  Diagram illustrates the process of the genetic algorithm [2].
of compromise solutions for resolving the multi-objective problem. Figure 5.6 provides a description of the
evolutionary algorithm execution. One of the most important variants of evolutionary algorithms is the
genetic algorithms [269]. These algorithms are inspired by the Genetics (phenotype of natural genetics).
This is the step that directly precedes the evaluation of the individual performance. A phenotype is the
set of characteristics that can be observed in an individual. A genotype is associated with a string of
binary symbols. This chain is then decoded in order to build a solution to the problem represented in
its natural formalism (phenotype). This phenotype is then evaluated using a Fitness function to give a
performance value that can be used by the selection operators. Figure 5.7 illustrates the basic components
of a simple genetic algorithm. Variation operators work on genotypes which are represented in the form
of binary chains makes them easier to treat by the crossover and mutation operators. The crossover
operator is an essential research operator, and the mutation is applied with a low rate (probability of
mutation: Pm). These operators maintain the diversity in the research area.
5.6.1.4 Ant colony
The ant colony method was introduced by Colorni Dorgio and Maniezzo in [270]. It is based on the
behaviour of ant colonies and aims to simulate their collective capacity to solve certain problems. It
should be noted that the various members of ant colonies have very limited capacities. Several studies
have focused on the habits of ants which are considered as one of the most prosperous species. The
process followed by ants emphasizes the collective faculty, i.e. the ability and the ease of a community to
quickly nd the shortest way [271]. Ant colonies algorithm have several important characteristics such
as [271]:
• Flexibility: an ant colony is characterized by a high degree of exibility to easily adapt its behaviour
when the environment changes,
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• Robustness: a colony is able to maintain its activity if some of its individuals are decient,
• Decentralization: this characteristic emphasizes the distributed aspect of the approach (a colony is
not centralized),
• Self-organization: a colony has a certain degree of autonomy because it can nd its own solution
that is not known in advance.
Thanks to its several advantages, this approach is eective and particularly suitable for distributed
problems that evolve dynamically, or that require a high tolerance to failures. The implementation of
these algorithms require a preliminary study and should be the subject of a specic treatment which can
be more or less dicult.
Metaheuristics have proven to be successful because of their advantages which have been lacking in
traditional optimization methods that have been proven ineective to solve the diculties of complex
problems. After the success of the dierent metaheuristics, other types of diculties emerged emphasizing
the notion of complementary of these new methods among them, and with other approaches, give rise
to a new concept of hybrid methods [1]. Moreover, to be really eective, it is usually necessary to use
specic representations and operators according to the problem.
5.7 Optimization problems in system biology
Several problems in biology can be considered and formulated as optimization problems. In this section,
we review and describe some applications of optimization in systems biology. We will classify these existing
works according to their application area or topic. Then, we will describe the major contributions made
in these topics. A summary of these works is given in the comparison Table 5.1.
5.7.1 Optimization in the design of optimal dynamic experiments
Among the various research problems that have been addressed in systems biology, we can cite the
optimal experimental design of dynamic experiments [272] which consists of the determination and the
modelling of the stimuli proles that maximize the amount and quality of information extracted from the
experiments.
In this topic, we found the works of Faller et al. [273] who propose an optimization solution to
compute polynomial input proles in order to enhance the parameter estimation accuracy for a mitogen-
activated protein kinase cascade. Also, Kutalik et al. [274] propose the calculation of optimal sampling
times in order to minimize the variation of the parameter estimates. Balsa-Canto et al. [275] propose
a multimodal non-linear programming problem that aims to maximize the ratio quantity/quality of
information for model calibration. The applicability of these approaches was illustrated through various
examples related to the modelling of cell signalling cascades.
5.7.2 Optimization in the parameter estimation in cell systems modelling
Another topic that was the subject of several optimization problems is the structure and parameter
estimation in cell systems modelling.
Various approaches have been developed in this area. Among them the works of Romero-Campero
et al. [276] who propose an approach based on evolutionary algorithms to optimize both the kinetic
parameters and the structure of their cell model. Their method consists of a P system2 integrated into
a stochastic simulation algorithm. Rodriguez-Fernandez et al. [277] propose a mixed-integer nonlinear
programming-based optimization approach for evaluating and reducing the parameters of cellular systems
modelling. Zomorrodi et al. [278] propose a constraint-based model enabling the maximization of an
ecosystem objective function. In this same topic, Budinich Marko et al. [279] propose an approach
based on Pareto optimality to describe all the feasible solutions of a microbial genome-scale considering
metabolic constraints.
2https://en.wikipedia.org/wiki/P_system
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5.7.3 Optimization in biological network alignment
Here we present the role of optimization in an important problem in systems biology: the biological
networks alignment. In fact, network alignment aims to compare, match and align the nodes of diverse
biological networks in order to identify sub-networks with similar nodes which could share the same
functions, structure, or common evolutionary history.
In this topic, a wide array of applications has been proposed such as the works of Yang et al. [280]
who develop a mixture of the global and local algorithm for network alignments so-called BinAligner.
In this work, the alignment problem is formulated as an assignment problem solved by a combinatorial
optimization algorithm (the Hungarian method). The proposed algorithm was applied and validated in
aligning the protein-protein interaction network of two viri: the varicella-zoster virus and Kaposi's sar-
coma virus. In addition, the network alignment problem was transferred into a linear or quadratic integer
programming problem and solved through linear relaxation [281], Lagrangian relaxation [282], and ILOG
CPLEX [283]. For example, in [281] authors develop an ecient algorithm for aligning molecular net-
works based on both molecule similarity and architecture similarity using integer quadratic programming.
Klau G. W. [282] introduces the maximum structural matching formulation for network alignment using
Lagrangian relaxation algorithm.
5.7.4 Optimization of biochemical reaction networks
Optimization approaches have been also used in systems biology to tackle the problem of optimizing
biochemical reaction networks. Indeed, dierent optimization methods have been developed in this area
which can be divided into two categories of applications: metabolic control analysis [284, 285] and
biochemical systems theory [286].
In metabolic control analysis, Heinrich and Schuste [284, 285] provide an overview of the work's interest
on metabolic control analysis which serves to measure the extent which dierent enzymes limit the ux
under particular conditions. This analysis provides also a framework for experimental investigations
and elucidates the regulatory properties of metabolic pathways. In the category of biochemical systems
theory, we can cite the works of Torres and Voit [286] who present several optimization researches applied
to metabolic networks in order to understand the biochemical processes that are involved in the synthesis
of the desired product.
In these works, linear programming has been the engine behind metabolic ux balance analysis to
represent the metabolic phenotype under certain conditions.
5.7.5 Optimization in the sequence alignment problem
Several optimization algorithms have been proposed to solve the multiple sequence alignment problem
[287]. This problem consists to assign a function to genes with the goal of reducing the similarity among
genes. This task is solved by comparing the corresponding sequences of nucleotides or amino acids to
obtain a possible alignment between similar sequences3.
Several sequence alignment methods have been developed to minimize the number of insertions or
deletions (gaps). These optimization methods are based on simulated annealing [288], iterative algorithms
[289], relaxation methods [290], genetic algorithms [291], tabu search [292] and Monte Carlo optimization
[293]. As well as, a number of optimization approaches have been proposed for predicting and analysing
the process of protein folding in simplied models. These optimization approaches were also based on
Monte Carlo methods [294], tabu search [295], estimation of distribution algorithms [296] and genetic
algorithms [297].
5.7.6 Optimization in inferring networks
Optimization problems have been used for inferring biomolecular networks which are also called reverse
engineering. This problem operate in the dierent biological networks such as transcriptional regulatory
networks [298], gene regulatory networks [299], signalling pathways [300], and protein-protein interaction
networks [301].
3https://www.cs.us.es/~fran/students/julian/sequence_alignment/sequence_alignment.html
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In transcriptional regulatory networks, we cite Wang Rui-Sheng et al. [298] who propose a linear
programming problem which has a globally optimal solution for inferring transcriptional regulatory net-
works from gene expression data based on protein transcription complexes and mass action law. In gene
regulatory networks, Thomas Reuben et al. [299] propose an optimization-based regulatory network in-
ference approach that uses time-varying data from DNA microarray analysis. In signalling pathways, Lin
Xiaoxia et al. [300] use mixed integer linear programming techniques to identify the network topology of
the glucose signalling pathway in yeast. Finally, in protein-protein interaction networks Han Soohee et
al. [301] present an optimization-based inference scheme to unravel the functional interaction structure of
biomolecular components within a cell. Villaverde and Banga [302] review these optimization applications
in reverse engineering and detail their strategies, perspectives and challenges in systems biology.
5.7.7 Optimization in the network controllability
Recently, a new area of systems biology was also solved by optimization theory. This is the task of
steering complex biomolecular networks also called the control theory [28, 303]. Only a few studies have
been focused on this problem.
Among them we cite the works of Wen-Xu Wang et al. [304] who propose a general approach to opti-
mize the controllability of complex networks by minimizing the structural perturbations. This approach
consists to drive the biological network using minimum signals of perturbation. Therefore, they aim to
minimize the number of signals to be applied to the biological network rather than using a signal for
each node. As well as, they propose to use only one control signal to achieve the optimal controllability
of networks by adding a minimum number of links. To do this, they formulate their approach into an
optimization problem using the concept of matching path which is based on the maximum matching algo-
rithm. In the same topic, Kim et al. [305] propose an optimization algorithm for searching the minimum
steering node set. This algorithm is used only with Boolean networks.
According to, Gao et al. [306], it is not necessary to control the whole network but it would be
preferable to explore the target control which is a preselected subset of nodes. To do this, they minimize
the number of driver nodes needed for target control. Their optimization approach is based on the
'k-walk' theory for directed networks, and on a greedy algorithm for treating general networks.
Wu et al. [307, 308, 309, 310] addressed the problem of drug target identication by formulating it as a
problem of nding steering kernel in the network. To accomplish this goal, they propose a graph-theoretic
algorithm to nd a minimum set of steering nodes in biomolecular networks which can be a potential set
of drug targets.
However, Wang Le-Zhi et al. [311] consider that the optimization methods cited previously (which
control the networks using the minimum set of driver nodes) can cause the development of an unexpected
phenomenon. As well as, they have seen that a network cannot be controlled with a small number of
drivers, but it is necessary to balance the number of driver nodes and control cost. To overcome this
diculty, they propose a physical controllability framework based on the probability of achieving real
control by increasing the set of input signals on properly chosen nodes.
5.8 Comparison among these optimization tools and problems
There are several reviews that cover the optimization problems in systems biology such as [312, 313,
314, 315, 316]. Indeed, as presented in Table 5.1 all these optimization and mathematical programming
techniques dier in the type of problem they have to solve, their intended purpose and their methods
adopted to solve their given problem. Moreover, we note that no method is better than the rest, but only
more suitable for a particular problem. Each of these optimization techniques has its own uses and is
best suited for solving specic problems with certain diculty. However, most of these technique interest
on dierent categories of problems such as sequence alignment problems, inferring networks problems,
parameter estimation problems, comparison networks problems, etc. and only a few works focus on the
driving of complex biomolecular networks. As well as, all these works are mono-objective and neglect
other criteria for steering these biomolecular networks. Therefore, we conclude that to understand how
these networks change we have to take into account more criteria such as the minimization of the number
of input signals, the minimization of their total cost, the minimization of the number of target nodes,
and the minimization of the patient discomfort.
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Table 5.1  Summary of optimization approaches in systems biology.
Topic/application area Description/objectives Examples/references
Design of optimal dynamic experi-
ments
Enhance the parameter estimation of network's
models. Maximize the quality of information ex-
tracted from experiments.
[272, 273, 274, 275]
Structure and parameter estimation in
cell systems biology modelling
Minimize the number of kinetic parameters. Op-
timize the structure and parameter estimation of
cell models.
[276, 277, 278, 279]
Biological network alignment Compare, match and align biological networks.
Identify sub-networks.
[280, 281, 282, 283]
Biochemical reaction networks Analyse and control metabolic networks. Under-
stand biochemical processes.
[284, 285, 286]
Sequence alignment problem Minimize the similarity among molecule compo-
nents. Minimize the number of insertions or dele-
tions.
[287, 288, 289, 290, 291, 292,
293, 294, 295, 296, 297, 317]
Reverse engineering Identify the network topology. Infer biological net-
works.
[298, 299, 300, 301, 302]
Network controllability Minimize the set of target nodes. Minimize the set
of control signals.
[304, 306, 307, 308, 309, 310,
311]
5.9 Thesis contribution in this eld
As discussed in the previous section (5.7.7), a few studies have started to address the dynamic aspects
of biological systems through the 'controllability' [28] of a network, where the ability to steer a complex
directed network from any initial state toward any other desired state is measured by the minimum
number of required driver nodes (nodes with the ability to steer the entire network). It has been shown
that in order to achieve complete controllability, the minimum number of driver nodes is 80% of the nodes
in a regulatory biomolecular network.
This result led other groups to develop a theoretic framework for studying transitions between two
specic states of directed complex networks, a concept they call 'transittability' [6]. In general, this
concept expresses the idea of steering the complex biomolecular network from an unexpected state to a
desired state. The theorems were developed with continuous time-invariant linear systems, and applied
to 4 dierent biological systems consisting of up to 17 molecules and 40 interactions.
With this idea in mind, we think that understanding the transittability of complex biomolecular
networks should take into account more criteria such as the minimization of the distance between the
simulated nal network state and the desired network state, the minimization of the number of input
signals, the minimization of the cost of these signals, the minimization of the number of target nodes,
the minimization of patient discomfort.
That is why we hope to contribute to this discipline by proposing a multi-objective genetic algorithm
for optimizing the transittability of complex biomolecular networks. This approach will provide the best
set of external stimuli for driving the network. This will be the topic of our contribution to Chapter 9.
5.10 Summary
In this chapter, we have introduced a brief reminder of the basic concepts of optimization theory. Then,
we focused on multi-objective optimization problems and dene their basic principles. We also pre-
sented the appropriate optimization methods for solving these multi-objective optimization problems.
We briey described them according to the classication proposed by Colette et al. [1]. Also, we re-
viewed and described some applications of optimization in systems biology. We classied these existing
works according to their application area and gave a comparative study. In the last section, we discussed
the limits of some researches that address the dynamic aspects of biomolecular networks, and suggest a
multi-objective genetic algorithm-based approach that might be useful for optimizing the transittability
of these networks.
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Part II
Contributions
After presenting the context and the state-of-the-art of our works in the rst part of this manuscript, this second
part is devoted to our contributions on the design and development of a platform to simulate the state changes of
complex biomolecular networks with the hope of understanding and steering their behaviour. This platform
consists of four basic modules: ( i) the modelling module to formalize the dynamic behaviour of biomolecular
networks, ( ii) the ontological module to provide a rich description of cellular entities and their interactions with
each other, ( iii) the simulation module to reproduce the dynamic behaviour of each network's component over the
time and ( iv) the optimization module to provide a set of transition sequences proposing the best steering of the
biomolecular network from a given state to another. These contributions are organized by specic domain.
According to each module of our proposed approach, four contributions have been made in this work. Therefore,
we develop these contributions according to four chapters:
6 Logical-based modelling of complex biomolecular networks .................................................. 69
7 Semantic modelling of complex biomolecular networks .............................................................79
8 Qualitative and discrete-event simulation of complex biomolecular networks ....................................97
9 A multi-objective genetic algorithm-based method for optimizing the transittability of complex biomolecular
networks ................................................................................................................................... 109
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Logical-based modelling of complex
biomolecular networks
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6.1. INTRODUCTION
6.1 Introduction
As discussed in the rst part of this dissertation, several formalisms have been proposed in recent years for
the modelling of biological networks. In Chapter 2, we have detailed some of these modelling approaches
and have compared their characteristics. We concluded that most of them focus only on modelling isolated
parts of this network, such as the metabolic network or the gene regulatory network, and do not study
the dynamics of the network as a whole. Indeed, they do not examine the interactions among all the
intervening molecules considering their types. As a result, these modelling approaches are impractical to
understand the transittability of complex biomolecular networks. To do so, it is necessary to take into
account the analysis of the structure and dynamics of the whole cell rather than just focusing on isolated
parts.
In this chapter, we present a logical-based approach for modelling the dynamic behaviour of biomolec-
ular networks. This formalism is based on the three levels of analysis dened by the systems theory:
structural, functional and behavioural modelling. Indeed, it aims at describing and analysing all the
properties and mechanisms of complex biomolecular networks. This logic-based modelling will form the
basic element for modelling and understanding the transittability of these complex networks.
In the rst section, we will present and dene the functioning of an applied case study, the au-
toregulation of the bacteriophage T4 gene 32. We will use this simple and small example throughout
the contribution chapters (Chapter 6 to Chapter 9) to explain the dierent notions of our proposed
approaches. The second section of this chapter presents a brief introduction to systemic approach by
presenting its dierent axes. In the third section, we will present our proposed logical-based modelling
by detailing its triple levels: structure, function and behavioural modelling. Finally, the last section is
dedicated to applying this modelling on the case study of the bacteriophage T4 gene 32.
6.2 Motivating example: the bacteriophage T4 gene 32
Figure 6.1  The bacteriophage T4 gene 32 use case.
The bacteriophage T4 gene 321 encodes a single-stranded DNA binding protein required for T4 DNA
replication, recombination, and repair [318]. It is a single polypeptide chain of 301 amino acid residues
that consists of three structural domains, each of which has a binding function. Despite its role in DNA
metabolism, the gene product 32 autoregulates its synthesis at the level of translation [319]. During the
infection, the gene product 32 is produced in large amounts to perform its function of binding all available
DNA at the replication fork, recombination nodes and at lesions in DNA resulting from damage [320].
When all the available DNA is bound, free gene product 32 accumulates within the cell until it reaches
a certain concentration which then attenuates further synthesis of gene product 32 [321]. More detail
about the bacteriophage T4 gene 32 can be found in [318, 320, 321].
As illustrated in Figure 6.1, this biomolecular network consists of three nodes a gene G32 coding
for a protein p32 and a metabolite m32 which can negatively regulates the protein synthesis of the
protein p32.
1http://genes.atspace.org/10.11.html
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It should be noted that the original example is composed of only the gene 'G32' and the protein
'p32'. However, to highlight the dierent level of the cell's components (gene, protein and metabolite),
we added a metabolite 'm32'. This metabolite negatively regulate the protein synthesis of the protein
p32. This negative regulation reaction is activated when the concentration of the metabolite m32 reached
the threshold Sm32 = 0.8 10−6 mol/dm3 [322].
Therefore, in this network, the concentration of p32 is self-regulated and normally should remain
between 0.2 10−6 mol/dm3 and 0.7 10−6 mol/dm3. When the concentration of p32 exceeds the threshold
Sp32 = 0.7 10
−6 mol/dm3, it is called an Inhibition, i.e. the protein p32 inhibits, or deactivates,
the translation of its gene G32. However, when the concentration of p32 decreases and becomes lower
than the threshold Sp32 = 0.2 10−6 mol/dm3, it is called an Activation, i.e. the protein p32 activates
the translation of its gene G32. When the gene G32 is activated by the protein p32, it is called a
Translation, in which we have a production of p32 thus increasing the value of its concentration. When
the concentration ofm32 exceeds the threshold Sm32 = 0.8 10−6 mol/dm3, the metabolitem32 negatively
regulate the protein synthesis of p32 thus decreasing the value of its concentration, called a Negative
regulation.
6.3 System theory
As discussed in part I, several approaches have been proposed for modelling and simulating biomolecular
networks. Nevertheless, the majority of those approaches concern only a specic level of the network,
such as metabolic or protein-protein interaction networks. The system theory seems to answer that need.
The logical-based modelling proposed in this chapter is then based on the systemic perspective for
modelling complex biomolecular networks taking account of their multi-level aspect, and the heterogeneity
of their molecular components and the diversity of the interactions among them. The system theory
enables the denition of the system from the dierent axis of the system, allowing a better description
of the dimensions and highlighting the relationship between them [323]. This theory aims at a successful
performance of a collaborative simulation.
6.3.1 Complex systems
Various levels of system complexity have been proposed in the literature. The most cited classications
of complex systems are those of von Bertalany [324] and Le Moigne [325]. These classications are both
based on a model composed of nine levels of complexity of a system imagined by Kenneth E. Boulding
in 1956. Table 6.1 presents these two classications.
Table 6.1  Levels of system complexity [7].
Von Bertalany [324] Le Moigne [325]
Level Description Level Description
1 Static struc-
tures
Atoms, molecules, crystals, etc. 1 Passive system It has nothing to do but being
2 Watchmaking
movements
Clocks, solar systems, etc. 2 Active system It is characterized by its activity
3 Self-regulatory
mechanisms
Thermostat, servomechanisms, etc. 3 Regulated sys-
tem
Emergence of regularities in its activity
4 Open Systems Flames, cells and organisms in general,
etc.
4 Informed sys-
tem
Emergence of information in its repre-
sentation
5 Low-level orga-
nizations
Plant type organisms, etc. 5 System decides Emergence of decision-making pro-
cesses
6 Animals Increasing importance of information
trac, etc.
6 Memory system Emergence of memory and importance
of communication
7 Human Symbolism, consequences, etc. 7 System is coor-
dinated
Emergence of coordination or steering
8 Socio-cultural
systems
Populations and organisms, etc. 8 System self-
organizing
Emergence of the imagination and ca-
pacity for self-organization
9 Symbolic sys-
tems
Language, logic, mathematics, etc. 9 System auto-
nalizes
Emergence of consciousness and ability
to nalize itself
Sharif and Irani [326] summarizes this notion of complexity into four concepts:
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• Self-organization. The organization is the structuring of a whole according to the distribution of
its elements on dierent levels. The system can create and recreate its structure.
• Non-linearity. Behaviours and responses are not deterministic and are inuenced by the presence
of non-linear relationships and feedback loops.
• Order. The implicit ability to exhibit linear or non-linear behaviours is a function of response to
the stimulus.
• Emerging behaviours. The non-linear or self-organized interactions result in emerging properties
and complex behaviours.
Table 6.2 depicts the main dierences between simple and complex systems according to Glouberman
and Zimmerman in [327].
Table 6.2  Comparison between simple and complex systems.
Cluster Simple systems Complex systems
Theory
Linearity Non-linearity
Absence of noise Presence of noise
External system solution Internal solution (part of the system)
Adaptation in a static environment Interaction with the dynamic environment
Causality
Simple causality Mutual causality
Determinist Probabilistic
Certainty Uncertainty
Focus on components Focus on relationships
Relationships determined by structures Interactive structures and relationships
Justication
Reductionism - Analysis Holism - Synthesis
Eectiveness, alignment and best practice measures Functioning of current relationships and feedback loops
Planning
Convergent Divergent
Reducing characteristics Emerging characteristics
Decision as an event Decision as emerging
An important issue involves a major change The size of the issue does not determine the size of the change
6.3.2 System theory objectives
As we have seen in the rst part and referring to the denition of complex systems proposed in the previous
section, we can note that biomolecular networks are also considered as complex systems. Indeed, they are
highly structured (composed of several interconnected subnetworks), subject to strong variations (internal
or external stimuli) and dicult to predict (their behaviour emerges according to their states and the
state of their environment).
This reality explains the presence of the science of complexity that aims to 'overcome the simplica-
tions and idealizations that lead to unrealistic views' [328]. This theory has been used in several elds
because it provides a set of concepts to model the dierent characteristics of a complex system. According
to Le Moigne, the analysis of a system requires to:
• give a systemic representation by dening an organization of structured sub-systems.
• ensure that the system behaviour can be simulated.
• improve the functioning of the system.
Denitions presented in this section refer to the work of Celine Bérard in [7].
6.3.3 System theory axes
The system theory was initially introduced in 1990 by Jean-Louis Le Moigne in his work [3]. From Le
Moigne's point of view, a complex system cannot be reduced to a model composed of a set of equations
describing its evolution (analytical, causal or deterministic). However, it conrms that any complex
system is in constant evolution, and therefore can be dened according to four main axes: teleological,
genetic, functional and ontological.
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• The teleological axis including the structure of the system denes the objectives of the system. It
consists of (i) dening the lifecycle, and (ii) understanding the structure of the system that will be
used to predict its future evolution.
• The genetic axis including the behaviour of the system denes the evolution of the system over
time.
• The functional axis describes the functions of the system components and the system itself: what
the system is supposed to do.
• The ontological axis concerns the description and semantics of system resources. It aims to facilitate
the human-computer interaction and access to system resources. As well as to make information
more meaningful to the system and users.
Figure 6.2 depicts these axes and their objectives (this gure is inspired by the Systems theory in [3]).
Figure 6.2  The four axes of Systems theory according to Le Moigne [3].
6.4 Logic-based approach for modelling biomolecular networks
Figure 6.3  The three axes of our proposed logical-based modelling.
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One of the rules for complexity management during the modelling task involves separating knowledge
of dierent nature. Here, we use a systemic approach to include the three types of knowledge required
to describe a system [3] (Figure 6.3):
• Structural modelling: to describe the architecture of the network;
• Functional modelling: to describe the activities of each component of the network, and the
associated conditions;
• Behavioural modelling: to describe how the network and its individual components evolve over
time.
Hence, a biomolecular network BN can be represented by its structure SR, its function FR and its
behaviour CR[t0,tn] that evolves over time t (generally a simulation interval [t0, tn]). Therefore, mathe-
matically, the network BN is dened as follows:
BN = (SR,FR,CR[t0,tn])
6.4.1 Structural modelling
The structure SR of the network is a directed graph dened by:
SR = (M, I) where:
• M represents all the molecules composing the network and denotes a nite set of nodes M =
{m1,m2, . . . ,mn}. We distinguish a tripartite partition of M : MG the set of genes, MP the set of
proteins and MM the set of metabolites.
M = MG ∪MP ∪MM
Mx ∩My = ∅ where: x, y ∈ {G,P,M} and x 6= y.
• I represents the set of interactions among the network's molecules and denotes a nite set of edges
I = {i1, i2, . . . , im}. An edge i = (ms,md), (where ms,md ∈ M) which starts at ms (origin) and
ends at md (destination) is also noted ms → md. Thus, for an edge i ∈ I, we denote by s(i) the
starting node and d(i) the destination node.
The partition of the graph nodes induces a partition into a range of dierent types of interactions:
. three interactions among nodes of the same type (intraomic interactions): IGG denotes the
interactions (activation or inhibition) among genes, IPP denotes the stable or transitional
associations among proteins and IMM denotes the interactions between metabolites (type of
chemical reaction among reactants and products).
. four interactions among the nodes of dierent types (interomic interactions): IGP denotes the
translation of genes encoding proteins, IPG denotes the action of proteins (e.g. transcription
factors) on genes, IPM denotes the proteins acting on chemical reactions of metabolites (e.g.
catalysis or hydrolysis), IMP denotes the action of metabolites on proteins (e.g. negative or
positive regulation).
. two interactions IGM and IMG are not taken into account because there is no direct interaction
between the genes and metabolites and vice versa.
I = IGG ∪ IPP ∪ IMM ∪ IGP ∪ IPM ∪ IMP ∪ IPG
Ix ∩ Iy = ∅ where: x, y ∈ {GG,PP,MM,GP, PM,MP,PG} and x 6= y.
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6.4.2 Functional modelling
The function FR of the network associates the graph edges ims,md ∈ I with an interaction type and the
condition that activates it. It depends on the type of the starting node ms:
FR :
∣∣∣∣∣∣∣∣∣ ims,md
FR7→

(TypeInteraction,Activation)
if ms ∈MG.
(TypeInteraction,6 OR >, Threshold)
if ms ∈MP ∪MM .
• If the starting node is a gene (ms ∈ MG), the function FR associates to each edge ims,md ∈ I, a
couple consisting of a label TypeInteraction that indicates whether the interaction is triggered on
the activation or on the deactivation of the gene.
• If the starting node is a protein or a metabolite (ms ∈ MG ∪MM ), the function FR associates
to each edge ims,md ∈ I, a triplet consisting of a label TypeInteraction representing the type of
the interaction, a comparison operator (6 or >) that is used to compare the concentration of the
starting nodems to the threshold associated with this edge, and nally, the Threshold which denes
the condition for activating the interaction ims,md depending on the concentration of the starting
node ms.
In both cases, the label TypeInteraction belongs to the set of concepts of the Interaction Ontology
proposed by Van Landeghem et al. [4] (Figure 6.4). As shown in Table 6.3, the possible types depend on
the type of the edge.
Figure 6.4  A subset of the taxonomy of the Interaction Ontology [4].
Table 6.3  Possible interaction types depending on the type of graph edge.
TypeInteraction Intraomic_Interactions Interomic_Interactions
IGG IPP IMM IGP IPG IPM IMP
Positive Regulation (Catalysis/Hydrolysis) - 3 3 - 3 3 3
Negative Regulation (Inhibition) - 3 3 - 3 3 3
Positive genetic interaction 3 - - - - - -
Negative genetic interaction 3 - - - - - -
Colocalization - 3 3 - - 3 3
Coexpression - 3 3 3 3 3 3
Transcription - - - - 3 - -
Phosphorylation - 3 - - - - 3
Dephosphrylation - 3 - - - - 3
6.4.3 Behavioural modelling
Complex biomolecular networks are dynamic systems characterised by continuous interactions.
Thus, in order to model the dynamic evolution of the network and reproduce its behaviour over time,
we have implemented a behavioural simulation following the discrete-event formalism. This simulation
allows studying the behaviour of the network through successive transitions.
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6.4.3.1 State of the network
The state of the network at a given time is dened by a function en(m, t) which assigns a state to each
node at time t.
en :
∣∣∣∣∣∣∣∣∣ (m, t)
en7→

Activation ∈ {True, False}
if m ∈MG.
[cm(t)] ∈ R
if m ∈MP ∪MM .
• For all m ∈ MP ∪MM : en(m, t) = [cm(t)] ∈ R where: cm(t): the value of the concentration
of the molecule denoted by the node m at a given time t.
• For all m ∈MG: en(m, t) = Activation where: Activation ∈ {True, False}.
Associating a gene with a concentration is not meaningful. Instead, a gene may have two specic
states, activated or not.
We dene ER(t), the state of the network at time t, by a set representing the states of all components
in the network at time t.
ER(t) = 〈en(m1, t), en(m2, t), ..., en(mn, t)〉
6.4.3.2 Transition of the network state
For a node m ∈ M , we dene ie(m) (resp. oe(m)) the set of incoming edges (resp. outgoing edges) on
m, dened as follows:
ie(m) = {i | d(i) = m}
oe(m) = {i | s(i) = m}
We also dene Pred(m) the set of predecessor nodes on the node m such that:
Pred(m) = {n ∈M ; ∃i ∈ I | s(i) = n and d(i) = m}
The state of a node at time t+ 1 depends on its state at time t, as well as the possible inuence of each
of its incoming edges. This inuence depends on the state of the starting node of the edges in question.
For each node m, we dene an aggregate function Am (relating to the node m) which computes
the evolution of the node status between two successive generations of the simulation. This aggregate
function Am depends on the current state of the node m, the state of its predecessor nodes Pred(m) and
the characteristics of its incoming edges ie(m).
en(m, t+ 1) = Am(en(m, t), ie(m), en(n, t) ;n ∈ Pred(m))
6.4.3.3 Steering the network to a given state
A state transition in the network occurs by changing the state of at least one of its nodes. The changes of
a node state (e.g. changes in the molecule concentration) can occur either by a internal stimulus modelled
by the aggregate function described above, or by a external stimulus generated outside the cell.
We dene a stimulus as an event that causes changes in the state of the molecule on which it acts
and therefore changes the state of the whole network.
An external stimulus S is represented by a triplet [t,m,∆c], where:
• t is the time of introduction of the stimulus S.
• m is the node targeted by the stimulus S.
• ∆c is the change in concentration caused by the stimulus S and depends on the type of the node:
 If m ∈MG, ∆c determines the activation or deactivation of a gene:
∆c ∈ {Activated,Deactivated}.
 Else, if m ∈ MP ∪MM , ∆c represents the concentration change caused by the stimulus S:
∆c ∈ R .
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We denote ER(t), with t ∈ N, the state of the network at time T (t) = t0 + t.∆T (where ∆T is the
time step and t0 the initial time of the simulation).
To simulate the dierent transition states of a network, we specify a state ER(0) at time t0 and a time
step size ∆T . Then, the successive states ER(t+1) are computed from the current state ER(t) according
to the interactions and the aggregate functions dened by the network, and the external stimuli.
At a given time t+ 1, for each m ∈M we have:
• If there are no external stimuli in time t for the node m then:
en(m, t+ 1) = Am(en(m, t), ie(m), en(n, t)) where: n ∈ Pred(m)
 Else If m ∈MG: en(m, t+ 1) = ∆c
 Else (m ∈MP ∪MM ):
en(m, t+ 1) = Am(en(m, t), ie(m), en(n, t) ) + ∆c where: n ∈ Pred(m)
6.4.3.4 Behaviour
The behaviour of the network CR[t0,tn] is given by the sequence of its successive states during the simu-
lation time.
CR[t0,tn] = [ER(0), ER(1), ..., ER(n)]
Thus, the behaviour of the network extends between two distinct times t0 and tn forming the simulation
interval [t0, tn].
6.5 Application to the motivating example
Table 6.4 presents the logic modelling of the example network shown in Figure 6.1 and presented in
Section 6.2.
6.6 Summary
The logic modelling presented in this chapter aims to provide biologists wishing to study complex
biomolecular networks with a simple and comprehensive modelling approach to assist them in build-
ing their networks. This method consists of formalizing, building and analysing the biological knowledge
of the dierent elements on which the biomolecular network is based.
In this chapter, we have focused only on the structural, functional and behavioural quality of biomolec-
ular networks. However, in order to have a complete and more realistic modelling of these networks, it is
essential to cover all the knowledge that manages the rules of their behaviour and organization. This is
what semantic modelling invites us to do in the next chapter.
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Structure Nodes: M = { G32 , p32 , m32 }
{G32} ∈MG ; {p32} ∈MP ; {m32} ∈MM
Edges: I = { i1 , i2 , i3 , i4}
{i1, i2} ∈ IPG; {i3} ∈ IGP and {i4} ∈ IMP
i1 : s(i1) = p32 et d(i1) = G32
i2 : s(i2) = p32 et d(i2) = G32
i3 : s(i3) = G32 et d(i3) = p32
i4 : s(i4) = m32 and d(i4) = p32
Function Edges: i1
FR7→ (Activation,≤, 0.2)
i2
FR7→ (Inhibition,≥, 0.7)
i3
FR7→ (Transcription,Activation)
i4
FR7→ (NegativeRegulation,≥, 0.8)
Behaviour Aggregate functions
Ap32:
Incoming edges Evolution
i3 i4 State of cp32
Deactivated < 0.8 ∆1 = 0
Activated < 0.8 ∆2 > 0
Deactivated ≥ 0.8 ∆3 < 0
Activated ≥ 0.8 ∆4
AG32:
Incoming edges Evolution
i1 i2 State of G32
Deactivated Deactivated Maintained state
Activated Deactivated Activated
Deactivated Activated Deactivated
Am32:
Incoming edges Evolution
No incoming edges State of m32
 Maintained state
States:
CR = {〈0, [minp32; 0.2[, [minm32, 0.8[〉, 〈0, [minp32; 0.2[, [0.8,maxm32[〉,
〈1, [minp32; 0.2[, [minm32, 0.8[〉, 〈1, [minp32; 0.2[, [0.8,maxm32[〉,
〈0, [0.2, 0.7[, [minm32, 0.8[〉, 〈0, [0.2, 0.7[, [0.8,maxm32[〉,
〈1, [0.2, 0.7[, [minm32, 0.8[〉, 〈1, [0.2, 0.7[, [0.8,maxm32[〉,
〈0, [0.7,maxp32[, [minm32, 0.8[〉, 〈0, [0.7,maxp32[, [0.8,maxm32[〉,
〈1, [0.7,maxp32[, [minm32, 0.8[〉, 〈1, [0.7,maxp32[, [0.8,maxm32[〉}
Table 6.4  Logical modelling of the autoregulation of the bacteriophage T4 gene 32.
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7.1 Introduction
In the previous chapter, we proposed a logical-based modelling that provides the dierent elements on
which the biomolecular network is based. However, to obtain an optimal and more realistic modelling,
we want to enhance it with an additional semantic layer. Semantic technologies, especially ontologies,
are one of the tools frequently used for this purpose. In fact, they are indispensable for understanding
the semantic knowledge about the functioning of cells at a molecular level.
In this chapter, we present a semantic approach for modelling biomolecular networks and describe the
proposed Biomolecular Network Ontology (BNO) created specially to address the needs of analysing
the complex biomolecular network's behaviour. This ontology provides a foundation for qualitative
simulation of these networks. The BNO ontology is freely available at https://github.com/AliAyadi/
The-Biomolecular-Network-Ontology.
The rst section of this chapter focuses on the proposed semantic approach for modelling the seman-
tics of complex biomolecular networks. We detail each one of the ontologies that constitute it and the
relationship among them. A second section is dedicated especially to describe in detail the main compo-
nents of the BNO ontology on which the transittability of complex biomolecular networks are meant to
be contextualised. The last section presents the application of the proposed ontology through the case
study related to the biological domain, the bacteriophage T4 gene 32 already used in Chapter 6.
7.2 Semantic approach for analysing the transittability of com-
plex biomolecular networks
Modelling the behaviour of complex biomolecular networks requires, rst and foremost, to formalize
the domain knowledge. However, it is not sucient to simply describe it. Certainly, the behaviour
of biomolecular networks is investigated through appropriate semantic structures for the description of
their components that must not be overlooked. Thus, the use of a formalized language such as ontologies
provides a rich description but also allows to perform reasoning. Therefore, in this section, we propose
a semantic architecture composed of four ontologies: three of them already exist in the literature, the
Gene Ontology (GO) [170, 329], the Simple Event Model Ontology (SEMO) [330], the Time Ontology
(TO) [331] and we are developing the Biomolecular Network Ontology (BNO). Linked together, these
ontologies provide the necessary concepts for modelling the dynamic behaviour and the transition states
of a complex biomolecular network. We will briey present the general architecture of the ontological
process and describe the set of ontologies which compose our approach.
7.2.1 The global architecture
We propose a semantic approach that aims to enrich the structural description of biomolecular networks by
contextual knowledge concerning their state transitions, the events that can steer these transitions but also
their entire temporal context linked to this information. Thus, we present an approach for understanding
the transittability [6] of biomolecular networks which is basically composed of four ontologies: the Gene
Ontology (GO) [170, 329], the Simple Event Model Ontology (SEMO) [330], the Time Ontology (TO)
[331] and our development, the Biomolecular Network Ontology (BNO).
Figure 7.1 describes the global architecture of our semantic approach for analysing the transittability
of complex biomolecular networks.
This semantic architecture is based and follows the logical-based modelling of complex biomolecular
networks detailed in Section 6.4. In fact, this correspondence between the logical and semantic mod-
elling is presented in Figure 7.2. The Biomolecular Network Ontology describes the static structure of
the biomolecular network which has already been presented in Section 6.4.1. Merging with the Simple
Event Model Ontology, the Biomolecular Network Ontology describes what can be carried out by each
component of the biomolecular network and the conditions for these activities, this notion was detailed
in Section 6.4.2. Finally, the Biomolecular Network Ontology, the Simple Event Model Ontology and the
Time Ontology describe how the biomolecular network and its individual components evolve over time
which is clearly mentioned in the previous Section 6.4.3.
These ontologies are described in more detail in the sections below.
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Figure 7.1  Global architecture of our proposed semantic modelling.
Figure 7.2  Correspondence between the logical and semantic modelling.
7.2.2 The Gene Ontology (GO)
In this study, the Gene ontology1 is considered as a core ontology. It ensures the description and the
classication of cellular components. As well as, it provides a structured terminology for the description
of gene functions and processes, and the relationships among these components [332].
We chose to use the Gene Ontology for the following reasons, (1) it is an initiative of several genomic
databases such as the Saccharomyces Genome Database (SGD), the Drosophila genome database (Fly-
Base), etc. to build a generic ontology for describing the role of genes and proteins, (2) it is the most
developed and most used in biology (since 2000), and (3) it provides annotation les about large number
of cellular entities.
1http://www.geneontology.org
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7.2.3 The Simple Event Model Ontology (SEMO)
The Simple Event Model ontology2 proposed by Van Hage et al. [330] provides the necessary knowledge
for the description of events. The ontological architecture of the Simple Event Model ontology consists of
four basic concepts: Event that species what is happening, Actor that indicates the participants of an
event, Place that describes the location where the event happened, and Time that describes the moment.
We chose to use the Simple Event Model ontology because it provides the necessary concepts to
describe and model events in various subject domains.
7.2.4 The Time Ontology (TO)
The Time ontology3 developed by Hobbs and Pan [331] enables a more intuitive use of the time dimension
while making the most of semantic knowledge. It gives a rich vocabulary to describe the topological
relationships that may exist between time points and intervals and also provides information about time.
The main concepts of this temporal ontology can be summarized as TemporalEntity which consists
of two sub-classes Instant and ProperInterval, DurationDescription, DateTimeDescription, TemporalU-
nit, etc. Also, it contains several proprerties such as hasDurationDescription, intervalStarts, hasDate-
TimeDescription, etc.
We chose to use the Time Ontology because of its basic structure that is not specic to a particular
application and because it is simple to adapt it in our context.
7.2.5 The Biomolecular Network Ontology (BNO)
We developed an ontology the 'Biomolecular Network Ontology (BNO)' which aims to describe the domain
knowledge of complex biomolecular networks in their static state. This ontology provides information on
the biomolecular network and its components (nodes, interactions, states, transition states, etc.) and an
indication of the network's context such as the type of sub-network, the type of node, the conditions and
nature of interactions, etc. This allows to precisely analyse and interpret the semantic context in order
to achieve intelligent modelling of biomolecular networks and their state changes.
The BNO ontology is the major contribution of this chapter, that is why an entire section has been
devoted to detail this ontology (Section 7.3).
7.2.6 The relations among these ontologies
Concepts in the Biomolecular Network ontology are linked to the Gene ontology concepts. In fact,
the concepts of the Gene ontology are used to enrich the denitions of the concepts of the Biomolec-
ular Network ontology by two relations: an equivalence relation owl:equivalenceClass and a specica-
tion relation owl:subClassOf. Some instances of these relations are shown in Figure 7.3. For example,
as described in Figure 7.3a, after inference the concept BNO:Protein will be specialized by the con-
cept GO:beta-galactosidase (GO: 0009341) because the BNO:Node concept is equivalent to the concept
GO:cellular_component (GO: 0005575). Other examples of these links are illustrated by Table 7.1.
The Biomolecular Network ontology is also linked with the Simple Event Model Ontology through the
BNO:Node concept, in fact, a SEM:event can stimulate a molecular entity (represented by the concept
BNO:Node). The Simple Event Model ontology will be used to describe the states of BNO:Node and its
behaviour.
Moreover, the Time Ontology (TO) has been integrated into the Simple Event Model ontology. The
concept SEM:Time was made equivalent to the concept TO:TemporalEntity which represents the root
of the Time ontology. Hence, the property SEM:hasTime will connect the Simple Event Model ontology
to the Time ontology and, as a consequence, the diverse types of temporal concepts will be dened as
specializations of the class SEM:Time. Figure 7.3b shows the use of this principle. Thus, we can exploit
the wealth of temporal concepts provided by this temporal ontology to describe the SEM:event class.
Using these relationships it is possible to merge these ontologies to formalize the necessary knowledge
to study the state changes of the biomolecular network's behaviour.
2http://semanticweb.cs.vu.nl/2009/11/sem/
3https://www.w3.org/TR/owl-time/
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(a) (b)
Figure 7.3  Example of merging: 7.3a The Gene ontology concepts to the Biomolecular Network ontology
concepts. 7.3b The Time ontology within the Simple Event Model ontology.
Table 7.1  Linking of Gene Ontology concepts to the Biomolecular Network ontology.
Type of relationship Biomolecular Network Ontology concept name Gene Ontology concept name
Equivalence: BNO ′owl : equivalenceClass′ GO
BNO : Node GO : cellular_component
BNO : Protein GO : protein_complex
Subclass: BNO ′owl : subClassOf ′ GO BNO : Interaction GO : biological_process
7.3 The Biomolecular Network Ontology
To study the dynamic behaviour and the transition states of biomolecular networks, it is required to model
their domain knowledge. Therefore, we developed the Biomolecular Network ontology. This ontology
is the major contribution of this chapter, it is intended to describe exhaustively the eld of complex
biomolecular networks by describing the static aspect of their structure. It was dened in collaboration
with domain experts.
Figure 7.15 presents the Biomolecular Network ontology. We use the graphical notation for OWL
ontologies dened by Brockmans et al. [333] and B	arzdin
,
² et al. [334] where boxes are OWL concepts;
full lines are object properties and dotted lines are data properties. Full lines can be labelled to indicate
restrictions meaning that the range of the relationship is specialized.
7.3.1 Development
As described in Figure 7.15 and 7.4, we have developed the BNO ontology using the OWL-language
[335] under the Protégé editor. Concepts, relations, and attributes were modelled as concepts, object
properties and data properties, respectively. Axioms were represented in Protégé using diverse OWL
restrictions (existential restrictions, universal restrictions, cardinality restrictions, hasValue restrictions),
characteristics of object property, and datatype restrictions.
7.3.2 The key concepts
Only a few of the object properties restrictions are displayed in Figure 7.15 for the sake of clarity. This
domain ontology consists of ve main concepts:
• The Biomolecular_Network class: This class includes the dierent types of complex biomolecular
networks. As mentioned earlier in Section 1.4, the complex biomolecular network can be com-
posed by Gene Regulatory networks (GRNs), Protein-Protein Interaction networks (PPINs) and
Metabolic networks (MNs) which correspond to the following concepts: Genomic_Network, Pro-
teomic_Network and Metabolomic_Network.
These types of networks can be connected to the other ontology's concepts through three properties,
has_node that depicts its cellular components, has_interaction that describes the interactions
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Figure 7.4  The Biomolecular Network Ontology: hierarchy of concepts, hierarchy of properties and
hierarchy of data properties.
linked to its components and the property has_node only that species exactly the nature and type
of its components.
The instances of these concepts will be dened later, among these instances we will focus on the
BacteriophageT4G32 instance in Section 7.4.1.
• The Node class: This class contains the dierent types of cellular entities M that constitute the
biomolecular network. In fact, we can identify three sub-classes: the Gene which describes the set of
genes MG, the set of proteins Protein which models the set MP and the Metabolite which describes
the set of metabolitesMM . The Gene sub-class is itself divided into two types the BNO : DNA and
BNO : RNA. The class Node is connected with the Node_State through the property has_state.
These BNO concepts are detailed on the logical-based modelling in Section 6.4.1.
• The Interaction class: This class covers all the diverse types of interactions that can be operated
among the dierent types of nodes of the biomolecular network. This class consists of two sub-
classes, Intraomic_Interactions that covers the interactions between molecular components of the
same type and the class Interomic_Interaction that describes the interactions between molecular
components of the dierent type. This class is connected to the Node class via two properties,
has_source and has_end. These BNO concepts are developed through the logical-based modelling
in Section 6.4.2.
• The Node_State class contains the possible states of the nodes. This class is composed of two
sub-classes, the ConcentrationState and the ActivationState.
• The Interaction_Type class allows to specify the types and the nature of the interaction among
cellular components. This class is linked to the BNO:Interaction class through the properties
Has_type.
The instances of this class belong to the set of concepts of the Interaction Ontology proposed by
Van Landeghem et al. [4] (in Figure 6.4. To successfully integrate the main Interaction ontology
concepts (IO:Activity_ow and IO:Process) with the Biomolecular Network ontology, we create an
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abstract BNO UML BNO:Interaction_Type to generalise those two Interaction ontology concepts
(Figure 7.15).
Table 7.2 and Figure 7.4 show the most important BNO concepts.
Table 7.2  A summary of concepts in the Biomolecular Network ontology. The left column presents the
ve major concepts and their immediate sub-classes. The right column presents the description of these
concepts.
BNO ontology concepts Description
BNO:BiomolecularNetwork denes the dierent kinds of complex biomolecular networks.
BNO:GenomicNetwork denes the interactions among genes forming Gene Regulatory networks.
BNO:ProteomicNetwork denes the interactions among proteins forming Protein-Protein Interaction networks.
BNO:MetabolomicNetwork denes the interactions among proteins forming Metabolic networks.
BNO:Node denes the dierent types of cellular entities.
BNO:Gene describes the set of genes MG.
BNO:DNA describes the set DNA.
BNO:RNA describes the set of RNA.
BNO:Protein describes the set proteins MP .
BNO:Metabolite describes the set metabolites MM .
BNO:Interaction denes all the types of interactions operated among the nodes.
BNO:IntraomicInteraction denes the interactions between molecular components of the same type.
BNO:I_GG denes the interactions between genes.
BNO:I_PP denes the interactions between proteins.
BNO:I_MM denes the interactions between metabolites.
BNO:InteromicInteraction denes the interactions between molecular components of the dierent type.
BNO:I_GP denes the interactions between genes and proteins.
BNO:I_PG denes the interactions between proteins and genes.
BNO:I_PM denes the interactions between proteins and metabolites.
BNO:I_MP denes the interactions between metabolites and proteins.
BNO:NodeState denes the possible states of the nodes.
BNO:ActivationState denes the states of the genes.
BNO:ConcentrationState denes the concentration of the proteins and metabolites.
BNO:InteractionType denes the nature of the interaction among cellular components.
7.3.3 The major properties and data types
After the denition of the major concepts of the BNO ontology and in order to describe the semantic
relations among them, we dene the domain, range, property type and inverse properties as constraint
conditions. The dierent properties and data types of the BNO ontology are explained below.
• hasBehaviour(object1, object2): where object1 is aBiomolecularNetwork and object2 is aBehaviour.
• hasInteraction(object1, object2): where object1 is a BiomolecularNetwork and object2 is an
Interaction.
• hasNode(object1, object2): where object1 is a BiomolecularNetwork and object2 is a Node.
• hasSource(object1, object2): where object1 is an Interaction and object2 is a Node.
• hasEnd(object1, object2): where object1 is an Interaction and object2 is a Node.
• hasState(object1, object2): where object1 is a Node and object2 is a NodeState.
• hasTypeInteraction(object1, object2): where object is an Interaction and object2 is a TypeInteraction.
• deltaC(object, dc): where object is an Interaction and dc is a float representing the change in
concentration caused by the interaction.
• forT ime(object, t): where object is a NodeState and t is a int representing its time.
• hasConcentrationV alue(object, c): where object is a Protein or a Metabolite and c is a float
representing the value of its concentration.
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• isActivated(object, bv): where object is an Gene and bv is a boolean equal to true if the gene is
activated.
• threshold(object, t′): where object is the threshold of an Interaction and t′ a comparison operator
(≤ or ≥) determining the minimum and maximum threshold, respectively.
Table 7.3 summarises the major properties of the BNO ontology, including their domain, range and
inverse.
Table 7.3  A summary of the properties, including their domain, range and inverse.
BNO ontology properties Domain Range Inverse
hasBehaviour BiomolecularNetwork Behaviour isBehaviourOf
hasInteraction BiomolecularNetwork Interaction isInteractionOf
hasNode BiomolecularNetwork Node isNodeOf
hasSource BiomolecularNetwork Node isSourceOf
hasEnd Interaction Node isEndOf
hasState Interaction State isStateOf
hasTypeInteraction Interaction TypeInteraction isTypeInteractionOf
7.4 Application to the motivating example: the bacteriophage
T4 gene 32
Figure 7.5  Instantiation of the BNO ontology for the given example.
The aim of this section is to illustrate the proposed BNO ontology for reasoning and inferring new
knowledge with sets of rules expressed in SWRL [335]. To do this, we test its performance by using the
real example presented in Section 6.2, the bacteriophage T4 gene 32.
7.4.1 Instantiation of the BNO ontology
Figure 7.5 presents the instantiation of the BNO ontology for the given example of the bacteriophage T4
gene 32. The BNO ontology provides detailed and rigorous semantics to model this biomolecular network.
86
7.4. APPLICATION TO THE MOTIVATING EXAMPLE: THE BACTERIOPHAGE T4 GENE 32
We use the Protégé editor to instantiate the BNO ontology for the bacteriophage T4 gene 32. Figure
7.6 illustrates the nodes instantiations respectively, the gene G32, protein p32 and metabolite m32. The
instantiations of the four reactions are detailed in Figure 7.7.
Figure 7.6  A snapshot look at the BNO node instances associated with the given example displaying
respectively: (1) the gene G32, (2) the protein p32 and (3) the metabolite m32.
Figure 7.7  A snapshot look at the BNO interaction instances associated with the given example dis-
playing respectively: (1) Activation, (2) Inhibition, (3) Transcription and (4) Catalysis.
7.4.2 SWRL rule-based reasoning
As detailed in Section 3.6.1, the Semantic Web Rule Language (SWRL) is an ontological language based
on OWL-DL and OWL-Lite that expresses the rule description language based on OWL [336]. SWRL can
be used to write rules to reason about OWL individuals and infer new knowledge about those individuals.
The rules in SWRL are implication rules, and follow this syntax: antecedent → consequent. This form
means that the consequent must be true when the antecedent is satised. In SWRL rules, the symbol '∧'
means conjunction, '?x' is a variable, '→' means implication. A symbol without the leading '?' denotes
the name of an instance (an individual) in the ontology. These SWRL rules can provide additional
expressiveness to OWL-based ontologies. Thus we adopt these SWRL rules to build the reasoning rules
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in order to represent the dynamic aspect of the biomolecular network. During this reasoning, inferences
are made, classifying the instances of the BNO ontology and associating new properties to create instances
while maintaining logical consistency.
7.4.2.1 Inhibition SWRL rule
The following rule models the inhibition interaction. When the concentration of the protein p32 exceeds
the threshold 0.7 10−6 Mol/L−1, it inhibits the translation of its gene G32.
ADN(?g) ∧ hasState(?g, ?gs1) ∧ forTime(?gs1, ?t) ∧ hasState(?g, ?gs2) ∧ forTime(?gs2,
?t2) ∧ swrlb:add(?t2, ?t, 1) ∧ Protein(?p) ∧ Activation(?activ) ∧ hasSource(?activ, ?p) ∧
hasEnd(?activ, ?g) ∧ hasState(?p, ?ps) ∧ forTime(?ps, ?t) ∧ hasConcentrationValue(?ps,
?c) ∧ swrlb:greaterThanOrEqual(?c, 0.7) → isActivated(?gs2, false)
As depicted in Figure 7.8, the results of this rule means that, If there is a gene g having a state gs equal
to true at a given time t and there is a protein p having a state ps1 and a concentration c at this time
t, and these two molecules g and p are related by an Inhibition interaction, and if the concentration of p
exceeds a threshold equal to 0.7, then the state of g move to false at time t+ 1.
Figure 7.8  Results of the reasoning process for the Inhibition SWRL rule.
7.4.2.2 Activation SWRL rule
In contrast to the rst rule, this rule models the activation interaction. When the concentration of the
protein p32 becomes less than the threshold 0.2 10−6 Mol/L−1, it activates the translation of the gene
G32.
ADN(?g) ∧ hasState(?g, ?gs1) ∧ forTime(?gs1, ?t) ∧ hasState(?g, ?gs2) ∧ forTime(?gs2,
?t2) ∧ swrlb:add(?t2, ?t, 1) ∧ Protein(?p) ∧ Activation(?activ) ∧ hasSource(?activ, ?p) ∧
hasEnd(?activ, ?g) ∧ hasState(?p, ?ps) ∧ forTime(?ps, ?t) ∧ hasConcentrationValue(?ps,
?c) ∧ swrlb:lessThanOrEqual(?c, 0.2) → isActivated(?gs2, true)
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As described in Figure 7.9, the results of this rule means that, If there is a gene g having a state gs equal
to false at a given time t and there is a protein p having a state ps1 and a concentration c at this time t,
and these two molecules g and p are related by an Activation interaction, and if the concentration of p is
under a threshold equal to 0.2, then the state of g move to true at time t+ 1.
Figure 7.9  Results of the reasoning process for the Activation SWRL rule.
7.4.2.3 Transcription SWRL rule
The following rule represents the gene transcription. In fact, if the gene G32 is activated, this one
generates the protein synthesis and produces an increase in the concentration of this protein p32.
ADN(?g) ∧ hasState(?g, ?gs) ∧ forTime(?gs, ?t) ∧ isActivated(?gs, true) ∧ Protein(?p)
∧ Transcription(?trans) ∧ hasSource(?trans, ?g) ∧ hasEnd(?trans, ?p) ∧ hasState(?p,
?ps1) ∧ forTime(?ps1, ?t) ∧ hasConcentrationValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧
forTime(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1) → hasConcentrationValue(?ps2, ?c2)
The result of this rule is interpreted as (Figure 7.10), If there is a gene g having a state gs equal to true at
a given time t and there is a protein p having a state ps1 and a concentration c at this time t, and these
two molecules g and p are related by a Transcription interaction, then the concentration of the protein p
increases at time t+ 1. In the opposite case, we have this rule:
ADN(?g) ∧ hasState(?g, ?gs) ∧ forTime(?gs, ?t) ∧ isActivated(?gs, false) ∧ Protein(?p)
∧ Transcription(?trans) ∧ hasSource(?trans, ?g) ∧ hasEnd(?trans, ?p) ∧ hasState(?p,
?ps1) ∧ forTime(?ps1, ?t) ∧ hasConcentrationValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧
forTime(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1) → hasConcentrationValue(?ps2, ?c1)
The result of this rule means that (Figure 7.11), If there is a gene g having a state gs equal to false at a
given time t and there is a protein p having a state ps1 and a concentration c at this time t, and these
two molecules g and p are related by a Transcription interaction, then the concentration of the protein p
remains stable at time t+ 1.
Results of the Transcription SWRL rule and its opposite rule are presented in Figure 7.10 and Figure
7.11, respectively.
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Figure 7.10  Results of the reasoning process for the Transcription SWRL rule.
Figure 7.11  Results of the reasoning process for the inverse of Transcription SWRL rule.
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7.4.2.4 Negative regulation SWRL rule
As well, following the increase of the concentration of the protein p32, a negative regulation interaction
resulted to create hormone balance. This reaction is ensured by the following rule:
Metabolite(?m) ∧ hasState(?m, ?ms) ∧ hasConcentrationValue(?ms, ?c) ∧ forTime(?ms,
?t) ∧ Protein(?p) ∧ Negative_regulation(?negreg) ∧ hasSource(?negreg, ?m) ∧ hasEnd(?negreg,
?p) ∧ deltaC(?negreg, ?delta) ∧ hasState(?p, ?ps1) ∧ forTime(?ps1, ?t) ∧ hasConcentra-
tionValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧ forTime(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1)
∧ swrlb:greaterThanOrEqual(?c, 0.8) ∧ swrlb:subtract(?c2, ?c1, ?delta) → hasConcentra-
tionValue(?ps2, ?c2)
The meaning of this rule is (Figure 7.12), If there is a metabolite m having a state ms associated to a
concentration value c at a given time t and there is a protein p having a state ps1 and a concentration
c1 at this time t, and these two molecules m and p are related by a negative regulation interaction, and if
the concentration of m exceeds a threshold equal to 0.8, then the concentration of the protein p decreases
at time t+ 1.
In contrast, when the concentration of the metabolite m32 is less than 0.8 we applied the following
rule:
Metabolite(?m) ∧ hasState(?m, ?ms) ∧ hasConcentrationValue(?ms, ?c) ∧ forTime(?ms,
?t) ∧ Protein(?p) ∧ Negative_regulation(?negreg) ∧ hasSource(?negreg, ?m) ∧ hasEnd(?negreg,
?p) ∧ deltaC(?negreg, ?delta) ∧ hasState(?p, ?ps1) ∧ forTime(?ps1, ?t) ∧ hasConcentra-
tionValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧ forTime(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1)
∧ swrlb:lessThan(?c, 0.8) → hasConcentrationValue(?ps2, ?c1)
Figure 7.12  Results of the reasoning process for the Negative regulation SWRL rule.
Which means (Figure 7.13), If there is a metabolite m having a state ms associated to a concentration
value c at a given time t and there is a protein p having a state ps1 and a concentration c1 at this time t,
and these two molecules m and p are related by a negative regulation interaction, and if the concentration
of m is under a threshold equal to 0.8, then the concentration of the protein p remains stable at time
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Figure 7.13  Results of the reasoning process for the inverse of the Negative regulation SWRL rule.
t + 1. Results of the Negative regulation SWRL rule and its opposite rule are presented in Figure 7.12
and Figure 7.13, respectively.
To conclude, the case study with OWL-SWRL rules represents a proof of concept since it demon-
strates the logical consistency of the BNO ontology and validates its relevance. To check the inconsis-
tencies and violations of these SWRL rules, we used the latest version of HermiT reasoning plugin in
the Protégé 5 environment4 version 1.3.8.3. Obtained results prove that the BNO ontology is consis-
tent, credible and eective in describing relevant knowledge required in understanding the behaviour of
complex biomolecular networks and their state changes. However, we must emphasise that, even if this
ontology provides useful knowledge and rich semantics allowing biologists to understand the dynamical
behaviour of complex biomolecular networks, it can not simulate large-scale networks. That is why more
ecient simulation tools should be used for scaling up and reason on large biomolecular networks.
7.4.3 Rule-based qualitative reasoner within MATLAB
Despite the SWRL rule-based reasoning, extensive experiments were conducted to validate our proposed
ontology including the implementation of the rule-based qualitative reasoner. This rule-based reasoner
is implemented under the MATLAB development environment and can be freely downloaded at https:
//github.com/AliAyadi/Qualitative\ReasoningInMATLAB. The reasoner is based on a qualitative
simulation algorithm 1, with specic reference to the SWRL rules dened in the previous Section 7.4.2.
Algorithm 1 provides a high-level description of the general reasoning algorithm of a complex biomolec-
ular network. The main steps of this algorithm are: (1) The denition of the set of SWRL rules and
their thresholds. (2) The initialization time and the state of all molecular components; (3) Evaluate the
node state; (4) Launch the specic reaction dened by the corresponding SWRL rule when the node state
reached a threshold; and (5) Update the novel value of the state node.
Figure 7.14 depicts the individual qualitative behaviour of the biomolecular components. Indeed,
for each node, a description of its dynamical time-evolution is graphically presented. The evolution is
4http://www.hermit-reasoner.com/
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Algorithm 1 Pseudocode of the qualitative simulation algorithm
1: Denition of the set of SWRL rules and their thresholds.
2:
3: Initialization of time and network's state.
4: for All time step from begining to end_of_simulation do
5: for Each molecular component do
6: Evaluate the node state
7: if the component's state achieves one threshold then
8: Execution of the reaction dened by the SWRL rule corresponding to this threshold.
9: . Measure the state if it is a gene and the concentration if it is a protein or a metabolite
10: Update the novel state of the node.
11: end if
12: end for
13: end for
displayed as a graph to easily see when and how the molecular component evolves during the simulation
and to precisely detect changes in the state in time. These results are not dicult to interpret, because
at each simulation step a qualitatively meaningful network state is reached. The results are close to
human reasoning. In fact, this qualitative reasoning is based on the SWRL rules presented above which
represent a set of constraints equations describing the relevant structural and functional relationships in
the biomolecular network. The possible behaviours and states of the network may be predicted from
these constraints rules and an initial state. The behavioural description of the biomolecular network and
its individual components may be used to explain a set of hypothesis and determine the change directions
of the network behaviour.
Figure 7.14  Simulation results plotted with the MATLAB environment: the individual qualitative
behaviour of the biomolecular components.
7.5 Summary
This chapter proposes an eective approach for analysis and understanding the behaviour of complex
biomolecular networks over time. The use of a semantic approach based on merging dierent ontologies
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can overcome issues of study the state changes of complex biomolecular networks and their behaviour.
Indeed, we developed the Biomolecular Network Ontology (BNO) to describe the static structure of
complex biomolecular networks and merge it with the Gene Ontology (GO) to provide structured ter-
minologies for the description of cellular components. We also chose the Simple Event Model Ontology
(SEMO) to describe events and stimuli which can stimulate the network's components and integrate the
Time Ontology (TO) to study the dierent states of the biomolecular network and its nodes over time.
The Biomolecular Network Ontology developed in this chapter aims to describe the domain knowl-
edge of complex biomolecular networks in their static state. This ontology provides information on the
biomolecular network and its components (nodes, interactions, states, transition states, etc.) and an
indication of the network's context such as the type of sub-network, the type of node, the conditions and
nature of interactions, etc. This allows to precisely analyse and interpret the semantic context in order
to achieve intelligent modelling of biomolecular networks and their state changes. These state changes
can be computed with a rule-based system.
The SWRL rule-based reasoning and rule-based qualitative reasoner within MATLAB have been
used to validate the BNO ontology and to demonstrate how it is capable of providing useful knowledge
and rich semantics allowing biologists to understand and simulate the dynamical behaviour of complex
biomolecular networks. However, the BNO ontology can not simulate large-scale networks. That is why
more ecient simulation tools should be used for scaling up and reason on large biomolecular networks,
this is the topic of the next chapter.
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Figure 7.15  The Biomolecular Network Ontology (BNO).
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8.1 Introduction
The complexity of biomolecular networks is rstly due to their large number of coupled components,
but also to the diversity of these molecular components and to their intricate interactions. Indeed,
biomolecular networks consist of various subnetworks which themselves are composed of several molecular
components interacting in turn with each other, producing a complex global behaviour. The complexity
and large size of these networks have prevented a fully quantitative simulation. Thus, biologists require
tools allowing them to gain insights into the behaviour of complex biomolecular networks by simulating
the dierent states of their components over time.
In this chapter, we propose two kinds of simulation: a qualitative and a discrete-event simulation.
The rst one responds to the complexity of calculating the quantitative reasoning methods which some-
times are impossible to implement. Then, the second method is an integrative discrete-event simulation
considering that the behaviour of the complex biomolecular network emerges from the network-level
interaction.
The rst section of this chapter presents the qualitative simulation method and detail all its construc-
tion steps. Then, the second section of this chapter presents a discrete-event simulation approach that is
able to reproduce the behaviour of complex biomolecular networks and their components over time. This
simulation is based on the combination of the logical-based modelling of complex biomolecular networks
(which is presented in Chapter 6) and a discrete-event simulation algorithm inspired by the discrete-
event system specication formalism (detailed in Section 4.3.4). Moreover, we enrich and explain these
simulation methods by applying them with the case study of the bacteriophage T4 gene 32.
8.2 Qualitative simulation model
In our works, the explicit representation of the network behaviour evolution, between two instants t0 and
tn is essential. Therefore, we must link the logical-based modelling dened in Chapter 6 to a qualitative
simulation mechanism. This simulation allows executing the model in order to simulate the network
evolution and its components over time.
8.2.1 Qualitative reasoning
The reasoning is a mental activity that humans practice to solve diculties they confront in their life.
This reasoning is often performed in the lack of quantitative knowledge and is then called qualitative
reasoning. In literature, we distinguish two types of reasoning, heuristic reasoning which is a mental
shortcut and causal reasoning which is based on a model [8]. The second case of reasoning is based on
the modelling of the system. Such reasoning is based on a model of causal type because it combines the
eects and causes, such as a causal graph. It solves a problem by reasoning about the structure and
function of the object in an application environment and their behaviour over time [337, 338].
We chose to use qualitative reasoning for two reasons: (1) To understand the overall functioning and
properties of complex biomolecular networks through the analysis and simulation of the dynamical model
(explained in the previous section), and the interpretation of the obtained knowledge. (2) To steer these
networks by allowing to evaluate their simulation at any time.
8.2.2 Basic concepts
In the following sections, we will dene the basic concepts of qualitative simulation [8] and detail the
major phases of construction.
8.2.2.1 The causal graph
The qualitative simulation model is based on the development of a causal graph whose nodes denote
variables that are related to this simulation and edges denote causality relations among these variables. By
analogy with the logical-base modelling presented in Chapter 6, the causal graph is itself the biomolecular
network SR where its nodes represent causal states of network's molecular components and its edges
represent the types of interactions that can occur among these components.
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8.2.2.2 Quantitative variables & Quantity space
A variable is a characteristic of interest. For example, in our case the variables of the qualitative model
denote the state of the molecular components at a given moment denoted by en(m, t). These
variables are qualitative because they are represented by qualities (nominal or ordinal).
The set of these qualitative values and their corresponding intervals constitutes the quantity space
of the variable en(m, t), denoted by EQen(m,t). Each variable en(m, t) takes its qualitative value in its
ordered set of qualitative values EQen(m,t) = {vq1, vq2, ..., vqn}. In fact, the quantity space is a partition
of the domain of a variable values into behaviour regions that are qualitatively homogeneous.
As dened in Algorithm 2, the partition of the quantity space EQen(m,t) depends on the type of node:
• If m ∈ MG : en(m, t) = {Deactivated,Activated}, its states can be 'Activated ' or 'Deactivated '.
So, we assign to its EQen(m,t) the qualitative values 0 and 1 meaning respectively 'Deactivated ' and
'Activated '.
en(m, t) = {Deactivated,Activated}
⇒ EQen(m,t) = {0, 1}
• If m ∈ MP ∪MM : EQen(m,t) depends on the outgoing arcs oe(m) starting from the node m. In
fact, as illustrated in Figure 8.1 for a quantity n of outgoing arcs, there will be n + 1 qualitative
values that are dened by an order relation on EQen(m,t), creating an ordered set of qualitative
values EQen(m,t) = {vq1, vq2, ..., vqn}.
en(m, t) = {[minm, Threshold1[, [Threshold1, Threshold2[, ..., [Thresholdn,maxm]}
⇒ EQen(m,t) = {vq1, vq2, ..., vqn}
To resolve the conicts of partitioning the EQen(m,t), we present the following algorithm.
Algorithm 2 Pseudocode of the EQen(m,t) partitioning algorithm
Require: m ∈M , oe(m), minm, maxm, EQen(m,t) ← ∅
Ensure: Partition of EQen(m,t)
1: if (m ∈MP ∪MM ) then
2: for outgoing edges i ∈ oe(m) do
3: Read its Threshold;
4: Sort the threshold values;
Threshold1 < Threshold2 <, ..., < Thresholdn
5: Quantitative partitioning of EQen(m,t);
EQen(m,t) = {[minm;Threshold1], [Threshold1, Threshold2], ..., [Thresholdn,maxm]}
6: Translate quantitative measures into qualitative values;
EQen(m,t) = {vq1, vq2, ..., vqn+1}
Where: vq1 = [minm, Threshold1] and ||EQen(m,t)|| = ||oe(m)||+ 1
7: end for
8: Return the quantity space
EQen(m,t) = {vq1, vq2, ..., vqn+1}
9: else
10: if (m ∈MG) then
11: Boolean partitioning of EQen(m,t);
EQen(m,t) = {true, false}
12: Translate boolean measures into qualitative values;
EQen(m,t) = {vq1, vq2}
Where: vq1 = 0, vq2 = 1 and ||EQen(m,t)|| = 2
13: Return the quantity space
EQen(m,t) = {vq1, vq2}
14: end if
15: end if
Figure 8.1 displays the execution of the EQen(m,t) partitioning algorithm in both cases. In addition
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Figure 8.1  Description of the EQen(m,t) partitioning algorithm.
to the quantity space of its variables, a qualitative reasoning method also includes algebraic relations
(constraints, inuences, etc.) that act among these quantity space.
8.2.2.3 Operations and rules
The operations In [8], the authors dene six operations for calculating the quantity spaces of the
variables. Among them, we will just use the three unary operations shown in Table 8.1: the incrementation
(incr), the decrementation (decr) and the inverse (inv) of a qualitative variable vqi.
Using these operators, we can combine several variables together to create our own operations as a
specic combination table.
The partition and propagation rules Based on the work presented in [8], we adapt a qualitative
reasoning mechanism to compute the qualitative value of the nodes. As shown in Figure 8.2, this mecha-
nism is based on both the partition rules and the propagation rules. These rules are used to compute the
value of the target variable (en(m, t+ 1)) at the next time t+ 1 based on its qualitative value (en(m, t))
and the value of its predecessors (en(Pred(m), t)) at the current time t.
• Partition rules allow the translation of quantitative measures of the variables (en(m, t)) into qual-
itative values. They match a quantitative (real) interval with its corresponding qualitative value
belonging to the quantity space EQen(m,t). They are dened by the pseudo code of the algorithm
2.
• Propagation rules compute the propagation of the qualitative values from the source components
to the target components of the causal graph. They are dened by the aggregate functions Am
which compute the evolution of the node status between two successive instants of the simulation
(this function is detailed in Section 6.4.3). These rules are expressed by combining the operations
presented in Table 8.1.
8.2.3 Application to the motivating example: the bacteriophage T4 gene 32
In order to demonstrate the dierent notions of this qualitative mechanism and to test its performance,
we apply it to the example of the bacteriophage T4 gene 32 detailed in Section 6.2.
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Operations on EQ
Unary operations
∀[en(m, t)] ∈ EQen(m,t) = {vq1, vq2, vq3, vq4, vq5}
and n ∈ N
Incrementation 'incr'
incr0([m]) = [en(m, t)]
[en(m, t)] : vq1 vq2 vq3 vq4 vq5
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
incr1([en(m, t)]) : vq2 vq3 vq4 vq5 vq5
incrn([en(m, t)]) = incrn−1(incr1([en(m, t)]))
Decrementation 'decr'
decr0([en(m, t)]) = [en(m, t)]
[en(m, t)] : vq1 vq2 vq3 vq4 vq5
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
decr1([en(m, t)]) : vq1 vq1 vq2 vq3 vq4
decrn([en(m, t)]) = decrn−1(decr1([en(m, t)]))
Inverse 'inv'
[en(m, t)] : vq1 vq2 vq3 vq4 vq5
- - - - - - - - - - - - - - - - - - - - - - - - - - - - -
inv([en(m, t)]) : vq5 vq4 vq3 vq2 vq1
Table 8.1  Unary operations on quantity spaces presented in [8].
Figure 8.2  Qualitative reasoning mechanism.
8.2.3.1 The variables
In the example presented in Figure 6.1, we have three variables en(G32, t), en(p32, t) and en(m32, t) that
respectively represent the state of the gene G32, the protein p32 and the metabolite m32.
8.2.3.2 The causal graph
We can use the structure of the biomolecular network as the causal graph of our example. This structure
is dened in more details in Section 6.4.1.
8.2.3.3 The partition rules
en(G32, t) ∈ {Deactivated , Activated},
⇒ EQen(G32,t) = {0 , 1}.
en(p32, t) ∈ {[minp32, 0.2[ , [0.2, 0.7[ , [0.7,maxp32[},
⇒ EQen(p32,t) = {vq1 , vq2 , vq3}.
en(m32, t) ∈ {[minm32, 0.8[ , [0.8,maxm32[},
⇒ EQen(m32,t) = {vq1 , vq2}.
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8.2.3.4 The propagation rules
For reasons of clarity, we note [m]t the qualitative value of the state of the component m at time t. It
means that the notation [m]t ≡ [en(m, t)] ∈ EQen(m,t). Now, let us dene the aggregate rules of each
variables.
For the variable G32:
[G32]t+1 = AG32([G32]
t, {i1, i2}, [p32]t) :
if ([p32]t = vq1) then
[G32]t+1 = 1
else if ([p32]t = vq2) then
[G32]t+1 = [G32]t
else if ([p32]t = vq3) then
[G32]t+1 = 0
For the variable p32:
[p32]t+1 = Ap32([p32]
t, {i3, i4}, [G32]t, [m32]t) :
if ([m32]t = vq1) ∧ ([G32]t = 0) then
[p32]t+1 = [p32]t
else if ([m32]t = vq2) ∧ ([G32]t = 0) then
[p32]t+1 = decr([p32]t)
else if ([m32]t = vq1) ∧ ([G32]t = 1) then
[p32]t+1 = incr([p32]t)
else if ([m32]t = vq2) ∧ ([G32]t = 1) then
[p32]t+1 = [p32]t
For the variable M32:
[m32]t+1 = Am32([m32]
t)
⇒ [m32]t+1 = [m32]t
8.2.3.5 The simulation
Let us dene the initial state of the network at t0: ER(t0) = 〈[G32]t0 , [p32]t0 , [m32]t0〉.
We chose the initial qualitative values of the components as: ER(t0) = 〈0, vq1, vq1〉.
Then, we have performed a series of simulations to assess the evolution of the network over time:
ER(t0 + 1) = 〈[G32]t0+1, [p32]t0+1, [m32]t0+1}
= 〈1, vq1, vq1〉
ER(t0 + 2) = 〈[G32](t0+1)+1, [p32](t0+1)+1, [m32](t0+1)+1〉
= 〈1, vq2, vq1〉
8.2.3.6 The behaviour
CR[t0,t2] = {ER(0), ER(1), ER(2)}
= {〈0, vq1, vq1〉, 〈1, vq1, vq1〉, 〈1, vq2, vq1〉}
Figure 8.3 presents the possible states of each molecular components during the simulation. This is the
qualitative simulation of the given example according to the possible initial states of the components.
The possible molecular states presented in this Figure referred to the set of the network states presented
in the last column of Table 6.4.
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Figure 8.3  All possible simulation results of our example.
8.3 Discrete-event simulation model
In this section, we present an approach for simulating the behaviour of complex biomolecular networks
inspired by the DEVS formalism [339] detailed in Section 4.3.4, a formalism for supporting the modelling
of complex systems.
8.3.1 Mapping the logical based modelling with the DEVS formalism
Before proposing our discrete-event algorithm, it is necessary to link the dierent parts of the logical
modelling with their corresponding notions of the DEVS formalism. As discussed in Section 6.4, the
logical-based modelling is based on three basic modelling pillars: (1) The structural modelling SR, to
describe the architecture of the biomolecular network. (2) The functional modelling FR, to describe
what can carry out each component of the biomolecular network, specifying the conditions for these
activities. (3) And the behavioural modelling CR[t0,tn], to describe how the biomolecular network
and its individual components evolve during the simulation period [t0, tn]. Therefore, the biomolecular
network BN is dened as: BN = (SR,FR,CR[t0,tn]).
We follow this tripartite classication to make the mapping between the logical-based modelling and
the DEVS formalism. The structure of the biomolecular network SR (Section 6.4.1) is composed by the set
of nodesM which corresponds to the set of DEVS componentsD, and the set of interactions I corresponds
to the set of the internal links among DEVS components IC. The function of the biomolecular network,
represented by the function FR, corresponds to the internal transition function δint. In the logical-based
modelling, the behaviour of complex biomolecular networks is represented with multiple parameters. The
rst parameter consists of the function en(m, t) that denes the state of each component, and the function
ER(t) that denes the state of the network at time t. These functions correspond to the set of DEVS
components S in the DEVS formalism. The aggregate function Am corresponds to a set of functions in
DEVS formalism which consists of the internal transition function δint, the external transition function
δext, the conuent transition function δcon and the time advance function ta. The external stimuli
represented by S corresponds in DEVS formalism to the set X of input events. Finally, the behaviour of
the network CR[t0,tn] corresponds in DEVS formalism to the set Y of output events which represent the
evolution of each DEVS component during the period of simulation.
8.3.2 Discrete-event simulation algorithm
In this section, we describe the basic model of the proposed discrete-event simulation algorithm, with
specic reference to the logical-based modelling developed in Chapter 6) and following the approach
presented in Zeigler et al. [339] (detailed in Section 4.3.4). Algorithm 6 provides a high-level description
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of the general simulator algorithm of a complex biomolecular network. The main steps of this algorithm
are: (1) The initialization time and the state of all molecular components; (2) The execution of the
aggregate function to compute the evolution of the node in the next iteration; (3) Evaluate the node
state; (4) Launch the specic reaction if the node state reached a threshold; and (5) Update the value of
the node.
Algorithm 3 Pseudocode of the general simulator algorithm
1: Initialization: t0, ER(t0) . Initialisation of time and network's state.
2: for All time step t from begining to end_of_simulation do
3: for Each component mi ∈M do
4: Execution of the aggregate function Ami . Launch the aggregate function manages the
evolution of the node mi
5: (Value, Threshold) = TestState(en(mi, t), FR(mi)) . Evaluate the node state
6: if Value = true then . If the state of a node state achieves a threshold
7: LaunchReaction(FR(en(mi, t))) . Launch the reaction dened by the function FR
8: Update the node's state (en(mi, t)) . Update the novel state of the node
9: end if
10: end for
11: end for
At the beginning of the simulation, the simulator initialises the network's state ER(0) = 〈en(m1, 0),
en(m2, 0), ..., en(mn, 0)〉, and time t = 0.
After each iteration, the simulator evaluates the state of each node. This step is done by the TestState
function 4. This function requires the specication of two parameters: the state of the node mi at this
time t which is provided by the function en(mi, t) (see Section 6.4.3) and its function FR(mi). This
function compares the value of the state with the set of Thresholds dened by its function FR. If the
value of en(mi, t) reached a threshold, it returns a boolean value equal to true and the reached threshold,
else it returns the boolean value false.
Algorithm 4 Pseudocode of the TestState function
function TestState(en(mi, t), FR(mi))
2: for Each Threshold ∈ ae(mi) do . Compare the state of the molecule mi with all thresholds
if en(mi, t) reached Threshold then
4: return (true, Threshold); . If a threshold is reached it returns true and the reached
threshold
else
6: return (false, );
end if
8: end for
end function
Once the comparison has been done and according to the result returned by the TestState function,
the simulator runs the LaunchReaction procedure dened by Algorithm 5. This procedure requires the
specication of two parameters: the Threshold returned by the TestState function and the function
FR(mi). According to these two parameters, the procedure launch the specic reaction corresponding
to the type of the interaction dened by the function FR (Section 6.4.2). This label TypeInteraction
represents the type of the interaction dened by the edge imi,md (with mi the actual node and md
the target node). These types of interactions belong to the set of concepts of the Interaction Ontol-
ogy (which is detailed in Section 6.4.1). After applying the specic reaction, the novel value of the
node mi is updated. This process will continue for all the nodes M and until the end of the simu-
lation. Finally, the simulator returns the sequence of the successive states during the simulation time
CR[t0,tend_of_simaulation] = [ER(0), ER(1), ..., ER(end_of_simaulation)] dening the behaviour of the
biomolecular network. These results are presented graphically.
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Algorithm 5 Pseudocode of the LaunchReaction procedure
procedure LaunchReaction(Threshold, FR(mi))
2: switch Threshold do
case TypeInteraction1
4: assert(Launch the reaction corresponding to this type of interaction)
case TypeInteraction2
6: assert(Launch the reaction corresponding to this type of interaction)
case TypeInteraction...
8: assert(Launch the reaction corresponding to this type of interaction)
case TypeInteractionn
10: assert(Launch the reaction corresponding to this type of interaction)
end procedure
8.3.3 Application to the motivating example: the bacteriophage T4 gene 32
Before simulation of the given example starts, it is necessary to dene its structure in a text le that
follows the structure SR of a biomolecular network dened in Section 6.4.1. This text le represents the
data input of the simulator. This simulator starts by reading the network data from the dened text
le. Figure 8.4 shows the input le containing the necessary elements describing the structure of the
bacteriophage T4 gene 32 network.
Figure 8.4  Denition of the necessary elements describing the structure of the bacteriophage T4 gene
32 network.
To simulate the behaviour of the given network, we implement the algorithm presented in the previous
section and dene the dierent interactions. For example, we dene the activation interaction by the
following rule: 'If the value of the concentration of the protein p32 rises above a certain threshold, then
the transcription of the gene G32 is switched on.' When the gene G32 is activated, a transcription
interaction is activated creating a protein production which means that the output of this interaction
is a production of the protein p32 with an increase of its concentration associated to a specic rate
of production. Further to this activation interaction and once the gene is activated, a transcription
interaction will automatically occur by creating the increased concentration of the protein p32, which
will additively increase its production to ∆c% (the change in concentration caused by the production
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interaction). It is the same with the inhibition interaction. We dene it by the following rule: 'If the
value of the concentration of the protein p32 rises above a certain threshold, then the transcription of
the gene G32 is switched on.' When the gene G32 is deactivated, the transcription interaction is also
deactivated, as well as stopping the protein production which means that the production reaction is inert
and never performs any actions. This allows maintaining a stable level of the protein p or its degradation.
Further to this inhibition interaction and once the gene is deactivated, the transcription interaction is
automatically stopped enabling the degradation of the concentration of the protein p32.
In cooperation with our biological collaborators (the Complex Systems and Translational Bioinfor-
matics CSTB team1  ICube Laboratory), we dene the values of the thresholds for each interaction, for
example, 0.2 for the activation reaction and 0.7 for the inhibition reaction. We also estimate the value
of a set of parameters needed to simulate the interactions with the discrete-event algorithm simulation
proposed in Section 8.3.2. Among them the production rate (which describes the rate of production of
the target protein per unit time when the activation interaction occurs), the degradation rate (which de-
scribes the rate of attenuation of the target protein per unit time when the inhibition interaction occurs).
Figure 8.5  The simulator's graphical interface. Evolution of the component's behaviour during the
simulation period: the red curve represents the dierent values of the protein p32 during the period of
simulation and the yellow surface represents the dierent states of the gene G32.
As presented in Figure 8.5, the simulation results of the given example were synthetically represented
in graphical form. During the simulation, the concentration of the protein p32 is represented by the red
curve and the state of the gene G32 by the yellow surface that appears when the gene is activated. We
run the simulation with dierent starting states and observe its results. We note that this simulator
can successfully reproduce the behaviour of the bacteriophage T4 gene 32 network. In fact, expert
biologists agree with the simulator results. Moreover, with the current graphical interface, the user can
easily analyse and observe the dierent states of the network components and consequently deduce the
behaviour of the biomolecular network. In addition, these results correspond with results which were
obtained earlier with the qualitative reasoning method presented in the previous Section 8.2.3 and the
semantic approach based on an SWRL rule-based system in Section 7.4.2.
1http://icube-cstb.unistra.fr/en/index.php/Home
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8.4 Summary
In this chapter, we draw inspiration from the works of [8] to propose a qualitative reasoning method to
simulate the behaviour of the biomolecular network. This method is completely based on the logical-
based modelling presented above in Chapter 6 that can be assimilated to a causal model. This qualitative
simulation clearly demonstrates all the elements that we need to understand the evolution of biomolecular
networks. Moreover, we integrate a discrete-event simulation algorithm inspired by the DEVS formalism,
into the logical-based modelling of biomolecular networks. This approach aims at providing biologists
with a exible tool for simulating biomolecular networks by reproducing their behaviour and the state
of their components over time and consequently allows them to analyse and understand simulated cell
phenomena. These approaches have been veried on the bacteriophage T4 gene 32 biomolecular network
use case. Simulation results obtained were formally treated and validated by expert biologists. Indeed,
these results correspond to their domain knowledge. More important examples will be presented in the
Experiments and discussion part (Part III).
In the next chapter, we will introduce a multi-objective genetic algorithm for optimizing the transit-
tability of complex biomolecular networks which will provide the best set of external stimuli for driving
the network.
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A multi-objective optimization method
for solving the transittability of
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9.1 Introduction
The computation of the transittability of complex biomolecular networks can be considered as an opti-
mization problem. As discussed in Chapter 5, only a few studies have been conducted on this problem.
Most of them focused only on the minimization of the required nodes to steer the entire network, and
others considered the minimization of the number of stimuli to be applied on the network. However,
this assumption is not very realistic, because steering complex biomolecular networks are, in general, a
multi-objective optimization problem. It requires nding appropriate trade-os among various objectives,
for example among the distance between the simulated nal network state and the desired network state,
the appropriate nodes to be stimulated and the number of external stimuli to be used, their cost and the
patient comfort.
In this chapter, we rstly propose a multi-objective mathematical formulation for optimizing the
transittability of complex biomolecular networks in which we take into account more criteria such as the
minimization of the distance between the simulated nal network state and the desired network state,
the minimization of the number of external stimuli, the minimization of their cost, the minimization of
the number of target nodes, the minimization of the patient discomfort. Then, we propose a two-step
multi-objective optimization approach for solving this multi-objective problem. Our proposed approach
is strongly based on the combination of both Non-dominated Sorting Genetic Algorithm (NSGA-II) [340]
to obtain the set of Pareto-optimal solutions, and the Technique for Order of Preference by Similarity to
Ideal Solution (TOPSIS) method [341] to provide the decision-maker with the best compromise solution
according to its preferences.
The rst section of this chapter presents a brief description of the problem tackled in this study. Then,
the second section proposes the theoretical and mathematical modelling of this problem by introducing
its parameters, decision variables, objective functions and constraints. The third section explains and
lists the steps of the proposed optimization approach used for solving the given problem, followed by the
concluding comments in the last section.
9.2 Problem statement
According to the transittability notion, a complex biomolecular network can be steered from a state to
another one through appropriate stimuli. These stimuli can be internal, such as the changes of the physical
and chemical properties of the cell, or external such as environmental eects and drugs. Therefore, we
can dene a stimulus as an action or condition that interferes with a node, which can, in turn, aect other
nodes and consequently causes the transition of the entire network. The transition of the biomolecular
network starts when one (or more) stimuli trigger one (or more) nodes. Indeed, when the stimulus triggers
a node, the state or the concentration of this molecular component will change to reach a specic node
threshold. This threshold denes the type of interaction that will occur and the condition that activates
it. The state change of a node provokes as well as the change of the overall network state (changing a node
automatically modies other network nodes) creating the stimulus-response behaviour of the biomolecular
network. Thus, the state of the biomolecular network at an instant t is a set represented by the set of
the states of all components in the network at time t.
Formally, the biomolecular network is dened as an undirected graph denoted by BN = (M, I). Where
a node mi ∈ M corresponds to a molecular component which can be a gene, protein or metabolite.
And an edge i = (mi,mj) ∈ I; mi,mj ∈ M expresses the dierent type of interaction among the
molecular components. These interactions can be categorized in the following way: there are three
interactions among molecular components of the same type (intraomic interactions), four interactions
(among the 6 possibilities) between the nodes belonging to dierent networks (interomic interactions),
and two interactions are not taken into account because there is no direct interaction between the genes
and metabolites and vice versa.
For each molecular component mi, we associate a concentration cti which represents the value of its
concentration at time t. The concentration level cti should be inside the interval [c
min
i , c
max
i ], where c
min
i
and cmaxi represent the minimum and maximum concentration value of the molecular component mi,
respectively.
The state transition of the biomolecular network occurs by changing at least the concentration of one
of its nodes. These changes in the concentration of the molecule can occur either by an internal stimulus
(for example, due to reactions that are internal to the cell) already seen with the aggregate function
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presented in Chapter 6) or by an external stimulus generated outside the cell (for example, because of a
medicine taken by the patient). Let S be the external stimuli set. Each stimulus interferes with a node
at a time of introduction Stk,i, changing its concentration with a certain concentration ∆
t
c,k,i leading to
an increase (or a decrease) of its actual concentration. Moreover, for each stimulus, we associate a cost
CostStimk and the patient discomfort DiscomfortStimk caused by the stimulus k which should not
exceed the maximum discomfort a patient can endure DiscomfortmaxP .
Our goal is to optimize simultaneously the dierent criteria involved in the transittability of biomolec-
ular networks, in particular, the distance between the simulated nal network state and the desired
network state, the number of external stimuli, their cost, the number of target nodes and the patient
discomfort. Especially by nding the best compromise among these criteria to optimize the steering of
the biomolecular network from an unexpected state to a desired state.
More details about the logical denition of this problem can be found in Chapter 6.
9.3 Proposed multi-objective mathematical model
In this section, we propose a multi-objective mathematical model for optimizing the transittability of
complex biomolecular networks considering diverse criteria, such as: the minimization of the distance
between the simulated nal network state and the desired network state, the minimization of the number
of external stimuli, the minimization of their total cost, the minimization of the number of target nodes,
and the minimization of the patient discomfort. It is important to note that the rst objective function
that focuses on the minimization of the distance between the simulated nal network state and the desired
network state will be estimated using the simulator dened in the precedent chapter. The notation,
parameters, decision variables and constraints of the model are presented in the following sections.
9.3.1 Parameters
Table 9.1 enumerates the parameters of the proposed multi-objective mathematical model.
Table 9.1  Nomenclature used in the proposed mathematical model.
Symbol Description
P a patient
BN = (M, I) the complex biomolecular network of nodes M and edges I
M = {1, . . . ,m} the set of all the molecular components of the network
I = {1, . . . , n} the set of all the interaction among the molecular components of the network
S = {1, . . . , k} the set of external stimuli
t = {1, . . . , T} the time period
StartTransiBN the starting time of the biomolecular network's transition
FinishTransiBN the nishing time of the biomolecular network's transition
Stk,i the time of introduction of the stimulus k to the node i
ek,i the execution time of the stimulus k on the node i
cti the level of concentration of the node i at time t
cmini the minimum level of concentration of the node i
cmaxi the maximum level of concentration of the node i
∆tc,k,i the change in concentration caused by the stimulus k on the node i at time t
DiscomfortStimk the amount of discomfort associated and caused by the stimulus k
DiscomfortmaxP the maximum amount of discomfort that a patient P can endure
9.3.2 Decision variables
• xtk,i: Binary variable equal to 1 if and only if the stimuli k aect the molecular component i at time
t, 0 otherwise.
• CostStimk: Real variable corresponding to the cost of the stimuli k which aect the molecular
component i at time t.
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• DiscomfortStimk: Nominal variable denotes the level of the discomfort of the patient during
the stimulation done by the stimulus k. As described in Section 9.3.3.5, this variable is catego-
rized as DiscomfortStimk = 0 : No discomfort; DiscomfortStimk = 1 : Light discomfort;
DiscomfortStimk = 2 : Medium discomfort; DiscomfortStimk = 3 : Strong discomfort;
DiscomfortStimk = 4 : Extremediscomfort.
9.3.3 Objective functions
In this section, we detail each one of the dierent criteria considered to optimize the transittability of
complex biomolecular networks.
9.3.3.1 Minimizing the distance between the simulated nal network state and the desired
network state
Before dening this objective function, let us briey describe how this optimization module is integrated
into the proposed simulator presented in the precedent chapter. First of all, we have as an input the
initial state of our network and its desired future state. Our goal is to use some stimuli to steer the
network from its initial state to the desired state. Thus, we launch our simulator with the initial state
and the list of stimuli for a period of time. After this time simulation, the simulator generates a simulated
nal network state. Now, the problem is how to measure and to evaluate the proximity of the obtained
simulated nal network state (outputted by the simulator) and the desired future state (provided by the
user as an input). Indeed, our main objective is that: the simulated nal network state should be as close
as possible to the desired future state.
Therefore, to assess the degree of proximity of these two states, we need to dene a function that
evaluates the degree of goal attainment. In other words, we need a function that evaluates the degree of
proximity between the two states: the simulated nal network state (SFNS) and the desired network
state (DNS). This evaluation function should evaluate and assess the individuals of our genetic algorithm.
We recall that in our optimization approach an individual represents a list of stimuli over time (see Section
9.4.1.3).
That is why we dened here an objective function that minimizes the dierence between the simulated
nal network state as computed by the simulator and the desired network state which is the goal of the
network optimization.
For the sake of clarity, we just use the Euclidean distance between the concentration vectors of the
simulated nal network state (SFNS) and the desired network state (DNS). We recall that the state
of the network is dened by the value of the concentration of its nodes. Thus, we compute the distance
between these two vectors (−−−−−→mSFNS and −−−−→mDNS) using the following formula:
d(−−−−−→mSFNS ,−−−−→mDNS) =
√∑M
i=1([mSFNS,i]− [mDNS,i])2
For the moment and in order to check our approach we want to have solutions. That is why we have
dened a proximity threshold to be able to decide if the simulated nal network state is close enough of
the desired network state. However, we are aware that this measure could be improved, for example, by
giving dierent weights to the dierent nodes according to their biological importance and the more or
less important eects of the deviation between the desired concentration and the concentration computed
by the simulator.
It is important to note that we treat all the nodes by using concentrations, even with genes (which
have states and no concentrations). This explains why we are working on standardized concentrations.
It is also important to remember that the simulated nal network state is evaluated by the simulator
dened in the previous chapter.
To do this, we dene the objective function Z1 which aims to minimize the distance between the
simulated nal network state denoted by SFNS and the desired network state denoted by DNS, using
Eq. (1).
Z1 : Min (Distance(SFNS,DNS)) (1)
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9.3.3.2 Minimizing the number of external stimuli
As discussed in the previous sections, external stimuli called also input signals or structural perturbations
are necessary for steering biomolecular networks from their actual state to a desired state. Indeed,
external stimuli are the key element since they are responsible for steering biomolecular networks.
Therefore, the goal of this objective function is to identify the minimum number of stimuli that are
most likely to steer the global biomolecular network from the initial state to the desired state. In other
words, this criteria aims to give priority to the quality of the external stimuli than their quantity. Figure
9.1 explain this notion through an example of a biomolecular network which can be steered to the desired
state through three possibilities. These possibilities here are explained from the point of view of the
number of indispensable external stimuli for steering the network from a state to another one. We can
reach the desired state via three dierent stimulation strategies (a, b and c). In the strategy a, each node
receives an external stimulus. In the strategy b, we use three external stimuli. And in the strategy c, we
only use two external stimuli. As a result, we note that the strategy c is the best one because we use the
minimum number of external stimuli for steering the network.
Figure 9.1  A simple illustration of the transittability of complex biomolecular networks from the number
and cost of external stimuli perspective.
To do this, we dene the objective function Z2 which aims to minimize the number of external stimuli
for achieving the transittability of complex biomolecular networks using Eq. (2).
Z2 : Min (
∑
k∈S
∑
i∈M
∑T
t=1 x
t
k,i) (2)
9.3.3.3 Minimizing the cost of the external stimuli
This criteria is related to the previous objective function (Section 9.3.3.2). In fact, the cost of external
stimuli can be proportional to the number of external stimuli. So, if we have a number of external stimuli
equal to the number of nodes and all the external stimuli have the same cost, the transittability process
of the complex biomolecular network will be very expensive. For these reasons, this criteria aims to nd
the best compromise between the quality of the external stimuli and their cost. We clarify this objective
in the same example used in the rst Section 9.3.3.2 (Figure 9.1). Here, we focus only on the cost of the
stimuli. In the strategy a, the total cost of external stimuli is 11 (5 + 3 + 1 + 2). In the strategy b, the
cost of external stimuli is 9 (5 + 1 + 3). And in the strategy c, the total cost of external stimuli is 15
(2 + 13). Consequently, the strategy b oers the best cost of external stimuli for steering the network.
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Thus, we dene the objective function Z3 which aims to minimize the cost of the external stimuli
considering their quality for achieving the transittability of complex biomolecular networks using Eq. (3).
Z3 : Min (
∑
k∈S
∑
i∈M
∑T
t=1 x
t
k,i × CostStimk) (3)
9.3.3.4 Minimizing the number of target nodes
Several research studies have revealed that among all the nodes composing the biomolecular network,
there are some specic nodes that have the ability to steer the network from its actual state to another
specic state. Moreover, if we stimulate all the nodes of the network, there would be a probability
that side and undesired eects of drugs on the biomolecular network [307, 308, 309]. Thus, instead of
stimulating all the nodes randomly, it is better to have a stimulation strategy which targets a set of
specic nodes. This will allow stimulating only a minimum number of nodes those allowing the transition
of the network to the desired state, so-called the minimum steering nodes.
As discussed in Section 5.7.7, a number of researches focused on the minimum steering sets and prove
that identify the minimum set of nodes to be aected by external stimuli is a primordial condition to
study biomolecular network's transitions. According to Butcher et al. [342] and Yang et al. [343] there
are some biomolecular networks for which the perturbation of only a subset nodes of all network molecules
can contribute to their transition from a state to a specic state, such as the promyelocytic leukaemia
network [343]. However, this is not the case for all biomolecular networks. That is why we have to select
only indispensable nodes (driver nodes) among neutral nodes (not protable nodes). Figure 9.1 explain
this notion through an example of a biomolecular network which can be steered to the desired state
through three possibilities. These possibilities here are explained from the point of view of the number
of indispensable nodes for steering the network from its initial state to the desired state. We can reach
the desired state via three dierent stimulation strategies (a, b and c). In the strategy a, we interfere
with all the network nodes. In the strategy b, we interfere three nodes among four. And in the strategy
c, we only perturb two nodes. Therefore, we note that the strategy c is the best one because there are
only two indispensable nodes for steering the network.
So, we dene the objective function Z4 which aims to identify the minimum number of nodes that are
indispensable for steering the network from a state to another using Eq. (4).
Z4 : Min (card(TN)) (4)
Notice that TN is the set of the target nodes aected by the stimuli, dened by: TN = { i ∈M ; ∃ k ∈
S; ∃t ∈ {1, . . . , T}; xtk,i = 1}.
9.3.3.5 Minimizing the patient discomfort
The transittability of a biomolecular network can potentially be uncomfortable. By way of example, let's
take the chemotherapy which is an anti-cancer treatment that consists of acting on cancer cells through
toxic drugs (either by injection or sometimes in the form of infusion) until they die and disappear.
This treatment corresponds to the transittability of a biomolecular network which generally causes acute
pain, vomiting, dizziness, fatigue and stress. As well as, it has been proved that the patient discomfort
negatively impacts the emotional and mental health of patients, the quality of their life and increases the
use of healthcare resources [344, 345]. For all these reasons, we must consider this important criterion in
the transittability process.
Therefore, our objective here is to reduce the patient discomfort during a certain treatment (while
nding the best compromise with the other objective functions cited previously). In our context, the
patient discomfort encompasses dierent aspects such as patient pain, stress, vomiting, dizziness, anxiety,
fatigue, etc.
Based on the IPREA questionnaire proposed by Kalfon et al. [346] which focuses on the assessment
of discomfort perceived by patients related to their intensive care, we dene the uncomfortable level felt
by a patient as an integer between 0 and 4. The patient is asked to mark his uncomfortable level on the
line between the two extremities. These levels are dened as follows:
• Level 0 corresponds to no discomfort,
• Level 1 corresponds to light discomfort,
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• Level 2 corresponds to medium discomfort,
• Level 3 corresponds to strong discomfort,
• Level 4 corresponds to extreme discomfort.
Similar to the minimization of the stimuli cost, this criterion focuses on the minimization the patient
discomfort is related to the rst objective function (Section 9.3.3.2). Indeed, we note that in our context,
the patient discomfort is treated in two distinct forms: (i) Explicitly and directly by associating it with
the stimulus. For example, swallowing a pill is more comfortable than an injection. This is explicitly
considered by this objective function (Eq. (5)). Or (ii) implicitly by controlling the side eects of node
concentrations. Indeed, for each node, its concentration is evaluated according to its minimum and
maximum threshold concentrations. These threshold concentrations (min and max) are dened by the
biologists and ensure to check and detect if the current concentration of the node becomes dangerous for
the patient. This is handled by the constraint dened later by Eq. (15).
Therefore, the patient discomfort is one of the major aims to be achieved during the optimization of
the transittability of biomolecular network. This goal is represented by the objective function Z5 that
aims to minimize the patient discomfort using Eq. (5).
Z5 : Min (
∑
k∈S
∑
i∈M
∑T
t=1 x
t
k,i ×DiscomfortStimk) (5)
9.3.4 Constraints
In this section, all constraints required to steer the complex biomolecular network from a state to another
are presented.
• Constraint (6) ensures that the time of introduction of the stimulus k on a node i is greater than
(after) the starting time of the transittability process of the biomolecular network BN .
Stk,i > StartTransiBN ∀k ∈ S, i ∈M, t ∈ T (6)
• Constraint (7) ensures that the time of introduction of the stimulus k on a node i is smaller than
(before) the nishing time of the transittability process of the biomolecular network BN .
Stk,i < FinishTransiBN ∀k ∈ S, i ∈M, t ∈ T (7)
• Constraint (8) ensures that the stimuli are introduced by order of time: stimulus k+ 1 begins after
the stimulus k nished.
Stk,i + ek,i ≤ Stk+1,i ∀k ∈ S, i ∈M, t ∈ T (8)
• Constraint (9) ensures that both stimuli and nodes are acting simultaneously.
if
∑
k∈S x
t
k,i = 1 then
∑
i∈M x
t
k,i = 1 ∀t ∈ {1 . . . T} (9)
• Constraint (10) ensures the minimum number of indispensable nodes required for the transittability
process. ∑M
i=1 xi,k ≥ 1 ∀k ∈ S (10)
• Constraint (11) ensures the minimum number of external stimuli required for the transittability
process. ∑S
k=1 xk,i ≥ 1 ∀i ∈M (11)
• Constraints (12) ensure the non-negativity constraints.
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cti ≥ 0
∆tc,k,i ≥ 0
DiscomfortStimk ≥ 0
CostStimk ≥ 0 (12)
• Constraint (13) represents the binary constraints.
xtk,i ∈ {0, 1} ∀k ∈ S, i ∈M, t ∈ T (13)
• Constraint (14) ensures that the patient discomfort felt during the stimulation should not exceed
the limit (maximum) of discomfort.∑
k∈S DiscomfortStimk ≤ DiscomfortmaxP ∀t ∈ T (14)
• Constraints (15) ensure that each stimulus aect only one node and each node is stimulated by only
one stimulus at a time t. ∑S
k=1 x
t
k,i = 1 ∀i ∈M, t ∈ T∑M
i=1 x
t
k,i = 1 ∀k ∈ S, t ∈ T (15)
• Constraints (16) ensure that the change in concentration applied by the stimulus k on the node i
do not exceed both limits minimum and maximum of concentration of the node i.
∆tc,k,i + c
t
i ≥ cmini ∀k ∈ S, i ∈M, t ∈ T
∆tc,k,i + c
t
i ≤ cmaxi ∀k ∈ S, i ∈M, t ∈ T (16)
According to the above assumptions, the proposed mathematical model for the transittability of
complex biomolecular networks is as follows:
Z1 : Min (Distance (SFNS,DNS)) (1)
Z2 : Min (
∑
k∈S
∑
i∈M
∑T
t=1 x
t
k,i) (2)
Z3 : Min (
∑
k∈S
∑
i∈M
∑T
t=1 x
t
k,i × CostStimk) (3)
Z4 : Min (card(TN)) (4)
Z5 : Min (
∑
k∈S
∑
i∈M
∑T
t=1 x
t
k,i ×DiscomfortStimk) (5)
S.t.
Stk,i > StartTransiBN ∀k ∈ S, i ∈M, t ∈ T (6)
Stk,i < FinishTransiBN ∀k ∈ S, i ∈M, t ∈ T (7)
Stk,i + ek,i ≤ Stk+1,i ∀k ∈ S, i ∈M, t ∈ T (8)
if
∑
k∈S x
t
k,i = 1 then
∑
i∈M x
t
k,i = 1 ∀t ∈ {1 . . . T} (9)∑M
i=1 xi,k ≥ 1 ∀k ∈ S (10)∑S
k=1 xk,i ≥ 1 ∀i ∈M (11)
cti ≥ 0
∆tc,k,i ≥ 0
DiscomfortStimk ≥ 0
CostStimk ≥ 0 (12)
xtk,i ∈ {0, 1} ∀k ∈ S, i ∈M, t ∈ T (13)∑
k∈S DiscomfortStimk ≤ DiscomfortmaxP ∀t ∈ T (14)∑S
k=1 x
t
k,i = 1 ∀i ∈M, t ∈ T∑M
i=1 x
t
k,i = 1 ∀k ∈ S, t ∈ T (15)
∆tc,k,i + c
t
i ≥ cmini ∀k ∈ S, i ∈M, t ∈ T
∆tc,k,i + c
t
i ≤ cmaxi ∀k ∈ S, i ∈M, t ∈ T (16)
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9.4 Multi-objective optimization approach
So the rst idea was to use some well-established genetic algorithm software such as the MOEA platform1
(in Java, mostly not parallel) or the EASY platform2 (in C and GPGPU cuda for highly parallel genetic
algorithm computing) for directly generating executing and solving our multi-objective problem. This
platform is a free and open source Java framework for solving multi-objective optimization problems.
Indeed, it supports a variety of multi-objective evolutionary algorithms, including genetic algorithms,
genetic programming, grammatical evolution, dierential evolution, and particle swarm optimization.
However, this idea quickly changed. Indeed, we draw inspiration from the documentation provided by
the MOEA platform and the works of Deb et al. [340] to develop our own genetic algorithm, in particular
by implementing a non-dominated sorting genetic algorithm. This optimization module was integrated to
the simulator presented in the precedent chapter for two main reasons: the rst is that we want to have
exibility for individuals which are more specic for the population management (we focus particularly
in this criterion). The second reason is to obtain a specic control on this criterion because it is useless
to keep bad quality networks.
This section details our proposed optimization approach which consists of two steps. The rst one is
the search of the of the set of Pareto-optimal solutions. And, the second step is based on the use of a
decision-making technique for generating the best compromise solution according to user preferences. As
illustrated in Figure 9.2, these two steps are ensured by the combination of the non-dominated sorting
genetic algorithm (NSGA-II) as proposed by Deb et al. [340] and the Technique for Order of Preference
by Similarity to Ideal Solution (TOPSIS) method [341], respectively.
Figure 9.2  Flowchart of the proposed resolution approach.
9.4.1 First step: search process
9.4.1.1 NSGA-II algorithm overview
Numerous methods such as the weighted-sum method, the goal programming, etc. have been proposed in
the literature to solve multi-objective problems by combining their objectives to form a single objective
problem and then the optimal solution is obtained [347]. However, in reality, dierent alternatives should
be obtained according to the decision-maker preferences and these methods do not allow it. That is why
we chose to use the NSGA-II algorithm which is a powerful metaheuristic to obtain the Pareto-optimal
solutions. Moreover, the NSGA-II algorithm is characterized by its elitist strategy, its few parameters,
and is less complicated than other variants of multi-objective algorithm [347].
1http://moeaframework.org/
2https://easyplatform.com/
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9.4.1.2 NSGA-II algorithm operation
Similarly to a simple genetic algorithm, the NSGA-II algorithm starts by generating a random set of
solutions called population. This population consists of a set of individuals also called chromosome. The
population has a size Np which is an important parameter in the NSGA-II. Then, the objective functions
are evaluated for each individual and ranked based on the concept of non-domination (if a solution cannot
improve any objective value without degrading one or more of the other objective values). After that,
the ospring population is created using the selection, crossover and mutation operators. Then, the
best chromosomes are selected using the elitism operator. These steps are repeated until the stopped
condition is reached. Finally, the output of the algorithm is a set of solutions that should be near the
Pareto-optimal.
9.4.1.3 Genetic algorithm implementation
Here, we explain and detail the steps of the genetic algorithm implementation. The logical diagram of
the employed multi-objective genetic algorithm on the basis of NSGA-II is given in Figure 9.3 and its
operation is detailed in Algorithm 6. As well as, the genetic algorithm operators were carefully selected
based on the requirements of the transittability problem.
Figure 9.3  Flowchart of the proposed multi-objective optimization method based on the NSGA-II
algorithm.
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Chromosome encoding In our context, the representation of a chromosome consists of a list of stimuli.
An individual is a couple with the rst part the stimuli and in the second part the time of its introduction.
These stimuli are part of the biological data imputed by biologists and which are dened by dierent
properties such as the index of the stimuli Si, the time of introduction of the stimulus Si into the node
mi, the target node mi by the stimulus Si, the variation of concentration caused by the stimulus Si on
the node mi, the cost of the stimulus Si, and the discomfort caused by the stimulus DiscomfortStimk.
Figure 9.4 illustrates the chromosome encoding considered for an example with S = 15. This example of
stimuli and their properties can be found in Table 10.2.
Figure 9.4  Chromosome encoding.
Initial population Initially, the chromosomes are generated randomly creating a rst population P0
(gen = 0) with a population of size Np. The objective functions from Equations (1) to (4) are evaluated
for each chromosome respectively. Then, the parent population are ranked based on the non-domination
concept. In a second step, a child population Q0 (gen = gen + 1) of size Np is created from the parent
population P0 by the use of the selection, crossover and mutation operators.
Selection (NSGA-II) Considering the obtained chromosomes, the population is sorted based on the
non-domination principle. This elitism method consists: (i) rstly in searching the dominated individuals
in the population and ranking them according to their dominance using Equation (17) (where X and Y
are two individuals and xi, yi are objective functions). Then, (ii) the selection of those which have the
greater rank. In the case of two individuals with the same rank of dominance, we compute the crowding
distance between them as dened by Equation (18) (where d(k) is the crowding distance of individual
k, fkj is the j
th objective function value of the kth individual, and fminj , f
max
j are the minimum and
maximum value of the jth objective function, respectively). Indeed, the crowding distance value of a
solution provides an estimation of the density of solutions surrounding that solution. In other words, the
crowding distance value of a particular solution is the average distance of its two neighbouring solutions.
It is a measure of "density of solutions surrounding a particular solution in the population" [340]. The
individual having the greater crowding distance value is better than those having a small value.
∀X = {x1, . . . , xM} and Y = {y1, . . . , yM} Then X  Y ⇔ ∀i : xi ≤ yi and ∃j : xj ≤ yj (17)
d(k) =
∑M
j=1
|fk+1j −f
k−1
j |
fmaxj −fminj
(18)
Crossover To perform the crossover, two parents are randomly selected. A point, representing here
the time of introduction of a stimulus, is randomly selected and designated as the crossover point. Then,
the stimuli that are very next to the crossover point are interchanged. Finally, ospring chromosomes
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are obtained by copying the beginning of one parent to the crossover point and the rest is copied from
the second parent. Figure 9.5 presents an example illustrating this single point crossover operator.
Figure 9.5  Single point crossover.
Mutation In our work, we use a simple mutation operator where a PM per cent of the chromosomes
are randomly mutated. Our mutation operator operates in two major ways. Firstly, we randomly select
an individual (by doing a random on the list of stimuli forming the chromosome). This random choice
is applied to the stimuli or their time. Then, we remove or add a stimulus at this selected point time.
This exploration phase consists of probing a much larger section of the search space looking for other
promising solutions that are yet to be rened. This operation aims to diversify the search in order to
avoid getting trapped in a local optimum. It is considered as a global search. Secondly, we randomly
select an existing stimulus. Then, we change its time by adding a very small value ∆t (+1 or -1) that
allows increments as well as decrements the time to an optimum value. This method allows obtaining
solution close to the optimum solution. This intensication phase allows rening our solutions looking
for nding better solutions.
Fitness function For the sake of clarity, we just use the Euclidean distance between the concentration
vectors of the simulated nal network state (SFNS) and the desired network state (DNS). That is why
our tness function is the same as the rst objective function Z1 that aims to minimize the distance
between the simulated nal network state denoted by SFNS and the desired network state denoted by
DNS. We recall this function:
Fitness function = Min (Distance(SFNS,DNS))
We remember that this evaluation function is done by the simulator dened in the previous chapter.
Stopping criteria The previous steps are repeated until reaching the stopping criterion. In our context,
the stopping criterion is the limitation on the maximum number of generations.
9.4.2 Second step: decision making
In order to select the appropriate "optimal" solution among the set of Pareto-optimal set generated by
the rst step, we integrate a multi-criteria decision-making analysis method called TOPSIS.
9.4.2.1 TOPSIS method overview
The decision-making process requires decision-maker interaction. TOPSIS aims to rank a certain number
of alternatives from the most preferred to the least preferred, with a view to supporting the decision-
maker in its selection of the most appropriate alternative under uncertain criteria. This method is a part
of the techniques used in the multiple criteria decision-making domain and it was developed by Hwang
and Yoon in 1981 [341]. TOPSIS is based on two main features, options which represent the list of
solutions that can be considered as a decision, and criteria which represent the criteria needed to make
an optimal decision.
As presented above, in our multi-objective problem no single solution exists that simultaneously
optimizes all the objectives. Besides, there exists a number of Pareto-optimal solutions generated by
the genetic algorithm dened in the previous section. optimal solutions and decisions required the user
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Algorithm 6 Pseudocode of the employed non-dominated sorting genetic algorithm (NSGA-II) [340]
Require: The parent population P = ϕ; The child population Q = ϕ; The collect population R = ϕ;
The generation index population gen = 0; The maximum number of generation MaxGen
Ensure: The populations P are the non-dominated solutions
1: Randomly initialize the parent population P0.
2: while stopping condition not satised (gen < Maxgen) do
3: Combine the parent and child populations Rgen = Pgen ∪Qgen
4: Rank individuals of Rgen to obtain the non-dominated fronts: F = fast-non-dominated (Rgen)
5: Pgen + 1 = ϕ and i = 1
6: while the parent population size |Pgen + 1|+ |Fi| < N do
7: Compute the crowding-distance of Fi
8: Add the ith non-dominated front Fi to the parent population Pgen + 1
9: i = i+ 1
10: end while
11: Rank the Fi according to the crowding distance
12: Complete the parent population Pgen + 1 with the rst N − |Pgen + 1| elements of Fi
13: Generate the child population Qgen + 1
14: gen = gen+ 1
15: end while
intervention and need to be taken in the presence of trade-os among all our objective functions. Such
decision-making involves confronting trade-os between multiple, conicting objectives or criteria. In the
transittability problem, the user is confronted with ve objective functions, even contradictory, and with
subjective and objective criteria in any mix. This requires to consider the user preferences. What makes
the decision task more dicult. For these reasons, we integrate the TOPSIS method to our optimization
module. Indeed, this method oers more exibility and freedom to the decision-maker considering its
preferences. The user selects amongst the objective functions which of them are to be used as objective
functions, albeit he can use them all, but also has the possibility to associate weights according to
their relative importance. Moreover, this method takes into account additional subjective preference
information, this allows classifying the Pareto-optimal solutions obtained in the search step by sorting
them in order of priority according to the decision-maker preferences.
9.4.2.2 TOPSIS method operation
According to the preferences given by the decision-maker, the TOPSIS method will select the appropri-
ate "optimal" solution (among the set of Pareto-optimal solution) that is close to its preferences and
requirements. In our context, the Pareto-optimal set constitutes the alternatives of the TOPSIS method.
Its principle consists on compute rstly the distance measure among the dierent alternatives to dene
the ideal and negative-ideal solution. The distance between the ideal point and each alternative can
be calculated using Eq. (19). Using the same separation measure, the distance between the negative
ideal point and each alternative can be determined (Eq. (20)) [348]. The relative closeness to the ideal
point can be calculated using Eq. (21). Where vij is the weighted standardized criterion value of the ith
alternative that is calculated by multiplying standardized criterion value by the corresponding weight,
and v+j is the ideal value and v−j is the negative ideal value for the jth criterion [348].
Si+ = [
∑n
j=1(vij − v+j)2] (19)
Si− = [
∑n
j=1(vij − v−j)2] (20)
ci+ =
Si−
Si++Si−
(21)
Then, it associates to each alternative a numerical coecient between 0 and 1 according to the
Euclidean distances between each alternative on the one hand, and the ideal and negative-ideal solutions
on the other hand. Next, it ranks the alternatives (their measures) according to the importance of the
attribute starting by the appropriate alternative (that have the shortest distance from the ideal solution
and the longest distance from the negative-ideal solution) to the bad one [349]. This is how the Pareto-
optimal solutions are ranked, compared and proposed to the decision-maker order by its preferences.
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Algorithm 7 Pseudocode of the TOPSIS technique
1: Establish a matrix of criteria and dierent alternatives
2: Normalize the decision matrix
3: Compute the weight of the normalized decision matrix
4: Determine the ideal solutions and nadir solution (negative ideal solution)
5: Compute the distance for each alternative
6: Compute the relative closeness to the ideal solution
7: Rank the preference order
Algorithm 7 depicted the pseudo-code of the TOPSIS decision-making technique. In our problem, the
alternatives of the TOPSIS are the set of Pareto-optimal solution generated by the search step (they are
the options which are to be evaluated for selection the best). The criteria are our ve objective functions,
the minimization of the distance between the simulated nal network state and the desired network state,
the minimization of the number of input signals, the minimization of the cost of these external stimuli,
the minimization of the number of target nodes and the minimization of the patient discomfort (these
will impact the selection of alternatives). In this method, two properties should be considered:
• The completeness: it is important to ensure that all the criteria are included.
• The operationality: it is important that each alternative can be judged against each criterion.
To each criterion, we associate a weight that will estimate the relative importance of this objective
function. All the TOPSIS steps (summarized in Algorithm 7) are detailed in the Wikipedia encyclopedia3.
9.5 Summary
The transittability of complex biomolecular networks is a multi-criteria problem by nature since there
are several potentially conicting criteria to consider while steering the network from an initial state to
a desired state. In this chapter, ve essential criteria, which need to be minimized simultaneously to
steer complex biomolecular networks, are presented and described in detail. There is the minimization of
the distance between the simulated nal network state and the desired network state, the minimization
of the number of input signals, the minimization of the cost of these external stimuli, the minimization
of the number of target nodes and the minimization of the patient discomfort. Applying a minimum
number of external stimuli on a minimum number of steering nodes has been already considered in
existing mathematical models in the literature, however, these criteria are not sucient for completely
steering complex biomolecular networks. That is why other criteria have been considered in this proposed
mathematical model.
Moreover, in this chapter, a multi-objective optimization approach for solving this problem has been
proposed and detailed. This optimization approach consists of two steps: the search and decision-making
steps. The search step is based on a powerful multi-objective genetic algorithm, the NSGA-II, to solve
our problem and obtain a Pareto-optimal set. Indeed, we draw inspiration from the documentation
provided by the MOEA platform and the works of Deb et al. [340] to develop our own genetic algorithm,
in particular by implementing a non-dominated sorting genetic algorithm. While the decision-making
step is based on a multi-criteria decision-making method, the TOPSIS, to compare the Pareto-optimal
solutions and provide the decision-maker with the best compromise solution according to its preferences.
This optimization module was integrated to the simulator presented in the precedent chapter for two
main reasons: the rst is that we want to have exibility for individuals which are more specic for the
population management (we focus particularly in this criterion). The second reason is to obtain a specic
control on this criterion because it is useless to keep bad quality networks.
The next part is devoted to the validation of our proposed approaches.
3https://en.wikipedia.org/wiki/TOPSIS
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Part III
Experiments and discussion
From Chapter 6 to Chapter 9, we have introduced the four contributions for achieving the overall goal of this
study, which is to propose a platform that enables biologists to simulate the state changes of biomolecular
networks with the goal of steering their behaviours.
In order to verify the proposed approaches, a prototype intituled CBNSimulator, which combines the function of
the approaches stated above in Part II, has been developed. In Chapter 10, we illustrate the potential of the
prototype based on three case studies. This chapter also introduces the prototype interfaces and features. Then,
in Chapter 11, we evaluate and discuss the performance of our proposed approaches according to the results
obtained by exploiting the case studies.
This part is divided into two chapters:
10 Prototype: the CBNSimulator ................................................................................125
11 Evaluation .......................................................................................................................149
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Prototype: the CBNSimulator
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10.1. INTRODUCTION
10.1 Introduction
From Chapter 6 to Chapter 9, we have detailed the dierent contributions for modelling, simulating,
understanding and optimizing the transittability of complex biomolecular networks. Indeed, Chapter 6
introduces the proposed logic-based modelling for describing the dierent elements required for modelling
the transittability of biomolecular networks following the systems theory. Chapter 7 enhances this logic-
based modelling with an additional semantic layer to obtain an optimal and more realistic modelling
describing the structure, function, behaviour and semantic of complex biomolecular networks. Both of
these Chapters 6 and 7 are the foundations of the simulator presented in Chapter 8 that deals with a
qualitative, discrete-time simulation for reproducing the behaviour of complex biomolecular networks.
Finally, Chapter 9 presents a multi-objective optimization approach for solving the transittability of
complex biomolecular networks.
In order to verify these contributions, we provide biologists with a exible platform called the 'CB-
NSimulator' which combines the function of the four approaches stated above. This chapter focus on
presenting the CBNSimulator as an innovative multi-domain collaborative platform for the modelling,
simulating, understanding and optimizing of complex biomolecular networks. The rst section presents
its main objectives. The general architecture of the proposed platform is explained in the second section.
The environment and tools for its implementation are illustrated in the third section. The last section
illustrates the advantages of this platform by applying it to three widely studied biomolecular networks,
the autoregulation of the bacteriophage T4 gene 32 network, the control of the phage lambda infection
of bacteria and the p53-mediated DNA damage response network.
10.2 Aims of the CBNSimulator platform
The main goals of the CBNSimulator platform can be grouped into four important points:
1. The logical modelling of complex biomolecular networks.
The main goal of the proposed CBNSimulator is to produce a whole-cell computational model.
This computational model consists of a logic-based modelling that aims to represent, analyze and
interpret the complex structure, the dierent functional aspects, and the dynamic behaviour of
these multi-level biomolecular networks.
2. The semantic modelling of complex biomolecular networks.
The second purpose of the CBNSimulator aims to provide a rich semantic description of the transit-
tability of biomolecular networks. This semantic modelling should infer more knowledge about the
functioning of biomolecular networks and provides the new knowledge required in understanding
their behaviours and their state changes.
3. The simulation of the behaviour of complex biomolecular networks.
The third goal of the CBNSimulator platform is to reproduce the conditions of the evaluated
biomolecular network and its components over time. This simulation should predict the important
properties of biomolecular networks even when quantitative data of such networks are unavailable
or unknown.
4. The optimization of the transittability of complex biomolecular networks.
The last goal of the CBNSimulator is to provide biologists with a tool that is able to control and
guide the behaviour and the transition states of complex biomolecular networks. In other words, by
optimizing the steering of complex biomolecular networks form their actual state to a desired state
taking into account dierent constraints such as, the distance between the simulated nal network
state and the desired network state, the number of external stimuli, their cost, the number of target
nodes and the patient discomfort.
10.3 Overview of the CBNSimulator platform
CBNSimulator provides a series of facilities (i) to model and simulate a given biomolecular network
formalised through a logic-based model and semantically described through a semantic modelling, and
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(ii) to steer these networks from their actual state to a desired state under specic and controlled
conditions. As illustrated in Figure 10.1, the platform is organized into four main modules: the logic
modelling module, the ontological module, the simulation module, and the optimization module.
Figure 10.1  Overall architecture of the CBNSimulator platform.
1. The logic modelling module: It represents the starting point for any new user-dened biomolecular
network. It has been designed to provide all the necessary elements for modelling the biomolecular
network by considering its dierent levels and molecular components. For example, the user can
specify the list of molecular components and their corresponding type, the list of interactions among
these components and their corresponding conditions that activate them, etc. This logic-based
modelling takes into account the complexity and heterogeneity of these molecular components and
their multilevel structure.
2. The ontological module: It ensures the management, modelling and sharing of expert knowledge.
This module takes as input all the native information introduced by the expert (state of the network,
its structure, etc.) through the logic-based formalization provided by the rst module. Then,
the ontological module provides output inferred network that is composed of native and inferred
knowledge. This represents useful features, especially when the logic-based model lacks these details.
Moreover, the additional information provided by this module about the network's elements can be
used to identify new potential relationships among them.
3. The simulation module: It allows users to simulate and/or reproduce the dynamical behaviour of
the network. Indeed, this simulator integrates all the information given by the expert (the enriched
network with native and inferred knowledge) with other parameters in order to better reproduce
the conditions of the evaluated biomolecular network and its components over time. The results
generated during the simulation may be displayed to the users in graphical form to facilitate their
interpretation, or used by the optimization module.
4. The optimization module: It provides a way to steer the states of the network from its actual
state to another specic state. This optimization is performed by specifying the initial and desired
states of the network, and all the possible external stimuli dened by the user. Then, based on
the values of the evaluation criteria, this module provides the best transition sequences for steering
the biomolecular network from its initial state to the desired state and, nally, presents the results
according to the user preferences. This model allows also to optimize the transittability of the
network by minimizing various criteria, such as the distance between the simulated nal network
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state and the desired network state, the number of external stimuli, their cost, the number of target
nodes and the patient discomfort.
10.4 Development tools
In this section, we present the dierent software used for developing the CBNSimulator platform:
• Java Platform, Standard Edition (Java SE)1 The platform uses Java programming language and
is part of the Java software-platform family. Java is particularly well-suited for creating complex
analytical applications and architecture.
• Eclipse2 It is an integrated development environment for developing with Java, but it may also be
used to develop applications in other programming languages via plug-ins. It is the most widely
used Java IDE. Eclipse contains a base workspace and an extensible plug-in system for customizing
the environment. Considering the features of the CBNSimulator platform, that is, a frame-based
Java SE application, Eclipse Luna Service Release 2 (4.4.2) is chosen as the environment for its
implementation.
• Protégé3 It is a free, open source ontology editor and knowledge-base framework building intelligent
systems. As well as the Protégé editor supports modelling ontologies through a web client or
desktop client. Protégé supports various ontologies formats, such as, RDF, RDF Schema, XML
Schema and OWL. In our researches, the proposed ontologies have been implemented within the
Protégé 5 environment, version 1.3.8.3.
10.5 Experimental results
In order to better explain how CBNSimulator can be applied for modelling, simulation and optimization
of complex biomolecular networks, we analysed, as case studies, the autoregulation of the bacteriophage
T4 gene 32 [318], the control of lifecycle of bacteriophage lambda [350], and the p53-mediated DNA
damage response network (cell fate decision) [6].
10.5.1 Case study 1: the bacteriophage T4 gene 32
This case study has already been used as a motivating example along the contributions clarifying their
notions. Indeed, it should be mention that along with our contributions, this example has been presented
as a three-node network consisting of the gene 'G32', the protein 'p32' and the metabolite 'm32'. The
node m32 has been arbitrarily added in order to highlight the dierent level of cell's components (gene,
protein and metabolite) and to better explain our contributions. Here, to conform to biology, we treat
the original network which is only the gene 'G32' and the protein 'p32'. We chose this case study due to
its simplicity and its well-known mechanism.
10.5.1.1 Description
The bacteriophage T4 gene 324 encodes a single-stranded DNA binding protein required for T4 DNA
replication, recombination, and repair [318]. It is a single polypeptide chain of 301 amino acid residues
that consists of three structural domains, each of which has a binding function. Despite its role in DNA
metabolism, the gene product 32 autoregulates its synthesis at the level of translation [319]. During the
infection, the gene product 32 is produced in large amounts to perform its function of binding all available
DNA at the replication fork, recombination nodes and at lesions in DNA resulting from damage [320].
When all the available DNA is bound, free gene product 32 accumulates within the cell until it reaches
a certain concentration which then attenuates further synthesis of gene product 32 [321]. More detail
about the bacteriophage T4 gene 32 can be found in [318, 320, 321].
1https://www.oracle.com/fr/java/technologies/java-se.html
2https://www.eclipse.org/
3http://www.hermit-reasoner.com/
4http://genes.atspace.org/10.11.html
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As illustrated in Figure 10.2, this biomolecular network consists of two nodes a gene G32 coding for
a protein p32, which in turn can inhibits or activates the gene G32 according to the value of its own
concentration. Therefore, in this network, the concentration of p32 is self-regulated and normally should
remain between 0.2 10−6 mol/dm3 and 0.7 10−6 mol/dm3. When the concentration of p32 exceeds
the threshold Sp32 = 0.7 10−6 mol/dm3, it is called an Inhibition, i.e. the protein p32 inhibits, or
deactivates, the translation of its gene G32. However, when the concentration of p32 decreases and
becomes lower than the threshold Sp32 = 0.2 10−6 mol/dm3, it is called an Activation, i.e. the protein
p32 activates the translation of its gene G32. When the gene G32 is activated by the protein p32, it is
called a Translation, in which we have a production of p32 thus increasing the value of its concentration.
Figure 10.2  The bacteriophage T4 gene 32 use case.
10.5.1.2 Logical modelling
The logic modelling of the bacteriophage T4 gene 32 is illustrated in Table 6.4 (Section 6.5).
10.5.1.3 Semantic modelling
The sematic modelling of the bacteriophage T4 gene 32 was already detailed in Section 7.4. Indeed, we
present the instantiation of the BNO ontology for the given example in Figure 7.5. We highlight also the
dierent properties of the instantiation its components (the gene G32, protein p32 and metabolite m32)
in Figure 7.6. We describe also the instantiations of its four interactions in Figure 7.7.
Moreover, we use the BNO ontology to simulate the behaviour of its components. To do this, we use
an SWRL rule-based reasoner, and we develop some SWRL rules such as the inhibition SWRL rule and
its opposite rule, activation SWRL rule and its opposite, the transcription SWRL rule and its opposite
rule, and the negative regulation SWRL rule and its opposite rule. Results of these rules are illustrated
in Figures 7.8, 7.9, 7.10, 7.11, 7.12, 7.13, respectively.
10.5.1.4 Simulation under the CBNSimulator
The simulation results of the bacteriophage T4 gene 32, provided by the CBNSimulator, were synthetically
represented in graphical form in Figure 8.5. These results were formally treated and validated by expert
biologists. Indeed, these results correspond to their domain knowledge and the real behaviour of the
network.
10.5.2 Case study 2: the control of the lifecycle of bacteriophage lambda
The control of the lifecycle of bacteriophage lambda infection is one of the best understood regulatory
systems [350]. We use this the phage lambda because it is a simple and realistic case study with a well-
known mechanism. Indeed, its functioning was investigated by several studies such as [350, 351, 352, 353,
354, 355].
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10.5.2.1 Description
The phage lambda5 is a virus that infects the bacteria Escherichia Coli. It is called a temperate bacterio-
phage, because it can alternate between two possible developmental pathways: the lytic cycle and the
lysogenic cycle under certain conditions [355]. During the lytic cycle, the phage infects the bacteria:
its DNA is replicated in large quantities within the bacteria to make lots of phages, and then kills the
cell by making it explode (its destruction). During the dormant lysogenic cycle, the phage inserts its
DNA into the bacterial chromosome allowing the phage DNA (called also prophage) to be copied and the
cell continues to reproduce normally [350]. Figure 10.3 illustrates the switching between the lytic and
lysogenic phase. Indeed, during the infection, the phage lambda have two choices: (i) replicate and kill
the host cell (Lysis) or (ii) integrate into the bacterial chromosome, where it replicates as a part of the
cell genome (Lysogeny) [5]. The phage lambda state generally in the lysogenic phase. However, when it
is in the lysogen phase it can be switched to the lytic phase through ultraviolet stimuli.
Figure 10.3  The lifecycle of bacteriophage lambda. (inspired from [5])
As illustrated in Figure 10.4, this biomolecular network consists of six nodes: four genes G_CI,
G_OR3, G_OR1, G_CRO, and two proteins P_CI, and P_CRO. During the lytic phase, the
gene G_CI is activated (and G_CRO is deactivated). This activation of the gene G_CI generates its
transcription by producing a protein P_CI. When the concentration of this protein reached a threshold
equal to 0.1, it deactivates the gene G_OR1, which in turn deactivates the gene G_CRO (this provides
the lysogenic phase). Then, when the gene G_CRO gene is deactivated, there is no production of the
protein P_CRO. The expression of lysogenic genes (G_CRO and G_OR1) is therefore deactivated. In
this case, we are totally in the lytic phase. After a certain time in this lytic state, the destruction of the
host cell occurs. For reason of clarity, we reduce this functioning in a set of rules (the black arrows in
Figure 10.4) as follows:
1. When the gene G_CI is activated, there is a transcription of the protein P_CI.
2. Once the protein concentration reached P_CI] > 0.1, it inhibits the gene G_OR1.
3. When the gene G_OR1 is deactivated, it deactivates the gene G_CRO.
4. Once the gene G_CRO is deactivated, there is an absence of transcription.
On the other hand, in the lysogenic phase the gene G_CRO is activated (and G_CI is deactivated).
This activation of the gene G_CRO generates its transcription by producing a protein P_CRO. When
5https://cshmonographs.org/index.php/monographs/issue/view/087969102.2
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the concentration of this protein reached a threshold equal to 0.2, it deactivates the gene G_OR3, which
in turn deactivates the gene G_CI (this provides the lytic phase). Then, when the gene G_CI is
deactivated, there is no production of the protein P_CI. The expression of lytic genes (G_CI and
G_OR3) is therefore deactivated. In this case, we are totally in the lysogenic phase. The state of the
phage lambda stays at this state even in the absence of ultraviolet stimuli. For reason of clarity, we
reduce this functioning in a set of rules (blue arrows in Figure 10.4) as follows:
1. When the gene G_CRO is activated, there is a transcription of the protein P_CRO.
2. Once the protein concentration reached P_CRO > 0.2, it inhibits the gene G_OR3.
3. When the gene G_OR3 is deactivated, it deactivates the gene G_CI.
4. Once the gene G_CI is deactivated, there is anabsence of transcription.
Figure 10.4  Functioning rules of the phage lambda.
10.5.2.2 Logic-based modelling
Table 10.1 presents the structure and the function of the logical modelling of the phage lambda. Its
causal graph is given by Figure 10.4. The possible states that can have the phage lambda network during
the simulation are represented by the behaviour CR, as illustrated by Figure 10.5:
Figure 10.5  An excerpt of the possible states that can have the phage lambda network during the
simulation.
10.5.2.3 Semantic modelling
Here, we use OWL and SWRL rules for semantically modelling our case study and simulating its be-
haviour. To do this we instantiate our ontology for the given example. Figure 10.6 depicted the BNO
individuals' of the phage lambda considering their various characteristics. The molecular components
131
10.5. EXPERIMENTAL RESULTS
and the interactions that occur among them are represented by individuals and corresponding relations.
The relations are restricted by specifying domain and range. All the concepts and individuals are linked
to primitive data (concentrations values, genes states, etc.) through the data properties. This semantic
modelling provides all the elements for modelling the states and the individuals behaviours of phage
lambda through the use of SWRL rules. This set of SWRL rules is able to reason and simulate the
behaviour of the phage lambda. The following paragraphs demonstrate the simulation of the given case
study using SWRL rules.
Figure 10.6  Semantic modelling of the phage lambda within the Protégé editor. The molecular compo-
nents: A- G_CI, B- G_CRO, C- G_OR3, D- G_OR1, E- P_CI, F- P_CRO. Some interactions: a-
i3, b- i7, c- i2, d- i6, e- i1, f- i5.
Inhibition SWRL rule between proteins and genes (interactions i2 and i6) The following
rule models the inhibition interaction that occurs between the proteins P_CI, P_CRO and the genes
G_OR1, G_OR3, respectively. When the concentration of the proteins (P_CI and P_CRO) exceeds
the threshold 0.2 10−6 Mol/L−1, they inhibit the translation of their targeted genes (G_OR1 and
G_OR3).
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ADN(?g) ∧ hasState(?g, ?gs1) ∧ forTime(?gs1, ?t) ∧ hasState(?g, ?gs2) ∧ forTime(?gs2,
?t2) ∧ swrlb:add(?t2, ?t, 1) ∧ Protein(?p) ∧ Inhibition(?inhi) ∧ hasSource(?inhi, ?p) ∧
hasEnd(?inhi, ?g) ∧ hasState(?p, ?ps) ∧ forTime(?ps, ?t) ∧ hasConcentrationValue(?ps,
?c) ∧ swrlb:greaterThanOrEqual(?c, 0.7) → isActivated(?gs2, false)
The results of this rule means that, If there is a protein p having a state ps equal to a concentration
c at a given time t and there is a gene g having a state gs equal to true at this time t, and these two
molecules p and g are related by an Inhibition interaction, and if the concentration c of the protein p
exceeds a threshold equal to 0.2, then the state of g move to false at time t+ 1. We treat for example the
Figure 10.7  Results of the reasoning process for the Inhibition SWRL rule between the proteins and
their targeted genes.
case of the inhibition that occurs between the protein P_CRO and the gene G_OR3. As illustrated in
Figure 10.7, we rstly, activate the gene G_OR3 and set the value of the concentration of the protein
P_CRO at 0.4 10−6 Mol/L−1 at time t = 22. Then, when we launch the reasoner, we note that at
time t = 23 the gene G_OR3 is automatically deactivated (because the value of the concentration of the
protein P_CRO exceeds the threshold 0.2).
Inhibition SWRL rule between genes (interactions i3 and i7) The following rule models the
inhibition interaction between the genes G_OR1 and G_CRO, and between G_OR3 and G_CI. When
the concentration of the a gene (the staring node) is deactivated, it inhibits its targeted gene (deactivates
the targeted node). This s the case of the two interactions i3 and i7.
ADN(?g) ∧ hasState(?g, ?gs) ∧ forTime(?gs, ?t) ∧ isActivated(?gs, false) ∧ swrlb:add(?t2,
?t, "1"8sd:int) ∧ ADN(?g2) ∧ InhibitionGG(?in) ∧ hasSource(?in, ?g) ∧ hasEnd(?in,
?g2) ∧ hasState(?g2, ?g1s) ∧ forTime(?g1s, ?t) ∧ isActivated(?g1s, true) ∧ hasState(?g2,
?g2s) ∧ forTime(?g2s, ?t2) → isActivated(?g2s, false)
The results of this rule means that, If there is a gene g having a state gs equal to true at a given time t
and there is another gene g1 equal to false at this time t, and these two molecules g and g1 are related by
an Inhibition interaction, then the state of the targeted gene g move to false at time t+ 1. For example,
we treat the case of the interaction i7 that occurs between the genes G_OR3 and G_CI. As depicted in
Figure 10.8, we rstly, activate the gene G_CI and deactivate the gene G_OR3 at time t = 25. Then,
when we launch the reasoner, we note that at time t = 26 the gene G_CI is automatically deactivated.
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Figure 10.8  Results of the reasoning process for the Inhibition SWRL rule between genes.
Transcription SWRL rule (interactions i1 and i5) The following rule represents the gene tran-
scription. In our case study, we have two transcription interactions i1 and i5. In fact, if the genes G_CI
and G_CRO are activated, these ones generates the proteins synthesis and produce an increase in the
concentration of these proteins P_CI and P_CRO.
ADN(?g) ∧ hasState(?g, ?gs) ∧ forTime(?gs, ?t) ∧ isActivated(?gs, true) ∧ Protein(?p)
∧ Transcription(?trans) ∧ hasSource(?trans, ?g) ∧ hasEnd(?trans, ?p) ∧ hasState(?p,
?ps1) ∧ forTime(?ps1, ?t) ∧ hasConcentrationValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧
forTime(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1) → hasConcentrationValue(?ps2, ?c2)
The result of this rule is interpreted as follows, If there is a gene g having a state gs equal to true at a
given time t and there is a protein p having a state ps1 and a concentration c at this time t, and these
two molecules g and p are related by a Transcription interaction, then the concentration of the protein
p increases at time t + 1. In Figure 10.9, we treat the transcription of the interaction i1 that occurs
between the gene G_CI and the protein P_CI. Firstly, we set the value of the concentration of the
protein P_CI at 0.6 10−6 Mol/L−1 and activate the gene G_CI at time t = 30. Then, when we launch
the reasoner, we note that the value of the concentration of the protein P_CI increases automatically
to 0.7 10−6 Mol/L−1 at time t = 31.
In the opposite case, the case corresponding to the interactions i4 and i8 showing an inhibition
interaction between the genes G_CI and G_CRO the proteins P_CI and P_CRO, respectively. We
have this rule in which there is not transcription and the concentration of the protein is maintained stable:
ADN(?g) ∧ hasState(?g, ?gs) ∧ forTime(?gs, ?t) ∧ isActivated(?gs, false) ∧ Protein(?p)
∧ Transcription(?trans) ∧ hasSource(?trans, ?g) ∧ hasEnd(?trans, ?p) ∧ hasState(?p,
?ps1) ∧ forTime(?ps1, ?t) ∧ hasConcentrationValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧
forTime(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1) → hasConcentrationValue(?ps2, ?c1)
The result of this rule means that, If there is a gene g having a state gs equal to false at a given time t
and there is a protein p having a state ps1 and a concentration c at this time t, and these two molecules
g and p are related by a Transcription interaction, then the concentration of the protein p remains stable
at time t+ 1.
10.5.2.4 Simulation under the CBNSimulator
The CBNSimulator also provides a powerful simulator based on both (i) the qualitative, discrete-event
simulation theory and (ii) the merging of the logic-based and semantic modelling. This simulation module
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Figure 10.9  Results of the reasoning process for the Transcription SWRL rule.
allows reproducing the behaviours of the biomolecular network and its dierent components. We use this
simulator to simulate the behaviour of the phage lambda. In general, the simulator starts by setting
the initial states and concentration values of the network components, and by dening the aggregation
rules from the logic-based and the SWRL rules from the semantic modelling. These rules determine
whether or not an interaction should be performing during the simulation process. After performing
these interactions, the states and concentration values of the dierent molecular components are updated
according to the corresponding interaction. Finally, the simulation results are displayed in a graphical
form to the biologist.
Figure 10.10 and 10.11 depict the simulation of the two lifecycles of the phage lambda: the lysogenic
cycle and the lytic cycle. In the rst cycle (Figure 10.10), the molecular components of the phage
lambda are xed to Activated, 0.0, Activated, Activated, Activated, 0.0 corresponding to G_CI, P_CI,
G_OR1, G_OR3, P_CRO, P_CRO, respectively. Then, when we launch the simulation we have a
production of the protein P_CRO the red curve in the third display screen of the simulator (this is
explained by the transcription interaction). When the concentration of this protein P_CRO reaches the
threshold 0.2, it inhibits the gene G_OR3. In fact, in the second display screen, we note at t = 4 an
inhibition of the gene G_OR3 that switch from the activated state to the deactivated state (represented
by the red curve). In turn, the deactivation of the gene G_OR3 induces the deactivation of the gene
G_CI at time t = 6 as represented by the yellow surface in the rst display screen. The deactivation of
this gene G_CI generates the degradation of its protein P_CI represented by the red curve in the rst
display screen, that is why we observe a decreasing of the concentration of the protein directly after the
deactivation of its coding gene.
In the second cycle (Figure 10.11), the molecular components are xed to Activated, 0.0, Activated,
Activated, Activated, 0.0 corresponding to G_CI, P_CI, G_OR1, G_OR3, P_CRO, P_CRO, re-
spectively. Then, when we launch the simulation, we have a production of the protein P_CI the red
curve in the rst display screen of the simulator (this is explained by the transcription interaction). When
the concentration of this protein P_CI reaches the threshold 0.1, it inhibits the gene G_OR1. In fact,
in the second display screen, we note at t = 12 an inhibition of the gene G_OR1 that switch from the
activated state to the deactivated state (represented by the yellow surface). In turn, the deactivation of
the gene G_OR1 induces the deactivation of the gene G_CRO at time t = 13 as represented by the yel-
low surface in the third display screen. The deactivation of this gene G_CRO generates the degradation
of its protein P_CRO represented by the red curve in the third display screen, that is why we observe
a decreasing of the concentration of the protein directly after the deactivation of its coding gene.
As shown in Figures 10.10 and 10.11, the CBNSimulator is able to reproduce the dierent states and
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Figure 10.10  The CBNSimulator's graphical interface. Evolution of the component's behaviour during
the lysogenic cycle of the phage lambda.
Figure 10.11  The CBNSimulator's graphical interface. Evolution of the component's behaviour during
the lytic cycle of the phage lambda.
behaviours of the phage lambda and its components over time. Indeed, the obtained results conrm that
the simulation performed by the CBNSimulator is consistent and in accordance with the simulation results
reported by researches [350, 354, 355] who developed this biomolecular network using other methods.
Moreover, the simulation results are displayed in a graphic form facilitating the analysis of the results.
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10.5.3 Case study 3: the p53-mediated DNA damage response network
We use this case study in order to see how the CBNSimulator is able to simulate and optimize the
transition states and behaviours of complex biomolecular networks. This case study was already treated
in the literature by Wu et al. [6] and Zhang et al. [356], therefore, we can compare our results with them.
In the following sections, we will only focus on the simulation and the optimization of the p53-mediated
DNA damage response network.
Figure 10.12  The p53-mediated DNA damage response network [6].
10.5.3.1 Description
The tumor protein p53 is a key mediator of cellular response to diverse stresses [356] (external stimuli)
such as ultraviolet (UV) or infrared radiation (IR) which can damage DNA in the form of DNA strand
breaks. In response to DNA damage, this network can stay at three states (called also phenotypes):
the normal, cell cycle arrest and apoptosis states [356]. This system is known as the p53-mediated DNA
damage response network [6]. This biomolecular network is composed of seventeen molecular components
and forty interactions. The seventeen nodes are: ATM2, ATM∗, PTEN , p53, p53∗, p53killer, p53arrester,
Mdm2, CytoC, casp3, p21, Wip1, P53DINP1, P53AIP1, CytoC, Akt∗, and PIP3 which constitute
the set of nodes M . The schematic description of this network is illustrated in Figure 10.12 [6].
This network has three states:
The normal state: If there are no external stimuli (DNA damages) the network remains at the nor-
mal state. In this state, the ATM2 and ATM∗ are deactivated. As a consequence, the p53 remains
deactivated, and there is no product.
In the presence of external stimuli the network can steer to two dierent states depending on the
number or the dose of external stimuli:
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The cell cycle arrest state: This state is the halt of the cell cycle progression in the case of unfavourable
conditions, stress or DNA damage. In this state, the ATM2 is activated through the stimuli, and produces
also the ATM∗. In turn, the ATM∗ activates the p53. At this stage, the p53 produces the p53∗ in order
to activate the p53arrester. When the p53arrester is produced, this one activates the p21. It is this
module, the p21 responsible for the cell cycle arrest. Thus, when we obtain a high concentration of p21
we conclude that we are in the cell arrest state.
The apoptosis state: This state is the process of the death of cells which occurs for maintaining the health
of the body by eliminating old cells. If the external stimuli still applied to the network, the ATM2 still
produces the ATM∗, which still activates the p53. As well as, the p53 still produces the p53∗ but in order
to activate the p53killer. Indeed, when the p53∗ is produced for a long time, most of it form the p53killer.
And once the p53killer is produced, it activates the p53AIP1 which in turn activates the Casp3. Finally,
the presence of Casp3 provides the cell apoptosis because when the Casp3 is present it activates also the
PTEN that fully activates the p53. Thus, when we obtain a high concentration of Casp3 we conclude
that we are in the cell apoptosis state.
10.5.3.2 Simulation under the CBNSimulator
Figure 10.13  The CBNSimulator's input le. Denition of the necessary elements describing the simu-
lation parameters of the p53-mediated DNA damage response network.
The p53 network has been simulated within the CBNSimulator under dierent doses of external
stimuli (IR). This simulator starts by reading the network data from the dened text le. Figure 10.13
shows the dierent part of the input le to the CBNSimulator. In this gure, we highlight the important
elements required to simulate and optimise our case study. For example, the black frame A presents
an excerpt of our genetic algorithm parameters such as the population size is xed at 50, the maximum
generation is xed at 100, the crossover rate which is set at 0.8, and the mutation rate which is set at 0.05.
The black frame B lists the dierent nodes of the p53-mediated DNA damage response network, their
type and their state: for example, the highlighted line in this frame means that we dene a node called
GATM which is a gene and its state is Deactivated (0). The black frame C lists the interactions that
occur among the nodes. For example, the highlight line in this frame means that there is an interaction
between the gene GATM (starting node of the interaction) and the protein PATM (targeted node of
the interaction) and their will we a production of PATM when the gene GATM is activated (its state
is greater than 0). The black frame D lists the dierent stimuli designed to stimulate the nodes of our
network. The complete list of these stimuli is presented in Table 10.2. For example, the highlighted line
in this frame means that the stimulus number 2 will aect the node PATM at time t = 4 with a variation
of concentration ∆c = 0.3, the cost of this stimulus is set to 1 and there is no discomfort feeling by the
patient during this stimulation. Since the number of nodes is large (seventeen nodes), we display only the
most important of them: ATM , p53arrester, p53killer, p21, Casp3, PTEN , and Wip1. The normal state
of the p53-mediated DNA damage response network is illustrated in Figure 10.14. In this Figure, all the
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components of the network are deactivated (proteins values setting at 0.0 and gene states Deactivated).
This normal state corresponds to the state when there are no stimuli and the ATM is not aected, by
consequence, is not activated.
Figure 10.14  The CBNSimulator's graphical interface. The p53-mediated DNA damage response net-
work at the normal state.
To validate our simulator, we chose to repeat the same experiments of Zhang et al. [356] by simulating
the p53 network with two dierent doses of infrared radiation: one less than 4Gy and the second greater
than 4Gy. The simulation results are shown in Figures 10.15 and 10.16.
As illustrated in Figure 10.15, we simulate the p53-mediated DNA damage response network by
aecting the ATM with three stimuli. These stimuli consisting on IR at doses less than 4Gy. As
depicted in the gure 10.15, we note that at t = 0, the ATM is activated by the stimuli inducing the
production of the protein ATM , they are displayed in the rst display screen by the yellow surface and
the red curve, respectively. In turn, the ATM activates the P53 which produces the p53arrester. This
is displayed in the third display screen, at t = 3 there is a production of the p53arrester represented by
the yellow surface. In the same screen, we note that there is no production of p53killer. Then, when
the p53arrester is produced, it induces a production of the protein p21 at t = 24 represented by the
yellow surface in the fourth display screen. We observe also that there is no production of Casp3 because
there is no production of p53killer. Here, we demonstrated through the CBNSimulator that we are in
the cell cycle arrest state. We note also that the Wip1, PTEN and P53DINP1 are not activated in
this simulation (the second display screen). So, to conclude, when we aect the p53 network with three
stimuli less than 4Gy, it steers to the cell cycle arrest state. These simulation results correspond to the
results obtained by Zhang et al. [356].
In Figure 10.16, we increase the number of external stimuli (IR) precisely with 5 stimuli at doses
greater than 4Gy. As illustrated by the gure 10.16, we note that at t = 0, the ATM is activated by the
stimuli inducing the production of the protein ATM , they are displayed in the rst display screen by the
yellow surface and the red curve, respectively. In turn, the ATM activates the P53 which produces the
p53killer. This is displayed in the third display screen, at t = 2 there is a high production of the p53killer
represented by the red curve. In the same screen, we note that there is no production of p53arrester.
Then, when the p53killer is produced, it induces a production of the protein Casp3 at t = 23 represented
by the red curve in the fourth display screen. We observe also that there is no production of p21 because
there is no production of p53arrester. Here, we demonstrated through the CBNSimulator that we are
in the apoptosis state. We note also that the Wip1, PTEN and P53DINP1 are not activated in this
simulation (the second display screen). So, to conclude, when we aect the p53 network with ve stimuli
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Figure 10.15  The CBNSimulator's graphical interface. Steering the p53-mediated DNA damage response
network from the normal state to the cell cycle arrest state (using three stimuli less than 3 Gy).
greater than 4Gy, it steers to the apoptosis state. These simulation results also correspond to the results
obtained by Zhang et al. [356].
Figure 10.16  The CBNSimulator's graphical interface. Steering the p53-mediated DNA damage response
network from the normal state to the apoptosis state (using 5 stimuli greater than 4 Gy).
In addition to the two simulations presented above and with the goal to further check the logic of
the CBNSimulator, we launch the rst simulation using three stimuli, then we added progressively two
others stimuli. This experiment is depicted by Figure 10.17. Indeed, we start the simulation with the
same conditions of the rst experiment presented above. As presented in the rst display screen of Figure
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10.17: at t = 0, we aect the p53 network with three stimuli, then at t = 63 we add the fourth stimulus
and at t = 68 we add the fth stimulus. We observe in the third display screen that at t = 68 there
has been a change: a degradation of p53arrester and a production of p53killer represented by the yellow
surface and the red curve, respectively. This generates another change at the level of p21 and Casp3,
indeed we observe in the fourth display screen that at t = 88 the protein p21 declines and the protein
Casp3 increases (represented by the yellow surface and the red curve, respectively). This is explained by
the fact that the stable activation of the ATM (for a long time or a high dose of IR) by these stimuli
activates constantly the p53 and p53∗ creating the p53killer rather than the p53arrester which in turn
provides the protein Casp3 and also activates the PTEN to maintain the full activation of the ATM for
a certain time. Therefore, we conclude that when there are high doses of IR, the p53 network transits to
the apoptosis state.
Figure 10.17  The CBNSimulator's graphical interface. The transition of the p53-mediated DNA damage
response network from the cell cycle arrest state to the apoptosis state (by progressively adding stimuli).
The correctness of the obtained results has been validated by matching and comparing our results with
the experimental results reported in the literature. The obtained simulation results of the p53 transition
states are in great agreement with those of Zhang et al. [356]. In fact, our simulation results for the cell
fate decision via the p53-mediated DNA damage response network conrm that at the low IR doses (less
than 4Gy) there is a production of p21 and the network transit to the cell cycle arrest state, and when the
IR doses are greater than 4Gy, there is a production of Casp3 and the network transit to the apoptosis
state. Based on these simulation results, we can note that minor DNA damage only induces the cell cycle
arrest and severe DNA damage induces the apoptosis. Through these simulations, we notice that the
CBNSimulator can successfully reproduce and optimize the transition states of the p53-mediated DNA
damage response network, in particular, by explaining how the p53 coordinates and regulates the cell
fate decision. Obtained results are very nearly with the results provided by Zhang et al. [356].
10.5.3.3 Optimization of the p53-mediated DNA damage response network
To optimize the steering of the p53-mediated DNA damage response network, we present its mathematical
model as follows. Let S be the set of 15 external stimuli that represent the infrared radiation to be applied
on the network during the transittability process. All the properties about these stimuli are shown in
Table 10.2: the index of the stimuli Si, the time of introduction of the stimulus Si into the node mi,
the target node mi by the stimulus Si, the variation of concentration caused by the stimulus Si on the
node mi, the cost of the stimulus Si, and the discomfort caused by the stimulus DiscomfortStimk. The
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molecular components to be targeted are randomly chosen among all the nodes composing the network
(the set M as listed above). Our objective is rst to steer this network from its normal state to the
apoptosis state by minimizing the number of external stimuli, their cost and the number of nodes to be
stimulated. It must be noted that for this case study, we do not consider the patient discomfort. Then,
our second goal is to steer this same network from its normal state to the arrest state by minimizing the
same objectives.
To solve this case study, we apply the NGSA-II as detailed in Section 9.4.1.3. The population size is
Np = 50. The number of generation isMaxGen = 100. The crossover rate is Pc = 0.8, and the mutation
rate is Pm = 0.05. We suppose that the decision-maker preferences are equal (because of the simplicity
and the small size of our biomolecular network). The simulation results were performed on a personal
computer Core i5 with a speed of 3.20 GHz × 4 and 15.5GB RAM running Ubuntu 16.04 LTS.
To get an idea of how the Pareto front looks like, and how the network components are evolving
in a visual way, we choose the 3D and 2D plot tool of R software6 (The R Foundation for Statistical
Computing), version 3.5.0 alpha (2018-03-25 r74463) to visualize them as shown in Figures 10.18 and
10.21. Therefore, the obtained results of the optimization approach are shown in Figure 10.18 as a three-
dimensional (3D) chart. Figure 10.18a depicts the solution obtained in the rst generation. We note that
the distribution of the initial population is not uniform and it is dicult to provide good individuals.
This can be explained by the fact that the rst population was generated randomly. Figure 10.18b depicts
the solution obtained in the last generation highlighting the trade-os between the number of external
stimuli, their costs, and the number of target nodes objectives to reach the apoptosis state. For all the
objectives the ideal solution is the minimum value. Consequently, the optimal trade-o satisfying all
three objectives is indicated by the red arrow in the second gure.
(a) (b)
Figure 10.18  Trade-os between the number of external stimuli, their costs, and the number of targeted
nodes objectives for the given example. 10.18a Obtained results in the rst generation. 10.18b Obtained
results in the last generation.
The best compromises solution is obtained after the search and decision-maker methods. Among all
the stimuli presented in Table 10.2, we can only treat the network with two stimuli to steer it from the
normal state to the apoptosis state or to the cell cycle arrest state. The number of nodes to be stimulated
for each state is two nodes corresponding to the nodes PTEN and P53DINP1 for the apoptosis state,
and the nodes Wip1 and P53DINP1 for the cell cycle arrest state. Indeed, we have integrated these
results provided by the optimization algorithm with the simulator module. The simulation results are
shown in Figures 10.19 and 10.20.
In the rst simulation (Figure 10.19) we do not activate the ATM , but we directly stimulate the nodes
Wip1 and P53DINP1. We observe that there is nothing in the rst display screen because the ATM
is not activated. In the second display screen, we note a production of the Wip1 at t=2 (yellow surface
in the second display screen). This production of Wip1 induces at t = 23 a production of p53arrester as
presented in the third display screen by the yellow surface. Then, at t = 44 we observe a production of the
protein p21 as presented in the fourth display screen by the yellow surface. Thus, we conrm the results
of the optimization approach: the stimulation of both Wip1 and P53DINP1 provides a production of
p53arrester and p21, and the p53 network steers to the cell cycle arrest state.
6https://www.r-project.org/
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Figure 10.19  The CBNSimulator's graphical interface. Steering the p53-mediated DNA damage response
network from the normal state to the cell cycle arrest state (with IR dose greater than 4 Gy).
Figure 10.20  The CBNSimulator's graphical interface. Steering the p53-mediated DNA damage response
network from the normal state to the cell cycle arrest state (with IR dose greater than 4 Gy).
In the second simulation (Figure 10.20) we do not activate the ATM , but we directly stimulate the
nodes PTEN and P53DINP1. We observe that there is nothing in the rst display screen because the
ATM is not activated. In the second display screen, we note a production of the PTEN at t=0. This
production of PTEN induces at t = 22 a production of p53killer as presented in the third display screen
by the red curve. Then, at t = 42 we observe a production of the protein Casp3 as presented in the
fourth display screen by the red curve. Thus, we conrm the results of the optimization approach: the
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stimulation of both PTEN and P53DINP1 provides a production of p53killer and Casp3, and the p53
network steers to the apoptosis state. We conclude that the stimulation of PTEN and P53DINP1 are
sucient to induce the apoptosis state, and the stimulation of Wip1 and P53DINP1 are sucient to
induce the cell cycle arrest state.
Moreover, we visualize the response of each component of the network during the optimization process
and their evolution are shown in Figure 10.21. As discussed above, the evolution of these components is
displayed using the 2D plot tool of R software7, version 3.5.0 alpha (2018-03-25 r74463). Indeed, we can
observe the dierent states of the important nodes under three and ve stimuli. These results correspond
also to the simulation results provided above by the simulation approach using dierent IR doses.
Figure 10.21  The simulation results showing the response of the p53 system to three stimuli versus its
response to ve stimuli.
Our collaborators have qualitatively analysed and evaluated the obtained results in view of validating
their signicance. The obtained results demonstrate that the proposed optimization method provides a
good quality of solutions minimizing the number of external stimuli, their cost and the number of targeted
nodes. The obtained Pareto solution satises all the objectives.
In addition, our obtained optimization results correspond to Wu et al. [6] results. Our results propose
the stimulation of the nodesWip1 and P53DINP1 for the transition between the normal state and the cell
cycle arrest state, and the stimulation of the nodes PTEN and P53DINP1 for the transition between
the normal state and the apoptosis state. However, it is important to mention that our optimization
approach cannot manage the transition of the p53 network from cell cycle arrest state to the apoptosis
state and vice versa. This case was usefully treated by the simulator through the progressive addition
of stimuli, but the optimization module has not proposed a set of nodes to be aected for steering the
network from cell cycle arrest state to the apoptosis state, and vice versa.
To conclude, the CBNSimulator platform can be considered as a powerful tool for modelling, simu-
lating, analysing and optimizing the behaviour of complex biomolecular networks. It was checked and
applied to three dierent networks. Obtained results agree with the literature results, in particular for
the simulation and the optimization modules of this platform. However, it is important to mention the
fact that this proposed platform was only tested with small examples. Results for larger biomolecular
networks will be provided in the short future. Moreover, the time level of the dierent biological processes
is not taken into account, this can be considered as a limit of the CBNSimulator.
7https://www.r-project.org/
144
10.6. SUMMARY
10.6 Summary
In this chapter, we have briey presented the objectives, the architecture of the CBNSimulator, and the
development tools used for its implementation. The rest of the chapter is devoted for testing and applying
our approaches (the main modules of the CBNSimulator) to three case studies: the bacteriophage T4
gene 32, the phage lambda and the p53-mediated DNA damage response network.
The CBNSimulator has been tested on these dierent case studies in terms of quality of solutions found
and its eciency to determine the optimal solutions for reproducing and optimising the transittability
of complex biomolecular networks. Indeed, the three case studies presented in this chapter illustrate
the strengths and limits of the CBNSimulator. Obtained results from these experiments were compared
with those obtained by researches in literature such as Wu et al. [6], Zhang et al. [356], etc. The
correspondence and the great agreement between the results obtained by the CBNSimulator and those
obtained by these researches, in the third case study, shows the eectiveness and the robustness of
this platform in optimizing the transittability of complex biomolecular networks and interpreting their
transition states.
Critical discussions and evaluations about these approaches and their results are presented in the next
chapter.
145
10.6. SUMMARY
Structure Nodes: M = { G_CI , P_CI , G_OR3 , G_CRO , G_OR1 , P_CRO }
{G_CI , G_OR3 , G_CRO , G_OR1} ∈MG and {P_CI , P_CRO} ∈MP
Edges: I = { i1 , i2 , i3 , i4, i5 , i6 , i7 , i8}
{i2, i6} ∈ IPG and {i1, i3, i4, i5, i7, i8, } ∈ IGP
i1 : s(i1) = G_CI and d(i1) = P_CI
i2 : s(i2) = P_CI and d(i2) = G_OR1
i3 : s(i3) = G_OR1 and d(i3) = G_CRO
i4 : s(i4) = G_CRO and d(i4) = P_CRO
i5 : s(i5) = G_CRO and d(i5) = P_CRO
i6 : s(i6) = P_CRO and d(i6) = G_OR3
i7 : s(i7) = G_OR3 and d(i7) = G_C1
i8 : s(i8) = G_C1 and d(i8) = P_C1
Function Edges: i1
FR7→ (Transcription,Activated)
i2
FR7→ (Inhibition,≥, 0.1)
i3
FR7→ (Inhibition,Deactivated)
i4
FR7→ (Inhibition,Deactivated)
i5
FR7→ (Transcription,Activated)
i6
FR7→ (Inhibition,≥, 0.2)
i7
FR7→ (Inhibition,Deactivated)
i8
FR7→ (Inhibition,Deactivated)
Behaviour Aggregate functions
AP_CI :
Incoming edges Evolution
i3 i4 State of cp32
Deactivated Deactivated ∆1 < 0
Activated Deactivated ∆2 = 0
Activated Activated ∆3 > 0
Deactivated Activated impossible
AP_CRO:
Incoming edges Evolution
i3 i4 State of cp32
Deactivated Deactivated ∆1 < 0
Activated Deactivated ∆2 = 0
Activated Activated ∆4 > 0
Deactivated Activated impossible
AG_CRO:
Incoming edges Evolution
i3 State of G_CRO
Activated Activated
Deactivated Deactivated
AG_CI :
Incoming edges Evolution
i7 State of G_CI
Activated Activated
Deactivated Deactivated
AG_OR1:
Incoming edges Evolution
i2 State of G_OR1
Activated Activated
Deactivated Deactivated
AG_OR3:
Incoming edges Evolution
i6 State of G_OR3
Activated Activated
Deactivated Deactivated
States: see Section 10.5.2.2
Table 10.1  Logical modelling of the phage lambda.146
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Table 10.2  Stimuli properties used for steering the states of the p53-mediated DNA damage response
network.
Stimulus its time of introduction its targeted node its variation of concentration ∆c its cost its associated discomfort
S1 t = 2 mi = p53 +0.3 4 0
S2 t = 4 mi = ATM +0.3 1 0
S3 t = 4 mi = P53DINP1 +0.6 4 0
S4 t = 6 mi = ATM +0.5 2 0
S5 t = 7 mi = ATM +0.7 3 0
S6 t = 8 mi = Wip1 +0.1 3 0
S7 t = 9 mi = p21 +0.8 8 0
S8 t = 4 mi = PTEN +0.1 3 0
S9 t = 12 mi = CytoC +0.6 9 0
S10 t = 15 mi = Wip1 +0.9 13 0
S11 t = 2 mi = Casp3 +0.3 4 0
S12 t = 13 mi = mdm2 +0.3 1 0
S13 t = 15 mi = P53DINP1 +0.6 4 0
S14 t = 2 mi = p53casp3 +0.3 2 0
S15 t = 7 mi = ATM +0.9 3 0
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11.1. INTRODUCTION
11.1 Introduction
In the previous chapter, we presented the experiments that have been conducted to verify and validate
our contributions, the prototype CBNSimulator, its implementation and its application. This chapter
proposes a discussion which aims to place our contributions in the context of similar works and to discuss
their relative advantages and disadvantages.
This chapter is divided into four sections. In the rst section, we discuss the eciency of the logic-
based modelling for formalizing complex biomolecular networks considering their structural, functional
and behavioural aspects. In the second section, we present an evaluation study of the semantic modelling
approach to check the ontology quality of the proposed Biomolecular Network Ontology. In the third
section, we discuss the performance of the proposed simulator in reproducing the behaviour and state
changes of complex biomolecular networks. And nally, the fourth section analyses the usefulness of the
optimization approach in optimizing the transition states of complex biomolecular networks.
11.2 Logic-based modelling discussion and evaluation
With the goal of studying and simulating the dynamics of cells, various modelling techniques have been
proposed in the literature. As detailed and discussed in Chapter 2, we can nd continuous methods such as
stochastic and dierential equations which provides good precision and are therefore powerful techniques
for describing and modelling a specic problem. However, these quantitative models have also notable
disadvantages such as the fact that they require complete numerical and quantitative data (parameters,
concentration levels, kinetic constants, timings, etc) which are usually unavailable or not up-to-date. For
example, the production of structural analysis matrices in biology may require the mobilisation many
of experts over several months. Also, quantitative data can be based on an inappropriate sample, using
inadequate parameters or being misinterpreted in various ways. The excessive formalisation of these
models can increase the level of complexity to solve the simulation of the network. Indeed, with large-
scale biomolecular networks, the quantitative model cannot be solved due to its complexity and its size.
Indeed, the high number of molecular components increases the complexity of solving the dierential
equation system modelling them.
As discussed in Chapter 2 biologists have various modelling techniques at their disposal, each with
its advantages and disadvantages, depending on the desired objectives and available resources. If all the
quantitative parameters are expected, a quantitative modelling is required. However, if global properties
are the main concerns, qualitative logic-based modelling is required. A major advantage of qualitative
logic-based models is that they do not require precise quantitative data and that they are well-suited for
simulating and analysing large-scale biomolecular networks, in particular for understanding the transit-
tability of complex biomolecular networks.
In the following paragraphs, we discuss the advantages and limits of the proposed logic-based mod-
elling. This discussion focuses on the important logic-based modelling features, such as the modelling of
the structure, function, behaviour of complex biomolecular networks. As well as, in the importance of
modelling the stimuli-induced state changes.
The structural modelling The rst step of logic-based modelling is the construction and denition of
the molecular elements of the complex biomolecular networks. In this structure modelling, the essential
elements of the biomolecular networks are formalized into nodes which are categorized into genes, proteins
and metabolites. These nodes are represented either by Boolean values and real values. In fact, logical
models in systems biology were initially developed based on Boolean networks starting with the works of
Thomas [357], Glass [358], Kauman [18], etc. However, the proposed logic-based modelling is not totally
based on Boolean models. Indeed, in our proposed model, the nodes of the biomolecular network are
formalized by Boolean variables (the case of genes which can be activated or deactivated), but also by real
variable (the case of the concentration of proteins and metabolites). Therefore, our proposed logic-based
modelling is able to model both discrete entities, that is valued in {0; 1}, and continuous entities, which
are valued in R. This property is considered useful because it allows adding further clarication and
details. Thus, the results provided by the proposed logic-based modelling, while remaining qualitative,
can be ner than those provided by the Boolean one.
Once dened, the nodes of the network are linked with edges. These edges represent the interaction
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that can occur between each couple of nodes. Indeed, the partition of the graph nodes induces a partition
into a range of dierent types of interactions which allow linking the dierent levels of the biomolecular
network. Thus, we conclude that the proposed logic-based modelling is a multi-level model. In fact,
in a biomolecular network, interactions can occur between molecular components at the same level (for
example interactions between genes) or between dierent levels (for example between proteins and genes)
forming a complex system with multiple spatial and temporal levels. Therefore, the proposed logic-based
modelling enable to model and integrate the experimental information that exists at dierent levels. This
is a hard and impossible task using quantitative models such as dierential equations or stochastic models,
because of the high number of molecular components inside the biomolecular network. In addition, this
property has been validated experimentally through the case studies presented in the previous chapter.
All of them are composed of molecules belonging to the dierent level and interacting with each other.
Thus, we note that the logic-based modelling is better suited for describing large-scale biomolecular
networks, where detailed and quantitative knowledge are incomplete and where the heterogenous sub-
cellular components belonging to dierent levels of the network can be represented in a single and complete
formalization.
The functional modelling In our logic-based modelling, the molecular components of the network
are not described by well-dened equations as in the quantitative models, but instead, rules are assigned
to the participating elements to study the properties that emerge due to the interactions of the elements,
usually considered as a rule-based modelling. Therefore, we note that this logic-based modelling is
suitable for describing large-scale biomolecular networks with several molecular components, and are
computationally much cheaper than the quantitative and continuous models. In addition, the proposed
logic-based modelling allows the classication of the dierent types of interactions that occur among
molecular entities. In order to add more clarication about the interactions and to precise the function
of each interaction, the functional modelling of the logic-based modelling is associated with the concepts
of the Interaction Ontology proposed by Van Landeghem et al. [4]. Indeed, through this ontology, we
provide to the logic model the necessary and precise knowledge about the interactions. This additional
feature allows to precisely dene the type of the interaction and the condition that activates it. This
precision contributes to the implementation of a valid model. This is essential for obtaining a multi-scale
modelling close to the reality and for minimizing the gaps between the proposed model and the real
experiments. We can see this precision with the modelling of the case studies. The function of each
interaction is precise and clearly dened.
The behavioural modelling According to the case studies presented in the previous chapter, the
proposed logic-based modelling showed its eciency in describing and modelling the dynamic evolution
of the biomolecular network and in reproducing its behaviour over time. This aspect is ensured by the
use of aggregation functions which compute the state transitions of the network during the simulation.
Indeed, for each molecular components, we dene an aggregate function which computes its evolution
based on its current state, the state of its predecessor components and the characteristics of its incoming
interactions.
In our logic-based modelling, the molecular components follow simple rules (generally dened by
expert biologists and represented by the aggregation functions), but their interactions may induce new
behaviours (phenotypes) at the level of the network. Thus, it can be used to investigate emergent
behaviours in complex biomolecular networks. The advantage is that it can be used for networks in
which the molecular components cannot be well dened by a precise mathematical equation but can
be dened with rules. Most importantly, they are computationally much simpler than the quantitative
models. The limit is that it is not accurate for quantitative modelling.
Stimuli-induced state changes Complex biomolecular networks are subject to strong variations
caused by internal or external stimuli. Therefore, it is dicult to predict their behaviour because it
emerges according to their states and the state of their environment. A biomolecular network exposed
to stimuli may exhibit more qualitatively dierent behaviours than a network working without stimuli.
In other words, a phase transition or a transition state can be induced by these stimuli. This aspect has
been considered and studied in the logic-based modelling. Most of the mathematical models presented
in Chapter 2 cannot represent and take into account these stimuli and the state changes they cause.
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This is a very important feature that makes the dierence from our logic-based approach to other
models. As shown in the second and third case studies presented in the previous chapter. The proposed
logic formalism considers and models the state changes of biomolecular networks caused by stimuli.
Indeed, the proposed logic-based modelling considers two types of stimuli: internal and external stimuli.
In fact, the changes of a molecular state can occur either by an internal stimulus modelled by the aggregate
function discussed above or by an external stimulus generated outside the cell. Therefore, we explicitly
dene this notion of stimuli as an event that causes changes in the state of the molecule on which it
acts and therefore changes the state of the whole network. Then, we integrate it with the aggregation
functions.
This point is very important and allows the logic-based modelling to understand the response of cell
in the presence of external or internal stimuli, to understand drugs mode of action (through stimuli) and
to predict the behaviour of complex biomolecular networks in response to drugs. This was proved by the
third case study, the p53-mediated DNA damage response network, based on this logic-based modelling
the CBNSimulator has successfully simulated and managed the transition states of the network from the
normal state to the apoptosis state and/or from the normal state to the arrest state. This case study
highlights the fact that our logic-based modelling can be also used for modelling and understanding the
relation and the mode of action between drug design and biomolecular networks modelling.
To conclude, the logic-based modelling allows biologists to produce formal models of the biomolecular
network of interest and then to simulate it on computers. All the properties discussed here were validated
experimentally in the previous chapter (Chapter 10). Indeed, the case studies were formalized within the
logic-based modelling and simulated within the CBNSimulator. The rst example network, the bacterio-
phage T4 gene 32 is chosen for its simplicity, it is simple enough to be mentally computed in order to easily
judge the produced results. However, for the other examples, we validate their modelling by comparison
with results of other works. We conclude that the logic-based modelling provides all the elements neces-
sary for formalizing and simulating the behaviours and transition states of these biomolecular networks.
This logic model provides a formal and mathematical formalism to model and simulates the complex
structure of biomolecular networks, the eect of stimuli which target some molecular components, and
the simulation of the dynamic evolution of their behaviours.
11.3 Ontology discussion and evaluation
Ontology evaluation and validation is a very important issue to check the ontology quality. A large group
of ontology evaluation approaches exists, among those, data-driven evaluation, task-based approach,
automated consistency checking, etc. [359]. Table 11.1 provides an overview of the best-known ontology
evaluation approaches and their limits. However, according to the current literature [360], there is no
agreement on a methodology for validation and evaluation of ontologies. The choice of a suitable approach
depends on the purpose of evaluation, the application in which the ontology is to be used, and on what
aspect of the ontology we are trying to validate and evaluate [361]. For all these reasons, we have chosen to
evaluate the BNO ontology by following dierent evaluation approaches. This choice of hybrid approaches
inherits many of the advantages of each of these approaches. The goal is to evaluate our ontology in a
dierent manner. Basing on the methods presented in Table 11.1, we adopted a combination of automated
consistency checking, expert knowledge evaluation, criteria-based evaluation, and task-based evaluation
for evaluating the BNO ontology.
Automated consistency checking The verication of the logical axioms is an essential task in on-
tology evaluation. Indeed, this evaluation ensures that the logical axioms are satisable and consistent.
This satisfaction consists in: (i) checking the encoding of the specication, (ii) detecting errors such
as class hierarchies, redundant axioms, etc., and (iii) conrming that the BNO ontology has been built
according to certain specied ontology quality criteria. By denition, consistency checking ensures that
an ontology does not include any contradictory facts. For denitions to be semantically consistent, they
must be able to obtain consistent conclusions using the meaning of all denitions and axioms [368, 369].
To evaluate the BNO ontology and check the inconsistencies and violations of its SWRL rules, we
used the latest version of the Description Logic reasoner HermiT reasoning plugin in the Protégé 5
environment 1 version 1.3.8.3. HermiT can not only determine whether or not the ontology is consistent
1http://www.hermit-reasoner.com/
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but also identify subsumption relationships between concepts and resolution of the error. In terms of the
time, HermiT is as fast as other DL reasoners when classifying relatively easy-to-process ontologies, and
usually much faster when classifying more dicult ontologies. In fact, HermiT can classify a number of
ontologies which no other reasoner has previously been able to handle. Using its HermiT reasoner plugin,
Protégé automatically checked the inferred concepts and relations and for hierarchies, domains, ranges,
and conicting disjoint assertions. Contradictory facts and inconsistent concepts are marked with red.
During the development of the BNO ontology, the automated consistency checking process was iterative.
Indeed, the BNO ontology was developed incrementally by adding new denitions and modifying old
ones. Moreover, the HermiT reasoner was used to check the correctness of the SWRL rules edited in the
SWRLTab (as shown in Chapter 7). Their consistency was veried by the results of our experiments as
shown in Figures 7.8 and 7.9.
Figure 11.1  Steps of the expert knowledge evaluation approach.
Expert knowledge evaluation Even if we have used best-known evaluation methods to test the
consistency of an ontology, the intervention of domain experts is always necessary, especially if a quality
level of the ontology is expected. The evaluation here focuses on the semantics of the BNO ontology
content and not on its formalization. As a consequence, we proposed a method based on questions
expressed in natural language and generated from the BNO ontology in order to test and, if necessary, to
correct the content of the ontology using the answers that will be provided by the expert biologists. This
questions and answers method facilitates the task of experts. We obtained the assistance and expertise
of our collaborators from the CSTB team who have evaluated the BNO ontology and conclude that it is
in accordance with their knowledge in the domain (expert knowledge).
As shown in Figure 11.1, the evaluation process consists of two steps:
Fist step - Generation of questions from the content of the BNO ontology : In this step, we generate a
set of questions from the ontological elements of the BNO ontology. Table 11.2 contains examples of
questions that we have dened in terms of ontology elements and their translation into boolean questions
addressed to expert biologists.
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Second step - Evaluation of the expert's answers: In this step, we evaluate the expert's answers in
order to decide the validity of the BNO ontological elements tested or (if necessary) their modication
to make them valid.
We study the correlation between the number of questions generated (in terms of the number of
ontological elements to be evaluated) and the size of the BNO ontology. Table 11.3 presents the number of
questions generated according to the size of the ontologies in terms of concepts, relations and individuals.
The number of questions highlights the role and the intervention of the expert biologist and its knowledge
to reduce the potential errors linked to the semantics of the content of the ontology.
The results obtained in Table 11.3 show that the number of questions generated depends on the
number of ontological elements to be evaluated and validated.
The notion of validity in this method depends on the domain expert answering the generated boolean
questions. Thus, from our point of view, the validity of the questions corresponds to the agreement
between the knowledge of the domain expert and the semantic content of the ontology.
Table 11.2  An excerpt of ontological questions and their translation into Boolean questions addressed
to biologists.
Questions made by an ex-
pert in ontology
Examples of its corresponding questions addressed to ex-
pert biologists
Is CLASS a type of CLASS ? Is the 'P04040 (CATA_HUMAN)' a type of 'Protein'?
Is the 'G32' a type of 'Gene'?
Is INSTANCE an example of
CLASS ?
Is the 'the bacteriophage T4 G32' an example of 'Biomolecu-
lar_Network'? Is the 'G32'
an example of 'Gene'?
Is SUB-PROPERTY a type
of PROPERTY ?
Is the 'the catalysis' is a type of 'Interaction'?
Table 11.3  Number of questions generated according to the size of the BNO ontology.
Concepts Properties Individuals Total Questions generated
29 20 29 78 75
Criteria-based evaluation In addition to the evaluation conducted by biologists, we adopted a
criteria-based evaluation method following the validation protocol proposed by Vrandecic in [365]. This
validation protocol is essentially based on a number of criteria that will enable us to determine whether
our ontology is relevant or not. This protocol is based on seven evaluation criteria, (1) the accuracy, (2)
the adaptability,(3) the clarity, (4) the completeness, (5) the computational eciency, (6) the conciseness,
and (7) the consistency. We evaluate the BNO ontology against these criteria as follows.
Accuracy: The denitions and descriptions in the ontology agree with the expert's knowledge about
the eld. The information regarding the concepts of the BNO ontology was developed from the well-
known Gene ontology (GO). Moreover, we obtained the assistance and expertise of our collaborators from
the CSTB team who have evaluated the BNO ontology and conclude that it does not contain semantic
mismatches, logical inconsistencies, and conceptual conicts.
Adaptability: We have opted for developing the BNO ontology as part of a global semantic archi-
tecture composed of four ontologies that are related to each other: the Gene Ontology (GO), the Simple
Event Model Ontology (SEMO), the Time Ontology (TO) and our development, the BNO ontology. This
architecture aims at aligning and merging the BNO ontology with the rest of ontologies through equiv-
alence owl:equivalenceClass or subclass owl:subclassOf relations. These relations among ontologies are
detailed in Chapter 7. This choice enhances extensibility and reusability and makes the BNO ontology
easily adaptable to dynamical contexts.
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Clarity: In developing the BNO ontology, we have been careful to assign a clear and unambiguous
description to dene and categorize concepts and the relationships among concepts within our particular
knowledge domain. This clarity is ensured by the use of the rdfs:comment that provides the obviously
needed capability to annotate an ontology. In this manner, the BNO ontology communicates eectively
the intended meaning of its terms.
Completeness: This criterion measures whether the ontology can answer all the questions that it
should be able to answer. It provides an estimation of how the BNO ontology represents the domain of
the complex biomolecular networks and their transittability. These questions were specied by the expert
biologists of the CSTB team and it has been veried that all of them can be answered.
Computational eciency: An ontology can be analysed by an inference system. In our case,
the BNO ontology was treated by the two reasoning mechanisms detailed in the previous section. We
concluded that the reasoning on the BNO ontology is consistent and allows inferences in a reasonable
time. Moreover, the complexity of this operation is adequate.
Conciseness: The terms of the BNO ontology was checked with the help of expert biologists, we
assume that the ontology does not contain any redundant terms. Moreover, we have used the OntOlogy
Pitfall Scanner2 tool to check for logical correctness of the BNO ontology and diagnostics of ontology-
design errors. Analysis results have provided great evidence of the correctness of BNO.
Consistency: This criterion ensures that the logical axioms are satisable and consistent. The
satisfaction of the logical axioms is recognized when it is possible to nd a situation under which all the
axioms are true, and their consistency when it is impossible to nd a contradiction within the axioms. As
detailed in the previous section, reasoning in the BNO ontology was performed using an SWRL rule-based
reasonner.anisms. No inconsistencies or violations were found.
As discussed in section 11.3, there is no single best approach to evaluate an ontology. For this reason,
we check the BNO ontology with dierent approaches. Firstly, we focus in particular on automated ontol-
ogy evaluation, which is a necessary precondition for the healthy development of an ontology. Automated
consistency checking was made through the Hermit reasoner. Based on the feedback of the reasoner, in-
consistencies have been corrected along the development process of the BNO ontology in an iterative way.
The nal results made by the reasoner revealed that there are no inconsistencies in the BNO ontology.
The BNO ontology has been also evaluated with dierent criteria in terms of accuracy, adaptability,
clarity, completeness, etc. For each criterion, the BNO ontology is evaluated. The combination of these
criteria allows us to check the BNO ontology from dierent levels. The nal results of the criteria-based
evaluation indicated that the BNO ontology was clear, extendable, and complete. Moreover, we evaluate
the usefulness of the BNO ontology through the expert knowledge evaluation. The BNO ontology was
used to model a set of case studies, among them the Bacteriophage T4 G32 case presented in this study.
Results proved that the BNO ontology is able to deduce the main concepts of the case studies and their
properties and is capable to infer new knowledge such as to compute the newt state of molecular compo-
nents. These results proved that the BNO ontology is able to describe and model the transittability of a
biomolecular network. However, it is important to note that the BNO ontology cannot be used directly
through a logic reasoner to compute the transittability of large-scale networks. This would exceed the
computing capabilities of current reasoners. Specic simulation tools must be designed for this task.
11.4 Simulation discussion and evaluation
The CBNSimulator is equipped with a qualitative, discrete-time simulator. This simulator allows sim-
ulating in silico the behaviour of complex biomolecular networks. It simulates and tests the dierent
state changes of biomolecular networks under various experimental conditions. The proposed qualita-
tive, discrete-event simulator can also help biologists to discover and detect the stimuli that regulate the
biomolecular network such as drug eects to the biomolecular network.
As discussed in Chapter 4 and in the previous sections, simulation techniques can be categorized into
two kinds: quantitative and qualitative techniques. Quantitative simulation provides the most precise
prediction in describing the behaviour of specic molecular entities. Nevertheless, the lack of quantitative
data limits its use with only specic case studies (when all the required quantitative data are available)
but cannot be used in more general or large-scale networks. On the other hand, qualitative simulation
simplies the real simulation of the biomolecular network and is usually able to reproduce the network
2http://oops.linkeddata.es/advanced.jsp
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behaviour. Moreover, this qualitative simulation can be used to explain and predict the behaviour and
state changes of the biomolecular and its components through discrete simulations.
Because of the lack of quantitative data, various qualitative simulation techniques have been proposed
in the literature (see Chapter 4) however, most of them cannot support the simulation of complex and
multi-level biomolecular networks. As well as, most of them suer from the lack of automation in
simulation biomolecular properties [370].
Our proposed simulator is dierent from the existing techniques. Indeed, it is totally based on logic-
based modelling. Therefore, the power of this simulator is essentially due to the ecient logic-based
modelling of complex biomolecular networks which is expressive enough to integrate and capture the
dierent elements and qualitative properties required to understand the dynamic behaviour and state
changes of biomolecular networks. But also, in the representation and the simulation of multi-level
biomolecular networks. Thus, the proposed qualitative, discrete-event simulation is able to simulate
complex and multi-level biomolecular networks. This property has been veried through the dierent
case studies in the previous chapter. All the case studies are composed of molecular components and
interactions belonging to a dierent level within the biomolecular network.
In addition, our proposed qualitative, discrete-event simulation is able to perform automatic and
ecient biomolecular networks simulation. Indeed, the simulation core rests on a discrete-event based
framework (the DEVS formalism), which is used as an ecient and accurate simulation tool of complex
systems at dierent levels of abstraction. This ensures both synchronous and asynchronous updating
methods for simulation. In the absence of perturbations, the simulator sets the initial states of the
molecular components and the initial time, then it updates the state of all the components at the same
time. This synchronization is based on the interactions rules (aggregate functions) dened by the bi-
ologist. It was the case of both the rst and second case studies in the previous chapter. However,
the asynchronous simulation takes into account the dierent perturbations caused by the stimuli. When
certain stimuli aect some molecular components, the simulator updated the state of these components
then synchronizes the state of the other components. This has experimented through the third case study
in the previous chapter.
Another important advantage of the proposed qualitative simulation mechanism is that it does not
require precise quantitative data, but even more it can simulate the behaviour of biomolecular networks
using only qualitative data. This simulation mechanism is well-suited to simulate and analyse large-scale
biomolecular networks even with a lack of quantitative data. This proposed qualitative mechanism have
been veried and illustrated for the example of the bacteriophage T4 gene 32, as detailed in Section 8.2.3.
The simulation mechanism is based on the development of a causal graph whose nodes denote variables
(representing the molecular components of the network) which this simulation is concerned and edges
denote causality relations among these variables (representing the interactions among the molecular
components). The state of the biomolecular network is described by a few qualitative distinct values
corresponding to precise quantitative values (called the quantity space). To compute the qualitative value
of the nodes, this mechanism is based on both the partition rules and propagation rules. These rules are
used to compute the value of the target variable at the next time t+1 based on its qualitative value at the
current time t and the value of its predecessors' nodes at the current time t. As detailed in Section 8.2.3,
the application of the qualitative simulation to the given example shows that the proposed qualitative
simulation mechanism is able to model and simulate complex biomolecular networks, predicting their
dierent behaviours for dierent simulations constraints.
To conclude, the qualitative, discrete-event simulation performed by the CBNSimulator can be used
to elucidate and predict the behaviour, state changes and properties of complex biomolecular networks.
Moreover, the simulator displays the dierent states of each molecular component in a graphic form that
is easy to interpret. We tested this simulator on the three case studies. The results show the performance
simulation of the proposed simulator in modelling and simulating complex multi-scale biomolecular net-
works under dierent environmental conditions and by considering the perturbations caused by external
stimuli.
While the proposed simulator has many advantages, it has the potential for signicant further im-
provements. Indeed, this proposed qualitative simulation is not able to precise the dierent time scales.
This can be considered as the main limit of our qualitative, discrete-event simulation. However, we hope
to enhance our simulator by working on this point. This future direction is described in details in the
perspective section of the next part. Moreover, integrating this qualitative, discrete-event simulation
with another quantitative continuous simulation tool would allow to increase the performance and obtain
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a semi-quantitative simulator including the advantages of both qualitative and quantitative simulations.
This is one of the possible future directions for this work.
11.5 Optimization discussion and evaluation
Optimizing the transittability of complex biomolecular networks is one of the main objectives of the
CBNSimulator. As discussed in 5.7.7, only a few studies have been focused on this problem and most
of them considered it as a mono-objective optimization problem and neglect other criteria for steering
these biomolecular networks. These researches only focus on the minimization of the number of required
driver nodes for steering the network and/or on the minimization of the number of external stimuli to be
applied on the network. However, even these two criteria are necessary conditions, they are not sucient
for completely steering complex biomolecular networks. Indeed, this assumption is not always realistic,
because steering complex biomolecular networks are in general a multi-objective optimization problem. It
requires nding appropriate trade-os among various objectives, such as the minimization of the distance
between the simulated nal network state and the desired network state, the minimization of the number
of external stimuli, the minimization of the cost of these stimuli, the minimization of the number of target
nodes, and the minimization of the patient discomfort.
Therefore, in this area we rstly propose a multi-objective mathematical formulation for optimizing the
transittability of complex biomolecular networks in which we take into account more criteria such as the
minimization of the distance between the simulated nal network state and the desired network state, the
minimization of the number of stimuli, the minimization of the cost of these stimuli, the minimization of
the number of target nodes, and the minimization of the patient discomfort. Indeed, these ve objectives
are the fundamental pillars for successfully steering the state of biomolecular networks. The rst objective
which is the most important is the minimization of the distance between the simulated nal network state
and the desired network state. This objective is ensured by the simulator and consists to compute the
distance between the obtained network and the desired network. This objective aims to provide simulated
network as close as possible to the desired network. The second one aims to identify the minimum number
of stimuli that are most likely to steer the global biomolecular network from the initial state to the desired
state. In other words, this criteria aims to give priority to the quality of the external stimuli over their
quantity. The third objective is closely related to the rst objective function and aims to minimize the
total cost of the external stimuli to be applied to the network components. In fact, the cost of external
stimuli maybe associated with the number of external stimuli. So, if we have a number of external stimuli
equal to the number of nodes and all the external stimuli have the same cost, the transittability process
of the complex biomolecular network will be very expensive. That is why this criterion aims to nd the
best compromise between the quality of the external stimuli and their cost. The fourth objective aims
to identify the minimum set of nodes to be aected by the external stimuli. Indeed, several studies have
revealed that, among all the nodes composing the biomolecular network, there are some specic nodes
that have the ability to steer the network from its actual state to another specic state. Moreover, the
stimulation of all the nodes of the network may place the patient at risk of developing additional adverse
eects caused by the external stimuli such as ultraviolet irradiation. Thus, instead of stimulating all
the nodes randomly, it is better to have a stimulation strategy which targets a set of specic nodes.
This will allow stimulating only a minimum number of nodes thus allowing the transition of the network
to the desired state. Then, the fth objective aims to reduce the patient discomfort during a certain
treatment (while nding the best compromise with the other objective functions cited previously). In
our context, the patient discomfort encompasses dierent aspects such as patient pain, stress, vomiting,
dizziness, anxiety, fatigue, etc. Indeed, the transittability of a biomolecular network can potentially be
uncomfortable and negatively impacts the emotional and mental health of patients, the quality of their
life and increases the use of health care resources. For all these reasons, we must consider this important
criterion in the transittability process. It is important to mention that both the rst and third objectives
have been already used in the literature for steering biomolecular networks. However, for the second and
fourth objectives, we have added them after a long discussion with expert biologists and because they
are crucial for achieving the transittability of biomolecular networks.
Moreover, we propose in Chapter 9 a two-step multi-objective optimization approach for solving
this multi-objective problem. Our proposed approach is strongly based on the combination of both
Non-dominated Sorting Genetic algorithm (NSGA-II) to obtain the set of Pareto-optimal solutions, and
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the Technique for Order of Preference by Similarity to Ideal Solution (TOPSIS) method to provide the
decision-maker with the best compromise solution according to its preferences. The NSGA-II is one of the
most widely used genetic algorithms for multi-objective problems. Thus, we think that it is interesting
for us to chose and adapt this algorithm to the problem of steering complex biomolecular networks.
Based on the results obtained in Chapter 10, we conclude that the NSGA-II is well suited to solve the
transittability of complex biomolecular networks as a multi-objective optimization problem. Indeed, it is
able to nd a set of non-dominated solutions in a single run. However, even the obtained results have
been satisfactory and positive, more can be done. In fact, we did not test our optimization problem with
other methods. Maybe it is recommended to enhance the NSGA-II parameters and why not to solve
the problem with other optimization heuristics with the goal of comparing and improving the obtained
solutions. This is remaining as future work. Moreover, it is important to note that this work of optimizing
the transittability of complex biomolecular networks is still the beginning phase in the literature. There
are no other works treating the same problematic based on optimization tools, and there is no existing
evaluation yet. We only compare our results according to the work of Wu et al. [6].
This proposed approach was tested and applied to solve the steering of the p53-mediated DNA damage
response network with the goal of optimizing simultaneously the dierent criteria involved in its tran-
sittability, in particular, the distance between the simulated nal network state and the desired network
state, the number of external stimuli, their cost, the number of target nodes and the patient discomfort.
We use this example because it has three states called also phenotypes, the normal, the apoptosis and
the arrest state. This case study has been already studied and simulated in the work of Wu et al. [6]
and Zhang et al. [356], this allows us to compare our results by referring to their experiments. Obtained
results are in great agreement with those of [6] and [356]. Indeed, we have succeeded in nding the
best compromise among the dierent criteria of the transittability and in optimizing the steering of the
biomolecular network from the normal state to one of the desired state (apoptosis or arrest state). The
experimental results illustrate the eectiveness of this approach in optimizing all the objective functions.
We compare our obtained results with the most representative works proposed for steering the
biomolecular networks using the controllability notion in literature. We note that the proposed approach
(in agreement with Wu et al. [6] results) proposes to aect the minimum set of nodes (not all nodes)
rather than the entire nodes of the biomolecular networks. As a consequence, the proposed approach
provides less external stimuli than the total number of the network nodes and consequently, the total
cost of these stimuli will certainly be less costly than the use of controllability notion [28]. In addition,
the proposed method considers as another objective the minimization of the patient discomfort. This
increases the applicability of translational medicine for improving human health and disease, including
genetic and environmental factors of patient's well-being. This is a great opportunity to understand
diseases and nd new diagnoses and treatments. Therefore, applications of the proposed optimization
approach can be used in the design of treatments such as chemotherapy, the identication of potential
drug targets in a signalling network of human cancer, or to study the phenotype transitions (for example,
to direct a biomolecular network from its abnormal or disease phenotype to a healthy phenotype).
11.6 Summary
In this chapter, we have presented a discussion of our four proposed approaches. These approaches are
combined together under the CBNSimulator platform. This platform enables the study of the behaviour of
complex biomolecular networks through the creation of their logic modelling. As seen with the three case
studies, the logic-based modelling provides all the necessary elements to model biomolecular networks.
This logical formalism treats the biomolecular network based on three aspects: the structural, functional,
and behavioural modelling of the network. Furthermore, with the goal of enriching this logic-based
modelling, the CBNSimulator integrates a semantic level to this logic modelling through the semantic
modelling. This semantic modelling aims to enrich and infer new knowledge, to detect more properties
and relationships among the molecular components, and to suggest new inferring data in order to provide
the logic model with complementary knowledge and data. This semantic approach joined to the logic-
based modelling provides a powerful formalism for modelling and representing complex biomolecular
networks. Moreover, the CBNSimulator provides a qualitative, discrete-event simulator. This simulation
approach was used to elucidate and predict the behaviour, state changes and properties of the three
case studies. Simulation results were displayed in a graphic form to facilitate their interpretation and
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analysis. Finally, the CBNSimulator proposes an optimization module allowing biologists to steer complex
biomolecular networks from their actual state to another specic state. The experimental results illustrate
the eectiveness of this approach in optimizing simultaneously the dierent criteria involved in their
transittability, in particular, the distance between the simulated nal network state and the desired
network state, the number of external stimuli, their cost, the number of target nodes and the patient
discomfort. Thus, using the CBNSimulator, biologists can perform in silico experiments, in particular,
the steering of the biomolecular network from a state to another one, which has the advantage of being
less costly in time and resources than the in vitro and in vivo experiments. However, this platform must
continue to be rened and enhanced. Interesting research directions are discussed in the next part.
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In this part, we conclude by briey foregrounding our thesis' contributions, and suggest specic open
questions and directions for future research.
Conclusion
An important objective of systems biology is the construction of predictive models for understanding the
dynamic behaviour of complex biomolecular networks and their transittability. Indeed, existing studies
have focused mainly on numerical models involving (highly non-linear) dierential equations and using
tools for estimating parameters [371] to formalize and simulate biomolecular networks. However, as
discussed in Chapter 2 to Chapter 4 state-of-the-art quantitative models cannot be reused or merged
with other models in a systematic fashion, and are limited to a small number of variables [371].
Moreover, with the recent development of high-throughput technologies, huge amounts of data have
been generated to describe the complex processes and molecular mechanisms at work in the cell, through
the study of cellular components on several levels.
With these advances, systems biology faces numerous novel challenges:
• The rst challenge is how to extract important knowledge from all this data in order to understand
and infer cellular functions and behaviours in dierent conditions.
• Another challenge is the modularity of complex biomolecular networks. It is not an easy task to
model and combines large-scale genomic, proteomic and metabolic data in order to obtain a mixed
model of the complex biomolecular network. This is a restriction to the re-use of models in systems
biology because they are implemented for a specic context.
• An important challenge is to simulate the behaviour of biomolecular networks using logic and
qualitative models to automate various forms of biological reasoning. Indeed, understanding the
transition states of biomolecular networks and drug target discovery, require qualitative tools to
assist the biologist when certain numerical data are unavailable.
• Another challenge for systems biology is to enrich existing quantitative models to include precise
semantics of biomolecular networks behaviour and build formal methods to reason about them.
• A supplementary important challenge is to understand the dynamic aspects of these biomolecular
networks in order to control and guide their behaviour. This issue is known through the "transitta-
bility" that focuses on the idea of steering the complex biomolecular network from an unexpected
state to a desired state.
To address these challenges, the overall goal of this study is to propose an intelligent platform that
enables biologists to simulate the state changes of biomolecular networks with the goal of steering their
behaviours. The development of such a platform involves several related computing methods belonging to
dierent domains such as mathematical systems modelling, knowledge engineering, computer simulation,
and combinatorial optimization. Thus, the intelligence of our platform derives from the combination of
diverse techniques and elds of study. The rst element of intelligence is presented in this dissertation
through the logic-based modelling approach that addresses the problem of modelling complex biomolec-
ular networks considering the diversity and heterogeneity of their molecular components, and adopting
a global vision which considers their multi-level aspects. This formalization focuses on the structure of
the network (modelling of the diverse components and their interactions), network control (identication
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of the function and role of each component) and network dynamics (observation of its behaviour over
time). The second feature of our intelligent platform concerns the semantic approach, which provides the
necessary knowledge for modelling and understanding the behaviour of complex biomolecular networks
and their state changes. The Biomolecular Network Ontology presented in this dissertation formalizes
the domain knowledge of complex biomolecular networks making it visible and accessible to all biologists
working on this topic. Moreover, the reasoning and simulation system exploits all this formally encoded
knowledge in order to reproduce the behaviour of complex biomolecular networks and their components
over time even with incomplete knowledge. Finally, the proposed multi-objective optimization approach
take into account several criteria, such as: the minimization of the distance between the simulated nal
network state and the desired network state, the minimization of the number of stimuli, the minimization
of the cost of these stimuli, the minimization of the number of target nodes, and the minimization of the
patient discomfort, for optimizing the transittability of complex biomolecular networks.
Contributions
We recall our four contributions here. For each contribution, we stress the results and general conclusions.
More general perspectives of our contributions are left to the next section.
In Chapter 6, we propose a logic-based formalization which allows biologists to model the dierent
elements that compose a complex biomolecular network, and to identify and categorize all its components
and the nature of their interactions. Indeed, the logic-based formalization was tested with dierent case
studies and provides a relatively simple modelling approach able to capture interesting and relevant
behaviours in the cell. In particular, in the case of the poorly understood biomolecular network where
quantitative data and parameters are often scarce and hard to obtain. However, to obtain an optimal
and more realistic modelling, we need to enhance it with an additional semantic layer. For this reason,
we propose a semantic architecture for providing and inferring more knowledge about the functioning of
cells at a molecular level.
The proposed semantic architecture (Chapter 7) consists of four ontologies: three of them already
exist in the literature, the Gene Ontology (GO), the Simple Event Model Ontology (SEMO), the Time
Ontology (TO) and we are developing the Biomolecular Network Ontology (BNO). Linked together, these
ontologies provide the necessary concepts for modelling the dynamic behaviour and the transition states
of a complex biomolecular network. The Biomolecular Network Ontology describes the static structure
of the biomolecular network. Merging with the Simple Event Model Ontology, the Biomolecular Network
Ontology describes what can carry out each component of the biomolecular network and the conditions
for these activities. Finally, the Biomolecular Network Ontology, the Simple Event Model Ontology and
the Time Ontology describe how the biomolecular network and its individual components evolve over
time.
In the same chapter, we focus on the implementation of the BNO ontology to describe the domain
knowledge of complex biomolecular networks in their static state. This ontology provides information
on the biomolecular network and its components (nodes, interactions, states, transition states, etc.) and
an indication of the network's context such as the type of sub-network, the type of node, the conditions
and nature of interactions, etc. This allows to precisely explain and interpret the semantic context in
order to achieve intelligent modelling of biomolecular networks and their state changes. These state
changes can be computed with a rule-based system using OWL-SWRL rules. These rules represent a
"proof of concept" demonstrating the logical consistency of the approach and validating the relevance
of the ontology. Additionally, we simulate the evolution of dierent biomolecular networks. Obtained
results are encouraging and indicated that the BNO is consistent, credible and eective in describing
relevant knowledge required in understanding the behaviour of complex biomolecular networks and their
state changes. Nevertheless, more ecient simulation tools should be used to study larger biomolecular
networks.
Moreover, it is important to note that the complexity of biomolecular networks is rstly due to their
large number of coupled components, but also to the diversity of these molecular components and to their
intricate interactions. Indeed, biomolecular networks consist of various subnetworks which themselves are
composed of several molecular components interacting in their turn with each other, producing a complex
global behaviour. The complexity and large size of these networks have prevented a fully quantitative
simulation. Thus, biologists require tools allowing them to gain insights into the behaviour of complex
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biomolecular networks by simulating the dierent states of their components over time.
Therefore, we propose a qualitative, discrete-event simulation in Chapter 8. The qualitative simulation
predicts the set of possible states based on the logic-based modelling of the real network. The link
between the logic model and the qualitative simulation is ensured by the partition and propagation rules.
The value of the qualitative simulation comes from the ability to describe natural types of incomplete
numerical knowledge, and the ability to deduce a complete set of possible states (using qualitative values
rather than real numbers). We chose to use qualitative reasoning for two reasons: (i) To understand the
overall functioning and properties of complex biomolecular networks through the analysis and simulation
of the dynamical model, and the interpretation of the obtained qualitative knowledge. (ii) To steer these
networks by allowing to evaluate their simulation at any time, even in the lack of quantitative knowledge.
In addition to the qualitative simulation, we propose a discrete-event simulation. This approach was
inspired by the DEVS formalism [339], a formalism for supporting the modelling of complex systems,
and based on the logic-based modelling. This simulation allows biologists to analyse and predict the
eect of changes, the behaviour of the biomolecular network components. It also enables the study of the
internal interaction of a subsystem with a complex system. This approach aims at providing biologists
with a exible tool for simulating biomolecular networks by reproducing their behaviour and the state
of their components over time and consequently allows them to analyse and understand simulated cell
phenomena. These approaches have been veried on diverse biomolecular networks, and the simulation
results obtained were formally treated and validated by expert biologists. Indeed, these results correspond
to their domain knowledge.
The computation of the transittability of complex biomolecular networks can be considered as an
optimization problem. As discussed in Chapter 5, only a few studies have been carried out for this
problem and most of them have focused only on the minimization of the nodes required to steer the
entire network and on the minimization of the number of stimuli to be applied on the network. However,
this assumption is not always realistic, because steering complex biomolecular networks are in general a
multi-objective optimization problem. It requires nding appropriate trade-os among various objectives,
for example between the appropriate nodes to be stimulated and the number of external stimuli to be
used, their cost and the patient discomfort.
Consequently, we propose (in Chapter 9) a multi-objective mathematical formulation for optimizing
the transittability of complex biomolecular networks in which we take into account more criteria such
as the minimization of the distance between the simulated nal network state and the desired network
state, the minimization of the number of stimuli, the minimization of the cost of these stimuli, the
minimization of the number of target nodes, and the minimization of the patient discomfort. Moreover,
we propose a two-step multi-objective optimization approach for solving this multi-objective problem.
Our proposed approach is strongly based on the combination of both Non-dominated Sorting Genetic
Algorithm (NSGA-II) [340] to obtain the set of Pareto-optimal solutions, and the Technique for Order
of Preference by Similarity to Ideal Solution (TOPSIS) method [341] to provide the decision-maker with
the best compromise solution according to its preferences.
In order to validate all these methods proposed in Chapter 6, 7, 8, and 9, the prototype CBNSimulator
has been developed in Chapter 10. The overall architecture of CBNSimulator is composed of four modules.
Each module corresponds to one of the proposed approaches discussed above. As well as, we have
applied all these approaches to various biomolecular networks, among them the autoregulation of the
bacteriophage T4 gene 32, the phage lambda and the p53-mediated DNA damage response network.
The logic-based modelling approach provides all the elements that we need to understand the structure,
function and behaviour of these case studies, but also to study its evolution over time. In addition, the
proposed semantic approach produces good quality (ecient) simulation and rapid reasoning of these
biomolecular networks behaviour. The SWRL reasoner is able to reproduce the overall behaviour of
these biomolecular networks induced by the SWRL rules dened by the expert biologists. It reproduces
behaviours similar to those observed in real life. Indeed, the qualitative simulation method provides
all possible simulation results of the given networks and their molecular components. Thus, based on
this qualitative method, it is possible to predict the behaviour of these networks even in the absence
of quantitative information. It is sucient to have some essential information to predict their future
behaviour. Moreover, the proposed multi-objective optimization approach for solving this multi-objective
problem takes into account dierent criteria which are important to study the transittability of complex
biomolecular networks. It provides a set of optimum solutions to the problem according to the user
preferences. The results obtained from this study are encouraging and it is expected that they will
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be useful in understanding the behaviour of complex biomolecular networks and in optimizing their
transittability.
However, our proposed CBNSimulator has some important limitations. First, the complexity of real
biomolecular networks means that a number of simplications are necessary. For example, we have not
included interactions between metabolites and genes, although it is known that specic metabolites, such
as nicotine, do interact directly with genes. Second, in order to completely understand biomolecular
networks, some quantitative aspects should be taken into account. To address this, the quantitative
methods described in the State-of-the-art could be used in combination with our tool. Third, the cases
studies used here are relatively small and medium-sized networks, and in fact, our semantic method
cannot simulate very large networks. The main reason is the time constraint and the exponential number
of interactions among the molecular components. It is dicult to compute the dynamics of all the
interactions at the same time. For this reason, we integrate a framework for dynamic simulation of
complex biomolecular networks based on the Discrete Event System Specication (DEVS) formalism
[339], which allows the description of biomolecular networks at dierent levels. In order to validate all
these methods proposed in Chapter 6, 7, 8, and 9, the prototype CBNSimulator has been developed
in Chapter 10. The overall architecture of CBNSimulator is composed of four modules. Each module
corresponds to one of the proposed approaches discussed above. As well as, we have applied all these
approaches to various biomolecular networks, among them the autoregulation of the bacteriophage T4
gene 32, the phage lambda and the p53-mediated DNA damage response network. The logic-based
modelling approach provides all the elements that we need to understand the structure, function and
behaviour of these case studies, but also to study its evolution over time. In addition, the proposed
semantic approach produces good quality (ecient) simulation and rapid reasoning of these biomolecular
networks behaviour. The SWRL reasoner is able to reproduce the overall behaviour of these biomolecular
networks induced by the SWRL rules dened by the expert biologists. It reproduces behaviours similar
to those observed in real life. Indeed, the qualitative simulation method provides all possible simulation
results of the given networks and their molecular components. Thus, based on this qualitative method, it
is possible to predict the behaviour of these networks even in the absence of quantitative information. It
is sucient to have some essential information to predict their future behaviour. Moreover, the proposed
multi-objective optimization approach for solving this multi-objective problem takes into account dierent
criteria which are important to study the transittability of complex biomolecular networks. It provides
a set of optimum solutions to the problem according to the user preferences. The results obtained from
this study are encouraging and it is expected that they will be useful in understanding the behaviour of
complex biomolecular networks and in optimizing their transittability.
However, our proposed CBNSimulator has some important limitations. First, the complexity of real
biomolecular networks means that a number of simplications are necessary. For example, we have not
included interactions between metabolites and genes, although it is known that specic metabolites, such
as nicotine, do interact directly with genes. Second, in order to completely understand biomolecular
networks, some quantitative aspects should be taken into account. To address this, the quantitative
methods described in the State-of-the-art could be used in combination with our tool. Third, the cases
studies used here are relatively small and medium-sized networks, and in fact our semantic method
cannot simulate very large networks. The main reason is the time constraint and the exponential number
of interactions among the molecular components. It is dicult to compute the dynamics of all the
interactions at the same time. For this reason, we integrate a framework for dynamic simulation of
complex biomolecular networks based on the Discrete Event System Specication (DEVS) formalism
[339], which allows the description of biomolecular networks at dierent levels.
Suggested future work
Our contributions detailed in the previous section suggest some specic open questions and directions for
future research. The remainder of this section will lay out some of these perspectives. Indeed, although
the dynamic synchronization among the four modules (corresponding to our contributions): logic-based
modelling, semantic approach, qualitative and quantitative simulation, and the multi-objective optimiza-
tion module to achieve the full development of our intelligent platform, the CBNSimulator, there are still
some important improvements that can be made in further researcher.
• About our rst contribution:
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As mentioned in the previous section, our proposed logic-based modelling does not include interactions
among metabolites and genes, although it is known that some specic metabolites, such as nicotine, do
interact directly with genes. One possible direction to explore is to extend the logic-based modelling with
the goal of integrating and considering this hypothesis.
• About our second contribution:
An interesting question which we are currently investigating is the problem of extending the semantic
approach presented in this thesis by applying it to large and concrete biomolecular networks and enhancing
its performance in order to apply it in the domain of drug discovery. This can be solved by integrating
other ontologies and adding them to our semantic approach. Considering that SWRL rules provide
powerful solutions for problems that cannot be solved with standard Description Logic-based reasoning,
we plan to provide a user interface (by adding a functionality to the CBNSimulator) that allow biologists
to dene their specic SWRL rules to represent their preferences and take prot of the knowledge required
for specic and personalized application.
• About our third contribution:
The components of the biomolecular network and their interactions are physically and temporally
organized to ensure the production of a particular behaviour or phenotype. These spatiotemporal aspects
are important to understand the functioning of a cell as a whole. The spatial organization of the network
includes the location of the dierent molecular components as well as their positions and levels (proteomic,
metabolic, etc.). The temporal organization includes the order of the sequence of state transitions of
each component, the duration and frequency of these interactions. Both of these spatiotemporal aspects
constitute the dynamic properties of the biomolecular network. In this work, to maintain simplicity we
take into account the multi-level aspect of the network (considering the dierent levels of the biomolecular
network), but we do not consider the dierent biological time levels. Indeed, the timing of processes
levels with size: from nanosecond at the level of single molecules to microseconds at the level of proteins
interaction, to hours at cellular processes, etc. We neglect this property and work within a xed time
level. To address this limitation, we must include our modelling with a timing generator that allows to
follow the dynamics of the system and change among dierent time levels according to the given spatial
level and the nature of the process. Moreover, to overcome these diculties of time levels, a simulator
based on agent-based systems may be proposed because they take into account the eects of dierent
time levels.
• About our fourth contribution:
The transittability of complex biomolecular networks has dierent perspectives in terms of optimiza-
tion criteria (minimization of total transittability time and other objectives), therefore, it will be interest-
ing to improve and detail some objectives such as the patient comfort. Moreover, we plan to improve the
performance of our NSGA-II algorithm by implementing a hybridisation with a local search algorithm,
such as the Nelder-Mead simplex method, and compare its performance with other meta-heuristics in
order to improve the computation time of our optimization algorithm and the quality of the solutions.
We can also use the EASEA platform3 (EAsy Specication of Evolutionary Algorithms) that ensures
the parallel implementation of genetic algorithms on a computer network furnished with GPGPU cards
(General-Purpose computation on Graphics Processing Units). Using this platform we can solve the
transittability of complex and large-scale networks by taking the advantages of the massive parallelism
of many-core architectures.
• About the prototype CBNSimulator:
Our prototype, the CBNSimulator, needs to be improved. First, we are actually working to make a
more dynamic synchronization among the four modules, the logic-based modelling, semantic approach,
qualitative and quantitative simulation, and the optimization module to improve the performance of our
platform. As well as, we plan to extend the experiments in order to assess and analyse in more detail
the impact of our dierent proposals. Indeed, simple cases studies are not enough to completely evaluate
3http://easea.unistra.fr/index.php/EASEA_platform
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and validate our approaches, therefore, new experiments could be carried out within the application
of the CBNSimulator. Moreover, the CBNSimulator platform currently oers only the simulation and
optimization layer for complex biomolecular networks. The logic and semantic modelling modules have
been implemented implicitly in the code and specically for each example. Thus, we plan to add new
interfaces allowing the user to dene and explicitly design the logical and semantic modelling of his own
biomolecular network. Solving these problems will contribute to the generality of our platform.
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La biologie des systèmes représente un nouveau domaine de la biologie qui pourrait avoir des applications
importantes en recherche biomédicale et en ingénierie biologique. En eet, ce domaine académique
vise à proposer des modèles de fonctionnement intégrant diérents niveaux d'informations pour décrire
et comprendre le comportement d'une cellule, représentée par un réseau biomoléculaire complexe. En
combinant les données biologiques expérimentales et les techniques de l'informatique, la biologie des
systèmes ore la possibilité d'avoir une vraie compréhension du fonctionnement et des interactions entre
les diérents composants moléculaires d'une cellule à tous les niveaux de son organisation (génétique,
protéomique et métabolique).
En eet, la cellule peut être considérée comme un système complexe composé de milliers d'entités
moléculaires diérentes (gènes, protéines et métabolites), qui interagissent physiquement, fonctionnelle-
ment et logiquement créant un réseau moléculaire. Pour réduire la complexité de ce réseau, la plupart
des études traditionnelles se sont concentrées uniquement sur un niveau particulier du système cellu-
laire, comme les réseaux de régulation des gènes, les réseaux d'interaction protéine-protéine ou encore les
réseaux métaboliques. Diverses approches ont été développées pour modéliser, analyser et comprendre
ces réseaux, y compris les équations diérentielles ordinaires, les méthodes stochastiques, les réseaux
booléens, les réseaux bayésiens, les réseaux de Petri, etc. et des études comparatives de ces techniques
ont été réalisées. Néanmoins, peu d'approches ont été développées pour étudier le système cellulaire dans
son ensemble, et en particulier les interactions entre les diérents types de réseaux moléculaires. De plus,
la plupart des techniques de modélisation existantes ne tiennent pas compte de l'évolution dynamique du
réseau ainsi que de ses diérentes transitions d'états.
Récemment, certains auteurs ont commencé à aborder les aspects dynamiques et ont introduit des
concepts tels que la "contrôlabilité" d'un réseau, où la capacité de diriger un réseau complexe d'un état
initial vers un autre état désiré est mesurée par le nombre minimum de n÷uds pilotes requis (n÷uds
ayant la capacité de diriger l'ensemble du réseau). Ils ont montré que pour avoir une contrôlabilité
complète, le nombre minimum de n÷uds pilote est de 80 % des n÷uds d'un réseau biomoléculaire. Ce
résultat a conduit d'autres groupes à développer un cadre théorique pour étudier les transitions entre
deux états spéciques de réseaux complexes, un concept qu'ils appellent la " transitabilité " du réseau.
Cette transitabilité exprime l'idée de pouvoir piloter un réseau complexe d'un état initial vers un autre
état désiré en stimulant un minimum de n÷uds.
Notre thèse s'inscrit dans ce contexte. Par conséquent, nous proposons une plate-forme qui permet
aux biologistes de simuler les changements d'état des réseaux biomoléculaires dans le but de piloter leurs
comportements et de les faire évoluer d'un état non désiré vers un état souhaitable. Cette plate-forme
considérée comme un système intelligent combine la modélisation logique, le raisonnement sémantique
et qualitatif, un outil de simulation et un algorithme d'optimisation. Ses objectifs généraux sont: Car-
actériser les composants moléculaires d'une cellule; Comprendre les interactions dynamiques entre les
composants moléculaires et les stimuli environnementaux; Fournir un outil aux biologistes pour repro-
duire le comportement de réseaux complexes; et Déduire un ensemble optimal de stimuli externes à
appliquer pendant un intervalle de temps prédéterminé pour piloter le réseau de son état actuel à un état
désiré.
Ainsi, cette plate-forme, que l'on a intitulé CBNSimulator, ore aux biologistes la possibilité de (i)
modéliser et simuler un réseau biomoléculaire complexe en se basant sur le modèle logique qui est décrit
sémantiquement par une modélisation sémantique, et (ii) guider et piloter la transition de ces réseaux
de leur état actuel à un état souhaité dans des conditions spéciques et contrôlées. CBNSimulator est
composée de quatre modules: un module de modélisation logique, un module ontologique, un module de
simulation et un module d'optimisation.
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1. Le module de modélisation logique: Ce module représente le point de départ de tout nouveau
réseau biomoléculaire déni par l'utilisateur. Cette modélisation logique a été conçue pour fournir
tous les éléments nécessaires à la modélisation du réseau biomoléculaire en tenant compte de ses
diérents niveaux et composants moléculaires. Par exemple, l'utilisateur peut spécier la liste des
composants moléculaires et leur type, la liste des interactions entre ces composants et les conditions
qui les activent, etc. Cette modélisation logique tient compte de la complexité et de l'hétérogénéité
de ces composants moléculaires et de leurs structures multi-niveaux.
2. Le module ontologique: Ce module assure la gestion, la modélisation et le partage des connaissances
des experts biologistes. Ce module prend en entrée toutes les informations natives introduites par
l'expert (état du réseau, sa structure, etc.) à travers la modélisation logique fournie par le premier
module. Ensuite, le module ontologique fournit, en sortie, un réseau composé de connaissances
natives et déduites (inférées). Ce module joue un rôle très utile pour l'enrichissement de la formal-
isation du réseau, surtout lorsque la modélisation logique du réseau manque de détails. De plus,
les informations supplémentaires fournies par ce module peuvent être utilisées pour identier de
nouvelles relations potentielles entre les composants moléculaires du réseau.
3. Le module de simulation: Ce module permet aux utilisateurs de simuler et/ou de reproduire le
comportement dynamique du réseau. En eet, ce simulateur intègre toutes les informations fournit
par l'expert (le réseau enrichi de connaissances natives et inférées) avec d'autres paramètres an de
mieux reproduire le comportement du réseau biomoléculaire et de ses composants dans le temps.
Les résultats générés lors de la simulation sont achés à l'utilisateur sous forme graphique an de
faciliter leur interprétation, et peuvent également être transmises au module d'optimisation.
4. Le module d'optimisation: Ce module fournit un moyen de diriger et piloter le réseau de son
état actuel vers un autre état spécique. Cette optimisation est réalisée en spéciant les états
initial et souhaité du réseau, ainsi que tous les stimuli externes possibles dénis par l'utilisateur.
Ensuite, ce module d'optimisation fournit les meilleures séquences de stimuli pour piloter le réseau
biomoléculaire de son état initial à l'état désiré et, enn, présente les résultats en fonction des
préférences de l'utilisateur. Ce module permet également d'optimiser la transitabilité du réseau en
minimisant divers critères, tels que: la distance de proximité entre l'état du réseau obtenu à la n
de la simulation et l'état du réseau désiré, le nombre de stimuli externes, leur coût global, le nombre
de n÷uds cibles et l'inconfort du patient.
Le manuscrit de thèse est divisé en trois parties et est composé de onze chapitres. Les parties "État
de l'art" et "Contributions" ont été divisées chacune en quatre chapitres en fonction des modules de
l'architecture de la plate-forme proposée. La première partie Etat de l'art vise d'abord à présenter
l'environnement biologique dans lequel nous travaillons en explorant l'histoire conceptuelle de la biologie
des systèmes et en dénissant ses principaux concepts. Ensuite, à présenter les diérents outils et ap-
proches qui ont été proposés dans les diérents domaines de recherche couverts par cette thèse. À la n de
chaque chapitre, une section est consacrée à la dénition de l'énoncé du problème lié à chaque domaine de
recherche spécique. Le premier chapitre présente l'environnement biologique et le contexte dans lequel
nous travaillons. Nous nous concentrons principalement sur les réseaux biomoléculaires complexes et leur
transitabilité. Le deuxième chapitre capitalise les notions de base des modèles mathématiques en biologie
systémique, synthétise les plus importants d'entre eux, et présente la principale problématique abordée
par notre thèse dans ce domaine: une modélisation logique des réseaux biomoléculaires complexes. Le
troisième chapitre donne un aperçu sur les ontologies, décrit les principales bio-ontologies qui ont été
proposées en biologie des systèmes et présente la principale problématique abordée par notre domaine:
une ontologie de domaine pour décrire le domaine des réseaux biomoléculaires complexes. Le quatrième
chapitre se focalise sur les notions de base de la simulation en biologie des systèmes, détaille les principaux
outils et plates-formes de simulation dans la littérature, et présente la principale problématique abordée
par notre thèse dans ce domaine: un simulateur qualitatif et à événements discrets pour comprendre le
comportement des réseaux biomoléculaires complexes. Enn, le dernier chapitre de cette partie présente
les connaissances de base sur les outils d'optimisation, y compris une synthèse des travaux menés sur les
problèmes d'optimisation en biologie des systèmes, et présente la principale problématique abordée par
notre thèse dans ce domaine: un algorithme génétique pour résoudre et optimiser la transitabilité des
réseaux biomoléculaires complexes.
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Après avoir présenté le contexte et l'état d'avancement de nos travaux dans la première partie de
ce manuscrit, la deuxième partie Contributions est consacrée à nos contributions sur la conception et
le développement d'une plate-forme de simulation des changements d'état de réseaux biomoléculaires
complexes dans l'espoir de comprendre et de piloter leur comportement. Cette plate-forme se compose de
quatre modules de base: (i) le module de modélisation pour formaliser le comportement dynamique des
réseaux biomoléculaires, (ii) le module ontologique pour fournir une description riche des entités cellulaires
et les interactions ayant lieux entre elles, (iii) le module de simulation pour reproduire le comportement
dynamique des composants de chaque réseau dans le temps et (iv) le module d'optimisation pour fournir
un ensemble de stimuli externes proposant le meilleur pilotage du réseau biomoléculaire d'un état donné
à un autre. Ces contributions sont organisées par domaine spécique. Ainsi, selon chacun des modules
de l'approche que nous proposons, quatre contributions ont été apportées à ce travail. C'est pourquoi
cette partie est divisée en quatre chapitres, chacun présentant nos contributions dans un domaine de
recherche spécique. Le sixième chapitre propose une approche logique pour modéliser le comportement
dynamique des réseaux biomoléculaires. Ce formalisme s'appuie sur les trois niveaux d'analyse dénis
par la théorie des systèmes: la modélisation structurelle, fonctionnelle et comportementale. En eet, il
vise à décrire et à analyser toutes les propriétés et les mécanismes des réseaux biomoléculaires complexes.
Cette modélisation basée sur la logique constituera l'élément de base pour la modélisation, la simulation
et la compréhension de la transitabilité de ces réseaux complexes. Le septième chapitre présente une
approche sémantique pour la modélisation des réseaux biomoléculaires et décrit l'implémentation de la
Biomolecular Network Ontology (BNO), une ontologie créée spécialement pour répondre aux besoins
de l'analyse du comportement des réseaux biomoléculaires complexes. Cette ontologie fournit une base
pour la simulation qualitative de ces réseaux. Le huitième chapitre propose deux types de simulation:
une simulation qualitative et une simulation à événements discrets. La première répond à la complexité
du calcul des méthodes de simulation quantitative qui sont parfois impossibles à mettre en ÷uvre. La
deuxième méthode est une simulation intégrative à événements discrets qui considère que le comportement
du réseau biomoléculaire complexe émerge de l'interaction des diérents niveaux du réseau. Enn le
dernier chapitre de cette partie, présente tout d'abord une formulation mathématique multi-objectifs
pour optimiser la transitabilité des réseaux biomoléculaires complexes considérant divers critères tels
que la minimisation de la distance de proximité entre l'état du réseau obtenu à la n de la simulation
et l'état du réseau désiré, la minimisation du nombre de stimuli externes, la minimisation de leur coût
global, la minimisation du nombre de n÷uds cibles, et la minimisation de l'inconfort du patient. Ce
chapitre présente également une approche d'optimisation multi-objectifs pour résoudre ce problème. Cette
approche est basée sur la combinaison de l'algorithme génétique de tri non dominé (NSGA-II) qui génère
l'ensemble des solutions optimales de Pareto-optimal, et de la méthode TOPSIS (Technique for Order of
Preference by Similarity to Ideal Solution) pour fournir au décideur la meilleure solution de compromis
en fonction de ses préférences.
La troisième partie Validation présente, détaille et discute nos résultats. Cette partie est divisée en
deux chapitres. Le dixième chapitre qui présente un prototype de plate-forme, intitulé CBNSimulator,
que nous avons développé pour valider nos contributions ainsi que les expériences que nous avons menées
pour déterminer les performances de ce prototype. Cette plate-forme est basée sur le modèle logique et
sémantique du réseau biomoléculaire ainsi que sur les performances de simulation à événements discrets
pour comprendre l'évolution et le comportement des réseaux biomoléculaires complexes dans le temps.
Le onzième et dernier chapitre discute les résultats des diverses expériences que nous avons menées an
d'évaluer nos contributions, tout en comparant nos résultats à ceux de la littérature.
Ainsi pour résumer, cette thèse présente quatre contributions:
En première partie, nous proposons une approche de modélisation logique permettant de décrire et
modéliser les réseaux biomoléculaires complexes. Cette modélisation logique se base sur la séparation
des trois axes de la théorie des systèmes, à savoir: l'aspect structurel, fonctionnel et comportemental du
réseau. Cette séparation des connaissances de nature diérente simplie la complexité de la tache de
modélisation des réseaux biomoléculaires complexes.
Par la suite, une deuxième contribution porte sur une approche sémantique composé de quatre on-
tologies, Gene Ontology, Simple Event Ontology, Time ontology et Biomolecular Network Ontology.
Conjointement, ces ontologies permettent d'enrichir la modélisation logique des réseaux biomoléculaires
en rajoutant une couche sémantique fournissant les concepts nécessaires à la modélisation du comporte-
ment dynamique et des états de transition d'un réseau biomoléculaire complexe. En particulier, nous
avons développé la Biomolecular Network Ontology (BNO) pour décrire les connaissances du domaine
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des réseaux biomoléculaires complexes et fournir toutes les connaissances et les éléments nécessaires à
la réalisation d'une modélisation intelligente des réseaux biomoléculaires et de leurs changements d'état.
Ces changements d'état sont simulés grâce à un système de raisonnement à base de règles SWRL.
En troisième partie, nous présentons une simulation qualitative à événements discrets, basée sur la
modélisation logique et sémantique, pour simuler qualitativement le réseau biomoléculaire et interpréter
son comportement (ainsi que celui de ses diérents composants moléculaires) dans le temps. Cette
technique de simulation facilite la compréhension, l'analyse et l'interprétation du fonctionnement global
et des propriétés des réseaux biomoléculaires complexes. Elle permet également de simuler ces réseaux
en permettant d'évaluer leur état à tout moment, même en cas d'absence de connaissances quantitatives.
Finalement, dans la quatrième contribution nous proposons une formulation mathématique multi-
objectifs pour optimiser la transitabilité des réseaux biomoléculaires complexes dans laquelle nous prenons
en compte davantage de critères tels que la minimisation de la distance de proximité entre l'état du réseau
obtenu à la n de la simulation et l'état du réseau désiré, du nombre de stimuli externes, la minimisation
du coût de ces stimuli, la minimisation du nombre de n÷uds cibles et la minimisation de l'inconfort
du patient. An de résoudre ce problème, nous avons aussi proposé une approche d'optimisation multi-
objectifs basée sur la combinaison de l'algorithme NSGA-II (Non-dominated Sorting Genetic Algrorithm)
permettant d'obtenir l'ensemble des solutions Pareto-optimales, et de la méthode TOPSIS (Technique for
Order of Preference by Similarity to Ideal Solution) fournissant le meilleur compromis entre les diérents
objectifs du décideur.
En se basant sur les quatre contributions citées précédemment, un prototype logiciel intitulé CBN-
Simulator a été développé. En outre, nous avons évalué ce prototype et ses diérents modules en les
appliquant à divers réseaux biomoléculaires, à savoir, le bactériophage T4 gene 32, le phage lambda et le
réseau de signalisation p53.
Nous avons montré sur les trois études de cas que l'approche de la modélisation logique des réseaux
biomoléculaires complexes démontre et décrit clairement tous les éléments dont nous avons besoin pour
comprendre la structure, la fonction et le comportement de ces réseaux biomoléculaires, mais aussi pour
en étudier leur évolution dynamique dans le temps.
La première étape de la modélisation logique est la construction et la dénition des éléments molécu-
laires des réseaux biomoléculaires complexes. Dans cette modélisation structurelle, les éléments essentiels
des réseaux biomoléculaires sont formalisés en n÷uds qui sont classés en gènes, protéines et métabolites.
Ces n÷uds sont représentés soit par des valeurs booléennes, soit par des valeurs réelles. En fait, les
modèles logiques en biologie des systèmes ont d'abord été développés à partir des réseaux booléens à
partir des travaux de Thomas [357]. Cependant, la modélisation logique proposée n'est pas entièrement
basée sur des modèles booléens. En eet, dans notre modélisation, les n÷uds du réseau biomoléculaire
sont formalisés par des variables booléennes (cas des gènes actifs ou inactifs), mais aussi par des vari-
ables réelles (cas de la concentration des protéines et métabolites). Par conséquent, notre modèle logique
proposé est capable de modéliser à la fois des entités discrètes, qui sont évaluées en {0; 1}, et des entités
continues, qui sont évaluées en domaine réel R. Cette propriété est considérée utile parce qu'elle permet
d'ajouter des clarications et des détails supplémentaires. Ainsi, les résultats fournis par la modélisation
logique proposée, tout en restant qualitatifs, peuvent être plus ns que ceux fournis par la modélisation
booléenne.
Une fois dénis, les n÷uds du réseau sont reliés par des arcs. Ces arcs représentent l'interaction qui
peut se produire entre chaque couple de n÷uds. En eet, la partition des n÷uds du graphe induit une
partition en une série de diérents types d'interactions qui permettent de relier les diérents niveaux
du réseau biomoléculaire. Nous concluons donc que la modélisation logique proposée est un modèle à
plusieurs niveaux. En eet, dans un réseau biomoléculaire, des interactions peuvent se produire entre
des composants moléculaires au même niveau (par exemple des interactions entre gènes) ou entre dif-
férents niveaux (par exemple entre protéines et gènes) formant un système complexe à plusieurs niveaux
spatio-temporels. Par conséquent, la modélisation logique proposée permet de modéliser et d'intégrer les
connaissances biologiques qui existent à diérents niveaux. C'est une tâche dicile et impossible avec
des modèles quantitatifs tels que les équations diérentielles ou les modèles stochastiques, en raison du
nombre élevé de composants moléculaires du réseau biomoléculaire.
De plus, cette propriété a été validée expérimentalement par les études de cas que nous avons présentées
dans la partie validation. Tous nos études de cas sont composées de molécules appartenant à des niveaux
diérents et interagissant les unes avec les autres.
Ainsi, nous constatons que la modélisation basée sur la logique est mieux adaptée pour décrire les
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réseaux biomoléculaires à grande échelle, où les données quantitatives sont incomplètes et où les com-
posantes sous-cellulaires hétérogènes appartenant aux diérents niveaux du réseau peuvent être représen-
tées dans une seule et complète formalisation.
Dans notre modélisation logique, les composantes moléculaires du réseau ne sont pas décrites par des
équations bien dénies comme dans les modèles quantitatifs, mais des règles sont assignées aux com-
posants moléculaires pour étudier les propriétés qui émergent par leur interaction, généralement consid-
érées comme une modélisation fondée sur des règles. Par conséquent, nous notons que cette modélisation
basée sur la logique convient pour décrire des réseaux biomoléculaires à grande échelle avec plusieurs
composantes moléculaires, et qu'elle est beaucoup moins coûteuse en termes de calcul que les modèles
quantitatif et continu.
De plus, la modélisation logique proposée permet de classer les diérents types d'interactions qui
se produisent entre les entités moléculaires. An de clarier les interactions et de préciser la fonction
de chacune d'elles, la modélisation fonctionnelle de de notre modèle vise à associer ces interactions
moléculaires avec les concepts de l'ontologie des interactions proposés par Van Landeghem et al. [4].
En eet, à travers cette ontologie, nous fournissons au modèle logique les connaissances nécessaires et
précises sur les interactions biologiques. Cette fonction supplémentaire permet de dénir précisément
le type d'interaction et la condition qui l'active. Cette précision contribue à la mise en ÷uvre d'un
modèle valide. Ceci est essentiel pour obtenir une modélisation multi-échelles proche de la réalité et pour
minimiser les écarts entre le modèle proposé et les expériences réelles. Cette précision se voit dans la
modélisation des études de cas. La fonction de chaque interaction est précise et clairement dénie.
Selon les études de cas présentées dans le chapitre précédent, la modélisation logique proposée a
démontré son ecacité pour décrire et modéliser l'évolution dynamique du réseau biomoléculaire et
pour reproduire son comportement dans le temps. Cet aspect est assuré par l'utilisation des fonctions
d'agrégation qui calculent les transitions d'état du réseau pendant la simulation. En eet, pour chaque
composant moléculaire, nous dénissons une fonction agrégée qui calcule son évolution en fonction de son
état actuel, de l'état des composants précédents et des caractéristiques de ses interactions entrantes.
Dans notre modélisation logique, les composants moléculaires suivent des règles simples (générale-
ment dénies par des experts biologistes et représentées par les fonctions d'agrégation), mais leurs inter-
actions peuvent induire de nouveaux comportements (phénotypes) à l'échelle du réseau. Ces fonctions
d'agrégations peuvent donc être utilisées pour étudier les comportements émergents dans les réseaux
biomoléculaires complexes. L'avantage est qu'elles peuvent être utilisées pour des réseaux dont les com-
posants moléculaires ne peuvent pas être bien dénis par une équation mathématique précise mais peu-
vent être dénis avec des règles. Plus important encore, ils sont beaucoup plus simples à calculer que les
modèles quantitatifs. Leur seule limite est qu'elles ne sont pas exactes pour la modélisation quantitative.
Les réseaux biomoléculaires complexes sont soumis à de fortes variations dues à des stimuli internes
ou externes. Il est donc dicile de prédire leurs comportements car ils émergent en fonction de leurs
états et de l'état de leur environnement. Un réseau biomoléculaire exposé à des stimuli peut présenter des
comportements qualitativement plus diérents qu'un réseau travaillant sans stimuli. En d'autres termes,
une transition de phase ou un état de transition peut être induit par ces stimuli. Cet aspect a été pris
en compte et étudié dans la modélisation logique. La plupart des modèles mathématiques présentés dans
la littérature ne peuvent représenter et prendre en compte ces stimuli et les changements d'état qu'ils
provoquent.
C'est une caractéristique très importante qui fait la diérence de notre approche logique par rapport
aux autres modèles. Comme le montrent les deuxième et troisième études de cas présentées dans la
partie validation. Le formalisme logique proposé prend en compte et modélise les changements d'état des
réseaux biomoléculaires causés par les stimuli. En eet, le modèle logique proposé tient compte de deux
types de stimuli: les stimuli internes et les stimuli externes. En fait, les changements d'un état moléculaire
peuvent se produire soit par un stimulus interne modélisé par la fonction d'agrégation décrite ci-dessus,
soit par un stimulus externe généré à l'extérieur de la cellule. Nous dénissons donc explicitement cette
notion de stimuli comme un événement qui provoque des changements dans l'état de la molécule sur
laquelle il agit et donc change l'état de l'ensemble du réseau. Ensuite, nous l'intégrons aux fonctions
d'agrégation.
Ce point est très important et permet à la modélisation logique de comprendre la réponse cellulaire en
présence de stimuli externes ou internes, de comprendre le mode d'action des médicaments (par stimuli)
et de prédire le comportement des réseaux biomoléculaires complexes en réponse aux médicaments. Ceci
a été prouvé par la troisième étude de cas, le réseau de réponse aux dommages de l'ADN à médiation p53,
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basé sur cette modélisation logique, le CBNSimulator a simulé et géré avec succès les états de transition
du réseau de l'état normal à l'état apoptose et/ou de l'état normal à l'état d'arrêt. Cette étude de cas
souligne le fait que notre modélisation basée sur la logique peut également être utilisée pour modéliser et
comprendre la relation et le mode d'action entre la conception des médicaments et la modélisation des
réseaux biomoléculaires.
En conclusion, cette modélisation logique permettra aux biologistes de produire des modèles formels
des réseaux biomoléculaires puis de les simuler sur ordinateur. Toutes les propriétés discutées ici ont
été validées expérimentalement dans la partie validation. En eet, les études de cas ont été formalisées
dans le cadre de la modélisation fondée sur la logique et simulées dans le simulateur CBNSimulator. Le
premier exemple de réseau, le bactériophage T4 gene 32 est choisi pour sa simplicité, il est assez simple
pour être calculé mentalement an de juger facilement des résultats produits. Cependant, pour les deux
autres exemples, nous validons leur modélisation par comparaison avec les résultats d'autres travaux.
Nous concluons que la modélisation logique fournit tous les éléments nécessaires à la formalisation et à
la simulation des comportements et des états de transition de ces réseaux biomoléculaires. Ce modèle
logique fournit un formalisme formel et mathématique pour modéliser et simuler la structure complexe des
réseaux biomoléculaires, l'eet des stimuli qui ciblent certains composants moléculaires, et la simulation
de l'évolution dynamique de leurs comportements.
Comme nous l'avons vu, il n'existe pas de meilleure approche pour évaluer une ontologie. Pour cette
raison, nous vérions l'ontologie BNO avec diérentes approches. Tout d'abord, nous nous concentrons
en particulier sur la validation automatisée de l'ontologie, qui est une condition préalable nécessaire
au développement sain d'une ontologie. La vérication automatisée de la cohérence a été eectuée par
l'intermédiaire du raisonneur Hermit. Sur la base des commentaires du raisonneur, les incohérences ont
été corrigées de manière itérative tout au long du processus de développement de l'ontologie BNO. Les
résultats naux obtenus par le raisonneur étaient statistiquement signicatifs et ont révélé qu'il n'y avait
pas d'incohérences dans l'ontologie BNO.
L'ontologie BNO a également été évaluée selon diérents critères en termes de précision, d'adaptabilité,
de clarté, d'exhaustivité, etc. Pour chaque critère, l'ontologie BNO est évaluée comme suit. (1) Précision:
Les dénitions et les descriptions de l'ontologie correspondent aux connaissances des experts dans ce
domaine. Les informations concernant les concepts de l'ontologie BNO ont été développées à partir de
la célèbre ontologie génétique (Gene Ontology). De plus, nous avons obtenu l'aide et l'expertise de nos
collaborateurs de l'équipe du CSTB qui ont évalué l'ontologie BNO et conclu qu'elle ne contient pas
d'erreurs sémantiques, d'incohérences logiques et de conits conceptuels. (2) Adaptabilité: Nous avons
opté pour le développement de l'ontologie BNO dans le cadre d'une architecture sémantique globale
composée de cinq ontologies reliées entre elles : l'ontologie génique (Gene Ontology), l'ontologie des
interactions biologiques (Interaction Ontology), l'ontologie de la modélisation des évènements (Simple
Event Model Ontology), l'ontologie du temps (Time Ontology) et celle que l'on a développée l'ontologie
BNO. Cette architecture vise à aligner et fusionner l'ontologie BNO avec le reste des ontologies à travers
les relations d'équivalence owl:equivalenceClass ou de spécialisation owl:subclassOf. Ce choix améliore
l'extensibilité, la réutilisabilité et rend l'ontologie BNO facilement adaptable aux contextes dynamiques
des réseaux biomoléculaires. (3) Clarté: Lors de l'élaboration de l'ontologie BNO, nous avons pris soin
d'attribuer une description claire et non ambiguë pour dénir et catégoriser les concepts et les relations
qui existent entre eux. Cette clarté est assurée par l'utilisation du rdfs:comment qui permet d'annoter
une ontologie. De cette manière, l'ontologie BNO communique ecacement le sens voulu de ses termes.
(4) Complétude: Ce critère détermine si l'ontologie peut répondre à toutes les questions auxquelles elle
est supposée être en mesure de répondre. Il fournit une estimation de la façon dont l'ontologie BNO
représente le domaine des réseaux biomoléculaires complexes et leur transitabilité. Ces questions ont été
précisées par les biologistes experts de l'équipe CSTB et il a été vérié qu'il est possible d'y répondre
à toutes ces questions. (5) Ecacité informatique: Une ontologie peut être analysée par un système
d'inférence. Dans notre cas, l'ontologie BNO a été analysée par les deux mécanismes de raisonnement
Hermit et Pellet. Nous avons conclu que le raisonnement sur l'ontologie BNO est cohérent et permet des
inférences dans un délai raisonnable. De plus, la complexité de cette opération est adéquate en terme de
temps de raisonnement. (6) Concision: Les termes de l'ontologie BNO ont été vériés sous l'assistance
d'experts biologistes qui ont vérié que l'ontologie ne contient pas de termes redondants. De plus,
nous avons utilisé l'outil OntOlogy Pitfall Scanner http://oops.linkeddata.es/advanced.jsp pour
vérier que l'ontologie BNO est logiquement correcte. Les résultats d'analyse ont prouvé l'exactitude
de l'ontologie BNO. (7) Consistance: Ce critère garantit que les axiomes logiques de l'ontologie sont
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satisfaisants et cohérents. La satisfaction des axiomes logiques est constatée lorsqu'il est impossible de
trouver une contradiction entre les axiomes. Comme nous l'avons expliqué précédement, les raisonneurs
OWL et SWRL n'ont détecté aucune incohérence. Aucune incohérence ou violation n'a été constatée.
La combinaison de ces critères nous permet de contrôler l'ontologie BNO à partir de diérents niveaux.
Les résultats naux de la validation fondée sur des critères ont indiqué que l'ontologie BNO était claire,
extensible et complète.
De plus, nous évaluons l'utilité de l'ontologie BNO à travers la validation des connaissances expertes.
L'ontologie BNO a été utilisée pour modéliser notre ensemble d'études de cas. Les résultats ont prouvé
que l'ontologie BNO est capable de déduire les principaux concepts des études de cas et leurs propriétés
et est capable de déduire de nouvelles connaissances telles que le calcul de l'état suivant des composants
moléculaires.
Ces résultats ont prouvé que l'ontologie BNO est capable de décrire et de modéliser la transitabilité
d'un réseau biomoléculaire. Cependant, il est important de noter que l'ontologie BNO ne peut pas
modéliser la transitabilité des réseaux à grande échelle, et que des outils de simulation plus ecaces
devraient être utilisés pour étudier les réseaux plus importants.
L'approche de simulation sémantique proposée a produit une simulation de bonne qualité (ecace) et
un raisonnement rapide du comportement de ces réseaux biomoléculaires. Le raisonneur à base de règles
SWRL est capable de reproduire le comportement global de ces réseaux biomoléculaires grâce aux règles
SWRL dénies par les biologistes experts. Comme il a été montré dans la partie validation, ce raisonneur
reproduit des comportements similaires à ceux observés par les biologistes in vivo.
Le CBNSimulateur est équipé d'un simulateur qualitatif à événements discrets. Ce simulateur per-
met de simuler in silico le comportement des réseaux biomoléculaires complexes. Il simule et teste les
diérents changements d'état des réseaux biomoléculaires dans diverses conditions expérimentales. Le
simulateur qualitatif à événements discrets proposé peut également aider les biologistes à découvrir et
à détecter les stimuli qui régulent le réseau biomoléculaire, comme les eets des médicaments sur un
réseau biomoléculaire. Comme on a pu le conclure au chapitre 4, les techniques de simulation peuvent
être classées en deux catégories: les techniques quantitatives et qualitatives. La simulation quantitative
fournit la prédiction la plus précise pour décrire le comportement d'entités moléculaires spéciques.
Néanmoins, le manque de données quantitatives limite son utilisation à des études de cas spéciques
(lorsque toutes les données quantitatives requises sont disponibles), mais ne peut être utilisé dans des
réseaux plus généraux ou à grande échelle. D'autre part, la simulation qualitative simplie la simulation
réelle du réseau biomoléculaire et est généralement capable de reproduire le comportement du réseau.
De plus, cette simulation qualitative peut être utilisée pour expliquer et prédire le comportement et les
changements d'état du biomoléculaire et de ses composantes au moyen de simulations discrètes. En rai-
son du manque de données quantitatives, diverses techniques de simulation qualitative ont été proposées
dans la littérature, mais la plupart d'entre elles ne peuvent soutenir la simulation de réseaux biomolécu-
laires complexes et multiniveaux. En outre, la plupart d'entre eux sourent du manque d'automatisation
dans la simulation des propriétés biomoléculaires. Le simulateur que l'on propose est diérent des tech-
niques existantes. En eet, il est entièrement basé sur une modélisation logique. Par conséquent, la
puissance de ce simulateur est essentiellement due à l'ecacité de la modélisation basée sur la logique
des réseaux biomoléculaires complexes qui est susamment expressive pour intégrer et capturer les dif-
férents éléments et propriétés qualitatives nécessaires pour comprendre le comportement dynamique et les
changements d'état des réseaux biomoléculaires. Mais aussi, dans la représentation et la simulation des
réseaux biomoléculaires multi-niveaux. Ainsi, la simulation qualitative à événements discrets proposée
permet de simuler des réseaux biomoléculaires complexes et multiniveaux. Cette propriété a été vériée
à travers les diérentes études de cas du chapitre précédent. Toutes les études de cas sont composées de
composants moléculaires et d'interactions appartenant à un niveau diérent au sein du réseau biomolécu-
laire. De plus, la simulation qualitative à événements discrets que nous proposons est capable d'eectuer
une simulation automatique et ecace des réseaux biomoléculaires.
En eet, le noyau de simulation repose sur un système discret basé sur les événements (le formalisme
DEVS), qui est utilisé comme un outil de simulation ecace et précis des systèmes complexes à diérents
niveaux d'abstraction. Cela permet de garantir des méthodes de mise à jour synchrones et asynchrones
pour la simulation. En l'absence de perturbations, le simulateur dénit les états initiaux des composants
moléculaires et le temps initial, puis met à jour l'état de tous les composants en même temps. Cette
synchronisation est basée sur les règles d'interactions (fonctions agrégées) dénies par le biologiste. C'était
le cas des première et deuxième étude de cas du chapitre précédent. Cependant, la simulation asynchrone
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tient compte des diérentes perturbations causées par les stimuli. Lorsque certains stimuli aectent
certains composants moléculaires, le simulateur met à jour l'état de ces composants puis synchronise
l'état des autres composants. C'est ce que nous avons expérimenté dans la troisième étude de cas du
chapitre précédent. Un autre avantage du mécanisme de simulation qualitative proposé est qu'il n'exige
pas de données quantitatives précises, mais encore plus il permet de simuler le comportement des réseaux
biomoléculaires en utilisant uniquement des données qualitatives. Ce mécanisme de simulation est bien
adapté pour simuler et analyser des réseaux biomoléculaires à grande échelle, même en l'absence de
données quantitatives. Ce mécanisme qualitatif proposé a été vérié et illustré pour l'exemple du gène
32 du bactériophage T4. Le mécanisme de simulation repose sur l'élaboration d'un graphe causal dont
les n÷uds sont des variables (représentant les composants moléculaires du réseau) concernées par cette
simulation et les arcs sont des relations de causalité entre ces variables (représentant les interactions entre
les composants moléculaires). L'état du réseau biomoléculaire est décrit par quelques valeurs qualitatives
distinctes correspondant à des valeurs quantitatives précises (appelées l'espace de quantité). Pour calculer
la valeur qualitative des n÷uds, ce mécanisme est basé à la fois sur les règles de partition et les règles de
propagation. Ces règles sont utilisées pour calculer la valeur de la variable cible au moment suivant (t+1)
en fonction de sa valeur qualitative au moment actuel (t) et de la valeur des n÷uds de ses prédécesseurs
en ce moment(t). L'application de la simulation qualitative à l'exemple donné montre que le mécanisme
de simulation qualitative proposé est capable de modéliser et de simuler des réseaux biomoléculaires
complexes en prédisant leurs diérents comportements pour diérentes contraintes de simulation.
En conclusion, la simulation qualitative à événements discrets eectuée par le simulateur CBNSimu-
lator peut être utilisée pour élucider et prédire le comportement, les changements d'état et les propriétés
des réseaux biomoléculaires complexes. De plus, le simulateur ache les diérents états de chaque com-
posant moléculaire sous une forme graphique facile à interpréter. Nous avons testé ce simulateur sur
les trois études de cas. Les résultats montrent la simulation des performances du simulateur proposé
dans la modélisation et la simulation de réseaux biomoléculaires complexes multi-échelles dans diérentes
conditions environnementales et en considérant les perturbations causées par des stimuli externes.
Bien que le simulateur proposé présente de nombreux avantages, il a le potentiel d'apporter d'autres
améliorations importantes. En eet, la simulation qualitative proposée ne permet pas de préciser les
diérentes échelles de temps. Ceci peut être considéré comme la limite principale de notre simulation
qualitative à événements discrets. Cependant, nous espérons améliorer notre simulateur en travaillant
sur ce point. Cette orientation future est décrite en détail dans la section perspective de la partie
suivante. De plus, l'intégration de cette simulation qualitative à événements discrets avec un autre outil
de simulation quantitative continue permettrait d'augmenter les performances et d'obtenir un simulateur
semi-quantitatif incluant les avantages des simulations qualitatives et quantitatives. C'est l'une des
orientations possibles pour l'avenir de ce travail.
L'optimisation de la transitabilité des réseaux biomoléculaires complexes est l'un des principaux objec-
tifs du CBNSimulator. En eet, comme indiqué précédemment, seules quelques études se sont concentrées
sur ce problème et la plupart l'ont considéré comme un problème d'optimisation mono-objectif et ont
négligé tout autre critère pour le pilotage de ces réseaux biomoléculaires. Ces recherches se concentrent
uniquement sur la minimisation du nombre de n÷uds nécessaires pour piloter le réseau et/ou sur la
minimisation du nombre de stimuli externes à appliquer sur le réseau. Cependant, même si ces deux
critères sont des conditions nécessaires, ils ne sont pas susants pour piloter complètement des réseaux
biomoléculaires complexes. En eet, cette hypothèse n'est pas toujours réaliste, car le pilotage de réseaux
biomoléculaires complexes est en général un problème d'optimisation multi-objectifs. Il faut trouver des
compromis appropriés entre divers objectifs, comme la minimisation de la distance entre l'état nal simulé
du réseau et l'état souhaité du réseau, la minimisation du nombre de stimuli externes, la minimisation
du coût de ces stimuli, la minimisation du nombre de n÷uds cibles et la minimisation de l'inconfort du
patient.
C'est pourquoi, dans ce domaine, nous proposons d'abord une formulation mathématique multi-
objectifs pour optimiser la transitabilité des réseaux biomoléculaires complexes dans laquelle nous prenons
en compte davantage de critères tels que la minimisation de la distance entre l'état nal simulé du réseau
et l'état souhaité du réseau, la minimisation du nombre de stimuli, la minimisation du coût de ces stimuli,
la minimisation du nombre de n÷uds cibles, et la minimalisation de l'inconfort du patient. En eet, ces
cinq objectifs sont les piliers fondamentaux pour piloter avec succès l'état des réseaux biomoléculaires.
Le premier objectif qui est le plus important est la minimisation de la distance entre l'état nal simulé
du réseau et l'état souhaité du réseau. Cet objectif est assuré par le simulateur et consiste à calculer la
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distance entre le réseau obtenu et le réseau souhaité. Cet objectif vise à fournir un réseau simulé aussi
proche que possible du réseau souhaité. Le second vise à identier le nombre minimum de stimuli les plus
susceptibles de faire passer le réseau biomoléculaire global de l'état initial à l'état souhaité. En d'autres
termes, ce critère vise à donner la priorité à la qualité des stimuli externes sur leur quantité.
En eet, ces cinq objectifs sont les piliers fondamentaux pour piloter avec succès l'état des réseaux
biomoléculaires. Le premier objectif qui est le plus important est la minimisation de la distance entre
l'état nal du réseau simulé et l'état souhaité du réseau. Cet objectif est assuré par le simulateur et
consiste à calculer la distance entre le réseau obtenu et le réseau souhaité. Il vise à fournir un réseau
simulé aussi proche que possible du réseau souhaité. Le second objectif vise à identier le nombre
minimum de stimuli les plus susceptibles de faire piloter le réseau biomoléculaire de l'état initial à l'état
souhaité. En d'autres termes, ce critère vise à donner la priorité à la qualité des stimuli externes par
rapport à leur quantité. Le troisième objectif est étroitement lié à la fonction du premier objectif et vise
à minimiser le coût total des stimuli externes à appliquer aux composants du réseau. En fait, le coût
des stimuli externes peut être associé au nombre de stimuli externes. Ainsi, si nous avons un nombre de
stimuli externes égal au nombre de n÷uds et que tous les stimuli externes ont le même coût, le processus
de transitabilité du réseau biomoléculaire complexe sera très coûteux. C'est pourquoi ce critère vise à
trouver le meilleur compromis entre la qualité des stimuli externes et leur coût. Le quatrième objectif vise
à identier l'ensemble minimal de n÷uds devant être aectés par les stimuli externes. En eet, plusieurs
études ont révélé que, parmi tous les n÷uds composant le réseau biomoléculaire, il existe des n÷uds
spéciques qui ont la capacité de faire passer le réseau de son état actuel à un autre état spécique. De
plus, la stimulation de tous les n÷uds du réseau peut exposer le patient au risque de développer des eets
indésirables supplémentaires causés par les stimuli externes tels que l'irradiation ultraviolette. Ainsi, au
lieu de stimuler tous les n÷uds au hasard, il est préférable d'avoir une stratégie de stimulation qui cible
un ensemble de n÷uds spéciques. Cela permettra de ne stimuler qu'un nombre minimum de n÷uds,
permettant ainsi la transition du réseau vers l'état désiré. Ensuite, le cinquième objectif vise à réduire
l'inconfort du patient lors d'un certain traitement (tout en trouvant le meilleur compromis avec les autres
fonctions objectives citées précédemment). Dans notre contexte, l'inconfort du patient englobe diérents
aspects tels que la douleur, le stress, les vomissements, les étourdissements, l'anxiété, la fatigue, etc.
En eet, la transitabilité d'un réseau biomoléculaire peut être potentiellement inconfortable et avoir un
impact négatif sur la santé émotionnelle et mentale des patients, sur leur qualité de vie et sur l'utilisation
des ressources médicales. Pour toutes ces raisons, nous devons tenir compte de cet important critère dans
le processus de transitabilité.
Il est important de mentionner que le premier et le troisième objectif ont été déjà utilisés dans la
littérature pour le pilotage des réseaux biomoléculaires. Cependant, pour le deuxième et quatrième
objectifs, nous les avons ajoutés après une longue discussion avec des experts biologistes et parce qu'ils
sont essentiels pour atteindre la transitabilité des réseaux biomoléculaires.
De plus, nous proposons une approche d'optimisation multi-objectifs en deux étapes pour résoudre ce
problème multi-objectifs. Notre approche proposée est fortement basée sur la combinaison de l'algorithme
génétique NSGA-II (Non-Dominated Sorting Genetic Algorithm II) pour obtenir l'ensemble des solutions
de Pareto-optimal, et de la méthode TOPSIS (Technique d'ordre de préférence par similarité de solution
idéale) pour fournir au décideur la meilleure solution en fonction de ses préférences.
L'algorithme génétique NSGA-II est l'un des algorithmes génétiques les plus utilisés pour les prob-
lèmes multi-objectifs. Ainsi, nous pensons qu'il est intéressant pour nous de choisir et d'adapter cet
algorithme à la problématique du pilotage de réseaux biomoléculaires complexes. En nous basant sur les
résultats obtenus, nous concluons que le NSGA-II est bien adapté pour résoudre la problématique de la
transitabilité des réseaux biomoléculaires complexes en tant que problème d'optimisation multi-objectif.
En eet, il est capable de trouver un ensemble de solutions non dominées en un seul essai. Cependant,
même si les résultats obtenus sont satisfaisants et positifs, il est possible de faire davantage. En eet, nous
n'avons pas testé notre problème d'optimisation avec d'autres méthodes. Il est peut-être recommandé
d'améliorer les paramètres NSGA-II et pourquoi pas de résoudre le problème avec d'autres heuristiques
d'optimisation dans le but de comparer et d'améliorer les solutions obtenues. Il s'agit là d'un travail
futur. De plus, il est important de noter que ce travail d'optimisation de la transitabilité des réseaux
biomoléculaires complexes en est encore à ses débuts dans la littérature. Il n'existe pas d'autres travaux
traitant la même problématique à partir d'outils d'optimisation, et il n'existe pas encore d'évaluation.
Nous ne comparons nos résultats qu'en fonction des travaux de Wu et al. [6] et de Zhang et al. [356].
Cette approche proposée a été testée et appliquée pour résoudre le pilotage du réseau de la régulation
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de la protéine p53 face aux dommages de l'ADN suite à des stimuli exteres  the p53-mediated DNA
damage response network  dans le but d'optimiser simultanément les diérents critères impliqués dans
sa transitabilité, en particulier la distance entre l'état nal du réseau simulé et celui souhaité, le nombre
de stimulus externes, leur coût, le nombre de points cibles et les gênes pour le patient. Nous utilisons
cet exemple parce qu'il a trois états appelés aussi phénotypes : l'état normal, l'apoptose et l'état d'arrêt.
Cette étude de cas a déjà été étudiée et simulée dans les travaux de Wu et al. [6] et Zhang et al.
[356], ce qui nous permet de comparer nos résultats en référence à leur résultat. En eet, nos résultats
sont en accord avec les résultats obtenus par ces deux derniers. Nous avons réussi à trouver le meilleur
compromis entre les diérents critères de transitabilité et à optimiser le pilotage du réseau biomoléculaire
de l'état normal à l'état souhaité (apoptose ou arrêt). Les résultats expérimentaux illustrent l'ecacité de
cette approche dans l'optimisation de toutes les fonctions objectives. L'approche d'optimisation multi-
objectifs proposée a permis de résoudre avec succès ce problème tout en fournissant un ensemble de
solutions optimales au problème de la tranitabilité des réseaux biomoléculaires complexes. La solution
optimale rendu à l'utilisateur est sélectionnée en fonction des préférences de l'utilisateur par la technique
TOPSIS.
Nous avons comparé les résultats obtenus avec les travaux les plus représentatifs proposés pour le pi-
lotage des réseaux biomoléculaires en utilisant la notion de contrôlabilité de la littérature. Nous notons que
l'approche proposée (et qui est en accord avec les résultats de Wu et al. [6]) propose d'aecter l'ensemble
minimal de n÷uds (pas tous les n÷uds) plutôt que l'ensemble des n÷uds des réseaux biomoléculaires.
Par conséquent, l'approche proposée fournit moins de stimuli externes que le nombre total de n÷uds du
réseau et, par conséquent, le coût total de ces stimuli sera certainement moins coûteux que l'utilisation
de la notion de contrôlabilité. De plus, la méthode proposée considère également la minimisation de
l'inconfort du patient comme un objectif primordial à atteindre. Cela accroît l'applicabilité de la médecine
translationnelle pour améliorer la santé et les maladies humaines, y compris les facteurs génétiques et
environnementaux du bien-être du patient. C'est une excellente occasion de comprendre les maladies et
de trouver de nouveaux diagnostics et traitements.
Par conséquent, les applications de l'approche d'optimisation proposée peuvent être utilisées dans la
conception de traitements médicamenteux tels que la chimiothérapie, l'identication de cibles médica-
menteuses potentielles dans un réseau de signalisation du cancer humain ou l'étude des transitions phéno-
typiques (par exemple, pour diriger un réseau biomoléculaire depuis son phénotype anormal ou malade
vers un phénotype sain).
Bien que les résultats de cette thèse soient satisfaisant et répondent à l'objectif attendu: le fait de
pourvoir proposer une plate-forme qui permet aux biologistes de simuler les changements d'état des
réseaux biomoléculaires dans le but de piloter leurs comportements et de les faire évoluer d'un état non
désiré vers un état souhaitable, néanmoins un eort important reste à faire an d'améliorer la qualité des
services proposés par cette plate-forme.
En eet, les contributions présentées dans cette thèse ouvrent plusieurs orientations de recherche. Par
exemple:
• Il sera intéressant d'étudier les interactions pouvant avoir lieu entre le niveau métabolique et le
niveau génétique. Comme mentionné dans le sixième chapitre, la modélisation logique que nous
proposons n'inclut pas les interactions entre les métabolites et les gènes, bien que l'on sache que
certains métabolites spéciques, comme la nicotine, interagissent directement avec les gènes. Une
perspective possible à explorer est d'étendre la modélisation logique dans le but d'intégrer et de
considérer cette hypothèse.
• Il sera intéressant de pouvoir étendre l'approche sémantique sur d'autres domaines proches de la
transitabilité telque le domaine des médicaments biologiques an de découvrir les diérents types
de molécules sur lesquelles agissent ces médicaments. Une question intéressante que nous étudions
actuellement est le problème de l'extension de l'approche sémantique présentée dans cette thèse en
l'appliquant à de grands réseaux biomoléculaires et en améliorant sa performance an de l'appliquer
dans le domaine de la découverte des médicaments biologiques. Ceci peut être résolu en alignant
l'ontologie BNO avec d'autres ontologies et en les ajoutant à notre approche sémantique.
• Il sera intéressant d'étudier les diérentes échelles de temps au sein du réseau biomoléulaire. En eet,
les composantes du réseau biomoléculaire et leurs interactions sont organisées temporellement: de
la nano-seconde au niveau des molécules individuelles, à la micro-seconde au niveau de l'interaction
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des protéines, aux heures au niveau des processus cellulaires, etc. Dans ce travail, pour des raisons
de simplicité, nous prenons en compte l'aspect multi-échelle du réseau, mais nous ne considérons
pas les diérentes échelles de temps biologiques. Nous négligeons cette propriété et travaillons à
l'intérieur d'une échelle de temps xe. Pour faire face à cette limite, nous devons améliorer notre
modélisation en incluant un générateur de temps qui permet de suivre la dynamique du système et
de changer entre diérents niveaux de temps en fonction du niveau spatial donné et de la nature
du processus.
• Il sera interessant d'améliorer l'optimisation de la transitabilité des réseaux biomoléculaires com-
plexes. Cette dernière approche necessite d'améliorer et de détailler certaines fonctions objectives
telle que l'inconfort du patient. Dans l'approche proposée la minimisation de l'inconfort du pa-
tient prends en compte divers crières tels que la minimisation des douleurs, la panique, etc. Nous
souhaitons expliciter ce critère et le détailler an de donner plus de clarté à la transitabilité du
réseau. Nous prévoyons également d'améliorer les performances de l'algorithme NSGA-II en im-
plémentant une hybridation avec un algorithme de recherche local, comme la méthode simplex de
Nelder-Mead an d'améliorer le temps de calcul de notre algorithme d'optimisation et la qualité
des solutions.
• Il sera intéressant d'améliorer le prototype CBNSimulator. Cette amélioration portera sur la syn-
chronisation des dierents modules de la plate-forme. En eet, nous travaillons actuellement à
rendre plus dynamique la synchronisation entre les quatre modules du CBNSimulator dans le but
d'améliorer sa performance. En outre, nous prévoyons d'étendre les expériences an d'évaluer et
d'analyser plus en détail l'impact de nos diérentes propositions sur des réseaux biomoléculaires
plus complexes. En eet, les études de cas que nous avons utilisé ne susent pas pour évaluer et
valider complètement nos approches, ainsi de nouvelles expériences pourraient être réalisées dans le
cadre de l'application du CBNSimulateur. De plus, une amélioration des interfaces de la plate-forme
sont nécessaires pour pouvoir la rendre plus simple et plus générique aux biologistes.
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Ali AYADI
Approches sémantiques pour la méta-optimisation des réseaux biomoléculaires
complexes
Résumé :
Les modèles de la biologie des systèmes visent à comprendre le comportement d’une cellule à travers un réseau
biomoléculaire complexe. Dans a littérature, la plupart des études ne se sont intéressés qu’à la modélisation des
parties isolées du réseau biomoléculaire com les réseaux métaboliques, etc. Cependant, pour bien comprendre
le comportement d’une cellule, nous devons modéliser et analyser le réseau biomoléculaire dans son ensem-
ble. Les approches existantes ne répondent pas suffisamment à ces exigences. Dans ce projet de recherche,
nous proposons une plate-forme qui permet aux biologistes de simuler les changements d’état des réseaux
biomoléculaires dans le but de piloter leurs comportements et de les faire évoluer d’un état non désiré vers un
état souhaitable. Cette plate-forme utilise des règles, des connaissances et de l’expérience, un peu comme celles
que pourrait en tirer un biologiste expert. La plate-forme comprend quatre modules : un module de modélisation
logique, un module de modélisation sémantique, un module de simulation qualitative à événements discrets et
un module d’optimisation. Dans ce but, nous présentons d’abord une approche logique pour la modélisation des
réseaux biomoléculaires complexes, incluant leurs aspects structurels, fonctionnels et comportementaux. En-
suite, nous proposons une approche sémantique basée sur quatre ontologies pour fournir une description riche
des réseaux biomoléculaires et de leurs changements d’état. Ensuite, nous présentons une méthode de simu-
lation qualitative à événements discrets pour simuler le comportement du réseau biomoléculaire dans le temps.
Enfin, nous proposons une méthode d’optimisation multi-objectifs pour optimiser la transitabilité des réseaux
biomoléculaires complexes dans laquelle nous prenons en compte différents critères tels que la minimisation du
nombre de stimuli externes, la minimisation du coût de ces stimuli, la minimisation du nombre de nœuds cibles
et la minimisation de l’inconfort du patient. En se fondant sur ces quatre contributions, un prototype appelé CBN-
Simulateur a été développé. Nous décrivons nos approches et montrons leurs applications sur des études de cas
réels, le bactériophage T4 gene 32, le phage lambda et le réseau de signalisation p53. Les résultats montrent
que ces approches fournissent les éléments nécessaires pour modéliser, raisonner et analyser le comportement
dynamique et les états de transition des réseaux biomoléculaires complexes.
Mots clés : Transittabilité, modélisation logique, raisonnement sémantique, simulation qualitative à événements
discrets, comportement dynamique des réseaux biomoléculaires complexes
Semantic approaches for the meta-optimization of complex biomolecular networks
Abstract :
Systems biology models aim to understand the behaviour of a cell trough a complex biomolecular network. In
the literature, most research focuses on modelling isolated parts of this network, such as metabolic networks.
However, to fully understand the cell’s behaviour we should analyze the biomolecular network as a whole. Avail-
able approaches do not address these requirements sufficiently. In this context, we aim at developing a platform
that enables biologists to simulate the state changes of biomolecular networks with the goal of steering their be-
haviours. The platform employs rules, knowledge and experience, much like those that an expert biologist might
derive. This platform consists of four modules: a logic-based modelling module, a semantic modelling module,
a qualitative discrete-event simulation module and an optimization module. For this purpose, we first present a
logic-based approach for modelling complex biomolecular networks including the structural, functional and be-
havioural aspects. Next, we propose a semantic approach based on four ontologies to provide a rich description
of biomolecular networks and their state changes. Then, we present a method of qualitative discrete-event simu-
lation to simulate the biomolecular network behaviour over time. Finally, we propose a multi-objective optimization
method for optimizing the transittability of complex biomolecular networks in which we take into account various
criteria such as minimizing the number of external stimuli, minimizing the cost of these stimuli, minimizing the
number of target nodes and minimizing patient discomfort. Based on these four contributions, a prototype called
the CBNSimulator was developed. We describe our approaches and show their applicability through real cases
studies, the bacteriophage T4 gene 32, the phage lambda, and the p53 signaling network. Results demonstrate
that these approaches provide the necessary elements to model, reason and analyse the dynamic behaviour and
the transition states of complex biomolecular networks.
Keywords : Transittability, logical-based modelling, semantic reasoning, qualitative discrete-event simulation, dy-
namic behaviour of complex biomolecular networks
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